data_2n2r_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n2r _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt . . . . . 0 CA--C 1.513 -0.458 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.9 mt -108.21 127.77 54.13 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.249 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.4 p -108.87 141.83 40.35 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.463 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 3.9 pt20 -96.71 144.13 27.0 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -174.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 -147.58 114.17 4.07 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -75.36 -39.02 1.21 Allowed 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.096 1.864 . . . . 0.0 114.728 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.2 m -94.4 139.37 31.2 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -172.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.7 -86.29 0.1 Allowed Glycine 0 N--CA 1.411 -3.025 0 N-CA-C 107.808 -2.117 . . . . 0.0 107.808 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.438 HG22 ' OE2' ' A' ' 29' ' ' GLU . 10.2 t -101.31 -33.72 9.92 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-O 121.263 0.554 . . . . 0.0 110.65 178.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.591 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 60.9 t90 -72.74 140.32 47.72 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.396 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.7 m -160.46 110.38 1.77 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.581 1.552 . . . . 0.0 107.588 170.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.19 -121.12 2.13 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.795 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -120.71 171.06 9.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 C-N-CA 122.977 0.511 . . . . 0.0 110.127 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.62 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 31.6 t -96.42 99.17 10.86 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 176.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.26 -71.27 1.14 Allowed Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.714 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -127.54 133.5 49.8 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -53.42 -56.76 14.16 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 124.369 1.043 . . . . 0.0 110.777 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.42 -34.26 77.35 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.411 -174.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.33 -60.0 3.7 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 124.04 0.837 . . . . 0.0 111.524 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.5 p -74.11 -23.53 59.33 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.763 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -55.53 -56.95 14.27 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 172.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -60.43 -41.39 93.91 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.973 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -60.1 -41.67 93.05 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.848 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 76.8 m -62.86 -56.49 16.91 Favored 'General case' 0 C--O 1.253 1.272 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 61.2 mt -53.24 -36.86 26.74 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.578 -176.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -78.9 -41.55 29.36 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.68 -62.72 1.41 Allowed 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.84 -168.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.438 ' OE2' HG22 ' A' ' 10' ' ' THR . 10.9 pt-20 -93.9 -6.88 44.63 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.532 0.682 . . . . 0.0 110.213 -176.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 56.6 mttp 64.19 66.84 0.61 Allowed 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 113.758 -1.564 . . . . 0.0 112.589 175.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.71 -178.91 4.69 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 113.363 -1.744 . . . . 0.0 108.189 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -102.79 -29.5 11.44 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.424 0.63 . . . . 0.0 109.894 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -152.63 179.54 8.51 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.06 139.58 4.48 Favored Glycine 0 C--N 1.302 -1.311 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.4 m -161.5 173.68 14.49 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 118.417 1.108 . . . . 0.0 111.762 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.6 m -75.05 102.22 4.79 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.311 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 . . . . . 0 C--N 1.29 -1.997 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.28 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.8 mttp . . . . . 0 N--CA 1.44 -0.96 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.62 ' SG ' ' HA ' ' A' ' 15' ' ' CYS . 78.0 m -79.25 104.97 10.24 Favored 'General case' 0 CA--C 1.479 -1.757 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.461 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 22.0 mm -103.48 129.82 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.761 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 60.1 m -84.61 136.9 33.57 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.463 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 76.9 m-85 -110.4 123.44 49.88 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-O 121.394 0.616 . . . . 0.0 110.957 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -105.99 157.65 34.27 Favored Pre-proline 0 C--N 1.283 -2.311 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.166 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -77.41 116.15 4.05 Favored 'Trans proline' 0 N--CA 1.435 -1.939 0 C-N-CA 121.548 1.499 . . . . 0.0 111.404 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 95.0 m . . . . . 0 C--N 1.282 -2.367 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.358 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.0 tttt . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 90.5 mt -89.08 99.88 12.77 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.78 0.8 . . . . 0.0 110.128 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.9 m -86.07 112.28 21.11 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.971 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -73.99 136.38 43.18 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.868 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -145.17 115.26 5.0 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -68.7 -73.31 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.683 2.255 . . . . 0.0 115.776 -176.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.9 m -90.29 97.36 11.14 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -170.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -119.92 -73.62 0.39 Allowed Glycine 0 N--CA 1.422 -2.234 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 168.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.434 HG23 ' OE2' ' A' ' 29' ' ' GLU . 8.7 t -108.25 -26.53 10.51 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 173.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.649 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 20.2 t90 -62.17 136.07 57.78 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-O 121.252 0.549 . . . . 0.0 112.3 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -157.4 108.22 2.27 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.288 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.31 -157.57 22.78 Favored Glycine 0 N--CA 1.431 -1.675 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.806 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.67 149.3 4.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 33.7 t -83.76 123.85 30.29 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.77 -64.26 0.88 Allowed Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.211 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -122.5 126.16 47.26 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -54.85 -47.72 73.79 Favored 'General case' 0 C--O 1.207 -1.162 0 O-C-N 123.903 0.752 . . . . 0.0 110.066 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -62.27 -40.5 96.44 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.704 -177.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.28 -47.06 65.68 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.54 -177.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.5 p -73.35 -34.48 65.65 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.5 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.403 ' HG3' ' N ' ' A' ' 34' ' ' GLY . 39.9 ttpt -55.33 -54.43 43.68 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.571 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 48.2 t30 -56.69 -46.74 81.02 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.228 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -56.2 -41.87 76.27 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.498 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.3 m -62.46 -51.97 65.39 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.6 mt -58.24 -35.7 54.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.08 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 9.3 mmp_? -74.78 -29.98 61.29 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.89 -57.67 2.07 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 119.463 -0.895 . . . . 0.0 112.546 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.434 ' OE2' HG23 ' A' ' 10' ' ' THR . 12.9 pt-20 -98.05 -5.12 34.59 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.555 -175.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 62.32 63.14 1.08 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.283 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.15 -179.02 5.56 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.648 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.527 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 4.5 mmp_? -106.88 -21.21 13.09 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.145 0.498 . . . . 0.0 110.534 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 78.2 t60 -158.13 170.28 22.64 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.403 ' N ' ' HG3' ' A' ' 22' ' ' LYS . . . -164.67 140.54 6.49 Favored Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 106.378 -2.689 . . . . 0.0 106.378 177.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.0 t -155.21 153.29 30.47 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 118.37 1.085 . . . . 0.0 111.025 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 61.0 m -73.16 93.52 1.84 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 . . . . . 0 C--N 1.294 -1.82 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -178.634 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.649 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 97.3 mttt . . . . . 0 N--CA 1.421 -1.895 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 24.6 t -90.67 123.9 34.65 Favored 'General case' 0 CA--C 1.48 -1.731 0 C-N-CA 118.624 -1.23 . . . . 0.0 109.278 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 mm -111.35 128.98 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.541 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 37.8 m -85.18 147.04 26.8 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.4 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 93.3 m-85 -118.11 122.82 44.07 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.913 -0.492 . . . . 0.0 110.539 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -104.85 152.39 39.54 Favored Pre-proline 0 C--N 1.3 -1.562 0 C-N-CA 123.589 0.756 . . . . 0.0 110.988 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -88.33 107.76 0.54 Allowed 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 122.79 2.326 . . . . 0.0 112.67 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 82.0 m . . . . . 0 C--N 1.279 -2.46 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 174.736 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt . . . . . 0 C--O 1.239 0.527 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.8 mt -121.95 132.04 54.33 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 67.7 m -106.69 129.6 54.56 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.65 151.42 25.3 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -144.45 123.74 7.12 Favored Pre-proline 0 C--N 1.305 -1.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.838 -177.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -68.65 103.03 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.022 1.815 . . . . 0.0 108.129 170.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.544 ' HB3' ' OE1' ' A' ' 29' ' ' GLU . 61.8 m -98.33 161.46 13.68 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -171.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.56 -35.21 52.26 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.307 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.2 t -60.85 -34.53 74.73 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.9 0.381 . . . . 0.0 110.142 175.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -57.82 106.34 0.35 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.784 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.4 t -150.28 91.69 1.79 Allowed 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.6 173.78 23.13 Favored Glycine 0 N--CA 1.422 -2.29 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.187 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.4 m -98.0 171.51 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 123.004 0.521 . . . . 0.0 110.248 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.5 t -69.03 108.38 3.52 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.031 -0.532 . . . . 0.0 112.175 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.36 -91.45 0.69 Allowed Glycine 0 N--CA 1.42 -2.402 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 173.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -91.13 114.92 27.58 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -65.38 -43.64 90.06 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 123.752 0.657 . . . . 0.0 111.002 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -70.16 -36.5 74.75 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.111 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.85 -43.68 95.42 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.981 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.2 p -76.2 -29.36 57.61 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.68 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -57.72 -56.68 18.79 Favored 'General case' 0 C--O 1.251 1.154 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -61.01 -36.87 80.63 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.46 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -63.5 -41.4 98.53 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.08 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 97.7 m -62.65 -49.71 74.09 Favored 'General case' 0 C--O 1.259 1.577 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 60.9 mt -58.91 -33.59 50.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.149 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -83.6 -21.49 32.56 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.74 -65.14 0.98 Allowed 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.245 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.544 ' OE1' ' HB3' ' A' ' 8' ' ' SER . 10.9 pt-20 -106.26 -1.3 23.66 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.845 -177.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.2 mttp 64.26 65.11 0.68 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.708 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.85 -176.17 5.4 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.437 175.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -101.97 -29.88 11.54 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.083 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 31.4 t60 -151.2 173.56 14.28 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.0 139.75 5.96 Favored Glycine 0 C--N 1.295 -1.735 0 N-CA-C 106.478 -2.649 . . . . 0.0 106.478 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.0 t -163.04 167.47 22.34 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 118.384 1.092 . . . . 0.0 109.974 -174.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 89.6 m -72.83 95.16 1.89 Allowed 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.061 175.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 . . . . . 0 C--N 1.291 -1.967 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 177.383 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm . . . . . 0 CA--C 1.507 -0.705 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.3 m -81.91 94.61 7.14 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.618 0.723 . . . . 0.0 111.458 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.75 143.59 11.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 74.2 m -90.0 148.22 23.21 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.481 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.455 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 38.9 m-85 -120.11 130.34 54.59 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.224 0.535 . . . . 0.0 110.844 -177.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -110.8 151.07 42.66 Favored Pre-proline 0 C--N 1.297 -1.678 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.338 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.57 132.06 10.8 Favored 'Trans proline' 0 C--O 1.253 1.262 0 C-N-CA 122.412 2.075 . . . . 0.0 113.276 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 68.9 m . . . . . 0 N--CA 1.435 -1.225 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.705 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.9 pttm . . . . . 0 CA--C 1.5 -0.947 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 92.4 mt -93.21 110.16 21.68 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-O 121.351 0.596 . . . . 0.0 110.46 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 8.2 p -89.08 127.43 35.7 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.46 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 4.3 pt20 -87.43 133.4 33.74 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.209 0.528 . . . . 0.0 111.516 -175.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -126.04 119.84 23.87 Favored Pre-proline 0 C--O 1.265 1.878 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.267 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -71.44 125.96 11.75 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.582 2.188 . . . . 0.0 107.427 169.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.5 t -144.27 160.89 40.23 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.878 -171.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.26 20.04 43.03 Favored Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.655 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.4 p -83.8 -58.29 2.86 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.461 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 1.6 t90 -57.8 144.46 38.44 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.161 169.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.8 t -146.33 119.68 8.99 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.26 -135.23 12.45 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.948 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -125.55 170.92 14.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -175.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.4 t -60.66 108.52 0.85 Allowed 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.093 0.473 . . . . 0.0 111.227 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -116.0 -88.41 1.45 Allowed Glycine 0 N--CA 1.427 -1.949 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -95.46 106.43 18.5 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 122.534 0.333 . . . . 0.0 110.228 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -59.9 -56.09 26.01 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.424 1.09 . . . . 0.0 111.751 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -71.53 -30.1 65.53 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.789 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.64 -42.01 64.86 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.363 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 30.6 p -70.66 -32.33 69.56 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.823 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -55.71 -56.7 17.36 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 172.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -58.8 -37.27 75.99 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.127 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.505 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 20.9 tt0 -63.77 -44.19 94.14 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.236 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 99.0 m -62.08 -49.48 75.79 Favored 'General case' 0 C--O 1.259 1.562 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.623 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 65.9 mt -59.24 -32.81 49.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.401 -177.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.516 ' HA ' ' NE ' ' A' ' 27' ' ' ARG . 4.1 mmp_? -97.05 -8.94 29.12 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 24' ' ' GLN . 42.4 mt -102.04 -62.98 1.19 Allowed 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.63 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -99.17 -3.85 33.48 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.177 0.513 . . . . 0.0 110.01 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.623 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 56.4 mtmt 68.92 50.74 0.59 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.646 175.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.08 178.66 7.35 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.063 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -98.74 -34.2 10.61 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -151.61 175.17 12.62 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 -176.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -169.0 141.34 6.67 Favored Glycine 0 C--N 1.289 -2.064 0 N-CA-C 106.869 -2.492 . . . . 0.0 106.869 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.0 p -169.03 169.51 9.49 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 118.114 0.957 . . . . 0.0 112.062 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 44' ' ' LYS . 78.0 m -80.63 117.49 21.37 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.631 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 . . . . . 0 C--N 1.287 -2.133 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.033 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 31.1 mmtp . . . . . 0 N--CA 1.422 -1.841 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 23.8 t -92.22 113.54 25.83 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.8 mm -105.71 142.07 19.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 61.3 m -88.46 145.63 25.66 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.46 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 70.6 m-85 -121.45 136.58 54.94 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.067 0.46 . . . . 0.0 111.375 -176.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -117.82 164.58 19.12 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -85.31 108.78 1.12 Allowed 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 121.893 1.729 . . . . 0.0 111.837 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 98.9 m . . . . . 0 C--N 1.302 -1.497 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.992 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 CA--C 1.5 -0.968 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 88.7 mt -96.76 108.58 21.26 Favored 'General case' 0 C--N 1.288 -2.085 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.096 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.7 m -82.22 129.63 34.89 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.423 ' HB2' HG23 ' A' ' 46' ' ' ILE . 4.0 pt20 -85.6 141.32 29.9 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.216 0.531 . . . . 0.0 110.987 -177.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -144.57 108.56 4.8 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -77.49 -55.25 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.472 2.114 . . . . 0.0 115.433 -175.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 m -98.22 109.85 22.54 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -172.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.85 -69.88 0.02 OUTLIER Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 108.051 -2.02 . . . . 0.0 108.051 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.445 HG21 ' HA ' ' A' ' 25' ' ' CYS . 7.0 t -103.96 -39.17 6.7 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 170.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.475 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 78.7 t90 -70.76 123.38 21.81 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-O 121.484 0.659 . . . . 0.0 110.731 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.1 m -162.06 96.62 1.0 Allowed 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 125.739 1.616 . . . . 0.0 106.661 174.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.33 -131.73 3.69 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.408 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.9 m -117.66 164.73 13.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 122.627 0.371 . . . . 0.0 110.696 -177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.7 t -92.74 106.71 18.64 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 120.821 0.343 . . . . 0.0 110.66 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.51 -67.75 1.5 Allowed Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 176.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -129.38 132.57 47.07 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -66.41 -47.1 74.35 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.682 0.753 . . . . 0.0 110.001 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -72.65 -16.86 61.7 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.786 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.94 -38.06 14.77 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.776 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.4 p -72.71 -30.88 64.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -53.25 -53.57 48.83 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 171.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -61.79 -40.27 94.62 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 113.855 -1.52 . . . . 0.0 110.062 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -59.88 -39.11 84.16 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 123.358 0.663 . . . . 0.0 110.4 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.445 ' HA ' HG21 ' A' ' 10' ' ' THR . 91.5 m -64.12 -55.5 21.53 Favored 'General case' 0 C--O 1.25 1.107 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 55.9 mt -58.17 -33.83 47.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.701 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -85.42 -21.4 28.79 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.25 -67.9 0.88 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.401 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -97.18 2.67 51.32 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.56 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 49.7 mttp 60.96 57.68 2.5 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 114.057 -1.429 . . . . 0.0 112.215 171.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.64 -179.09 7.23 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.256 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -101.19 -27.23 13.34 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.681 0.753 . . . . 0.0 109.256 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -151.55 171.48 17.53 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.722 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.96 143.63 8.17 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 106.829 -2.508 . . . . 0.0 106.829 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.6 p -165.58 151.3 9.29 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 117.888 0.844 . . . . 0.0 111.284 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 62.5 m -81.79 100.32 9.49 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.718 0.771 . . . . 0.0 110.241 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.8 t30 . . . . . 0 C--N 1.307 -1.249 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.603 -177.766 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.475 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 97.6 mttt . . . . . 0 CA--C 1.506 -0.735 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 11.7 t -84.66 125.95 32.94 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 121.178 0.513 . . . . 0.0 110.739 -173.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.423 HG23 ' HB2' ' A' ' 5' ' ' GLN . 18.4 mm -117.22 134.2 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.451 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 67.6 m -82.9 149.88 26.82 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.445 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 76.1 m-85 -127.24 126.84 43.43 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.086 0.469 . . . . 0.0 111.266 -177.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -110.53 144.87 31.09 Favored Pre-proline 0 C--N 1.302 -1.472 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.775 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -82.65 114.31 2.35 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 122.337 2.025 . . . . 0.0 112.269 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 C--N 1.288 -2.069 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.929 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.0 mttm . . . . . 0 N--CA 1.437 -1.102 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 83.4 mt -79.94 117.35 20.71 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-O 121.193 0.521 . . . . 0.0 110.653 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.1 p -98.18 129.88 44.94 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -87.89 130.74 34.81 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.308 0.575 . . . . 0.0 111.774 -173.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -132.69 120.03 16.41 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.138 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -74.79 142.62 28.79 Favored 'Trans proline' 0 C--O 1.247 0.937 0 C-N-CA 122.21 1.94 . . . . 0.0 107.759 168.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.1 t -151.67 161.74 42.17 Favored 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.925 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.6 -7.32 87.19 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.399 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 p -65.54 -56.72 10.81 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.506 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 1.7 t90 -59.51 138.04 57.82 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.492 166.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.8 t -134.02 110.42 9.64 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-O 120.659 0.266 . . . . 0.0 111.052 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.78 -115.5 5.91 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 115.936 1.134 . . . . 0.0 115.936 171.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 p -83.94 137.15 21.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.807 0.813 . . . . 0.0 112.47 -174.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.1 t -90.73 112.5 24.29 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.36 -59.33 1.04 Allowed Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -112.92 120.35 41.13 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -54.97 -44.67 74.62 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.731 0.645 . . . . 0.0 110.354 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -66.04 -33.51 75.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.011 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.15 -46.41 56.56 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.11 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.4 p -73.22 -32.0 64.5 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.868 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -53.07 -60.08 3.74 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 123.854 0.862 . . . . 0.0 109.177 173.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -61.54 -34.47 75.6 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.004 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -65.8 -38.62 89.48 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.451 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.1 m -64.93 -49.07 71.81 Favored 'General case' 0 C--O 1.255 1.374 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.568 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 73.0 mt -57.14 -42.79 80.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.844 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -81.24 -14.15 57.76 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.7 mt -107.06 -55.72 2.29 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 119.087 -1.045 . . . . 0.0 112.078 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -110.89 1.42 17.58 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.097 0.475 . . . . 0.0 111.626 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 36.5 mtmm 66.82 45.92 1.78 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.122 174.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.21 172.42 11.17 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.999 -1.001 . . . . 0.0 108.88 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -91.62 -35.95 13.93 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -152.63 176.56 11.6 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -175.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.62 150.64 11.55 Favored Glycine 0 C--N 1.308 -0.987 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.2 p -172.27 168.27 5.66 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-N 118.372 1.086 . . . . 0.0 111.696 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.0 m -68.41 107.57 2.92 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.4 t30 . . . . . 0 C--N 1.311 -1.079 0 CA-C-O 121.702 0.763 . . . . 0.0 109.866 -177.58 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.506 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 32.4 mmtp . . . . . 0 C--O 1.242 0.666 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 45.2 t -103.9 131.7 50.87 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 50.1 mm -116.68 137.55 50.14 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.7 m -89.49 153.0 21.15 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.441 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 87.6 m-85 -126.0 135.96 52.43 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -116.78 159.42 40.7 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -82.42 101.4 1.08 Allowed 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.936 1.758 . . . . 0.0 112.149 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 85.2 m . . . . . 0 C--N 1.298 -1.635 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.709 179.117 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 51' ' ' CYS . 23.0 pttm . . . . . 0 CA--C 1.511 -0.529 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.2 mt -95.43 105.47 17.44 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.248 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 86.3 m -80.78 135.65 36.0 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.732 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -90.67 128.72 36.73 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.208 0.527 . . . . 0.0 110.696 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -129.07 117.99 19.28 Favored Pre-proline 0 C--N 1.301 -1.52 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.161 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -78.53 116.78 3.88 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.036 1.824 . . . . 0.0 109.301 173.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.1 m -124.79 160.12 29.42 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.33 -25.67 60.67 Favored Glycine 0 C--N 1.334 0.421 0 O-C-N 124.217 0.948 . . . . 0.0 114.142 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.7 t -53.81 -47.64 70.65 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 117.219 0.51 . . . . 0.0 110.052 174.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -71.44 121.94 19.5 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 121.25 0.548 . . . . 0.0 109.796 173.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.0 p -153.41 100.2 2.41 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.432 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.96 -145.39 16.86 Favored Glycine 0 N--CA 1.427 -1.951 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.502 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.6 m -99.61 153.01 4.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -177.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.8 t -90.77 91.66 8.47 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.96 -60.17 2.98 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -120.95 129.9 53.62 Favored 'General case' 0 CA--C 1.486 -1.508 0 CA-C-N 115.472 -0.364 . . . . 0.0 110.111 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -56.17 -46.8 79.19 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 124.313 1.008 . . . . 0.0 109.577 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -64.64 -30.9 71.92 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.89 -53.37 21.54 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.5 p -74.89 -29.11 60.9 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.599 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.454 ' HE2' ' CE1' ' A' ' 33' ' ' HIS . 38.5 ttmt -52.62 -58.68 6.02 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-O 122.021 0.915 . . . . 0.0 108.623 173.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -59.17 -41.38 88.28 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.69 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -65.04 -32.34 74.01 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.327 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 98.5 m -66.97 -49.65 64.77 Favored 'General case' 0 C--O 1.255 1.359 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 57.0 mt -61.24 -28.03 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.33 -1.304 . . . . 0.0 111.176 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.456 ' HA ' ' NE ' ' A' ' 27' ' ' ARG . 3.3 mmp_? -92.82 -15.7 26.2 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -103.91 -62.41 1.31 Allowed 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.194 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -102.66 -1.4 30.21 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.199 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 56.0 mtpt 69.62 37.41 1.92 Allowed 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.215 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.58 175.88 3.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.144 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.404 ' HG2' ' HD3' ' A' ' 50' ' ' PRO . 6.7 mmp_? -90.94 -32.14 16.1 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.146 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.454 ' CE1' ' HE2' ' A' ' 22' ' ' LYS . 28.9 t60 -155.82 175.02 14.48 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -174.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -169.96 142.75 7.43 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 107.145 -2.382 . . . . 0.0 107.145 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.7 p -163.0 169.92 18.85 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 117.892 0.846 . . . . 0.0 110.9 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 68.6 m -67.91 107.4 2.64 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 175.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 . . . . . 0 C--N 1.296 -1.722 0 CA-C-O 121.751 0.786 . . . . 0.0 109.092 -175.532 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.9 t -100.55 128.96 46.44 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.9 mm -122.85 141.02 44.82 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 41.5 m -88.73 156.92 18.71 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' A' ' 4' ' ' CYS . 95.9 m-85 -126.54 142.65 51.47 Favored 'General case' 0 C--O 1.252 1.211 0 CA-C-O 121.039 0.447 . . . . 0.0 112.182 -177.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -126.67 151.31 73.1 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 124.312 1.045 . . . . 0.0 109.908 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.404 ' HD3' ' HG2' ' A' ' 32' ' ' ARG . 94.5 Cg_endo -86.99 107.37 0.7 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.725 2.283 . . . . 0.0 112.38 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 20.7 m . . . . . 0 C--N 1.291 -1.967 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 N--CA 1.435 -1.216 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 90.6 mt -96.74 99.99 11.56 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.7 p -87.63 114.68 24.47 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 114.596 -1.183 . . . . 0.0 109.681 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.496 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 18.8 pt20 -83.14 144.32 29.92 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -173.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -138.22 120.7 10.85 Favored Pre-proline 0 C--N 1.313 -1.004 0 C-N-CA 124.743 1.217 . . . . 0.0 108.453 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -73.82 108.76 2.72 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 121.681 1.587 . . . . 0.0 108.991 173.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.7 p -79.73 160.97 26.03 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.373 0.606 . . . . 0.0 112.567 -174.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.01 -24.64 57.41 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.3 t -71.34 -41.24 70.05 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.765 -0.218 . . . . 0.0 110.575 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -48.92 130.93 18.65 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.05 0.54 . . . . 0.0 112.225 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.9 t -91.23 127.94 36.86 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -33.23 -48.47 0.43 Allowed Glycine 0 N--CA 1.478 1.447 0 N-CA-C 117.513 1.765 . . . . 0.0 117.513 -171.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.6 131.67 36.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 117.355 0.577 . . . . 0.0 110.024 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.6 t -73.58 127.7 33.48 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.838 0.351 . . . . 0.0 110.143 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.77 -73.31 0.81 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -122.46 125.18 45.28 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -59.03 -46.03 89.25 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 123.756 0.66 . . . . 0.0 111.123 -175.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -75.02 -9.37 58.47 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.79 -47.04 8.49 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.6 p -75.16 -34.66 61.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.321 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -54.4 -55.02 32.91 Favored 'General case' 0 C--O 1.25 1.087 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 174.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.594 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 7.2 t30 -60.51 -41.9 95.32 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.052 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -58.29 -39.4 79.18 Favored 'General case' 0 C--O 1.211 -0.969 0 C-N-CA 122.795 0.438 . . . . 0.0 110.524 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 99.1 m -64.69 -54.5 30.65 Favored 'General case' 0 C--O 1.253 1.265 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 69.5 mt -58.38 -30.15 39.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.165 -1.379 . . . . 0.0 111.788 -175.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 28.3 mmt180 -89.5 -32.69 17.07 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.414 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.12 -66.55 0.91 Allowed 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.423 -172.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -94.59 -3.06 50.34 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.762 0.792 . . . . 0.0 110.154 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 47.9 mttp 61.84 65.44 0.92 Allowed 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 113.801 -1.545 . . . . 0.0 112.552 173.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.91 -177.53 4.54 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.401 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -99.43 -26.95 13.96 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.316 178.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -153.03 176.19 12.16 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -174.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.74 142.27 7.5 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 107.871 -2.091 . . . . 0.0 107.871 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.0 m -155.29 154.01 31.45 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 118.019 0.909 . . . . 0.0 111.064 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 76.1 m -87.08 91.23 8.63 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 122.397 1.094 . . . . 0.0 109.389 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 . . . . . 0 C--N 1.298 -1.633 0 CA-C-N 113.652 -1.613 . . . . 0.0 107.818 -176.616 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp . . . . . 0 N--CA 1.439 -0.982 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 6.9 t -79.62 115.26 19.13 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.531 0.681 . . . . 0.0 110.583 -173.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.474 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 22.5 mm -112.27 141.11 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.43 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 5' ' ' GLN . 51.7 m -83.61 144.3 29.54 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.496 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 63.5 m-85 -119.09 118.35 31.18 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.499 0.666 . . . . 0.0 111.643 -177.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -100.59 163.49 18.04 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.081 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -88.06 126.12 1.99 Allowed 'Trans proline' 0 N--CA 1.441 -1.586 0 C-N-CA 122.136 1.89 . . . . 0.0 111.667 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 69.6 m . . . . . 0 C--N 1.294 -1.829 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.662 177.554 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.2 mt -118.86 130.56 55.81 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 66.8 m -108.81 133.38 52.93 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 175.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.543 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 17.5 pt20 -94.52 134.84 36.63 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.658 0.742 . . . . 0.0 112.305 -177.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -137.53 120.77 11.54 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.634 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -66.72 132.94 30.1 Favored 'Trans proline' 0 C--O 1.246 0.88 0 C-N-CA 122.146 1.897 . . . . 0.0 109.415 172.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -118.43 160.36 21.84 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.496 -174.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.0 -12.52 76.68 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.263 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.9 p -71.01 -43.8 67.2 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.526 0.679 . . . . 0.0 109.592 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.412 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 3.9 t90 -64.97 140.21 58.84 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.261 171.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.8 t -146.07 119.61 9.11 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.064 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.19 -135.12 11.99 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 172.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.8 p -108.31 168.4 3.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.7 t -59.29 118.26 5.74 Favored 'General case' 0 C--O 1.25 1.109 0 C-N-CA 123.495 0.718 . . . . 0.0 112.642 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.47 -76.7 1.05 Allowed Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 171.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -143.32 138.21 29.35 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -50.81 -54.91 19.68 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.205 1.002 . . . . 0.0 112.408 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -70.23 -32.22 69.99 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.597 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.29 -49.13 68.14 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.825 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 11.0 p -76.53 -22.9 53.77 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 119.205 -0.998 . . . . 0.0 112.287 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -57.87 -53.42 58.39 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -58.78 -42.3 88.69 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.898 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.98 -39.29 71.59 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.457 0.473 . . . . 0.0 111.268 177.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 89.4 m -68.91 -51.48 39.61 Favored 'General case' 0 C--O 1.255 1.373 0 CA-C-O 121.993 0.902 . . . . 0.0 108.869 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.5 mt -57.01 -36.6 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.702 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -73.6 -32.3 64.03 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.0 mt -100.01 -57.1 2.2 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.19 -1.004 . . . . 0.0 113.265 -170.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -105.79 -10.35 16.76 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 120.026 -0.669 . . . . 0.0 111.605 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.8 mttm 72.26 68.97 0.14 Allowed 'General case' 0 C--N 1.319 -0.733 0 O-C-N 124.355 1.035 . . . . 0.0 111.498 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.49 175.71 7.82 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -98.66 -27.3 14.05 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.14 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -151.66 173.82 14.23 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.22 141.68 6.96 Favored Glycine 0 C--N 1.283 -2.367 0 N-CA-C 106.457 -2.657 . . . . 0.0 106.457 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.5 t -159.54 165.33 33.16 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 118.387 1.094 . . . . 0.0 110.069 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.7 m -86.61 102.59 14.31 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.73 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 . . . . . 0 C--N 1.295 -1.77 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -179.85 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.412 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 56.0 mttm . . . . . 0 N--CA 1.433 -1.291 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 86.9 m -83.23 113.33 20.6 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.393 0.616 . . . . 0.0 111.081 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.412 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 33.2 mm -109.56 138.05 38.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 60.5 m -88.43 136.04 33.18 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.543 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 34.7 m-85 -107.83 124.69 50.45 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.421 0.629 . . . . 0.0 110.355 -177.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -108.83 153.41 42.38 Favored Pre-proline 0 C--N 1.292 -1.895 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.188 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -77.7 133.52 12.85 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 122.21 1.94 . . . . 0.0 113.03 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 81.7 m . . . . . 0 C--N 1.294 -1.817 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.823 178.501 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt . . . . . 0 CA--C 1.505 -0.758 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -110.6 120.19 41.61 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.114 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 31.3 m -93.66 116.68 29.18 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.475 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 4.3 pt20 -85.89 119.62 26.41 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -133.19 129.03 20.71 Favored Pre-proline 0 C--N 1.307 -1.244 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.118 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -72.46 134.61 22.83 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.898 1.732 . . . . 0.0 109.575 173.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.0 m -116.03 160.34 20.42 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.17 -15.11 75.35 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.235 -0.438 . . . . 0.0 112.036 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 p -69.63 -51.07 38.2 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.487 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 2.2 t90 -58.77 136.67 57.81 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.379 171.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.2 p -148.85 129.66 14.22 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.868 173.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.42 -173.32 27.23 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-O 121.656 0.587 . . . . 0.0 114.258 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.3 t -81.41 148.38 5.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.3 t -67.35 112.55 4.64 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 123.303 0.377 . . . . 0.0 111.145 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.1 -50.46 1.91 Allowed Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -123.13 117.16 24.75 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.531 ' HA ' ' SG ' ' A' ' 36' ' ' CYS . 13.2 m120 -57.79 -52.35 65.83 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 124.163 0.915 . . . . 0.0 110.748 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -66.47 -24.69 66.46 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.366 -0.833 . . . . 0.0 113.004 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.05 -57.77 4.6 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 123.051 0.219 . . . . 0.0 110.591 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.4 p -69.95 -30.36 67.73 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.404 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 38.1 ttmt -53.89 -57.31 11.4 Favored 'General case' 0 C--O 1.251 1.135 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -60.71 -39.12 87.42 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.329 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -60.33 -41.27 93.22 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.808 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.4 m -63.63 -52.33 61.29 Favored 'General case' 0 C--O 1.257 1.476 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 66.4 mt -55.95 -30.29 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.173 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -87.13 -33.9 19.28 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.2 mt -96.61 -47.65 5.83 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.196 -1.002 . . . . 0.0 113.352 -169.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -107.51 -5.93 17.32 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 120.906 0.384 . . . . 0.0 110.73 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 99.7 mttt 64.55 54.85 1.4 Allowed 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.7 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.53 159.85 33.25 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -81.84 -29.55 32.51 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.933 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -156.46 174.8 14.9 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 22' ' ' LYS . . . -153.59 144.01 10.82 Favored Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 107.634 -2.186 . . . . 0.0 107.634 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.534 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 41.7 t -154.52 148.99 26.23 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 117.899 0.849 . . . . 0.0 109.31 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 18' ' ' ASN . 60.6 m -87.35 108.21 18.88 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.842 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.2 t30 . . . . . 0 C--N 1.301 -1.51 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.737 -178.502 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.487 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 39.8 mmtm . . . . . 0 CA--C 1.499 -0.997 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.479 ' HB2' ' CD1' ' A' ' 11' ' ' TRP . 85.0 m -87.13 107.65 18.55 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.443 0.64 . . . . 0.0 109.622 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.9 mm -104.4 135.39 42.43 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 33.9 m -91.5 132.93 35.93 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.534 ' CE1' ' HB3' ' A' ' 35' ' ' SER . 27.6 m-85 -105.93 120.1 40.88 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.543 0.687 . . . . 0.0 110.671 -176.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -102.58 161.42 23.3 Favored Pre-proline 0 C--N 1.288 -2.079 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.312 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -80.76 119.72 3.71 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 121.552 1.501 . . . . 0.0 112.704 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 56.8 m . . . . . 0 C--N 1.312 -1.06 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 174.589 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt . . . . . 0 N--CA 1.443 -0.802 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.9 mt -113.4 121.07 43.23 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 121.047 0.451 . . . . 0.0 109.964 177.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 80.9 m -94.89 132.09 40.08 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.443 ' HG2' ' CE1' ' A' ' 48' ' ' TYR . 16.1 mt-30 -83.39 146.22 28.58 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.235 0.54 . . . . 0.0 111.691 -174.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -131.83 101.81 15.23 Favored Pre-proline 0 C--N 1.291 -1.954 0 C-N-CA 124.111 0.964 . . . . 0.0 108.904 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.62 -74.29 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.127 1.885 . . . . 0.0 113.895 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.5 m -100.63 83.56 2.61 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -170.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.11 -71.36 0.25 Allowed Glycine 0 N--CA 1.427 -1.926 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 172.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.497 HG22 ' HA ' ' A' ' 25' ' ' CYS . 5.6 t -103.69 -30.17 10.6 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 120.808 0.337 . . . . 0.0 110.902 173.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.561 ' CZ2' ' HB2' ' A' ' 44' ' ' LYS . 27.0 t90 -59.96 127.75 33.47 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.5 m -157.41 109.39 2.38 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 125.239 1.415 . . . . 0.0 107.944 171.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.01 -166.36 24.04 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 119.662 -1.256 . . . . 0.0 113.431 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.1 t -83.38 150.54 4.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.614 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 17.5 t -94.91 100.85 12.63 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.09 -55.54 1.37 Allowed Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.085 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -121.61 121.97 38.59 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.907 0.384 . . . . 0.0 110.519 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -63.19 -42.33 99.31 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.984 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -73.75 -21.98 60.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.156 0.503 . . . . 0.0 110.835 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.81 -51.09 20.33 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.651 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.6 p -73.3 -31.3 63.95 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.966 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -54.55 -57.51 11.12 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -56.8 -40.13 75.39 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.957 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -64.33 -37.97 89.38 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.497 ' HA ' HG22 ' A' ' 10' ' ' THR . 72.8 m -63.06 -53.53 52.23 Favored 'General case' 0 C--O 1.256 1.419 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 73.0 mt -55.45 -37.09 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.441 -178.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -83.14 -27.56 30.02 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -98.13 -57.47 2.21 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -108.25 -0.51 20.82 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.065 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 62.1 mttp 67.14 47.22 1.38 Allowed 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.077 173.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.69 177.08 8.91 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.893 -1.048 . . . . 0.0 108.231 175.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -99.69 -27.29 13.74 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.538 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -149.19 170.35 18.66 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -175.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.14 138.52 4.96 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.5 m -163.14 162.48 25.64 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 117.437 0.619 . . . . 0.0 109.941 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 38.1 m -59.36 118.26 5.77 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 175.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 . . . . . 0 C--N 1.296 -1.723 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.448 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.561 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 4.0 mptp? . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.614 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 33.6 t -68.5 126.8 30.8 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 118.345 0.521 . . . . 0.0 109.981 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.403 ' CG2' ' HB3' ' A' ' 5' ' ' GLN . 41.5 mm -120.11 135.77 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.316 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 56.1 m -82.97 160.24 22.07 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.443 ' CE1' ' HG2' ' A' ' 5' ' ' GLN . 98.5 m-85 -129.58 127.64 41.09 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 120.844 0.354 . . . . 0.0 111.468 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -106.53 148.93 37.67 Favored Pre-proline 0 C--N 1.305 -1.33 0 C-N-CA 123.936 0.894 . . . . 0.0 109.836 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.47 129.47 6.59 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.674 2.249 . . . . 0.0 112.363 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 82.8 m . . . . . 0 N--CA 1.427 -1.603 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.6 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 51' ' ' CYS . 3.7 mptp? . . . . . 0 CA--C 1.511 -0.556 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -111.68 112.55 24.33 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.621 0.724 . . . . 0.0 111.155 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 70.8 m -86.99 111.12 20.54 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.607 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 3.8 pt20 -76.11 135.82 39.85 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.487 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.466 ' HD3' ' CE1' ' A' ' 49' ' ' PHE . 51.9 ttt180 -146.38 116.3 4.66 Favored Pre-proline 0 C--N 1.296 -1.753 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.555 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -79.17 86.14 1.74 Allowed 'Trans proline' 0 N--CA 1.438 -1.759 0 C-N-CA 122.058 1.839 . . . . 0.0 109.06 173.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.469 ' HB3' ' OE2' ' A' ' 29' ' ' GLU . 61.6 m -69.49 160.06 32.13 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.419 -176.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.58 -9.79 82.7 Favored Glycine 0 CA--C 1.502 -0.727 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.524 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 p -68.78 -44.62 73.24 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.478 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 2.8 t90 -66.75 132.46 48.14 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.199 169.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.9 t -145.99 112.02 5.69 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.14 -145.87 15.89 Favored Glycine 0 N--CA 1.425 -2.094 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.787 176.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 p -118.43 162.68 16.31 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.8 t -67.07 134.56 52.11 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.7 -49.58 0.31 Allowed Glycine 0 N--CA 1.421 -2.315 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 173.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -145.99 120.14 9.49 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.185 0.594 . . . . 0.0 110.129 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -55.24 -52.74 62.41 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.072 0.949 . . . . 0.0 111.925 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -65.61 -31.58 72.69 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.935 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.42 -44.28 65.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.503 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.3 p -76.53 -32.18 58.08 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.181 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -54.9 -54.87 37.03 Favored 'General case' 0 C--O 1.253 1.239 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.497 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 47.4 t30 -57.36 -44.39 84.3 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.672 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -56.24 -43.0 78.22 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.264 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.8 m -63.62 -48.8 75.84 Favored 'General case' 0 C--O 1.271 2.224 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 64.9 mt -59.94 -37.73 73.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 114.24 -1.345 . . . . 0.0 111.372 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 31.7 mmt180 -81.47 -19.98 41.21 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -98.01 -63.61 1.11 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.209 -176.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 8' ' ' SER . 8.3 pt-20 -113.29 3.47 15.96 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.3 0.571 . . . . 0.0 111.685 -177.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 94.4 mttt 67.92 63.74 0.39 Allowed 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.421 174.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.07 177.48 9.02 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 173.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -96.01 -41.09 8.93 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -147.15 176.33 10.04 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -173.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.7 143.5 8.9 Favored Glycine 0 C--N 1.307 -1.059 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 m -149.03 152.84 36.96 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 118.466 1.133 . . . . 0.0 110.895 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.0 m -89.13 100.4 13.19 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.501 0.667 . . . . 0.0 109.697 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.1 t30 . . . . . 0 C--N 1.297 -1.681 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.454 -175.78 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.478 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 95.1 mttt . . . . . 0 N--CA 1.442 -0.858 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 22.4 t -92.87 117.11 29.68 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.86 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.432 HG23 ' HB2' ' A' ' 5' ' ' GLN . 25.0 mm -101.44 134.49 41.58 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 66.5 m -84.75 136.78 33.56 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.607 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 77.9 m-85 -113.1 122.96 49.14 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.473 0.654 . . . . 0.0 110.925 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.466 ' CE1' ' HD3' ' A' ' 6' ' ' ARG . 81.4 m-85 -107.98 156.53 38.07 Favored Pre-proline 0 C--N 1.288 -2.093 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.709 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -77.66 126.86 8.44 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 121.638 1.558 . . . . 0.0 112.701 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 2' ' ' LYS . 12.2 m . . . . . 0 C--N 1.294 -1.843 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 172.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.1 tttm . . . . . 0 N--CA 1.434 -1.234 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 86.6 mt -80.53 110.89 16.44 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.0 p -102.22 129.97 48.76 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.862 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.477 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 4.0 pt20 -78.76 140.64 38.23 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.35 0.595 . . . . 0.0 111.054 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -137.23 127.93 16.07 Favored Pre-proline 0 C--N 1.282 -2.329 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.26 106.24 0.14 Allowed 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 122.698 2.265 . . . . 0.0 109.751 174.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.498 ' HB2' ' HB3' ' A' ' 11' ' ' TRP . 1.5 m -53.94 133.38 43.13 Favored 'General case' 0 N--CA 1.417 -2.101 0 C-N-CA 125.806 1.642 . . . . 0.0 111.461 -176.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.93 -32.04 6.36 Favored Glycine 0 N--CA 1.428 -1.879 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.985 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -74.53 -38.05 62.89 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 120.708 0.29 . . . . 0.0 110.659 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 8' ' ' SER . 1.7 t90 -58.97 132.91 55.42 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.466 0.706 . . . . 0.0 111.654 174.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.1 p -156.46 97.58 1.76 Allowed 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.22 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.98 -156.48 26.71 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -91.72 150.94 3.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 41.1 t -93.51 101.07 13.25 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 173.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.66 -35.88 7.63 Favored Glycine 0 N--CA 1.429 -1.817 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.654 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -133.62 128.47 35.19 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-O 120.906 0.384 . . . . 0.0 110.964 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -60.39 -47.57 85.49 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.402 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.4 p30 -63.46 -36.69 84.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.219 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.73 -47.41 63.2 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.345 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.9 p -76.17 -25.36 55.16 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.46 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -54.81 -57.72 10.45 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -62.83 -36.67 83.98 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.132 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -61.03 -41.71 97.08 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 122.846 0.459 . . . . 0.0 109.815 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.3 m -64.81 -56.04 15.9 Favored 'General case' 0 C--O 1.257 1.488 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 77.0 mt -54.16 -36.42 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.425 1.49 . . . . 0.0 112.251 -176.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -87.18 -25.07 24.24 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . 0.264 7.3 mp -104.35 -50.98 3.2 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 117.983 -1.487 . . . . 0.0 113.63 -174.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -109.24 1.98 20.58 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.305 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 27.7 mtpp 59.39 63.01 1.65 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 125.773 1.629 . . . . 0.0 114.034 174.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.25 179.73 7.7 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.375 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -94.32 -30.45 14.52 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -156.41 174.0 16.06 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -165.23 150.86 19.22 Favored Glycine 0 C--N 1.304 -1.237 0 N-CA-C 107.868 -2.093 . . . . 0.0 107.868 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.0 t -167.04 151.84 7.26 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 118.31 1.055 . . . . 0.0 112.06 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 38.5 m -63.62 117.37 6.7 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 170.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 . . . . . 0 C--N 1.297 -1.686 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.724 -175.628 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.43 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 45.7 mtmt . . . . . 0 C--O 1.25 1.094 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.503 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 41.9 t -98.75 131.12 45.14 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 175.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.4 mm -113.02 137.36 46.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 73.1 m -89.38 141.31 28.67 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -177.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.477 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 62.1 m-85 -111.22 126.38 54.81 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.22 0.533 . . . . 0.0 110.588 -178.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -113.93 161.46 27.75 Favored Pre-proline 0 C--N 1.286 -2.158 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.149 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -86.21 112.81 1.16 Allowed 'Trans proline' 0 N--CA 1.436 -1.868 0 C-N-CA 121.993 1.795 . . . . 0.0 111.692 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 47.8 m . . . . . 0 C--N 1.285 -2.238 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.046 175.929 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 C--O 1.256 1.421 0 CA-C-O 121.24 0.543 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 95.1 mt -99.15 119.33 37.68 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.652 177.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.3 m -73.68 120.54 19.42 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -91.97 139.34 30.74 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.062 0.458 . . . . 0.0 110.479 -176.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -145.4 121.68 5.97 Favored Pre-proline 0 N--CA 1.431 -1.391 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.024 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -76.08 86.39 1.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.859 1.706 . . . . 0.0 108.882 171.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.411 ' HB3' ' OE1' ' A' ' 29' ' ' GLU . 61.4 m -75.38 160.86 29.79 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.673 -173.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.64 -6.09 85.96 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.421 -0.809 . . . . 0.0 113.68 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 p -70.93 -58.65 3.38 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.504 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 2.8 t90 -59.65 143.29 50.98 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.793 168.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.4 m -149.87 123.77 9.32 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 119.29 -122.98 5.5 Favored Glycine 0 C--O 1.247 0.915 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.689 176.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.3 p -134.03 170.06 20.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.6 t -67.48 109.96 3.43 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 118.013 0.37 . . . . 0.0 110.414 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.87 -57.36 0.92 Allowed Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 176.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -138.93 118.7 13.14 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -50.36 -50.03 52.44 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.984 0.914 . . . . 0.0 110.898 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -60.64 -36.41 78.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.863 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.15 -47.55 35.19 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.457 -173.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.3 p -75.48 -32.52 60.61 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -56.45 -54.5 44.95 Favored 'General case' 0 C--O 1.253 1.254 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 173.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.502 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 64.1 t30 -59.24 -43.54 92.38 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.744 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -58.06 -36.92 73.48 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.139 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.2 m -68.25 -54.4 17.91 Favored 'General case' 0 C--O 1.258 1.537 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 69.8 mt -60.08 -32.87 51.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.242 -174.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 30.4 mmt180 -91.46 -17.47 25.7 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.48 -52.07 2.97 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 118.833 -1.147 . . . . 0.0 112.558 -174.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.411 ' OE1' ' HB3' ' A' ' 8' ' ' SER . 9.0 pt-20 -109.09 -8.44 15.17 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.706 0.765 . . . . 0.0 109.986 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 53.9 mtmt 69.14 63.36 0.29 Allowed 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 113.906 -1.497 . . . . 0.0 112.155 176.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.38 169.91 16.64 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 114.656 -1.157 . . . . 0.0 109.098 176.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -88.61 -34.23 17.37 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.934 0.873 . . . . 0.0 108.674 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -152.02 171.62 17.55 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.287 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.29 137.16 4.59 Favored Glycine 0 N--CA 1.424 -2.151 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.1 p -161.77 174.88 12.6 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 117.751 0.775 . . . . 0.0 111.232 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 51.3 m -90.13 109.48 20.54 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.153 0.501 . . . . 0.0 110.025 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 . . . . . 0 C--N 1.307 -1.249 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 179.777 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.47 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 68.4 mttm . . . . . 0 N--CA 1.432 -1.372 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.504 ' HB2' ' CD1' ' A' ' 11' ' ' TRP . 97.0 m -80.14 114.55 19.13 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.474 0.654 . . . . 0.0 110.318 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 50.7 mm -111.23 135.85 49.12 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.696 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 61.3 m -87.63 139.92 30.04 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.425 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 88.6 m-85 -117.48 129.2 55.67 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.441 0.639 . . . . 0.0 111.305 -176.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -114.61 157.69 42.17 Favored Pre-proline 0 C--N 1.286 -2.177 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -79.51 127.35 7.25 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.354 1.369 . . . . 0.0 110.758 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 73.8 m . . . . . 0 C--N 1.315 -0.905 0 O-C-N 122.097 -0.377 . . . . 0.0 111.334 -179.161 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? . . . . . 0 N--CA 1.439 -1.004 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 89.8 mt -88.77 101.69 14.27 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 64.5 m -83.3 133.88 34.95 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.913 -175.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -81.17 132.96 35.38 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.973 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -144.15 125.31 7.92 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.87 135.01 49.51 Favored 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.628 2.219 . . . . 0.0 110.896 176.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.778 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . 5.9 p -90.03 160.45 16.33 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -176.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.13 -13.61 38.8 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.5 t -81.86 -37.94 26.17 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.158 0.504 . . . . 0.0 109.953 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.557 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 1.6 t90 -82.09 145.17 30.31 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 173.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 t -157.32 95.6 1.48 Allowed 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.35 -140.48 8.82 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.724 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 p -104.4 170.98 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.3 t -58.99 133.6 56.23 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 123.253 0.621 . . . . 0.0 112.656 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.99 -76.05 0.9 Allowed Glycine 0 N--CA 1.426 -1.979 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 173.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -142.5 130.54 21.89 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -48.42 -57.4 6.13 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.459 1.104 . . . . 0.0 112.105 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -66.56 -31.51 72.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.993 -174.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.18 -48.12 68.91 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.755 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.434 ' HA ' ' HB3' ' A' ' 24' ' ' GLN . 5.6 p -78.6 -23.55 45.92 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -58.53 -55.14 38.85 Favored 'General case' 0 C--O 1.256 1.44 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -57.95 -46.27 85.34 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.067 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.434 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 61.6 tt0 -55.82 -40.56 72.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.762 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 97.0 m -62.98 -57.35 11.03 Favored 'General case' 0 C--O 1.257 1.492 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.1 mt -55.0 -39.59 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 114.141 -1.39 . . . . 0.0 111.465 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -79.44 -26.45 41.79 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.4 -55.99 2.24 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 118.558 -1.257 . . . . 0.0 113.177 -174.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -108.05 2.25 22.98 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.8 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 61.48 59.3 1.9 Allowed 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.367 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.07 175.44 9.51 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.416 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 26.2 tpt180 -85.81 -41.34 15.12 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -147.54 173.43 12.7 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -177.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.27 149.56 15.67 Favored Glycine 0 CA--C 1.476 -2.396 0 N-CA-C 107.036 -2.425 . . . . 0.0 107.036 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.3 t -169.88 173.38 6.14 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 118.544 1.172 . . . . 0.0 109.432 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 75.4 m -78.32 92.06 4.5 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.611 0.72 . . . . 0.0 110.215 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 . . . . . 0 C--N 1.295 -1.796 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -179.644 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.557 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 98.6 mttt . . . . . 0 N--CA 1.44 -0.956 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.418 ' HB2' ' CD1' ' A' ' 11' ' ' TRP . 71.2 m -82.51 98.27 8.85 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.942 0.877 . . . . 0.0 111.519 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 50.8 mm -105.62 138.47 30.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.778 ' SG ' ' HB3' ' A' ' 8' ' ' SER . 60.6 m -91.73 154.63 18.84 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -177.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 4' ' ' CYS . 84.8 m-85 -122.31 129.43 52.17 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -111.58 152.68 44.19 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HD3' ' HB2' ' A' ' 32' ' ' ARG . 70.7 Cg_endo -79.6 133.98 10.78 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.104 1.87 . . . . 0.0 112.256 -175.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 67.6 m . . . . . 0 C--N 1.291 -1.957 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.745 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? . . . . . 0 N--CA 1.432 -1.369 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.447 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 78.1 mt -114.1 115.49 27.62 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-O 121.195 0.522 . . . . 0.0 110.181 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.3 m -89.76 117.18 28.42 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.441 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -72.04 139.54 48.56 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.712 -175.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.415 ' HD3' ' OE1' ' A' ' 29' ' ' GLU . 51.6 ttt180 -142.16 108.18 5.78 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 175.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -72.27 -62.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.01 1.807 . . . . 0.0 112.904 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.2 m -91.79 101.0 13.59 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.746 0.784 . . . . 0.0 112.683 -172.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.62 -71.4 0.04 OUTLIER Glycine 0 C--N 1.286 -2.196 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 172.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.456 HG22 ' OE2' ' A' ' 29' ' ' GLU . 8.1 t -112.75 -30.26 7.13 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.077 -0.562 . . . . 0.0 109.946 172.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.433 ' CZ2' ' HB2' ' A' ' 44' ' ' LYS . 48.1 t90 -55.71 129.79 40.65 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.389 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 m -140.5 89.43 2.28 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.049 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 56.05 45.63 86.72 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 115.495 0.958 . . . . 0.0 115.495 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.9 t -120.31 124.12 71.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 117.232 0.516 . . . . 0.0 111.932 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 44' ' ' LYS . 42.4 t -141.72 82.75 1.82 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 167.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.69 -82.99 0.08 OUTLIER Glycine 0 N--CA 1.426 -2.0 0 C-N-CA 120.471 -0.871 . . . . 0.0 110.944 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -88.29 96.28 10.51 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.54 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 2.6 m-20 -58.56 -44.0 89.57 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.261 0.624 . . . . 0.0 112.153 -176.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -67.43 -28.84 68.23 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.131 0.491 . . . . 0.0 110.893 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.26 -39.35 23.11 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.901 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' A' ' 18' ' ' ASN . 21.5 p -71.45 -31.13 66.82 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.178 177.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -58.06 -53.01 63.06 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 172.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -57.59 -43.79 84.88 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.773 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -57.07 -40.7 77.41 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.447 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 71.2 m -63.08 -54.37 39.1 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 62.3 mt -56.16 -37.41 49.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 124.626 1.17 . . . . 0.0 111.027 -177.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -83.52 -23.06 32.25 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -177.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.58 -49.33 3.18 Favored 'General case' 0 CA--C 1.501 -0.934 0 C-N-CA 119.017 -1.073 . . . . 0.0 112.961 -175.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.456 ' OE2' HG22 ' A' ' 10' ' ' THR . 12.5 pt-20 -107.31 -4.8 18.28 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.128 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 55.2 mtmt 66.12 41.56 3.51 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.029 176.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.13 164.48 26.12 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.148 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -95.18 -22.09 18.06 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.368 0.604 . . . . 0.0 110.193 -175.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -155.11 170.15 22.48 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.86 141.38 5.98 Favored Glycine 0 CA--C 1.482 -2.003 0 N-CA-C 107.562 -2.215 . . . . 0.0 107.562 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.3 t -175.79 168.48 3.06 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 86.1 m -63.51 106.67 0.98 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.835 0.826 . . . . 0.0 110.065 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 t30 . . . . . 0 C--N 1.295 -1.789 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.151 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 15' ' ' CYS . 33.7 mmtp . . . . . 0 N--CA 1.45 -0.425 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 99.0 m -60.55 111.05 1.44 Allowed 'General case' 0 C--O 1.203 -1.389 0 CA-C-N 118.661 0.664 . . . . 0.0 110.208 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.9 mm -110.71 137.7 41.99 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 59.6 m -86.56 148.52 25.47 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.447 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 92.2 m-85 -123.79 132.26 53.75 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 122.113 -0.367 . . . . 0.0 110.43 -177.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -105.97 148.79 37.18 Favored Pre-proline 0 C--N 1.285 -2.221 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.514 175.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.28 132.18 11.19 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 122.256 1.971 . . . . 0.0 112.259 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 74.2 m . . . . . 0 C--N 1.284 -2.246 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.555 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.1 tttp . . . . . 0 N--CA 1.444 -0.735 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 88.5 mt -93.2 99.99 12.45 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.33 0.586 . . . . 0.0 109.872 176.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.8 m -89.74 118.64 29.49 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.477 ' HB2' ' CG2' ' A' ' 46' ' ' ILE . 3.8 pt20 -81.89 138.44 35.02 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -173.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -133.38 118.28 14.82 Favored Pre-proline 0 C--N 1.308 -1.201 0 C-N-CA 125.161 1.384 . . . . 0.0 108.121 178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.25 -63.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.732 1.621 . . . . 0.0 113.035 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.6 p -88.63 128.06 35.58 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -172.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.07 -75.28 0.06 OUTLIER Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.8 t -104.22 -36.82 7.52 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 171.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -67.62 135.68 53.24 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.448 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.7 t -156.26 89.67 1.14 Allowed 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.67 34.42 83.44 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.062 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.5 t -118.82 102.41 13.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.166 0.508 . . . . 0.0 110.783 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.8 t -140.28 80.24 1.75 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.452 0.644 . . . . 0.0 109.528 176.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.87 -60.98 0.53 Allowed Glycine 0 N--CA 1.426 -2.021 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -122.94 132.82 54.33 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -63.89 -45.1 90.87 Favored 'General case' 0 C--O 1.205 -1.285 0 O-C-N 123.746 0.654 . . . . 0.0 109.863 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -63.76 -33.68 76.2 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.6 -46.52 63.25 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.2 p -76.38 -28.48 56.78 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.524 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -56.02 -56.26 22.96 Favored 'General case' 0 C--O 1.251 1.137 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 173.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -58.74 -40.71 84.59 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.026 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -59.78 -40.88 89.73 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.9 m -64.98 -55.02 21.48 Favored 'General case' 0 C--O 1.252 1.209 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 54.9 mt -56.78 -41.52 75.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.159 -177.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -82.82 -17.02 45.47 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -106.7 -59.95 1.73 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 119.507 -0.877 . . . . 0.0 113.124 -177.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -104.83 1.08 28.73 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.988 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 97.2 mttt 65.95 60.57 0.67 Allowed 'General case' 0 CA--C 1.498 -1.042 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.567 172.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.38 176.02 7.09 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.241 176.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -93.66 -39.75 10.63 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.237 0.542 . . . . 0.0 109.625 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -146.57 170.68 16.41 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.78 137.81 4.81 Favored Glycine 0 C--N 1.292 -1.884 0 N-CA-C 108.029 -2.028 . . . . 0.0 108.029 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.2 p -172.14 161.54 5.51 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 117.451 0.626 . . . . 0.0 111.352 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 81.4 m -73.47 101.42 3.51 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.29 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 . . . . . 0 C--N 1.291 -1.965 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.16 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 66.6 mttm . . . . . 0 CA--C 1.499 -1.009 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 22.9 t -78.2 119.43 21.58 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.517 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.477 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 21.2 mm -114.44 138.92 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.446 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 69.0 m -85.67 137.93 32.49 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.421 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 88.8 m-85 -113.15 122.25 46.95 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 122.043 -0.411 . . . . 0.0 110.444 -178.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -103.6 143.59 26.94 Favored Pre-proline 0 C--N 1.293 -1.876 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.537 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -79.84 116.08 3.41 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 122.464 2.109 . . . . 0.0 112.737 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 84.3 m . . . . . 0 C--N 1.293 -1.873 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.695 176.659 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.3 mttm . . . . . 0 N--CA 1.442 -0.842 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.9 mt -123.35 113.93 19.5 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.586 0.707 . . . . 0.0 110.048 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.9 m -98.33 123.57 42.51 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.416 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -85.94 143.64 28.08 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.424 -176.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -148.84 123.01 4.75 Favored Pre-proline 0 C--N 1.298 -1.673 0 C-N-CA 123.756 0.822 . . . . 0.0 109.564 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.96 153.65 63.33 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 122.357 2.038 . . . . 0.0 109.389 173.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.8 t -147.73 160.3 42.86 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.52 -3.85 86.86 Favored Glycine 0 C--O 1.239 0.45 0 O-C-N 123.42 0.45 . . . . 0.0 112.572 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.6 p -71.6 -55.76 7.16 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -56.53 143.69 34.43 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.324 169.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.2 t -156.98 137.33 12.91 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.271 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.22 -164.85 31.13 Favored Glycine 0 C--O 1.249 1.075 0 C-N-CA 121.462 -0.399 . . . . 0.0 113.543 175.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.9 t -84.48 147.52 5.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.6 t -93.01 129.93 38.76 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -122.2 -44.88 0.34 Allowed Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -107.92 104.69 14.21 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -54.97 -53.5 54.86 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.484 1.114 . . . . 0.0 111.183 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -64.83 -32.65 74.45 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.819 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.9 -49.33 65.94 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.459 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.8 p -77.3 -27.84 53.13 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.495 -177.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -55.92 -56.97 14.31 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 173.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -59.5 -38.78 81.79 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.102 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -60.68 -46.22 91.17 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.897 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.51 ' HA ' ' OE2' ' A' ' 29' ' ' GLU . 75.1 m -62.42 -45.29 93.77 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-O 122.451 1.12 . . . . 0.0 108.943 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 72.6 mt -59.97 -32.44 50.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.678 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -86.23 -15.23 41.46 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.2 mt -109.27 -60.62 1.74 Allowed 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.864 -176.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.51 ' OE2' ' HA ' ' A' ' 25' ' ' CYS . 1.8 pm0 -99.38 -1.35 38.97 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.04 0.448 . . . . 0.0 111.347 178.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 68.2 mttm 63.64 45.73 4.47 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.584 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.442 ' O ' HG12 ' A' ' 26' ' ' ILE . . . -71.81 179.99 2.91 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.986 177.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -104.99 -31.3 9.29 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.557 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.472 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 84.4 t60 -147.39 171.56 15.29 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -176.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.9 136.04 3.67 Favored Glycine 0 CA--C 1.488 -1.634 0 N-CA-C 107.471 -2.252 . . . . 0.0 107.471 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.8 m -158.63 163.64 36.74 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 118.531 1.165 . . . . 0.0 113.709 -177.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 34.0 m -70.11 100.64 1.68 Allowed 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 113.9 -1.5 . . . . 0.0 109.35 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.3 t30 . . . . . 0 C--N 1.297 -1.683 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.925 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? . . . . . 0 C--O 1.219 -0.526 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.0 t -90.95 126.49 36.08 Favored 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.22 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.5 mm -116.57 139.61 42.6 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.2 m -88.46 140.62 29.28 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.472 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 30.9 m-85 -114.49 129.25 56.64 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.275 0.56 . . . . 0.0 109.986 -177.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -109.19 152.36 42.51 Favored Pre-proline 0 C--N 1.288 -2.069 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -78.02 142.57 19.72 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 121.642 1.561 . . . . 0.0 111.529 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 76.2 m . . . . . 0 C--N 1.287 -2.126 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.836 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 C--O 1.253 1.241 0 CA-C-O 121.152 0.501 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 80.8 mt -126.73 138.8 53.44 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.78 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.2 m -89.12 123.54 33.49 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.49 ' HG2' ' CE2' ' A' ' 48' ' ' TYR . 41.7 mt-30 -85.44 130.82 34.5 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.152 -176.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -135.79 107.39 9.83 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -68.24 -74.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.703 2.269 . . . . 0.0 115.325 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 p -84.91 134.82 34.25 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -169.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.23 -85.38 0.09 OUTLIER Glycine 0 N--CA 1.42 -2.419 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 t -86.14 -39.71 16.41 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.48 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 21.5 t90 -62.57 128.73 37.36 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.349 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.2 m -155.49 102.17 2.23 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 124.988 1.315 . . . . 0.0 107.675 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.23 -146.77 18.37 Favored Glycine 0 N--CA 1.42 -2.373 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.43 170.69 13.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.2 t -69.84 110.81 5.17 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.382 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.52 -55.03 1.37 Allowed Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -140.72 129.59 23.15 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -58.26 -46.64 85.63 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.483 0.489 . . . . 0.0 110.972 -176.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -65.75 -31.27 72.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.604 -177.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -48.45 65.44 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.709 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.1 p -74.46 -25.55 59.48 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.873 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -56.13 -57.92 10.13 Favored 'General case' 0 C--O 1.249 1.059 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 171.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -61.2 -36.29 79.47 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.8 -1.546 . . . . 0.0 110.629 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -64.89 -38.78 92.1 Favored 'General case' 0 C--O 1.21 -0.982 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 86.6 m -66.81 -54.49 22.0 Favored 'General case' 0 C--O 1.253 1.268 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 65.9 mt -56.47 -37.06 49.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.742 -177.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -86.53 -21.91 26.66 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -104.0 -55.56 2.35 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 118.9 -1.12 . . . . 0.0 113.156 -175.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -107.81 1.19 22.67 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.566 -0.853 . . . . 0.0 111.821 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm 62.64 60.99 1.25 Allowed 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.548 -1.206 . . . . 0.0 112.709 174.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.08 171.84 9.25 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.807 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -81.78 -33.38 30.92 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -157.85 171.58 20.03 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.9 137.88 5.75 Favored Glycine 0 C--N 1.295 -1.744 0 N-CA-C 106.813 -2.515 . . . . 0.0 106.813 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.1 t -160.14 162.52 33.98 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 118.113 0.957 . . . . 0.0 110.717 -176.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 21.0 m -78.59 104.55 9.27 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.409 ' HB3' ' CG1' ' A' ' 46' ' ' ILE . 6.8 t30 . . . . . 0 C--N 1.3 -1.555 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.372 -173.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 48.2 mtmt . . . . . 0 N--CA 1.434 -1.245 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.1 m -86.28 132.18 34.05 Favored 'General case' 0 CA--C 1.494 -1.196 0 O-C-N 123.608 0.567 . . . . 0.0 109.638 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.409 ' CG1' ' HB3' ' A' ' 37' ' ' ASN . 36.2 mm -120.91 139.89 46.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 82.9 m -87.03 138.15 31.74 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.49 ' CE2' ' HG2' ' A' ' 5' ' ' GLN . 93.3 m-85 -113.33 116.31 29.5 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -177.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -99.89 148.21 34.49 Favored Pre-proline 0 C--N 1.295 -1.801 0 C-N-CA 122.769 0.427 . . . . 0.0 110.379 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.16 125.04 9.96 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.045 1.83 . . . . 0.0 112.97 -175.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 77.6 m . . . . . 0 C--O 1.252 1.192 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 176.5 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.2 tttp . . . . . 0 N--CA 1.428 -1.567 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.443 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 86.2 mt -76.42 104.89 7.17 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.677 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.7 m -87.19 126.71 34.97 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -80.89 145.74 31.17 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.201 0.524 . . . . 0.0 111.779 -173.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -125.42 109.14 26.47 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.4 -56.16 0.95 Allowed 'Trans proline' 0 C--O 1.203 -1.248 0 C-N-CA 122.542 2.161 . . . . 0.0 113.62 -176.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.3 m -137.66 101.43 4.47 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.687 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -109.63 -61.01 0.51 Allowed Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 171.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 t -118.1 -36.95 3.47 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.441 -0.38 . . . . 0.0 111.689 172.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.608 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 17.8 t90 -46.5 130.97 11.19 Favored 'General case' 0 C--N 1.358 0.941 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.5 m -150.44 121.2 7.54 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.2 -159.23 22.67 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.46 161.12 4.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.448 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 30.3 t -85.5 90.37 7.95 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.25 -35.81 4.06 Favored Glycine 0 C--N 1.313 -0.72 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.607 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -137.67 110.91 7.87 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -56.19 -43.16 78.19 Favored 'General case' 0 CA--C 1.49 -1.333 0 O-C-N 123.624 0.578 . . . . 0.0 109.872 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -59.41 -35.47 74.03 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.315 -177.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.59 -53.16 9.92 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.971 -177.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 4.8 p -70.55 -32.23 69.59 Favored 'General case' 0 C--O 1.214 -0.792 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -54.62 -52.22 62.92 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 173.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -58.49 -46.58 86.37 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.632 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -54.32 -44.21 71.85 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.784 0.677 . . . . 0.0 111.225 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 68.8 m -61.45 -56.96 14.4 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 59.6 mt -55.23 -35.78 37.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 124.894 1.277 . . . . 0.0 111.322 -177.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -75.99 -34.15 59.74 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -110.47 -49.3 3.07 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 118.483 -1.287 . . . . 0.0 113.639 -171.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -97.03 -9.64 27.74 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.629 0.728 . . . . 0.0 109.414 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 97.2 mttt 61.51 61.55 1.47 Allowed 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 113.921 -1.491 . . . . 0.0 112.619 177.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.25 -179.51 5.44 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.009 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -100.96 -34.93 9.57 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.173 0.511 . . . . 0.0 110.084 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -143.2 168.91 18.64 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.76 132.63 2.89 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.7 p -155.07 -179.88 8.49 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 117.737 0.769 . . . . 0.0 112.234 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 84.6 m -81.91 126.5 31.98 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.009 0.433 . . . . 0.0 110.948 -176.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.4 m120 . . . . . 0 C--N 1.289 -2.063 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 169.241 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.408 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 53.9 mttp . . . . . 0 N--CA 1.439 -1.003 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.608 ' HB2' ' CD1' ' A' ' 11' ' ' TRP . 96.4 m -88.49 113.03 23.66 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.6 mm -105.28 135.65 42.48 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.718 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.6 m -87.46 159.96 18.47 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 123.692 0.62 . . . . 0.0 109.701 -177.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.443 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 96.3 m-85 -132.15 128.1 37.34 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -176.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -111.17 150.73 42.41 Favored Pre-proline 0 C--N 1.308 -1.218 0 C-N-CA 123.637 0.775 . . . . 0.0 110.158 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -84.18 113.91 1.83 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.73 2.287 . . . . 0.0 113.466 -177.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 82.9 m . . . . . 0 C--N 1.295 -1.798 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.224 175.821 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.423 ' HA ' ' OXT' ' A' ' 51' ' ' CYS . 7.4 tt0 . . . . . 0 CA--C 1.511 -0.546 0 CA-C-O 120.677 0.275 . . . . 0.0 110.657 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -134.04 -173.51 3.28 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 171.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.9 mt -108.21 127.77 54.13 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.249 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.4 p -108.87 141.83 40.35 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.463 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 3.9 pt20 -96.71 144.13 27.0 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -174.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 -147.58 114.17 4.07 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -75.36 -39.02 1.21 Allowed 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.096 1.864 . . . . 0.0 114.728 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.2 m -94.4 139.37 31.2 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -172.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.7 -86.29 0.1 Allowed Glycine 0 N--CA 1.411 -3.025 0 N-CA-C 107.808 -2.117 . . . . 0.0 107.808 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.438 HG22 ' OE2' ' A' ' 29' ' ' GLU . 10.2 t -101.31 -33.72 9.92 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-O 121.263 0.554 . . . . 0.0 110.65 178.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.591 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 60.9 t90 -72.74 140.32 47.72 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.396 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.7 m -160.46 110.38 1.77 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.581 1.552 . . . . 0.0 107.588 170.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.19 -121.12 2.13 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.795 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -120.71 171.06 9.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 C-N-CA 122.977 0.511 . . . . 0.0 110.127 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.62 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 31.6 t -96.42 99.17 10.86 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 176.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.26 -71.27 1.14 Allowed Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.714 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -127.54 133.5 49.8 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -53.42 -56.76 14.16 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 124.369 1.043 . . . . 0.0 110.777 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.42 -34.26 77.35 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.411 -174.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.33 -60.0 3.7 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 124.04 0.837 . . . . 0.0 111.524 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.5 p -74.11 -23.53 59.33 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.763 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -55.53 -56.95 14.27 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 172.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -60.43 -41.39 93.91 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.973 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -60.1 -41.67 93.05 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.848 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 76.8 m -62.86 -56.49 16.91 Favored 'General case' 0 C--O 1.253 1.272 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 61.2 mt -53.24 -36.86 26.74 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.578 -176.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -78.9 -41.55 29.36 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.68 -62.72 1.41 Allowed 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.84 -168.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.438 ' OE2' HG22 ' A' ' 10' ' ' THR . 10.9 pt-20 -93.9 -6.88 44.63 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.532 0.682 . . . . 0.0 110.213 -176.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 56.6 mttp 64.19 66.84 0.61 Allowed 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 113.758 -1.564 . . . . 0.0 112.589 175.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.71 -178.91 4.69 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 113.363 -1.744 . . . . 0.0 108.189 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -102.79 -29.5 11.44 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.424 0.63 . . . . 0.0 109.894 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -152.63 179.54 8.51 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.06 139.58 4.48 Favored Glycine 0 C--N 1.302 -1.311 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.4 m -161.5 173.68 14.49 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 118.417 1.108 . . . . 0.0 111.762 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.6 m -75.05 102.22 4.79 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.311 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -99.54 132.95 44.54 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -85.34 92.59 8.5 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-O 121.79 0.805 . . . . 0.0 111.69 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.1 m -99.6 144.38 12.22 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 169.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -62.34 134.56 94.86 Favored Pre-proline 0 C--N 1.301 -1.507 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.042 -176.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -107.03 19.01 7.98 Favored 'Cis proline' 0 CA--C 1.548 1.223 0 C-N-CA 124.841 -0.899 . . . . 0.0 114.41 0.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.65 151.33 20.23 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 118.574 0.625 . . . . 0.0 112.41 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -59.76 132.87 55.28 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.771 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -131.43 152.31 50.78 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.841 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.62 ' SG ' ' HA ' ' A' ' 15' ' ' CYS . 78.0 m -79.25 104.97 10.24 Favored 'General case' 0 CA--C 1.479 -1.757 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.461 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 22.0 mm -103.48 129.82 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.761 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 60.1 m -84.61 136.9 33.57 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.463 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 76.9 m-85 -110.4 123.44 49.88 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-O 121.394 0.616 . . . . 0.0 110.957 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -105.99 157.65 34.27 Favored Pre-proline 0 C--N 1.283 -2.311 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.166 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -77.41 116.15 4.05 Favored 'Trans proline' 0 N--CA 1.435 -1.939 0 C-N-CA 121.548 1.499 . . . . 0.0 111.404 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.423 ' OXT' ' HA ' ' A' ' 1' ' ' GLN . 95.0 m . . . . . 0 C--N 1.282 -2.367 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 . . . . . 0 N--CA 1.448 -0.563 0 CA-C-O 121.529 0.681 . . . . 0.0 109.65 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -131.53 141.97 49.84 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 90.5 mt -89.08 99.88 12.77 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.78 0.8 . . . . 0.0 110.128 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.9 m -86.07 112.28 21.11 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.971 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -73.99 136.38 43.18 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.868 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -145.17 115.26 5.0 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -68.7 -73.31 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.683 2.255 . . . . 0.0 115.776 -176.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.9 m -90.29 97.36 11.14 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -170.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -119.92 -73.62 0.39 Allowed Glycine 0 N--CA 1.422 -2.234 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 168.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.434 HG23 ' OE2' ' A' ' 29' ' ' GLU . 8.7 t -108.25 -26.53 10.51 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 173.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.649 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 20.2 t90 -62.17 136.07 57.78 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-O 121.252 0.549 . . . . 0.0 112.3 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -157.4 108.22 2.27 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.288 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.31 -157.57 22.78 Favored Glycine 0 N--CA 1.431 -1.675 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.806 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.67 149.3 4.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 33.7 t -83.76 123.85 30.29 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.77 -64.26 0.88 Allowed Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.211 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -122.5 126.16 47.26 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -54.85 -47.72 73.79 Favored 'General case' 0 C--O 1.207 -1.162 0 O-C-N 123.903 0.752 . . . . 0.0 110.066 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -62.27 -40.5 96.44 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.704 -177.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.28 -47.06 65.68 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.54 -177.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.5 p -73.35 -34.48 65.65 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.5 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.403 ' HG3' ' N ' ' A' ' 34' ' ' GLY . 39.9 ttpt -55.33 -54.43 43.68 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.571 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 48.2 t30 -56.69 -46.74 81.02 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.228 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -56.2 -41.87 76.27 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.498 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.3 m -62.46 -51.97 65.39 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.6 mt -58.24 -35.7 54.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.08 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 9.3 mmp_? -74.78 -29.98 61.29 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.89 -57.67 2.07 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 119.463 -0.895 . . . . 0.0 112.546 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.434 ' OE2' HG23 ' A' ' 10' ' ' THR . 12.9 pt-20 -98.05 -5.12 34.59 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.555 -175.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 62.32 63.14 1.08 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.283 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.15 -179.02 5.56 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.648 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.527 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 4.5 mmp_? -106.88 -21.21 13.09 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.145 0.498 . . . . 0.0 110.534 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 78.2 t60 -158.13 170.28 22.64 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.403 ' N ' ' HG3' ' A' ' 22' ' ' LYS . . . -164.67 140.54 6.49 Favored Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 106.378 -2.689 . . . . 0.0 106.378 177.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.0 t -155.21 153.29 30.47 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 118.37 1.085 . . . . 0.0 111.025 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 61.0 m -73.16 93.52 1.84 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -105.21 143.49 33.31 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -81.35 120.31 24.79 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.556 0.693 . . . . 0.0 110.917 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.6 m -129.07 -177.38 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.576 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 172.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 67.8 t80 -75.92 129.73 80.26 Favored Pre-proline 0 C--N 1.285 -2.22 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.816 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 61.3 Cg_endo -110.86 25.93 3.34 Favored 'Cis proline' 0 CA--C 1.555 1.533 0 C-N-CA 124.806 -0.914 . . . . 0.0 111.647 -5.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.22 175.84 12.94 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 120.906 0.384 . . . . 0.0 111.84 -174.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -73.85 110.92 8.52 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.049 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.649 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 97.3 mttt -119.43 157.64 27.82 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 24.6 t -90.67 123.9 34.65 Favored 'General case' 0 CA--C 1.48 -1.731 0 C-N-CA 118.624 -1.23 . . . . 0.0 109.278 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 mm -111.35 128.98 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.541 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 37.8 m -85.18 147.04 26.8 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.4 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 93.3 m-85 -118.11 122.82 44.07 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.913 -0.492 . . . . 0.0 110.539 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -104.85 152.39 39.54 Favored Pre-proline 0 C--N 1.3 -1.562 0 C-N-CA 123.589 0.756 . . . . 0.0 110.988 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -88.33 107.76 0.54 Allowed 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 122.79 2.326 . . . . 0.0 112.67 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 82.0 m . . . . . 0 C--N 1.279 -2.46 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 174.736 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.439 ' H1 ' ' C ' ' A' ' 51' ' ' CYS . 15.5 mm100 . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 120.883 0.373 . . . . 0.0 111.491 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -104.69 -175.43 2.79 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.8 mt -121.95 132.04 54.33 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 67.7 m -106.69 129.6 54.56 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.65 151.42 25.3 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -144.45 123.74 7.12 Favored Pre-proline 0 C--N 1.305 -1.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.838 -177.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -68.65 103.03 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.022 1.815 . . . . 0.0 108.129 170.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.544 ' HB3' ' OE1' ' A' ' 29' ' ' GLU . 61.8 m -98.33 161.46 13.68 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -171.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.56 -35.21 52.26 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.307 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.2 t -60.85 -34.53 74.73 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.9 0.381 . . . . 0.0 110.142 175.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -57.82 106.34 0.35 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.784 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.4 t -150.28 91.69 1.79 Allowed 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.6 173.78 23.13 Favored Glycine 0 N--CA 1.422 -2.29 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.187 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.4 m -98.0 171.51 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 123.004 0.521 . . . . 0.0 110.248 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.5 t -69.03 108.38 3.52 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.031 -0.532 . . . . 0.0 112.175 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.36 -91.45 0.69 Allowed Glycine 0 N--CA 1.42 -2.402 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 173.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -91.13 114.92 27.58 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -65.38 -43.64 90.06 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 123.752 0.657 . . . . 0.0 111.002 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -70.16 -36.5 74.75 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.111 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.85 -43.68 95.42 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.981 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.2 p -76.2 -29.36 57.61 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.68 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -57.72 -56.68 18.79 Favored 'General case' 0 C--O 1.251 1.154 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -61.01 -36.87 80.63 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.46 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -63.5 -41.4 98.53 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.08 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 97.7 m -62.65 -49.71 74.09 Favored 'General case' 0 C--O 1.259 1.577 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 60.9 mt -58.91 -33.59 50.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.149 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -83.6 -21.49 32.56 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.74 -65.14 0.98 Allowed 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.245 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.544 ' OE1' ' HB3' ' A' ' 8' ' ' SER . 10.9 pt-20 -106.26 -1.3 23.66 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.845 -177.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.2 mttp 64.26 65.11 0.68 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.708 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.85 -176.17 5.4 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.437 175.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -101.97 -29.88 11.54 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.083 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 31.4 t60 -151.2 173.56 14.28 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.0 139.75 5.96 Favored Glycine 0 C--N 1.295 -1.735 0 N-CA-C 106.478 -2.649 . . . . 0.0 106.478 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.0 t -163.04 167.47 22.34 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 118.384 1.092 . . . . 0.0 109.974 -174.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 89.6 m -72.83 95.16 1.89 Allowed 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.061 175.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -90.9 137.21 32.54 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -81.61 95.58 7.22 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.474 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.1 m -99.49 159.41 3.55 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 172.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -74.05 133.69 78.39 Favored Pre-proline 0 C--N 1.28 -2.439 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.377 -175.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -106.69 19.82 8.52 Favored 'Cis proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.779 -0.925 . . . . 0.0 112.702 -2.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -155.72 151.0 26.82 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 122.145 -0.347 . . . . 0.0 110.887 -175.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -58.99 133.8 56.41 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.819 0.848 . . . . 0.0 112.313 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -134.63 156.31 48.95 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.3 m -81.91 94.61 7.14 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.618 0.723 . . . . 0.0 111.458 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.75 143.59 11.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 74.2 m -90.0 148.22 23.21 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.481 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.455 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 38.9 m-85 -120.11 130.34 54.59 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.224 0.535 . . . . 0.0 110.844 -177.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -110.8 151.07 42.66 Favored Pre-proline 0 C--N 1.297 -1.678 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.338 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.57 132.06 10.8 Favored 'Trans proline' 0 C--O 1.253 1.262 0 C-N-CA 122.412 2.075 . . . . 0.0 113.276 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.439 ' C ' ' H1 ' ' A' ' 1' ' ' GLN . 68.9 m . . . . . 0 N--CA 1.435 -1.225 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 . . . . . 0 C--O 1.237 0.401 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -120.59 161.66 20.96 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 172.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 92.4 mt -93.21 110.16 21.68 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-O 121.351 0.596 . . . . 0.0 110.46 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 8.2 p -89.08 127.43 35.7 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.46 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 4.3 pt20 -87.43 133.4 33.74 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.209 0.528 . . . . 0.0 111.516 -175.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -126.04 119.84 23.87 Favored Pre-proline 0 C--O 1.265 1.878 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.267 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -71.44 125.96 11.75 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.582 2.188 . . . . 0.0 107.427 169.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.5 t -144.27 160.89 40.23 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.878 -171.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.26 20.04 43.03 Favored Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.655 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.4 p -83.8 -58.29 2.86 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.461 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 1.6 t90 -57.8 144.46 38.44 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.161 169.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.8 t -146.33 119.68 8.99 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.26 -135.23 12.45 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.948 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -125.55 170.92 14.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -175.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.4 t -60.66 108.52 0.85 Allowed 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.093 0.473 . . . . 0.0 111.227 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -116.0 -88.41 1.45 Allowed Glycine 0 N--CA 1.427 -1.949 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -95.46 106.43 18.5 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 122.534 0.333 . . . . 0.0 110.228 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -59.9 -56.09 26.01 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.424 1.09 . . . . 0.0 111.751 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -71.53 -30.1 65.53 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.789 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.64 -42.01 64.86 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.363 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 30.6 p -70.66 -32.33 69.56 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.823 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -55.71 -56.7 17.36 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 172.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -58.8 -37.27 75.99 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.127 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.505 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 20.9 tt0 -63.77 -44.19 94.14 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.236 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 99.0 m -62.08 -49.48 75.79 Favored 'General case' 0 C--O 1.259 1.562 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.623 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 65.9 mt -59.24 -32.81 49.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.401 -177.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.516 ' HA ' ' NE ' ' A' ' 27' ' ' ARG . 4.1 mmp_? -97.05 -8.94 29.12 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 24' ' ' GLN . 42.4 mt -102.04 -62.98 1.19 Allowed 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.63 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -99.17 -3.85 33.48 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.177 0.513 . . . . 0.0 110.01 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.623 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 56.4 mtmt 68.92 50.74 0.59 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.646 175.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.08 178.66 7.35 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.063 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -98.74 -34.2 10.61 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -151.61 175.17 12.62 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 -176.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -169.0 141.34 6.67 Favored Glycine 0 C--N 1.289 -2.064 0 N-CA-C 106.869 -2.492 . . . . 0.0 106.869 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.0 p -169.03 169.51 9.49 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 118.114 0.957 . . . . 0.0 112.062 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 44' ' ' LYS . 78.0 m -80.63 117.49 21.37 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.631 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -126.25 142.85 51.37 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -75.65 120.45 21.07 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.208 0.528 . . . . 0.0 111.103 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.5 m -133.77 -177.52 2.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 175.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -75.77 132.16 75.3 Favored Pre-proline 0 C--N 1.285 -2.207 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -104.76 10.32 10.77 Favored 'Cis proline' 0 CA--C 1.553 1.451 0 C-N-CA 124.498 -1.042 . . . . 0.0 113.797 -1.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -163.95 -176.82 4.74 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -67.33 117.22 9.03 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.473 0.654 . . . . 0.0 110.232 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 31.1 mmtp -120.95 162.96 19.0 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 23.8 t -92.22 113.54 25.83 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.8 mm -105.71 142.07 19.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 61.3 m -88.46 145.63 25.66 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.46 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 70.6 m-85 -121.45 136.58 54.94 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.067 0.46 . . . . 0.0 111.375 -176.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -117.82 164.58 19.12 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -85.31 108.78 1.12 Allowed 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 121.893 1.729 . . . . 0.0 111.837 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 98.9 m . . . . . 0 C--N 1.302 -1.497 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.992 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 . . . . . 0 CA--C 1.505 -0.76 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -113.01 151.54 30.51 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 88.7 mt -96.76 108.58 21.26 Favored 'General case' 0 C--N 1.288 -2.085 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.096 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.7 m -82.22 129.63 34.89 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.423 ' HB2' HG23 ' A' ' 46' ' ' ILE . 4.0 pt20 -85.6 141.32 29.9 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.216 0.531 . . . . 0.0 110.987 -177.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -144.57 108.56 4.8 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -77.49 -55.25 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.472 2.114 . . . . 0.0 115.433 -175.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 m -98.22 109.85 22.54 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -172.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.85 -69.88 0.02 OUTLIER Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 108.051 -2.02 . . . . 0.0 108.051 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.445 HG21 ' HA ' ' A' ' 25' ' ' CYS . 7.0 t -103.96 -39.17 6.7 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 170.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.475 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 78.7 t90 -70.76 123.38 21.81 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-O 121.484 0.659 . . . . 0.0 110.731 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.1 m -162.06 96.62 1.0 Allowed 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 125.739 1.616 . . . . 0.0 106.661 174.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.33 -131.73 3.69 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.408 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.9 m -117.66 164.73 13.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 122.627 0.371 . . . . 0.0 110.696 -177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.7 t -92.74 106.71 18.64 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 120.821 0.343 . . . . 0.0 110.66 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.51 -67.75 1.5 Allowed Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 176.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -129.38 132.57 47.07 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -66.41 -47.1 74.35 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.682 0.753 . . . . 0.0 110.001 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -72.65 -16.86 61.7 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.786 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.94 -38.06 14.77 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.776 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.4 p -72.71 -30.88 64.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -53.25 -53.57 48.83 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 171.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -61.79 -40.27 94.62 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 113.855 -1.52 . . . . 0.0 110.062 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -59.88 -39.11 84.16 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 123.358 0.663 . . . . 0.0 110.4 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.445 ' HA ' HG21 ' A' ' 10' ' ' THR . 91.5 m -64.12 -55.5 21.53 Favored 'General case' 0 C--O 1.25 1.107 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 55.9 mt -58.17 -33.83 47.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.701 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -85.42 -21.4 28.79 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.25 -67.9 0.88 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.401 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -97.18 2.67 51.32 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.56 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 49.7 mttp 60.96 57.68 2.5 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 114.057 -1.429 . . . . 0.0 112.215 171.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.64 -179.09 7.23 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.256 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -101.19 -27.23 13.34 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.681 0.753 . . . . 0.0 109.256 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -151.55 171.48 17.53 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.722 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.96 143.63 8.17 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 106.829 -2.508 . . . . 0.0 106.829 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.6 p -165.58 151.3 9.29 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 117.888 0.844 . . . . 0.0 111.284 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 62.5 m -81.79 100.32 9.49 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.718 0.771 . . . . 0.0 110.241 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -79.36 142.77 35.73 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.603 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -73.27 105.94 4.89 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.412 0.625 . . . . 0.0 110.322 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.6 m -126.84 164.48 27.23 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -82.0 137.24 46.65 Favored Pre-proline 0 C--N 1.289 -2.03 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -98.83 3.61 29.36 Favored 'Cis proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.209 -1.163 . . . . 0.0 113.281 -1.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.83 156.03 41.75 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -61.78 123.98 19.47 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 123.54 0.525 . . . . 0.0 110.473 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.475 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 97.6 mttt -118.58 147.77 43.37 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 11.7 t -84.66 125.95 32.94 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 121.178 0.513 . . . . 0.0 110.739 -173.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.423 HG23 ' HB2' ' A' ' 5' ' ' GLN . 18.4 mm -117.22 134.2 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.451 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 67.6 m -82.9 149.88 26.82 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.445 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 76.1 m-85 -127.24 126.84 43.43 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.086 0.469 . . . . 0.0 111.266 -177.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -110.53 144.87 31.09 Favored Pre-proline 0 C--N 1.302 -1.472 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.775 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -82.65 114.31 2.35 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 122.337 2.025 . . . . 0.0 112.269 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 C--N 1.288 -2.069 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.929 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 . . . . . 0 C--O 1.236 0.37 0 CA-C-O 121.254 0.549 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -93.53 168.34 11.1 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 83.4 mt -79.94 117.35 20.71 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-O 121.193 0.521 . . . . 0.0 110.653 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.1 p -98.18 129.88 44.94 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -87.89 130.74 34.81 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.308 0.575 . . . . 0.0 111.774 -173.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -132.69 120.03 16.41 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.138 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -74.79 142.62 28.79 Favored 'Trans proline' 0 C--O 1.247 0.937 0 C-N-CA 122.21 1.94 . . . . 0.0 107.759 168.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.1 t -151.67 161.74 42.17 Favored 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.925 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.6 -7.32 87.19 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.399 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 p -65.54 -56.72 10.81 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.506 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 1.7 t90 -59.51 138.04 57.82 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.492 166.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.8 t -134.02 110.42 9.64 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-O 120.659 0.266 . . . . 0.0 111.052 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.78 -115.5 5.91 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 115.936 1.134 . . . . 0.0 115.936 171.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 p -83.94 137.15 21.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.807 0.813 . . . . 0.0 112.47 -174.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.1 t -90.73 112.5 24.29 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.36 -59.33 1.04 Allowed Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -112.92 120.35 41.13 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -54.97 -44.67 74.62 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.731 0.645 . . . . 0.0 110.354 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -66.04 -33.51 75.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.011 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.15 -46.41 56.56 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.11 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.4 p -73.22 -32.0 64.5 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.868 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -53.07 -60.08 3.74 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 123.854 0.862 . . . . 0.0 109.177 173.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -61.54 -34.47 75.6 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.004 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -65.8 -38.62 89.48 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.451 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.1 m -64.93 -49.07 71.81 Favored 'General case' 0 C--O 1.255 1.374 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.568 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 73.0 mt -57.14 -42.79 80.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.844 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -81.24 -14.15 57.76 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.7 mt -107.06 -55.72 2.29 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 119.087 -1.045 . . . . 0.0 112.078 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -110.89 1.42 17.58 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.097 0.475 . . . . 0.0 111.626 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 36.5 mtmm 66.82 45.92 1.78 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.122 174.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.21 172.42 11.17 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.999 -1.001 . . . . 0.0 108.88 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -91.62 -35.95 13.93 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -152.63 176.56 11.6 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -175.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.62 150.64 11.55 Favored Glycine 0 C--N 1.308 -0.987 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.2 p -172.27 168.27 5.66 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-N 118.372 1.086 . . . . 0.0 111.696 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.0 m -68.41 107.57 2.92 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -94.64 -29.69 14.71 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.702 0.763 . . . . 0.0 109.866 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.513 ' HB3' ' H ' ' A' ' 44' ' ' LYS . 19.3 t80 -93.16 -178.93 4.93 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.503 ' HA ' ' CD2' ' A' ' 43' ' ' HIS . 16.5 m -133.51 -155.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 125.303 1.441 . . . . 0.0 108.039 -176.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.567 ' CD1' ' HA ' ' A' ' 41' ' ' PRO . 87.1 t80 -48.69 145.24 6.22 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 124.38 1.072 . . . . 0.0 110.35 175.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.567 ' HA ' ' CD1' ' A' ' 40' ' ' PHE . 59.3 Cg_endo -90.26 6.8 67.73 Favored 'Cis proline' 0 C--N 1.353 0.775 0 C-N-CA 124.15 -1.188 . . . . 0.0 113.805 2.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.78 105.8 1.62 Allowed 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.503 ' CD2' ' HA ' ' A' ' 39' ' ' VAL . 56.5 m80 -59.51 128.34 36.54 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.513 ' H ' ' HB3' ' A' ' 38' ' ' TYR . 32.4 mmtp -105.33 146.4 29.43 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 45.2 t -103.9 131.7 50.87 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 50.1 mm -116.68 137.55 50.14 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.7 m -89.49 153.0 21.15 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.441 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 87.6 m-85 -126.0 135.96 52.43 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -116.78 159.42 40.7 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -82.42 101.4 1.08 Allowed 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.936 1.758 . . . . 0.0 112.149 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 85.2 m . . . . . 0 C--N 1.298 -1.635 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.709 179.117 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 . . . . . 0 CA--C 1.515 -0.37 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 51' ' ' CYS . 23.0 pttm -146.82 156.67 43.3 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.2 mt -95.43 105.47 17.44 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.248 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 86.3 m -80.78 135.65 36.0 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.732 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -90.67 128.72 36.73 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.208 0.527 . . . . 0.0 110.696 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -129.07 117.99 19.28 Favored Pre-proline 0 C--N 1.301 -1.52 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.161 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -78.53 116.78 3.88 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.036 1.824 . . . . 0.0 109.301 173.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.1 m -124.79 160.12 29.42 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.33 -25.67 60.67 Favored Glycine 0 C--N 1.334 0.421 0 O-C-N 124.217 0.948 . . . . 0.0 114.142 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.7 t -53.81 -47.64 70.65 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 117.219 0.51 . . . . 0.0 110.052 174.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -71.44 121.94 19.5 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 121.25 0.548 . . . . 0.0 109.796 173.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.0 p -153.41 100.2 2.41 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.432 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.96 -145.39 16.86 Favored Glycine 0 N--CA 1.427 -1.951 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.502 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.6 m -99.61 153.01 4.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -177.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.8 t -90.77 91.66 8.47 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.96 -60.17 2.98 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -120.95 129.9 53.62 Favored 'General case' 0 CA--C 1.486 -1.508 0 CA-C-N 115.472 -0.364 . . . . 0.0 110.111 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -56.17 -46.8 79.19 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 124.313 1.008 . . . . 0.0 109.577 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -64.64 -30.9 71.92 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.89 -53.37 21.54 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.5 p -74.89 -29.11 60.9 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.599 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.454 ' HE2' ' CE1' ' A' ' 33' ' ' HIS . 38.5 ttmt -52.62 -58.68 6.02 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-O 122.021 0.915 . . . . 0.0 108.623 173.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -59.17 -41.38 88.28 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.69 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -65.04 -32.34 74.01 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.327 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 98.5 m -66.97 -49.65 64.77 Favored 'General case' 0 C--O 1.255 1.359 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 57.0 mt -61.24 -28.03 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.33 -1.304 . . . . 0.0 111.176 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.456 ' HA ' ' NE ' ' A' ' 27' ' ' ARG . 3.3 mmp_? -92.82 -15.7 26.2 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -103.91 -62.41 1.31 Allowed 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.194 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -102.66 -1.4 30.21 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.199 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 56.0 mtpt 69.62 37.41 1.92 Allowed 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.215 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.58 175.88 3.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.144 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.404 ' HG2' ' HD3' ' A' ' 50' ' ' PRO . 6.7 mmp_? -90.94 -32.14 16.1 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.146 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.454 ' CE1' ' HE2' ' A' ' 22' ' ' LYS . 28.9 t60 -155.82 175.02 14.48 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -174.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -169.96 142.75 7.43 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 107.145 -2.382 . . . . 0.0 107.145 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.7 p -163.0 169.92 18.85 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 117.892 0.846 . . . . 0.0 110.9 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 68.6 m -67.91 107.4 2.64 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 175.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -90.96 -28.95 17.71 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.751 0.786 . . . . 0.0 109.092 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.403 ' HD1' ' O ' ' A' ' 39' ' ' VAL . 14.1 t80 -110.82 162.5 14.73 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.571 ' HA ' ' CD2' ' A' ' 43' ' ' HIS . 8.7 p -118.27 -179.5 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -171.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.611 ' CG ' ' HA ' ' A' ' 41' ' ' PRO . 50.8 t80 -51.83 145.59 16.34 Favored Pre-proline 0 C--N 1.31 -1.147 0 C-N-CA 124.188 0.995 . . . . 0.0 109.527 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.611 ' HA ' ' CG ' ' A' ' 40' ' ' PHE . 5.9 Cg_exo -78.87 -7.58 37.42 Favored 'Cis proline' 0 C--N 1.35 0.621 0 N-CA-C 115.147 1.172 . . . . 0.0 115.147 5.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -131.1 79.79 1.91 Allowed 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -175.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.571 ' CD2' ' HA ' ' A' ' 39' ' ' VAL . 73.9 m80 -64.41 113.1 3.42 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 175.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -98.49 141.61 31.14 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.9 t -100.55 128.96 46.44 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.9 mm -122.85 141.02 44.82 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 41.5 m -88.73 156.92 18.71 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' A' ' 4' ' ' CYS . 95.9 m-85 -126.54 142.65 51.47 Favored 'General case' 0 C--O 1.252 1.211 0 CA-C-O 121.039 0.447 . . . . 0.0 112.182 -177.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -126.67 151.31 73.1 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 124.312 1.045 . . . . 0.0 109.908 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.404 ' HD3' ' HG2' ' A' ' 32' ' ' ARG . 94.5 Cg_endo -86.99 107.37 0.7 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.725 2.283 . . . . 0.0 112.38 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 20.7 m . . . . . 0 C--N 1.291 -1.967 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 . . . . . 0 CA--C 1.503 -0.829 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.77 158.5 15.64 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 90.6 mt -96.74 99.99 11.56 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.7 p -87.63 114.68 24.47 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 114.596 -1.183 . . . . 0.0 109.681 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.496 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 18.8 pt20 -83.14 144.32 29.92 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -173.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -138.22 120.7 10.85 Favored Pre-proline 0 C--N 1.313 -1.004 0 C-N-CA 124.743 1.217 . . . . 0.0 108.453 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -73.82 108.76 2.72 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 121.681 1.587 . . . . 0.0 108.991 173.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.7 p -79.73 160.97 26.03 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.373 0.606 . . . . 0.0 112.567 -174.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.01 -24.64 57.41 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.3 t -71.34 -41.24 70.05 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.765 -0.218 . . . . 0.0 110.575 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -48.92 130.93 18.65 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.05 0.54 . . . . 0.0 112.225 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.9 t -91.23 127.94 36.86 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -33.23 -48.47 0.43 Allowed Glycine 0 N--CA 1.478 1.447 0 N-CA-C 117.513 1.765 . . . . 0.0 117.513 -171.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.6 131.67 36.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 117.355 0.577 . . . . 0.0 110.024 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.6 t -73.58 127.7 33.48 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.838 0.351 . . . . 0.0 110.143 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.77 -73.31 0.81 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -122.46 125.18 45.28 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -59.03 -46.03 89.25 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 123.756 0.66 . . . . 0.0 111.123 -175.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -75.02 -9.37 58.47 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.79 -47.04 8.49 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.6 p -75.16 -34.66 61.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.321 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -54.4 -55.02 32.91 Favored 'General case' 0 C--O 1.25 1.087 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 174.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.594 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 7.2 t30 -60.51 -41.9 95.32 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.052 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -58.29 -39.4 79.18 Favored 'General case' 0 C--O 1.211 -0.969 0 C-N-CA 122.795 0.438 . . . . 0.0 110.524 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 99.1 m -64.69 -54.5 30.65 Favored 'General case' 0 C--O 1.253 1.265 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 69.5 mt -58.38 -30.15 39.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.165 -1.379 . . . . 0.0 111.788 -175.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 28.3 mmt180 -89.5 -32.69 17.07 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.414 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.12 -66.55 0.91 Allowed 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.423 -172.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -94.59 -3.06 50.34 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.762 0.792 . . . . 0.0 110.154 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 47.9 mttp 61.84 65.44 0.92 Allowed 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 113.801 -1.545 . . . . 0.0 112.552 173.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.91 -177.53 4.54 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.401 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -99.43 -26.95 13.96 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.316 178.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -153.03 176.19 12.16 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -174.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.74 142.27 7.5 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 107.871 -2.091 . . . . 0.0 107.871 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.0 m -155.29 154.01 31.45 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 118.019 0.909 . . . . 0.0 111.064 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 76.1 m -87.08 91.23 8.63 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 122.397 1.094 . . . . 0.0 109.389 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -79.45 129.96 34.96 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.652 -1.613 . . . . 0.0 107.818 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.413 ' HB2' ' CD2' ' A' ' 43' ' ' HIS . 25.2 t80 -79.31 109.65 13.85 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.202 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.4 m -125.0 -170.69 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.528 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -77.65 131.25 71.45 Favored Pre-proline 0 C--N 1.287 -2.117 0 C-N-CA 118.737 -1.185 . . . . 0.0 108.878 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -109.66 18.72 4.85 Favored 'Cis proline' 0 CA--C 1.546 1.109 0 C-N-CA 124.855 -0.894 . . . . 0.0 112.55 -2.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.64 -178.73 6.75 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 120.846 0.355 . . . . 0.0 110.958 -173.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.413 ' CD2' ' HB2' ' A' ' 38' ' ' TYR . 49.0 m80 -73.8 113.54 11.07 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -119.38 136.47 54.26 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 6.9 t -79.62 115.26 19.13 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.531 0.681 . . . . 0.0 110.583 -173.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.474 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 22.5 mm -112.27 141.11 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.43 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 5' ' ' GLN . 51.7 m -83.61 144.3 29.54 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.496 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 63.5 m-85 -119.09 118.35 31.18 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.499 0.666 . . . . 0.0 111.643 -177.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -100.59 163.49 18.04 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.081 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -88.06 126.12 1.99 Allowed 'Trans proline' 0 N--CA 1.441 -1.586 0 C-N-CA 122.136 1.89 . . . . 0.0 111.667 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 69.6 m . . . . . 0 C--N 1.294 -1.829 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.662 177.554 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 . . . . . 0 CA--C 1.496 -1.097 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -96.12 175.55 6.42 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.2 mt -118.86 130.56 55.81 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 66.8 m -108.81 133.38 52.93 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 175.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.543 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 17.5 pt20 -94.52 134.84 36.63 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.658 0.742 . . . . 0.0 112.305 -177.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -137.53 120.77 11.54 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.634 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -66.72 132.94 30.1 Favored 'Trans proline' 0 C--O 1.246 0.88 0 C-N-CA 122.146 1.897 . . . . 0.0 109.415 172.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -118.43 160.36 21.84 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.496 -174.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.0 -12.52 76.68 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.263 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.9 p -71.01 -43.8 67.2 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.526 0.679 . . . . 0.0 109.592 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.412 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 3.9 t90 -64.97 140.21 58.84 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.261 171.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.8 t -146.07 119.61 9.11 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.064 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.19 -135.12 11.99 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 172.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.8 p -108.31 168.4 3.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.7 t -59.29 118.26 5.74 Favored 'General case' 0 C--O 1.25 1.109 0 C-N-CA 123.495 0.718 . . . . 0.0 112.642 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.47 -76.7 1.05 Allowed Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 171.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -143.32 138.21 29.35 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -50.81 -54.91 19.68 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.205 1.002 . . . . 0.0 112.408 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -70.23 -32.22 69.99 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.597 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.29 -49.13 68.14 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.825 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 11.0 p -76.53 -22.9 53.77 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 119.205 -0.998 . . . . 0.0 112.287 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -57.87 -53.42 58.39 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -58.78 -42.3 88.69 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.898 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.98 -39.29 71.59 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.457 0.473 . . . . 0.0 111.268 177.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 89.4 m -68.91 -51.48 39.61 Favored 'General case' 0 C--O 1.255 1.373 0 CA-C-O 121.993 0.902 . . . . 0.0 108.869 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.5 mt -57.01 -36.6 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.702 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -73.6 -32.3 64.03 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.0 mt -100.01 -57.1 2.2 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.19 -1.004 . . . . 0.0 113.265 -170.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -105.79 -10.35 16.76 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 120.026 -0.669 . . . . 0.0 111.605 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.8 mttm 72.26 68.97 0.14 Allowed 'General case' 0 C--N 1.319 -0.733 0 O-C-N 124.355 1.035 . . . . 0.0 111.498 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.49 175.71 7.82 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -98.66 -27.3 14.05 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.14 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -151.66 173.82 14.23 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.22 141.68 6.96 Favored Glycine 0 C--N 1.283 -2.367 0 N-CA-C 106.457 -2.657 . . . . 0.0 106.457 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.5 t -159.54 165.33 33.16 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 118.387 1.094 . . . . 0.0 110.069 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.7 m -86.61 102.59 14.31 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.73 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -95.76 145.7 25.11 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -79.4 118.66 21.5 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.826 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.3 m -128.11 176.94 6.69 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.821 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 172.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -80.34 129.35 69.68 Favored Pre-proline 0 C--N 1.281 -2.383 0 C-N-CA 119.184 -1.006 . . . . 0.0 109.288 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -106.25 9.81 8.59 Favored 'Cis proline' 0 CA--C 1.549 1.228 0 C-N-CA 124.628 -0.988 . . . . 0.0 113.984 -0.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -151.07 169.41 21.91 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.707 0.289 . . . . 0.0 110.609 -175.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -66.22 122.96 18.64 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.929 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.412 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 56.0 mttm -123.69 153.26 41.08 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.268 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 86.9 m -83.23 113.33 20.6 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.393 0.616 . . . . 0.0 111.081 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.412 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 33.2 mm -109.56 138.05 38.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 60.5 m -88.43 136.04 33.18 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.543 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 34.7 m-85 -107.83 124.69 50.45 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.421 0.629 . . . . 0.0 110.355 -177.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -108.83 153.41 42.38 Favored Pre-proline 0 C--N 1.292 -1.895 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.188 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -77.7 133.52 12.85 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 122.21 1.94 . . . . 0.0 113.03 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 81.7 m . . . . . 0 C--N 1.294 -1.817 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.823 178.501 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 CA--C 1.507 -0.692 0 CA-C-O 121.379 0.609 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -121.71 -172.9 2.52 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 174.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -110.6 120.19 41.61 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.114 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 31.3 m -93.66 116.68 29.18 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.475 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 4.3 pt20 -85.89 119.62 26.41 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -133.19 129.03 20.71 Favored Pre-proline 0 C--N 1.307 -1.244 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.118 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -72.46 134.61 22.83 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.898 1.732 . . . . 0.0 109.575 173.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.0 m -116.03 160.34 20.42 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.17 -15.11 75.35 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.235 -0.438 . . . . 0.0 112.036 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 p -69.63 -51.07 38.2 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.487 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 2.2 t90 -58.77 136.67 57.81 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.379 171.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.2 p -148.85 129.66 14.22 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.868 173.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.42 -173.32 27.23 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-O 121.656 0.587 . . . . 0.0 114.258 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.3 t -81.41 148.38 5.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.3 t -67.35 112.55 4.64 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 123.303 0.377 . . . . 0.0 111.145 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.1 -50.46 1.91 Allowed Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -123.13 117.16 24.75 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.531 ' HA ' ' SG ' ' A' ' 36' ' ' CYS . 13.2 m120 -57.79 -52.35 65.83 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 124.163 0.915 . . . . 0.0 110.748 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -66.47 -24.69 66.46 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.366 -0.833 . . . . 0.0 113.004 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.05 -57.77 4.6 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 123.051 0.219 . . . . 0.0 110.591 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.4 p -69.95 -30.36 67.73 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.404 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 38.1 ttmt -53.89 -57.31 11.4 Favored 'General case' 0 C--O 1.251 1.135 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -60.71 -39.12 87.42 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.329 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -60.33 -41.27 93.22 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.808 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.4 m -63.63 -52.33 61.29 Favored 'General case' 0 C--O 1.257 1.476 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 66.4 mt -55.95 -30.29 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.173 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -87.13 -33.9 19.28 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.2 mt -96.61 -47.65 5.83 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.196 -1.002 . . . . 0.0 113.352 -169.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -107.51 -5.93 17.32 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 120.906 0.384 . . . . 0.0 110.73 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 99.7 mttt 64.55 54.85 1.4 Allowed 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.7 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.53 159.85 33.25 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -81.84 -29.55 32.51 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.933 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -156.46 174.8 14.9 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 22' ' ' LYS . . . -153.59 144.01 10.82 Favored Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 107.634 -2.186 . . . . 0.0 107.634 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.534 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 41.7 t -154.52 148.99 26.23 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 117.899 0.849 . . . . 0.0 109.31 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 18' ' ' ASN . 60.6 m -87.35 108.21 18.88 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.842 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -94.37 137.97 32.88 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.737 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -81.72 116.22 21.33 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.4 m -126.13 -178.99 2.28 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -84.03 134.0 44.59 Favored Pre-proline 0 C--N 1.287 -2.14 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.655 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -96.61 -7.66 23.31 Favored 'Cis proline' 0 CA--C 1.547 1.141 0 C-N-CA 124.213 -1.161 . . . . 0.0 113.27 -4.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.55 168.02 20.76 Favored 'General case' 0 C--O 1.25 1.109 0 O-C-N 122.366 -0.209 . . . . 0.0 111.293 -176.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -59.76 131.15 50.01 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.237 1.015 . . . . 0.0 112.186 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.487 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 39.8 mmtm -117.7 154.93 30.83 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.479 ' HB2' ' CD1' ' A' ' 11' ' ' TRP . 85.0 m -87.13 107.65 18.55 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.443 0.64 . . . . 0.0 109.622 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.9 mm -104.4 135.39 42.43 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 33.9 m -91.5 132.93 35.93 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.534 ' CE1' ' HB3' ' A' ' 35' ' ' SER . 27.6 m-85 -105.93 120.1 40.88 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.543 0.687 . . . . 0.0 110.671 -176.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -102.58 161.42 23.3 Favored Pre-proline 0 C--N 1.288 -2.079 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.312 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -80.76 119.72 3.71 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 121.552 1.501 . . . . 0.0 112.704 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 56.8 m . . . . . 0 C--N 1.312 -1.06 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 174.589 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 . . . . . 0 C--O 1.24 0.557 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -100.95 165.97 11.06 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.9 mt -113.4 121.07 43.23 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 121.047 0.451 . . . . 0.0 109.964 177.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 80.9 m -94.89 132.09 40.08 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.443 ' HG2' ' CE1' ' A' ' 48' ' ' TYR . 16.1 mt-30 -83.39 146.22 28.58 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.235 0.54 . . . . 0.0 111.691 -174.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -131.83 101.81 15.23 Favored Pre-proline 0 C--N 1.291 -1.954 0 C-N-CA 124.111 0.964 . . . . 0.0 108.904 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.62 -74.29 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.127 1.885 . . . . 0.0 113.895 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.5 m -100.63 83.56 2.61 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -170.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.11 -71.36 0.25 Allowed Glycine 0 N--CA 1.427 -1.926 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 172.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.497 HG22 ' HA ' ' A' ' 25' ' ' CYS . 5.6 t -103.69 -30.17 10.6 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 120.808 0.337 . . . . 0.0 110.902 173.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.561 ' CZ2' ' HB2' ' A' ' 44' ' ' LYS . 27.0 t90 -59.96 127.75 33.47 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.5 m -157.41 109.39 2.38 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 125.239 1.415 . . . . 0.0 107.944 171.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.01 -166.36 24.04 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 119.662 -1.256 . . . . 0.0 113.431 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.1 t -83.38 150.54 4.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.614 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 17.5 t -94.91 100.85 12.63 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.09 -55.54 1.37 Allowed Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.085 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -121.61 121.97 38.59 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.907 0.384 . . . . 0.0 110.519 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -63.19 -42.33 99.31 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.984 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -73.75 -21.98 60.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.156 0.503 . . . . 0.0 110.835 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.81 -51.09 20.33 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.651 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.6 p -73.3 -31.3 63.95 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.966 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -54.55 -57.51 11.12 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -56.8 -40.13 75.39 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.957 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -64.33 -37.97 89.38 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.497 ' HA ' HG22 ' A' ' 10' ' ' THR . 72.8 m -63.06 -53.53 52.23 Favored 'General case' 0 C--O 1.256 1.419 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 73.0 mt -55.45 -37.09 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.441 -178.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -83.14 -27.56 30.02 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -98.13 -57.47 2.21 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -108.25 -0.51 20.82 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.065 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 62.1 mttp 67.14 47.22 1.38 Allowed 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.077 173.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.69 177.08 8.91 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.893 -1.048 . . . . 0.0 108.231 175.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -99.69 -27.29 13.74 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.538 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -149.19 170.35 18.66 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -175.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.14 138.52 4.96 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.5 m -163.14 162.48 25.64 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 117.437 0.619 . . . . 0.0 109.941 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 38.1 m -59.36 118.26 5.77 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 175.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -124.27 96.1 4.79 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -90.56 110.59 21.72 Favored 'General case' 0 N--CA 1.421 -1.922 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.063 -177.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.1 m -127.62 159.99 37.55 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 171.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.522 ' CD1' ' HA ' ' A' ' 41' ' ' PRO . 89.2 t80 -61.55 138.16 94.96 Favored Pre-proline 0 C--N 1.309 -1.18 0 O-C-N 123.79 0.681 . . . . 0.0 109.768 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.522 ' HA ' ' CD1' ' A' ' 40' ' ' PHE . 7.0 Cg_exo -74.74 -57.02 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.625 0 C-N-CA 123.999 -1.25 . . . . 0.0 112.943 1.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -155.62 101.76 2.18 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.443 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -108.63 160.42 15.94 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.014 0.435 . . . . 0.0 110.639 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.561 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 4.0 mptp? -116.42 -142.09 0.37 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -176.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.614 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 33.6 t -68.5 126.8 30.8 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 118.345 0.521 . . . . 0.0 109.981 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.403 ' CG2' ' HB3' ' A' ' 5' ' ' GLN . 41.5 mm -120.11 135.77 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.316 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 56.1 m -82.97 160.24 22.07 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.443 ' CE1' ' HG2' ' A' ' 5' ' ' GLN . 98.5 m-85 -129.58 127.64 41.09 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 120.844 0.354 . . . . 0.0 111.468 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -106.53 148.93 37.67 Favored Pre-proline 0 C--N 1.305 -1.33 0 C-N-CA 123.936 0.894 . . . . 0.0 109.836 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.47 129.47 6.59 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.674 2.249 . . . . 0.0 112.363 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 82.8 m . . . . . 0 N--CA 1.427 -1.603 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.6 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 . . . . . 0 C--O 1.242 0.663 0 CA-C-O 122.048 0.928 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 51' ' ' CYS . 3.7 mptp? -112.79 -178.62 3.44 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 174.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -111.68 112.55 24.33 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.621 0.724 . . . . 0.0 111.155 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 70.8 m -86.99 111.12 20.54 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.607 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 3.8 pt20 -76.11 135.82 39.85 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.487 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.466 ' HD3' ' CE1' ' A' ' 49' ' ' PHE . 51.9 ttt180 -146.38 116.3 4.66 Favored Pre-proline 0 C--N 1.296 -1.753 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.555 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -79.17 86.14 1.74 Allowed 'Trans proline' 0 N--CA 1.438 -1.759 0 C-N-CA 122.058 1.839 . . . . 0.0 109.06 173.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.469 ' HB3' ' OE2' ' A' ' 29' ' ' GLU . 61.6 m -69.49 160.06 32.13 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.419 -176.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.58 -9.79 82.7 Favored Glycine 0 CA--C 1.502 -0.727 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.524 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 p -68.78 -44.62 73.24 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.478 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 2.8 t90 -66.75 132.46 48.14 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.199 169.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.9 t -145.99 112.02 5.69 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.14 -145.87 15.89 Favored Glycine 0 N--CA 1.425 -2.094 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.787 176.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 p -118.43 162.68 16.31 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.8 t -67.07 134.56 52.11 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.7 -49.58 0.31 Allowed Glycine 0 N--CA 1.421 -2.315 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 173.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -145.99 120.14 9.49 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.185 0.594 . . . . 0.0 110.129 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -55.24 -52.74 62.41 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.072 0.949 . . . . 0.0 111.925 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -65.61 -31.58 72.69 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.935 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.42 -44.28 65.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.503 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.3 p -76.53 -32.18 58.08 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.181 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -54.9 -54.87 37.03 Favored 'General case' 0 C--O 1.253 1.239 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.497 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 47.4 t30 -57.36 -44.39 84.3 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.672 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -56.24 -43.0 78.22 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.264 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.8 m -63.62 -48.8 75.84 Favored 'General case' 0 C--O 1.271 2.224 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 64.9 mt -59.94 -37.73 73.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 114.24 -1.345 . . . . 0.0 111.372 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 31.7 mmt180 -81.47 -19.98 41.21 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -98.01 -63.61 1.11 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.209 -176.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 8' ' ' SER . 8.3 pt-20 -113.29 3.47 15.96 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.3 0.571 . . . . 0.0 111.685 -177.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 94.4 mttt 67.92 63.74 0.39 Allowed 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.421 174.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.07 177.48 9.02 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 173.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -96.01 -41.09 8.93 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -147.15 176.33 10.04 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -173.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.7 143.5 8.9 Favored Glycine 0 C--N 1.307 -1.059 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 m -149.03 152.84 36.96 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 118.466 1.133 . . . . 0.0 110.895 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.0 m -89.13 100.4 13.19 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.501 0.667 . . . . 0.0 109.697 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -93.03 134.38 35.22 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.454 -175.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -78.34 110.64 13.55 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 121.513 0.673 . . . . 0.0 110.15 177.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.44 175.46 10.91 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 174.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -77.15 137.7 64.96 Favored Pre-proline 0 C--N 1.28 -2.434 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 175.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -101.67 7.17 18.49 Favored 'Cis proline' 0 CA--C 1.546 1.108 0 C-N-CA 124.195 -1.169 . . . . 0.0 113.138 -2.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.85 171.3 20.31 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -176.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -65.42 117.23 7.64 Favored 'General case' 0 C--O 1.24 0.576 0 O-C-N 123.551 0.532 . . . . 0.0 111.172 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.478 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 95.1 mttt -109.29 146.55 34.11 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 22.4 t -92.87 117.11 29.68 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.86 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.432 HG23 ' HB2' ' A' ' 5' ' ' GLN . 25.0 mm -101.44 134.49 41.58 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 66.5 m -84.75 136.78 33.56 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.607 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 77.9 m-85 -113.1 122.96 49.14 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.473 0.654 . . . . 0.0 110.925 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.466 ' CE1' ' HD3' ' A' ' 6' ' ' ARG . 81.4 m-85 -107.98 156.53 38.07 Favored Pre-proline 0 C--N 1.288 -2.093 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.709 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -77.66 126.86 8.44 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 121.638 1.558 . . . . 0.0 112.701 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 2' ' ' LYS . 12.2 m . . . . . 0 C--N 1.294 -1.843 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 172.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 . . . . . 0 CA--C 1.509 -0.614 0 CA-C-O 120.938 0.399 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -161.52 144.97 12.59 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 86.6 mt -80.53 110.89 16.44 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.0 p -102.22 129.97 48.76 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.862 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.477 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 4.0 pt20 -78.76 140.64 38.23 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.35 0.595 . . . . 0.0 111.054 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -137.23 127.93 16.07 Favored Pre-proline 0 C--N 1.282 -2.329 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.26 106.24 0.14 Allowed 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 122.698 2.265 . . . . 0.0 109.751 174.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.498 ' HB2' ' HB3' ' A' ' 11' ' ' TRP . 1.5 m -53.94 133.38 43.13 Favored 'General case' 0 N--CA 1.417 -2.101 0 C-N-CA 125.806 1.642 . . . . 0.0 111.461 -176.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.93 -32.04 6.36 Favored Glycine 0 N--CA 1.428 -1.879 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.985 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -74.53 -38.05 62.89 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 120.708 0.29 . . . . 0.0 110.659 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 8' ' ' SER . 1.7 t90 -58.97 132.91 55.42 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.466 0.706 . . . . 0.0 111.654 174.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.1 p -156.46 97.58 1.76 Allowed 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.22 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.98 -156.48 26.71 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -91.72 150.94 3.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 41.1 t -93.51 101.07 13.25 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 173.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.66 -35.88 7.63 Favored Glycine 0 N--CA 1.429 -1.817 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.654 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -133.62 128.47 35.19 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-O 120.906 0.384 . . . . 0.0 110.964 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -60.39 -47.57 85.49 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.402 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.4 p30 -63.46 -36.69 84.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.219 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.73 -47.41 63.2 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.345 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.9 p -76.17 -25.36 55.16 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.46 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -54.81 -57.72 10.45 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -62.83 -36.67 83.98 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.132 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -61.03 -41.71 97.08 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 122.846 0.459 . . . . 0.0 109.815 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.3 m -64.81 -56.04 15.9 Favored 'General case' 0 C--O 1.257 1.488 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 77.0 mt -54.16 -36.42 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.425 1.49 . . . . 0.0 112.251 -176.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -87.18 -25.07 24.24 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . 0.264 7.3 mp -104.35 -50.98 3.2 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 117.983 -1.487 . . . . 0.0 113.63 -174.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -109.24 1.98 20.58 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.305 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 27.7 mtpp 59.39 63.01 1.65 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 125.773 1.629 . . . . 0.0 114.034 174.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.25 179.73 7.7 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.375 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -94.32 -30.45 14.52 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -156.41 174.0 16.06 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -165.23 150.86 19.22 Favored Glycine 0 C--N 1.304 -1.237 0 N-CA-C 107.868 -2.093 . . . . 0.0 107.868 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.0 t -167.04 151.84 7.26 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 118.31 1.055 . . . . 0.0 112.06 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 38.5 m -63.62 117.37 6.7 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 170.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -119.03 -22.04 7.42 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.724 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.464 ' HD2' ' O ' ' A' ' 42' ' ' ALA . 32.8 t80 -92.58 179.0 5.64 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.409 ' HA ' ' CD2' ' A' ' 43' ' ' HIS . 20.3 m -124.41 -162.46 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 124.069 0.948 . . . . 0.0 109.191 -172.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.547 ' CG ' ' HA ' ' A' ' 41' ' ' PRO . 66.5 t80 -59.86 144.45 85.91 Favored Pre-proline 0 C--N 1.312 -1.057 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.547 ' HA ' ' CG ' ' A' ' 40' ' ' PHE . 1.6 Cg_endo -86.78 -15.45 29.41 Favored 'Cis proline' 0 C--O 1.239 0.535 0 C-N-CA 124.287 -1.13 . . . . 0.0 114.336 3.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.464 ' O ' ' HD2' ' A' ' 38' ' ' TYR . . . -126.6 93.73 3.86 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -174.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.409 ' CD2' ' HA ' ' A' ' 39' ' ' VAL . 72.9 m80 -64.96 104.42 0.86 Allowed 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 175.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.443 ' H ' ' HB3' ' A' ' 38' ' ' TYR . 45.7 mtmt -92.86 149.26 21.38 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.503 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 41.9 t -98.75 131.12 45.14 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 175.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.4 mm -113.02 137.36 46.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 73.1 m -89.38 141.31 28.67 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -177.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.477 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 62.1 m-85 -111.22 126.38 54.81 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.22 0.533 . . . . 0.0 110.588 -178.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -113.93 161.46 27.75 Favored Pre-proline 0 C--N 1.286 -2.158 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.149 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -86.21 112.81 1.16 Allowed 'Trans proline' 0 N--CA 1.436 -1.868 0 C-N-CA 121.993 1.795 . . . . 0.0 111.692 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 47.8 m . . . . . 0 C--N 1.285 -2.238 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.046 175.929 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 . . . . . 0 CA--C 1.507 -0.71 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -84.9 128.32 34.57 Favored 'General case' 0 C--O 1.256 1.421 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.296 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 95.1 mt -99.15 119.33 37.68 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.652 177.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.3 m -73.68 120.54 19.42 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -91.97 139.34 30.74 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.062 0.458 . . . . 0.0 110.479 -176.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -145.4 121.68 5.97 Favored Pre-proline 0 N--CA 1.431 -1.391 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.024 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -76.08 86.39 1.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.859 1.706 . . . . 0.0 108.882 171.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.411 ' HB3' ' OE1' ' A' ' 29' ' ' GLU . 61.4 m -75.38 160.86 29.79 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.673 -173.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.64 -6.09 85.96 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.421 -0.809 . . . . 0.0 113.68 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 p -70.93 -58.65 3.38 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.504 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 2.8 t90 -59.65 143.29 50.98 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.793 168.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.4 m -149.87 123.77 9.32 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 119.29 -122.98 5.5 Favored Glycine 0 C--O 1.247 0.915 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.689 176.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.3 p -134.03 170.06 20.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.6 t -67.48 109.96 3.43 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 118.013 0.37 . . . . 0.0 110.414 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.87 -57.36 0.92 Allowed Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 176.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -138.93 118.7 13.14 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -50.36 -50.03 52.44 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.984 0.914 . . . . 0.0 110.898 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -60.64 -36.41 78.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.863 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.15 -47.55 35.19 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.457 -173.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.3 p -75.48 -32.52 60.61 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -56.45 -54.5 44.95 Favored 'General case' 0 C--O 1.253 1.254 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 173.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.502 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 64.1 t30 -59.24 -43.54 92.38 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.744 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -58.06 -36.92 73.48 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.139 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.2 m -68.25 -54.4 17.91 Favored 'General case' 0 C--O 1.258 1.537 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 69.8 mt -60.08 -32.87 51.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.242 -174.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 30.4 mmt180 -91.46 -17.47 25.7 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.48 -52.07 2.97 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 118.833 -1.147 . . . . 0.0 112.558 -174.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.411 ' OE1' ' HB3' ' A' ' 8' ' ' SER . 9.0 pt-20 -109.09 -8.44 15.17 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.706 0.765 . . . . 0.0 109.986 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 53.9 mtmt 69.14 63.36 0.29 Allowed 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 113.906 -1.497 . . . . 0.0 112.155 176.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.38 169.91 16.64 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 114.656 -1.157 . . . . 0.0 109.098 176.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -88.61 -34.23 17.37 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.934 0.873 . . . . 0.0 108.674 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -152.02 171.62 17.55 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.287 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.29 137.16 4.59 Favored Glycine 0 N--CA 1.424 -2.151 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.1 p -161.77 174.88 12.6 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 117.751 0.775 . . . . 0.0 111.232 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 51.3 m -90.13 109.48 20.54 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.153 0.501 . . . . 0.0 110.025 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -101.06 143.72 30.85 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.514 ' CZ ' ' HA ' ' A' ' 42' ' ' ALA . 3.9 t80 -87.21 111.27 20.83 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 118.961 -1.095 . . . . 0.0 109.468 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.3 m -125.46 -171.58 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -78.72 132.75 63.86 Favored Pre-proline 0 C--N 1.294 -1.848 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.704 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -101.87 5.92 18.02 Favored 'Cis proline' 0 CA--C 1.544 0.98 0 C-N-CA 124.46 -1.058 . . . . 0.0 112.979 -2.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.514 ' HA ' ' CZ ' ' A' ' 38' ' ' TYR . . . -158.62 -173.09 4.11 Favored 'General case' 0 C--O 1.244 0.816 0 C-N-CA 122.37 0.268 . . . . 0.0 110.577 -175.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -67.87 122.34 17.95 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.331 0.586 . . . . 0.0 110.214 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.47 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 68.4 mttm -124.93 153.06 43.28 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.504 ' HB2' ' CD1' ' A' ' 11' ' ' TRP . 97.0 m -80.14 114.55 19.13 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.474 0.654 . . . . 0.0 110.318 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 50.7 mm -111.23 135.85 49.12 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.696 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 61.3 m -87.63 139.92 30.04 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.425 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 88.6 m-85 -117.48 129.2 55.67 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.441 0.639 . . . . 0.0 111.305 -176.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -114.61 157.69 42.17 Favored Pre-proline 0 C--N 1.286 -2.177 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -79.51 127.35 7.25 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.354 1.369 . . . . 0.0 110.758 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 73.8 m . . . . . 0 C--N 1.315 -0.905 0 O-C-N 122.097 -0.377 . . . . 0.0 111.334 -179.161 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 . . . . . 0 CA--C 1.506 -0.721 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -108.49 131.92 54.33 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 89.8 mt -88.77 101.69 14.27 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 64.5 m -83.3 133.88 34.95 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.913 -175.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -81.17 132.96 35.38 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.973 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -144.15 125.31 7.92 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.87 135.01 49.51 Favored 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.628 2.219 . . . . 0.0 110.896 176.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.778 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . 5.9 p -90.03 160.45 16.33 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -176.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.13 -13.61 38.8 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.5 t -81.86 -37.94 26.17 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.158 0.504 . . . . 0.0 109.953 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.557 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 1.6 t90 -82.09 145.17 30.31 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 173.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 t -157.32 95.6 1.48 Allowed 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.35 -140.48 8.82 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.724 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 p -104.4 170.98 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.3 t -58.99 133.6 56.23 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 123.253 0.621 . . . . 0.0 112.656 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.99 -76.05 0.9 Allowed Glycine 0 N--CA 1.426 -1.979 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 173.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -142.5 130.54 21.89 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -48.42 -57.4 6.13 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.459 1.104 . . . . 0.0 112.105 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -66.56 -31.51 72.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.993 -174.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.18 -48.12 68.91 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.755 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.434 ' HA ' ' HB3' ' A' ' 24' ' ' GLN . 5.6 p -78.6 -23.55 45.92 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -58.53 -55.14 38.85 Favored 'General case' 0 C--O 1.256 1.44 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -57.95 -46.27 85.34 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.067 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.434 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 61.6 tt0 -55.82 -40.56 72.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.762 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 97.0 m -62.98 -57.35 11.03 Favored 'General case' 0 C--O 1.257 1.492 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.1 mt -55.0 -39.59 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 114.141 -1.39 . . . . 0.0 111.465 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -79.44 -26.45 41.79 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.4 -55.99 2.24 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 118.558 -1.257 . . . . 0.0 113.177 -174.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -108.05 2.25 22.98 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.8 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 61.48 59.3 1.9 Allowed 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.367 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.07 175.44 9.51 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.416 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 26.2 tpt180 -85.81 -41.34 15.12 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -147.54 173.43 12.7 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -177.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.27 149.56 15.67 Favored Glycine 0 CA--C 1.476 -2.396 0 N-CA-C 107.036 -2.425 . . . . 0.0 107.036 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.3 t -169.88 173.38 6.14 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 118.544 1.172 . . . . 0.0 109.432 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 43' ' ' HIS . 75.4 m -78.32 92.06 4.5 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.611 0.72 . . . . 0.0 110.215 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -80.11 144.56 32.98 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -95.97 119.07 33.8 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.995 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.09 171.0 16.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 175.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 79.0 t80 -77.13 131.71 72.03 Favored Pre-proline 0 C--N 1.289 -2.033 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 175.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 71.6 Cg_endo -106.71 12.66 8.09 Favored 'Cis proline' 0 CA--C 1.546 1.103 0 C-N-CA 124.485 -1.048 . . . . 0.0 113.551 -1.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -150.76 170.71 18.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.957 0.408 . . . . 0.0 111.114 -174.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 70.1 m80 -76.13 136.76 39.82 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.566 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.557 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 98.6 mttt -131.97 152.31 51.19 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.418 ' HB2' ' CD1' ' A' ' 11' ' ' TRP . 71.2 m -82.51 98.27 8.85 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.942 0.877 . . . . 0.0 111.519 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 50.8 mm -105.62 138.47 30.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.778 ' SG ' ' HB3' ' A' ' 8' ' ' SER . 60.6 m -91.73 154.63 18.84 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -177.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 4' ' ' CYS . 84.8 m-85 -122.31 129.43 52.17 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -111.58 152.68 44.19 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HD3' ' HB2' ' A' ' 32' ' ' ARG . 70.7 Cg_endo -79.6 133.98 10.78 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.104 1.87 . . . . 0.0 112.256 -175.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 67.6 m . . . . . 0 C--N 1.291 -1.957 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.745 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 . . . . . 0 C--O 1.237 0.433 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -103.41 157.05 17.3 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 174.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.447 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 78.1 mt -114.1 115.49 27.62 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-O 121.195 0.522 . . . . 0.0 110.181 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.3 m -89.76 117.18 28.42 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.441 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -72.04 139.54 48.56 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.712 -175.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.415 ' HD3' ' OE1' ' A' ' 29' ' ' GLU . 51.6 ttt180 -142.16 108.18 5.78 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 175.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -72.27 -62.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.01 1.807 . . . . 0.0 112.904 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.2 m -91.79 101.0 13.59 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.746 0.784 . . . . 0.0 112.683 -172.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.62 -71.4 0.04 OUTLIER Glycine 0 C--N 1.286 -2.196 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 172.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.456 HG22 ' OE2' ' A' ' 29' ' ' GLU . 8.1 t -112.75 -30.26 7.13 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.077 -0.562 . . . . 0.0 109.946 172.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.433 ' CZ2' ' HB2' ' A' ' 44' ' ' LYS . 48.1 t90 -55.71 129.79 40.65 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.389 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 m -140.5 89.43 2.28 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.049 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 56.05 45.63 86.72 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 115.495 0.958 . . . . 0.0 115.495 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.9 t -120.31 124.12 71.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 117.232 0.516 . . . . 0.0 111.932 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 44' ' ' LYS . 42.4 t -141.72 82.75 1.82 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 167.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.69 -82.99 0.08 OUTLIER Glycine 0 N--CA 1.426 -2.0 0 C-N-CA 120.471 -0.871 . . . . 0.0 110.944 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -88.29 96.28 10.51 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.54 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 2.6 m-20 -58.56 -44.0 89.57 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.261 0.624 . . . . 0.0 112.153 -176.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -67.43 -28.84 68.23 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.131 0.491 . . . . 0.0 110.893 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.26 -39.35 23.11 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.901 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' A' ' 18' ' ' ASN . 21.5 p -71.45 -31.13 66.82 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.178 177.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -58.06 -53.01 63.06 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 172.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -57.59 -43.79 84.88 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.773 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -57.07 -40.7 77.41 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.447 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 71.2 m -63.08 -54.37 39.1 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 62.3 mt -56.16 -37.41 49.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 124.626 1.17 . . . . 0.0 111.027 -177.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -83.52 -23.06 32.25 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -177.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.58 -49.33 3.18 Favored 'General case' 0 CA--C 1.501 -0.934 0 C-N-CA 119.017 -1.073 . . . . 0.0 112.961 -175.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.456 ' OE2' HG22 ' A' ' 10' ' ' THR . 12.5 pt-20 -107.31 -4.8 18.28 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.128 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 55.2 mtmt 66.12 41.56 3.51 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.029 176.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.13 164.48 26.12 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.148 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -95.18 -22.09 18.06 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.368 0.604 . . . . 0.0 110.193 -175.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -155.11 170.15 22.48 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.86 141.38 5.98 Favored Glycine 0 CA--C 1.482 -2.003 0 N-CA-C 107.562 -2.215 . . . . 0.0 107.562 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.3 t -175.79 168.48 3.06 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 86.1 m -63.51 106.67 0.98 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.835 0.826 . . . . 0.0 110.065 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -109.29 95.17 5.45 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -84.58 106.76 16.39 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.284 -176.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.0 m -130.79 162.4 38.94 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 172.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -59.54 140.67 88.75 Favored Pre-proline 0 C--N 1.305 -1.349 0 O-C-N 124.285 0.991 . . . . 0.0 109.669 178.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -74.6 -52.68 0.16 OUTLIER 'Cis proline' 0 N--CA 1.474 0.352 0 C-N-CA 124.018 -1.243 . . . . 0.0 111.952 -1.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -156.68 96.23 1.62 Allowed 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -98.43 159.08 15.18 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.402 0.62 . . . . 0.0 111.4 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 15' ' ' CYS . 33.7 mmtp -120.34 -144.2 0.35 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -174.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 99.0 m -60.55 111.05 1.44 Allowed 'General case' 0 C--O 1.203 -1.389 0 CA-C-N 118.661 0.664 . . . . 0.0 110.208 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.9 mm -110.71 137.7 41.99 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 59.6 m -86.56 148.52 25.47 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.447 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 92.2 m-85 -123.79 132.26 53.75 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 122.113 -0.367 . . . . 0.0 110.43 -177.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -105.97 148.79 37.18 Favored Pre-proline 0 C--N 1.285 -2.221 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.514 175.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.28 132.18 11.19 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 122.256 1.971 . . . . 0.0 112.259 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 74.2 m . . . . . 0 C--N 1.284 -2.246 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.555 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 . . . . . 0 CA--C 1.508 -0.669 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -83.22 147.59 27.92 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 88.5 mt -93.2 99.99 12.45 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.33 0.586 . . . . 0.0 109.872 176.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.8 m -89.74 118.64 29.49 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.477 ' HB2' ' CG2' ' A' ' 46' ' ' ILE . 3.8 pt20 -81.89 138.44 35.02 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -173.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -133.38 118.28 14.82 Favored Pre-proline 0 C--N 1.308 -1.201 0 C-N-CA 125.161 1.384 . . . . 0.0 108.121 178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.25 -63.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.732 1.621 . . . . 0.0 113.035 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.6 p -88.63 128.06 35.58 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -172.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.07 -75.28 0.06 OUTLIER Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.8 t -104.22 -36.82 7.52 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 171.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -67.62 135.68 53.24 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.448 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.7 t -156.26 89.67 1.14 Allowed 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.67 34.42 83.44 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.062 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.5 t -118.82 102.41 13.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.166 0.508 . . . . 0.0 110.783 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.8 t -140.28 80.24 1.75 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.452 0.644 . . . . 0.0 109.528 176.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.87 -60.98 0.53 Allowed Glycine 0 N--CA 1.426 -2.021 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -122.94 132.82 54.33 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -63.89 -45.1 90.87 Favored 'General case' 0 C--O 1.205 -1.285 0 O-C-N 123.746 0.654 . . . . 0.0 109.863 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -63.76 -33.68 76.2 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.6 -46.52 63.25 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.2 p -76.38 -28.48 56.78 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.524 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -56.02 -56.26 22.96 Favored 'General case' 0 C--O 1.251 1.137 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 173.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -58.74 -40.71 84.59 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.026 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -59.78 -40.88 89.73 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.9 m -64.98 -55.02 21.48 Favored 'General case' 0 C--O 1.252 1.209 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 54.9 mt -56.78 -41.52 75.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.159 -177.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -82.82 -17.02 45.47 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -106.7 -59.95 1.73 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 119.507 -0.877 . . . . 0.0 113.124 -177.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -104.83 1.08 28.73 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.988 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 97.2 mttt 65.95 60.57 0.67 Allowed 'General case' 0 CA--C 1.498 -1.042 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.567 172.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.38 176.02 7.09 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.241 176.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -93.66 -39.75 10.63 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.237 0.542 . . . . 0.0 109.625 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -146.57 170.68 16.41 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.78 137.81 4.81 Favored Glycine 0 C--N 1.292 -1.884 0 N-CA-C 108.029 -2.028 . . . . 0.0 108.029 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.2 p -172.14 161.54 5.51 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 117.451 0.626 . . . . 0.0 111.352 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 81.4 m -73.47 101.42 3.51 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.29 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -97.84 148.8 23.04 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -79.87 92.45 5.5 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-O 122.292 1.044 . . . . 0.0 109.52 174.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.2 m -101.11 158.95 4.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.537 0 N-CA-C 105.437 -2.061 . . . . 0.0 105.437 172.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -68.91 132.21 90.62 Favored Pre-proline 0 C--N 1.279 -2.474 0 C-N-CA 119.11 -1.036 . . . . 0.0 108.884 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -108.04 18.07 6.72 Favored 'Cis proline' 0 CA--C 1.555 1.541 0 C-N-CA 124.865 -0.89 . . . . 0.0 113.949 -1.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -156.02 163.92 39.09 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.857 -0.527 . . . . 0.0 111.474 -174.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -70.13 113.97 7.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.89 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 66.6 mttm -129.82 147.69 51.62 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 22.9 t -78.2 119.43 21.58 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.517 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.477 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 21.2 mm -114.44 138.92 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.446 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 69.0 m -85.67 137.93 32.49 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.421 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 88.8 m-85 -113.15 122.25 46.95 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 122.043 -0.411 . . . . 0.0 110.444 -178.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -103.6 143.59 26.94 Favored Pre-proline 0 C--N 1.293 -1.876 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.537 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -79.84 116.08 3.41 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 122.464 2.109 . . . . 0.0 112.737 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 84.3 m . . . . . 0 C--N 1.293 -1.873 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.695 176.659 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 . . . . . 0 C--O 1.242 0.702 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -88.9 170.67 10.51 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.9 mt -123.35 113.93 19.5 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.586 0.707 . . . . 0.0 110.048 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.9 m -98.33 123.57 42.51 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.416 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -85.94 143.64 28.08 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.424 -176.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -148.84 123.01 4.75 Favored Pre-proline 0 C--N 1.298 -1.673 0 C-N-CA 123.756 0.822 . . . . 0.0 109.564 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.96 153.65 63.33 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 122.357 2.038 . . . . 0.0 109.389 173.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.8 t -147.73 160.3 42.86 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.52 -3.85 86.86 Favored Glycine 0 C--O 1.239 0.45 0 O-C-N 123.42 0.45 . . . . 0.0 112.572 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.6 p -71.6 -55.76 7.16 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -56.53 143.69 34.43 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.324 169.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.2 t -156.98 137.33 12.91 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.271 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.22 -164.85 31.13 Favored Glycine 0 C--O 1.249 1.075 0 C-N-CA 121.462 -0.399 . . . . 0.0 113.543 175.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.9 t -84.48 147.52 5.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.6 t -93.01 129.93 38.76 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -122.2 -44.88 0.34 Allowed Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -107.92 104.69 14.21 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -54.97 -53.5 54.86 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.484 1.114 . . . . 0.0 111.183 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -64.83 -32.65 74.45 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.819 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.9 -49.33 65.94 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.459 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.8 p -77.3 -27.84 53.13 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.495 -177.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -55.92 -56.97 14.31 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 173.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -59.5 -38.78 81.79 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.102 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -60.68 -46.22 91.17 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.897 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.51 ' HA ' ' OE2' ' A' ' 29' ' ' GLU . 75.1 m -62.42 -45.29 93.77 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-O 122.451 1.12 . . . . 0.0 108.943 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 72.6 mt -59.97 -32.44 50.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.678 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -86.23 -15.23 41.46 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.2 mt -109.27 -60.62 1.74 Allowed 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.864 -176.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.51 ' OE2' ' HA ' ' A' ' 25' ' ' CYS . 1.8 pm0 -99.38 -1.35 38.97 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.04 0.448 . . . . 0.0 111.347 178.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 68.2 mttm 63.64 45.73 4.47 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.584 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.442 ' O ' HG12 ' A' ' 26' ' ' ILE . . . -71.81 179.99 2.91 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.986 177.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -104.99 -31.3 9.29 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.557 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.472 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 84.4 t60 -147.39 171.56 15.29 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -176.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.9 136.04 3.67 Favored Glycine 0 CA--C 1.488 -1.634 0 N-CA-C 107.471 -2.252 . . . . 0.0 107.471 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.8 m -158.63 163.64 36.74 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 118.531 1.165 . . . . 0.0 113.709 -177.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 43' ' ' HIS . 34.0 m -70.11 100.64 1.68 Allowed 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 113.9 -1.5 . . . . 0.0 109.35 176.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -97.33 142.5 29.13 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -84.25 104.49 14.33 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.852 0.835 . . . . 0.0 111.969 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.7 m -105.97 160.11 5.83 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 171.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -73.57 128.3 87.33 Favored Pre-proline 0 C--N 1.279 -2.477 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.103 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -112.59 24.31 2.37 Favored 'Cis proline' 0 CA--C 1.561 1.859 0 C-N-CA 125.058 -0.809 . . . . 0.0 112.949 -3.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.55 160.7 40.69 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.048 0.451 . . . . 0.0 111.154 -175.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 73.6 m80 -76.5 122.54 24.71 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.374 0.607 . . . . 0.0 111.853 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -120.35 153.47 36.43 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.0 t -90.95 126.49 36.08 Favored 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.22 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.5 mm -116.57 139.61 42.6 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.2 m -88.46 140.62 29.28 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.472 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 30.9 m-85 -114.49 129.25 56.64 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.275 0.56 . . . . 0.0 109.986 -177.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -109.19 152.36 42.51 Favored Pre-proline 0 C--N 1.288 -2.069 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -78.02 142.57 19.72 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 121.642 1.561 . . . . 0.0 111.529 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 76.2 m . . . . . 0 C--N 1.287 -2.126 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.836 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -93.42 154.23 18.05 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.152 0.501 . . . . 0.0 110.588 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 80.8 mt -126.73 138.8 53.44 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.78 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.2 m -89.12 123.54 33.49 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.49 ' HG2' ' CE2' ' A' ' 48' ' ' TYR . 41.7 mt-30 -85.44 130.82 34.5 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.152 -176.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -135.79 107.39 9.83 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -68.24 -74.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.703 2.269 . . . . 0.0 115.325 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 p -84.91 134.82 34.25 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -169.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.23 -85.38 0.09 OUTLIER Glycine 0 N--CA 1.42 -2.419 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 t -86.14 -39.71 16.41 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.48 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 21.5 t90 -62.57 128.73 37.36 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.349 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.2 m -155.49 102.17 2.23 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 124.988 1.315 . . . . 0.0 107.675 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.23 -146.77 18.37 Favored Glycine 0 N--CA 1.42 -2.373 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.43 170.69 13.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.2 t -69.84 110.81 5.17 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.382 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.52 -55.03 1.37 Allowed Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -140.72 129.59 23.15 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -58.26 -46.64 85.63 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.483 0.489 . . . . 0.0 110.972 -176.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -65.75 -31.27 72.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.604 -177.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -48.45 65.44 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.709 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.1 p -74.46 -25.55 59.48 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.873 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -56.13 -57.92 10.13 Favored 'General case' 0 C--O 1.249 1.059 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 171.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -61.2 -36.29 79.47 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.8 -1.546 . . . . 0.0 110.629 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -64.89 -38.78 92.1 Favored 'General case' 0 C--O 1.21 -0.982 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 86.6 m -66.81 -54.49 22.0 Favored 'General case' 0 C--O 1.253 1.268 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 65.9 mt -56.47 -37.06 49.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.742 -177.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -86.53 -21.91 26.66 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -104.0 -55.56 2.35 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 118.9 -1.12 . . . . 0.0 113.156 -175.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -107.81 1.19 22.67 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.566 -0.853 . . . . 0.0 111.821 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm 62.64 60.99 1.25 Allowed 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.548 -1.206 . . . . 0.0 112.709 174.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.08 171.84 9.25 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.807 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -81.78 -33.38 30.92 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -157.85 171.58 20.03 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.9 137.88 5.75 Favored Glycine 0 C--N 1.295 -1.744 0 N-CA-C 106.813 -2.515 . . . . 0.0 106.813 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.1 t -160.14 162.52 33.98 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 118.113 0.957 . . . . 0.0 110.717 -176.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 21.0 m -78.59 104.55 9.27 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.409 ' HB3' ' CG1' ' A' ' 46' ' ' ILE . 6.8 t30 -99.04 -39.33 8.58 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.372 -173.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.41 ' HB3' ' H ' ' A' ' 44' ' ' LYS . 14.9 t80 -80.78 168.41 18.83 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -177.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.523 ' HA ' ' CD2' ' A' ' 43' ' ' HIS . 18.6 m -126.55 -159.25 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 124.539 1.136 . . . . 0.0 108.921 -173.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.617 ' CD1' ' HA ' ' A' ' 41' ' ' PRO . 75.8 t80 -49.72 140.81 14.39 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 123.105 0.562 . . . . 0.0 110.31 178.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.617 ' HA ' ' CD1' ' A' ' 40' ' ' PHE . 87.1 Cg_endo -82.99 -5.26 51.07 Favored 'Cis proline' 0 C--O 1.242 0.678 0 C-N-CA 123.876 -1.302 . . . . 0.0 115.269 4.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.82 106.24 3.64 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.702 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.523 ' CD2' ' HA ' ' A' ' 39' ' ' VAL . 62.5 m80 -61.0 120.87 11.08 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 173.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 48.2 mtmt -111.18 141.02 45.23 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -177.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.1 m -86.28 132.18 34.05 Favored 'General case' 0 CA--C 1.494 -1.196 0 O-C-N 123.608 0.567 . . . . 0.0 109.638 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.409 ' CG1' ' HB3' ' A' ' 37' ' ' ASN . 36.2 mm -120.91 139.89 46.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 82.9 m -87.03 138.15 31.74 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.49 ' CE2' ' HG2' ' A' ' 5' ' ' GLN . 93.3 m-85 -113.33 116.31 29.5 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -177.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -99.89 148.21 34.49 Favored Pre-proline 0 C--N 1.295 -1.801 0 C-N-CA 122.769 0.427 . . . . 0.0 110.379 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.16 125.04 9.96 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.045 1.83 . . . . 0.0 112.97 -175.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 77.6 m . . . . . 0 C--O 1.252 1.192 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 176.5 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 . . . . . 0 CA--C 1.496 -1.131 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -102.3 121.38 42.17 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.259 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.443 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 86.2 mt -76.42 104.89 7.17 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.677 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.7 m -87.19 126.71 34.97 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -80.89 145.74 31.17 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.201 0.524 . . . . 0.0 111.779 -173.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -125.42 109.14 26.47 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.4 -56.16 0.95 Allowed 'Trans proline' 0 C--O 1.203 -1.248 0 C-N-CA 122.542 2.161 . . . . 0.0 113.62 -176.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.3 m -137.66 101.43 4.47 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.687 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -109.63 -61.01 0.51 Allowed Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 171.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 t -118.1 -36.95 3.47 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.441 -0.38 . . . . 0.0 111.689 172.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.608 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 17.8 t90 -46.5 130.97 11.19 Favored 'General case' 0 C--N 1.358 0.941 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.5 m -150.44 121.2 7.54 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.2 -159.23 22.67 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.46 161.12 4.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.448 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 30.3 t -85.5 90.37 7.95 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.25 -35.81 4.06 Favored Glycine 0 C--N 1.313 -0.72 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.607 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -137.67 110.91 7.87 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -56.19 -43.16 78.19 Favored 'General case' 0 CA--C 1.49 -1.333 0 O-C-N 123.624 0.578 . . . . 0.0 109.872 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -59.41 -35.47 74.03 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.315 -177.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.59 -53.16 9.92 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.971 -177.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 4.8 p -70.55 -32.23 69.59 Favored 'General case' 0 C--O 1.214 -0.792 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -54.62 -52.22 62.92 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 173.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -58.49 -46.58 86.37 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.632 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -54.32 -44.21 71.85 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.784 0.677 . . . . 0.0 111.225 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 68.8 m -61.45 -56.96 14.4 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 59.6 mt -55.23 -35.78 37.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 124.894 1.277 . . . . 0.0 111.322 -177.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -75.99 -34.15 59.74 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -110.47 -49.3 3.07 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 118.483 -1.287 . . . . 0.0 113.639 -171.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -97.03 -9.64 27.74 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.629 0.728 . . . . 0.0 109.414 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 97.2 mttt 61.51 61.55 1.47 Allowed 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 113.921 -1.491 . . . . 0.0 112.619 177.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.25 -179.51 5.44 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.009 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -100.96 -34.93 9.57 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.173 0.511 . . . . 0.0 110.084 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -143.2 168.91 18.64 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.76 132.63 2.89 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.7 p -155.07 -179.88 8.49 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 117.737 0.769 . . . . 0.0 112.234 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 84.6 m -81.91 126.5 31.98 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.009 0.433 . . . . 0.0 110.948 -176.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -119.8 132.34 55.57 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -87.51 112.08 21.86 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 121.617 0.722 . . . . 0.0 110.232 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 m -122.93 142.1 40.79 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 171.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -55.99 131.09 73.77 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 123.317 0.386 . . . . 0.0 110.449 -175.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -110.73 20.8 3.67 Favored 'Cis proline' 0 CA--C 1.554 1.496 0 C-N-CA 124.692 -0.962 . . . . 0.0 114.272 -0.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -153.76 154.33 33.85 Favored 'General case' 0 C--O 1.243 0.73 0 O-C-N 121.709 -0.62 . . . . 0.0 112.32 -173.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -73.59 121.38 20.57 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.449 -177.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.408 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 53.9 mttp -117.21 157.75 25.47 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.553 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.608 ' HB2' ' CD1' ' A' ' 11' ' ' TRP . 96.4 m -88.49 113.03 23.66 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.6 mm -105.28 135.65 42.48 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.718 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.6 m -87.46 159.96 18.47 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 123.692 0.62 . . . . 0.0 109.701 -177.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.443 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 96.3 m-85 -132.15 128.1 37.34 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -176.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -111.17 150.73 42.41 Favored Pre-proline 0 C--N 1.308 -1.218 0 C-N-CA 123.637 0.775 . . . . 0.0 110.158 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -84.18 113.91 1.83 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.73 2.287 . . . . 0.0 113.466 -177.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 82.9 m . . . . . 0 C--N 1.295 -1.798 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.224 175.821 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt . . . . . 0 CA--C 1.513 -0.458 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.9 mt -108.21 127.77 54.13 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.249 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.4 p -108.87 141.83 40.35 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.519 ' HB2' HG21 ' A' ' 46' ' ' ILE . 10.2 pt20 -96.71 144.13 27.0 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -174.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 -147.58 114.17 4.07 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -75.36 -39.02 1.21 Allowed 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.096 1.864 . . . . 0.0 114.728 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.2 m -94.4 139.37 31.2 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -172.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.7 -86.29 0.1 Allowed Glycine 0 N--CA 1.411 -3.025 0 N-CA-C 107.808 -2.117 . . . . 0.0 107.808 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.442 HG22 ' OE2' ' A' ' 29' ' ' GLU . 10.2 t -101.31 -33.72 9.92 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-O 121.263 0.554 . . . . 0.0 110.65 178.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.59 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 60.9 t90 -72.74 140.32 47.72 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.396 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.7 m -160.46 110.38 1.77 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.581 1.552 . . . . 0.0 107.588 170.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.19 -121.12 2.13 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.795 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -120.71 171.06 9.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 C-N-CA 122.977 0.511 . . . . 0.0 110.127 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.649 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 31.6 t -96.42 99.17 10.86 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 176.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.26 -71.27 1.14 Allowed Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.714 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -127.54 133.5 49.8 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -53.42 -56.76 14.16 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 124.369 1.043 . . . . 0.0 110.777 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.42 -34.26 77.35 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.411 -174.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.33 -60.0 3.7 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 124.04 0.837 . . . . 0.0 111.524 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.5 p -74.11 -23.53 59.33 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.763 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -55.53 -56.95 14.27 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 172.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -60.43 -41.39 93.91 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.973 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -60.1 -41.67 93.05 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.848 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 76.8 m -62.86 -56.49 16.91 Favored 'General case' 0 C--O 1.253 1.272 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 61.2 mt -53.24 -36.86 26.74 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.578 -176.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -78.9 -41.55 29.36 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.68 -62.72 1.41 Allowed 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.84 -168.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.442 ' OE2' HG22 ' A' ' 10' ' ' THR . 10.9 pt-20 -93.9 -6.88 44.63 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.532 0.682 . . . . 0.0 110.213 -176.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 56.6 mttp 64.19 66.84 0.61 Allowed 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 113.758 -1.564 . . . . 0.0 112.589 175.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.71 -178.91 4.69 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 113.363 -1.744 . . . . 0.0 108.189 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -102.79 -29.5 11.44 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.424 0.63 . . . . 0.0 109.894 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 68.7 t60 -152.63 179.54 8.51 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.06 139.58 4.48 Favored Glycine 0 C--N 1.302 -1.311 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.4 m -161.5 173.68 14.49 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 118.417 1.108 . . . . 0.0 111.762 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.6 m -75.05 102.22 4.79 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.311 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.425 ' HB3' HG13 ' A' ' 46' ' ' ILE . 26.0 t-20 . . . . . 0 C--N 1.29 -1.997 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.8 mttp . . . . . 0 N--CA 1.44 -0.96 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.649 ' SG ' ' HA ' ' A' ' 15' ' ' CYS . 78.0 m -79.25 104.97 10.24 Favored 'General case' 0 CA--C 1.479 -1.757 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.519 HG21 ' HB2' ' A' ' 5' ' ' GLN . 22.0 mm -103.48 129.82 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.761 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 60.1 m -84.61 136.9 33.57 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.476 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 76.9 m-85 -110.4 123.44 49.88 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-O 121.394 0.616 . . . . 0.0 110.957 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -105.99 157.65 34.27 Favored Pre-proline 0 C--N 1.283 -2.311 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.166 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -77.41 116.15 4.05 Favored 'Trans proline' 0 N--CA 1.435 -1.939 0 C-N-CA 121.548 1.499 . . . . 0.0 111.404 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 95.0 m . . . . . 0 C--N 1.282 -2.367 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.358 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.0 tttt . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 90.5 mt -89.08 99.88 12.77 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.78 0.8 . . . . 0.0 110.128 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.9 m -86.07 112.28 21.11 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.971 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.484 ' HB2' HG21 ' A' ' 46' ' ' ILE . 27.7 pt20 -73.99 136.38 43.18 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.868 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 46.6 ttp180 -145.17 115.26 5.0 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 6' ' ' ARG . 13.8 Cg_exo -68.7 -73.31 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.683 2.255 . . . . 0.0 115.776 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.9 m -90.29 97.36 11.14 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -170.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -119.92 -73.62 0.39 Allowed Glycine 0 N--CA 1.422 -2.234 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 168.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.442 HG22 ' OE2' ' A' ' 29' ' ' GLU . 8.7 t -108.25 -26.53 10.51 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 173.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.656 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 20.2 t90 -62.17 136.07 57.78 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-O 121.252 0.549 . . . . 0.0 112.3 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -157.4 108.22 2.27 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.288 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.31 -157.57 22.78 Favored Glycine 0 N--CA 1.431 -1.675 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.806 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.67 149.3 4.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 33.7 t -83.76 123.85 30.29 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.77 -64.26 0.88 Allowed Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.211 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 56.0 t-20 -122.5 126.16 47.26 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -177.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -54.85 -47.72 73.79 Favored 'General case' 0 C--O 1.207 -1.162 0 O-C-N 123.903 0.752 . . . . 0.0 110.066 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -62.27 -40.5 96.44 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.704 -177.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 17' ' ' ASN . . . -69.28 -47.06 65.68 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.54 -177.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.5 p -73.35 -34.48 65.65 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.5 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -55.33 -54.43 43.68 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.586 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 48.2 t30 -56.69 -46.74 81.02 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.228 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -56.2 -41.87 76.27 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.498 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.3 m -62.46 -51.97 65.39 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.6 mt -58.24 -35.7 54.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.08 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 9.3 mmp_? -74.78 -29.98 61.29 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.89 -57.67 2.07 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 119.463 -0.895 . . . . 0.0 112.546 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.442 ' OE2' HG22 ' A' ' 10' ' ' THR . 12.9 pt-20 -98.05 -5.12 34.59 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.555 -175.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 62.32 63.14 1.08 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.283 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.15 -179.02 5.56 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.648 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.543 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 4.5 mmp_? -106.88 -21.21 13.09 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.145 0.498 . . . . 0.0 110.534 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 78.2 t60 -158.13 170.28 22.64 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.67 140.54 6.49 Favored Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 106.378 -2.689 . . . . 0.0 106.378 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.0 t -155.21 153.29 30.47 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 118.37 1.085 . . . . 0.0 111.025 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 61.0 m -73.16 93.52 1.84 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 . . . . . 0 C--N 1.294 -1.82 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -178.634 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.656 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 97.3 mttt . . . . . 0 N--CA 1.421 -1.895 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 24.6 t -90.67 123.9 34.65 Favored 'General case' 0 CA--C 1.48 -1.731 0 C-N-CA 118.624 -1.23 . . . . 0.0 109.278 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.484 HG21 ' HB2' ' A' ' 5' ' ' GLN . 20.0 mm -111.35 128.98 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.541 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 37.8 m -85.18 147.04 26.8 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.427 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 93.3 m-85 -118.11 122.82 44.07 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.913 -0.492 . . . . 0.0 110.539 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -104.85 152.39 39.54 Favored Pre-proline 0 C--N 1.3 -1.562 0 C-N-CA 123.589 0.756 . . . . 0.0 110.988 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -88.33 107.76 0.54 Allowed 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 122.79 2.326 . . . . 0.0 112.67 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 82.0 m . . . . . 0 C--N 1.279 -2.46 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 174.736 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt . . . . . 0 C--O 1.239 0.527 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.8 mt -121.95 132.04 54.33 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 67.7 m -106.69 129.6 54.56 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.65 151.42 25.3 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -144.45 123.74 7.12 Favored Pre-proline 0 C--N 1.305 -1.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.838 -177.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -68.65 103.03 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.022 1.815 . . . . 0.0 108.129 170.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.533 ' HB3' ' OE1' ' A' ' 29' ' ' GLU . 61.8 m -98.33 161.46 13.68 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -171.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.56 -35.21 52.26 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.307 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.2 t -60.85 -34.53 74.73 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.9 0.381 . . . . 0.0 110.142 175.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -57.82 106.34 0.35 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.784 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.4 t -150.28 91.69 1.79 Allowed 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.6 173.78 23.13 Favored Glycine 0 N--CA 1.422 -2.29 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.187 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.4 m -98.0 171.51 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 123.004 0.521 . . . . 0.0 110.248 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.5 t -69.03 108.38 3.52 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.031 -0.532 . . . . 0.0 112.175 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.36 -91.45 0.69 Allowed Glycine 0 N--CA 1.42 -2.402 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 173.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -91.13 114.92 27.58 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -65.38 -43.64 90.06 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 123.752 0.657 . . . . 0.0 111.002 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -70.16 -36.5 74.75 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.111 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.85 -43.68 95.42 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.981 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.2 p -76.2 -29.36 57.61 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.68 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -57.72 -56.68 18.79 Favored 'General case' 0 C--O 1.251 1.154 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -61.01 -36.87 80.63 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.46 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -63.5 -41.4 98.53 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.08 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 97.7 m -62.65 -49.71 74.09 Favored 'General case' 0 C--O 1.259 1.577 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 60.9 mt -58.91 -33.59 50.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.149 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -83.6 -21.49 32.56 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.74 -65.14 0.98 Allowed 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.245 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.533 ' OE1' ' HB3' ' A' ' 8' ' ' SER . 10.9 pt-20 -106.26 -1.3 23.66 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.845 -177.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.2 mttp 64.26 65.11 0.68 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.708 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.85 -176.17 5.4 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.437 175.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.405 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 4.1 tpm_? -101.97 -29.88 11.54 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.083 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.563 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 31.4 t60 -151.2 173.56 14.28 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.0 139.75 5.96 Favored Glycine 0 C--N 1.295 -1.735 0 N-CA-C 106.478 -2.649 . . . . 0.0 106.478 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.0 t -163.04 167.47 22.34 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 118.384 1.092 . . . . 0.0 109.974 -174.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 89.6 m -72.83 95.16 1.89 Allowed 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.061 175.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 . . . . . 0 C--N 1.291 -1.967 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 177.383 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm . . . . . 0 CA--C 1.507 -0.705 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.3 m -81.91 94.61 7.14 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.618 0.723 . . . . 0.0 111.458 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.75 143.59 11.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 74.2 m -90.0 148.22 23.21 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.481 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.563 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 38.9 m-85 -120.11 130.34 54.59 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.224 0.535 . . . . 0.0 110.844 -177.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -110.8 151.07 42.66 Favored Pre-proline 0 C--N 1.297 -1.678 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.338 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.57 132.06 10.8 Favored 'Trans proline' 0 C--O 1.253 1.262 0 C-N-CA 122.412 2.075 . . . . 0.0 113.276 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 68.9 m . . . . . 0 N--CA 1.435 -1.225 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.705 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.9 pttm . . . . . 0 CA--C 1.5 -0.947 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 92.4 mt -93.21 110.16 21.68 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-O 121.351 0.596 . . . . 0.0 110.46 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.42 ' SG ' ' HB2' ' A' ' 49' ' ' PHE . 8.2 p -89.08 127.43 35.7 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.5 ' HB2' HG21 ' A' ' 46' ' ' ILE . 26.9 pt20 -87.43 133.4 33.74 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.209 0.528 . . . . 0.0 111.516 -175.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -126.04 119.84 23.87 Favored Pre-proline 0 C--O 1.265 1.878 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.267 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -71.44 125.96 11.75 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.582 2.188 . . . . 0.0 107.427 169.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.5 t -144.27 160.89 40.23 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.878 -171.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.26 20.04 43.03 Favored Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.655 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.4 p -83.8 -58.29 2.86 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.466 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 1.6 t90 -57.8 144.46 38.44 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.161 169.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.8 t -146.33 119.68 8.99 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.26 -135.23 12.45 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.948 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -125.55 170.92 14.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -175.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.4 t -60.66 108.52 0.85 Allowed 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.093 0.473 . . . . 0.0 111.227 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -116.0 -88.41 1.45 Allowed Glycine 0 N--CA 1.427 -1.949 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -95.46 106.43 18.5 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 122.534 0.333 . . . . 0.0 110.228 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -59.9 -56.09 26.01 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.424 1.09 . . . . 0.0 111.751 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -71.53 -30.1 65.53 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.789 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.64 -42.01 64.86 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.363 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 30.6 p -70.66 -32.33 69.56 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.823 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -55.71 -56.7 17.36 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 172.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -58.8 -37.27 75.99 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.127 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.52 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 20.9 tt0 -63.77 -44.19 94.14 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.236 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 99.0 m -62.08 -49.48 75.79 Favored 'General case' 0 C--O 1.259 1.562 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.632 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 65.9 mt -59.24 -32.81 49.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.401 -177.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.515 ' HA ' ' NE ' ' A' ' 27' ' ' ARG . 4.1 mmp_? -97.05 -8.94 29.12 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 24' ' ' GLN . 42.4 mt -102.04 -62.98 1.19 Allowed 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.63 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -99.17 -3.85 33.48 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.177 0.513 . . . . 0.0 110.01 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 56.4 mtmt 68.92 50.74 0.59 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.646 175.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.08 178.66 7.35 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.063 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -98.74 -34.2 10.61 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 80.0 t60 -151.61 175.17 12.62 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 -176.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -169.0 141.34 6.67 Favored Glycine 0 C--N 1.289 -2.064 0 N-CA-C 106.869 -2.492 . . . . 0.0 106.869 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.0 p -169.03 169.51 9.49 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 118.114 0.957 . . . . 0.0 112.062 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 44' ' ' LYS . 78.0 m -80.63 117.49 21.37 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.631 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 . . . . . 0 C--N 1.287 -2.133 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.033 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 31.1 mmtp . . . . . 0 N--CA 1.422 -1.841 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 23.8 t -92.22 113.54 25.83 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' A' ' 5' ' ' GLN . 38.8 mm -105.71 142.07 19.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 61.3 m -88.46 145.63 25.66 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.471 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 70.6 m-85 -121.45 136.58 54.94 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.067 0.46 . . . . 0.0 111.375 -176.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.42 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 73.3 m-85 -117.82 164.58 19.12 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -85.31 108.78 1.12 Allowed 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 121.893 1.729 . . . . 0.0 111.837 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 98.9 m . . . . . 0 C--N 1.302 -1.497 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.992 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 CA--C 1.5 -0.968 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 88.7 mt -96.76 108.58 21.26 Favored 'General case' 0 C--N 1.288 -2.085 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.096 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.7 m -82.22 129.63 34.89 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.608 ' HB2' HG21 ' A' ' 46' ' ' ILE . 11.1 pt20 -85.6 141.32 29.9 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.216 0.531 . . . . 0.0 110.987 -177.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -144.57 108.56 4.8 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -77.49 -55.25 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.472 2.114 . . . . 0.0 115.433 -175.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 m -98.22 109.85 22.54 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -172.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.85 -69.88 0.02 OUTLIER Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 108.051 -2.02 . . . . 0.0 108.051 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.524 HG21 ' HA ' ' A' ' 25' ' ' CYS . 7.0 t -103.96 -39.17 6.7 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 170.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.48 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 78.7 t90 -70.76 123.38 21.81 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-O 121.484 0.659 . . . . 0.0 110.731 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.1 m -162.06 96.62 1.0 Allowed 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 125.739 1.616 . . . . 0.0 106.661 174.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.33 -131.73 3.69 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.408 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.9 m -117.66 164.73 13.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 122.627 0.371 . . . . 0.0 110.696 -177.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.7 t -92.74 106.71 18.64 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 120.821 0.343 . . . . 0.0 110.66 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.51 -67.75 1.5 Allowed Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 176.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.618 ' HB2' ' HB3' ' A' ' 20' ' ' ALA . 32.8 m-80 -129.38 132.57 47.07 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -66.41 -47.1 74.35 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.682 0.753 . . . . 0.0 110.001 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -72.65 -16.86 61.7 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.786 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 17' ' ' ASN . . . -88.94 -38.06 14.77 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.776 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.4 p -72.71 -30.88 64.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -53.25 -53.57 48.83 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 171.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -61.79 -40.27 94.62 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 113.855 -1.52 . . . . 0.0 110.062 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -59.88 -39.11 84.16 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 123.358 0.663 . . . . 0.0 110.4 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.524 ' HA ' HG21 ' A' ' 10' ' ' THR . 91.5 m -64.12 -55.5 21.53 Favored 'General case' 0 C--O 1.25 1.107 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 55.9 mt -58.17 -33.83 47.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.701 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -85.42 -21.4 28.79 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.25 -67.9 0.88 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.401 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -97.18 2.67 51.32 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.56 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 49.7 mttp 60.96 57.68 2.5 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 114.057 -1.429 . . . . 0.0 112.215 171.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.64 -179.09 7.23 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.256 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -101.19 -27.23 13.34 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.681 0.753 . . . . 0.0 109.256 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 86.5 t60 -151.55 171.48 17.53 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.722 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.96 143.63 8.17 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 106.829 -2.508 . . . . 0.0 106.829 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.6 p -165.58 151.3 9.29 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 117.888 0.844 . . . . 0.0 111.284 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 62.5 m -81.79 100.32 9.49 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.718 0.771 . . . . 0.0 110.241 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.8 t30 . . . . . 0 C--N 1.307 -1.249 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.603 -177.766 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 97.6 mttt . . . . . 0 CA--C 1.506 -0.735 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 11.7 t -84.66 125.95 32.94 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 121.178 0.513 . . . . 0.0 110.739 -173.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.608 HG21 ' HB2' ' A' ' 5' ' ' GLN . 18.4 mm -117.22 134.2 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.451 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 67.6 m -82.9 149.88 26.82 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.478 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 76.1 m-85 -127.24 126.84 43.43 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.086 0.469 . . . . 0.0 111.266 -177.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -110.53 144.87 31.09 Favored Pre-proline 0 C--N 1.302 -1.472 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.775 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -82.65 114.31 2.35 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 122.337 2.025 . . . . 0.0 112.269 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 C--N 1.288 -2.069 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.929 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.0 mttm . . . . . 0 N--CA 1.437 -1.102 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 83.4 mt -79.94 117.35 20.71 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-O 121.193 0.521 . . . . 0.0 110.653 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.1 p -98.18 129.88 44.94 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.468 ' HB2' HG21 ' A' ' 46' ' ' ILE . 4.7 pt20 -87.89 130.74 34.81 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.308 0.575 . . . . 0.0 111.774 -173.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -132.69 120.03 16.41 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.138 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -74.79 142.62 28.79 Favored 'Trans proline' 0 C--O 1.247 0.937 0 C-N-CA 122.21 1.94 . . . . 0.0 107.759 168.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.1 t -151.67 161.74 42.17 Favored 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.925 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.6 -7.32 87.19 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.399 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 p -65.54 -56.72 10.81 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.5 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 1.7 t90 -59.51 138.04 57.82 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.492 166.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.8 t -134.02 110.42 9.64 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-O 120.659 0.266 . . . . 0.0 111.052 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.78 -115.5 5.91 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 115.936 1.134 . . . . 0.0 115.936 171.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 p -83.94 137.15 21.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.807 0.813 . . . . 0.0 112.47 -174.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.1 t -90.73 112.5 24.29 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.36 -59.33 1.04 Allowed Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -112.92 120.35 41.13 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -54.97 -44.67 74.62 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.731 0.645 . . . . 0.0 110.354 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -66.04 -33.51 75.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.011 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.15 -46.41 56.56 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.11 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.4 p -73.22 -32.0 64.5 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.868 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -53.07 -60.08 3.74 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 123.854 0.862 . . . . 0.0 109.177 173.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -61.54 -34.47 75.6 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.004 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -65.8 -38.62 89.48 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.451 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.1 m -64.93 -49.07 71.81 Favored 'General case' 0 C--O 1.255 1.374 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 73.0 mt -57.14 -42.79 80.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.844 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -81.24 -14.15 57.76 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.7 mt -107.06 -55.72 2.29 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 119.087 -1.045 . . . . 0.0 112.078 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -110.89 1.42 17.58 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.097 0.475 . . . . 0.0 111.626 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 36.5 mtmm 66.82 45.92 1.78 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.122 174.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.21 172.42 11.17 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.999 -1.001 . . . . 0.0 108.88 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -91.62 -35.95 13.93 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -152.63 176.56 11.6 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -175.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.62 150.64 11.55 Favored Glycine 0 C--N 1.308 -0.987 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.2 p -172.27 168.27 5.66 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-N 118.372 1.086 . . . . 0.0 111.696 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.0 m -68.41 107.57 2.92 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.4 t30 . . . . . 0 C--N 1.311 -1.079 0 CA-C-O 121.702 0.763 . . . . 0.0 109.866 -177.58 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.5 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 32.4 mmtp . . . . . 0 C--O 1.242 0.666 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 45.2 t -103.9 131.7 50.87 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.468 HG21 ' HB2' ' A' ' 5' ' ' GLN . 50.1 mm -116.68 137.55 50.14 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.7 m -89.49 153.0 21.15 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.479 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 87.6 m-85 -126.0 135.96 52.43 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -116.78 159.42 40.7 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -82.42 101.4 1.08 Allowed 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.936 1.758 . . . . 0.0 112.149 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 85.2 m . . . . . 0 C--N 1.298 -1.635 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.709 179.117 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 51' ' ' CYS . 23.0 pttm . . . . . 0 CA--C 1.511 -0.529 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 82.2 mt -95.43 105.47 17.44 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.248 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 86.3 m -80.78 135.65 36.0 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.732 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.425 ' HB2' HG21 ' A' ' 46' ' ' ILE . 19.0 pt20 -90.67 128.72 36.73 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.208 0.527 . . . . 0.0 110.696 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -129.07 117.99 19.28 Favored Pre-proline 0 C--N 1.301 -1.52 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.161 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -78.53 116.78 3.88 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.036 1.824 . . . . 0.0 109.301 173.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.1 m -124.79 160.12 29.42 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.33 -25.67 60.67 Favored Glycine 0 C--N 1.334 0.421 0 O-C-N 124.217 0.948 . . . . 0.0 114.142 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.7 t -53.81 -47.64 70.65 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 117.219 0.51 . . . . 0.0 110.052 174.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -71.44 121.94 19.5 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 121.25 0.548 . . . . 0.0 109.796 173.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.0 p -153.41 100.2 2.41 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.432 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.96 -145.39 16.86 Favored Glycine 0 N--CA 1.427 -1.951 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.502 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.6 m -99.61 153.01 4.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -177.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.8 t -90.77 91.66 8.47 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.96 -60.17 2.98 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -120.95 129.9 53.62 Favored 'General case' 0 CA--C 1.486 -1.508 0 CA-C-N 115.472 -0.364 . . . . 0.0 110.111 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -56.17 -46.8 79.19 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 124.313 1.008 . . . . 0.0 109.577 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -64.64 -30.9 71.92 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.89 -53.37 21.54 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.5 p -74.89 -29.11 60.9 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.599 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -52.62 -58.68 6.02 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-O 122.021 0.915 . . . . 0.0 108.623 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -59.17 -41.38 88.28 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.69 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -65.04 -32.34 74.01 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.327 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 98.5 m -66.97 -49.65 64.77 Favored 'General case' 0 C--O 1.255 1.359 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 57.0 mt -61.24 -28.03 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.33 -1.304 . . . . 0.0 111.176 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.46 ' HA ' ' NE ' ' A' ' 27' ' ' ARG . 3.3 mmp_? -92.82 -15.7 26.2 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -103.91 -62.41 1.31 Allowed 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.194 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -102.66 -1.4 30.21 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.199 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 56.0 mtpt 69.62 37.41 1.92 Allowed 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.215 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.58 175.88 3.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.144 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.483 ' HG2' ' HD3' ' A' ' 50' ' ' PRO . 6.7 mmp_? -90.94 -32.14 16.1 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.146 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 43.1 t-80 -155.82 175.02 14.48 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -174.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -169.96 142.75 7.43 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 107.145 -2.382 . . . . 0.0 107.145 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.7 p -163.0 169.92 18.85 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 117.892 0.846 . . . . 0.0 110.9 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 68.6 m -67.91 107.4 2.64 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 175.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 . . . . . 0 C--N 1.296 -1.722 0 CA-C-O 121.751 0.786 . . . . 0.0 109.092 -175.532 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.9 t -100.55 128.96 46.44 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.425 HG21 ' HB2' ' A' ' 5' ' ' GLN . 47.9 mm -122.85 141.02 44.82 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 41.5 m -88.73 156.92 18.71 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.481 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 95.9 m-85 -126.54 142.65 51.47 Favored 'General case' 0 C--O 1.252 1.211 0 CA-C-O 121.039 0.447 . . . . 0.0 112.182 -177.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -126.67 151.31 73.1 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 124.312 1.045 . . . . 0.0 109.908 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.483 ' HD3' ' HG2' ' A' ' 32' ' ' ARG . 94.5 Cg_endo -86.99 107.37 0.7 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.725 2.283 . . . . 0.0 112.38 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 20.7 m . . . . . 0 C--N 1.291 -1.967 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 N--CA 1.435 -1.216 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 90.6 mt -96.74 99.99 11.56 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.7 p -87.63 114.68 24.47 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 114.596 -1.183 . . . . 0.0 109.681 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.507 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 18.8 pt20 -83.14 144.32 29.92 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -173.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -138.22 120.7 10.85 Favored Pre-proline 0 C--N 1.313 -1.004 0 C-N-CA 124.743 1.217 . . . . 0.0 108.453 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -73.82 108.76 2.72 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 121.681 1.587 . . . . 0.0 108.991 173.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.7 p -79.73 160.97 26.03 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.373 0.606 . . . . 0.0 112.567 -174.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.01 -24.64 57.41 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.3 t -71.34 -41.24 70.05 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.765 -0.218 . . . . 0.0 110.575 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -48.92 130.93 18.65 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.05 0.54 . . . . 0.0 112.225 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.9 t -91.23 127.94 36.86 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -33.23 -48.47 0.43 Allowed Glycine 0 N--CA 1.478 1.447 0 N-CA-C 117.513 1.765 . . . . 0.0 117.513 -171.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.6 131.67 36.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 117.355 0.577 . . . . 0.0 110.024 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.6 t -73.58 127.7 33.48 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.838 0.351 . . . . 0.0 110.143 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.77 -73.31 0.81 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -122.46 125.18 45.28 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -59.03 -46.03 89.25 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 123.756 0.66 . . . . 0.0 111.123 -175.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -75.02 -9.37 58.47 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.79 -47.04 8.49 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.6 p -75.16 -34.66 61.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.321 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -54.4 -55.02 32.91 Favored 'General case' 0 C--O 1.25 1.087 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 174.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.597 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 7.2 t30 -60.51 -41.9 95.32 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.052 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -58.29 -39.4 79.18 Favored 'General case' 0 C--O 1.211 -0.969 0 C-N-CA 122.795 0.438 . . . . 0.0 110.524 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 99.1 m -64.69 -54.5 30.65 Favored 'General case' 0 C--O 1.253 1.265 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 69.5 mt -58.38 -30.15 39.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.165 -1.379 . . . . 0.0 111.788 -175.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.597 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 28.3 mmt180 -89.5 -32.69 17.07 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.414 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.12 -66.55 0.91 Allowed 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.423 -172.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -94.59 -3.06 50.34 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.762 0.792 . . . . 0.0 110.154 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 47.9 mttp 61.84 65.44 0.92 Allowed 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 113.801 -1.545 . . . . 0.0 112.552 173.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.401 ' H ' ' HA ' ' A' ' 26' ' ' ILE . . . -92.91 -177.53 4.54 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.401 177.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -99.43 -26.95 13.96 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.316 178.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 81.0 t60 -153.03 176.19 12.16 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -174.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.74 142.27 7.5 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 107.871 -2.091 . . . . 0.0 107.871 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.0 m -155.29 154.01 31.45 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 118.019 0.909 . . . . 0.0 111.064 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 76.1 m -87.08 91.23 8.63 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 122.397 1.094 . . . . 0.0 109.389 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 . . . . . 0 C--N 1.298 -1.633 0 CA-C-N 113.652 -1.613 . . . . 0.0 107.818 -176.616 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp . . . . . 0 N--CA 1.439 -0.982 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 6.9 t -79.62 115.26 19.13 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.531 0.681 . . . . 0.0 110.583 -173.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.487 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 22.5 mm -112.27 141.11 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.43 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 5' ' ' GLN . 51.7 m -83.61 144.3 29.54 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.507 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 63.5 m-85 -119.09 118.35 31.18 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.499 0.666 . . . . 0.0 111.643 -177.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -100.59 163.49 18.04 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.081 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -88.06 126.12 1.99 Allowed 'Trans proline' 0 N--CA 1.441 -1.586 0 C-N-CA 122.136 1.89 . . . . 0.0 111.667 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 69.6 m . . . . . 0 C--N 1.294 -1.829 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.662 177.554 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.2 mt -118.86 130.56 55.81 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 66.8 m -108.81 133.38 52.93 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 175.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.552 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 17.5 pt20 -94.52 134.84 36.63 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.658 0.742 . . . . 0.0 112.305 -177.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -137.53 120.77 11.54 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.634 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -66.72 132.94 30.1 Favored 'Trans proline' 0 C--O 1.246 0.88 0 C-N-CA 122.146 1.897 . . . . 0.0 109.415 172.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -118.43 160.36 21.84 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.496 -174.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.0 -12.52 76.68 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.263 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.9 p -71.01 -43.8 67.2 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.526 0.679 . . . . 0.0 109.592 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.415 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 3.9 t90 -64.97 140.21 58.84 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.261 171.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.8 t -146.07 119.61 9.11 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.064 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.19 -135.12 11.99 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 172.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.8 p -108.31 168.4 3.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.7 t -59.29 118.26 5.74 Favored 'General case' 0 C--O 1.25 1.109 0 C-N-CA 123.495 0.718 . . . . 0.0 112.642 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.47 -76.7 1.05 Allowed Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 171.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -143.32 138.21 29.35 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -50.81 -54.91 19.68 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.205 1.002 . . . . 0.0 112.408 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.403 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 29.5 p-10 -70.23 -32.22 69.99 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.597 -177.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.29 -49.13 68.14 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.825 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 24' ' ' GLN . 11.0 p -76.53 -22.9 53.77 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 119.205 -0.998 . . . . 0.0 112.287 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 19' ' ' ASN . 28.2 ttpp -57.87 -53.42 58.39 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -58.78 -42.3 88.69 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.898 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 0.8 OUTLIER -55.98 -39.29 71.59 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.457 0.473 . . . . 0.0 111.268 177.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 89.4 m -68.91 -51.48 39.61 Favored 'General case' 0 C--O 1.255 1.373 0 CA-C-O 121.993 0.902 . . . . 0.0 108.869 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.5 mt -57.01 -36.6 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.702 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -73.6 -32.3 64.03 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.0 mt -100.01 -57.1 2.2 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.19 -1.004 . . . . 0.0 113.265 -170.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -105.79 -10.35 16.76 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 120.026 -0.669 . . . . 0.0 111.605 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.8 mttm 72.26 68.97 0.14 Allowed 'General case' 0 C--N 1.319 -0.733 0 O-C-N 124.355 1.035 . . . . 0.0 111.498 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.49 175.71 7.82 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -98.66 -27.3 14.05 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.14 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 79.9 t60 -151.66 173.82 14.23 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.22 141.68 6.96 Favored Glycine 0 C--N 1.283 -2.367 0 N-CA-C 106.457 -2.657 . . . . 0.0 106.457 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.5 t -159.54 165.33 33.16 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 118.387 1.094 . . . . 0.0 110.069 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.7 m -86.61 102.59 14.31 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.73 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 . . . . . 0 C--N 1.295 -1.77 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -179.85 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.415 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 56.0 mttm . . . . . 0 N--CA 1.433 -1.291 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 86.9 m -83.23 113.33 20.6 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.393 0.616 . . . . 0.0 111.081 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.424 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 33.2 mm -109.56 138.05 38.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 60.5 m -88.43 136.04 33.18 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.552 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 34.7 m-85 -107.83 124.69 50.45 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.421 0.629 . . . . 0.0 110.355 -177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -108.83 153.41 42.38 Favored Pre-proline 0 C--N 1.292 -1.895 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.188 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -77.7 133.52 12.85 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 122.21 1.94 . . . . 0.0 113.03 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 81.7 m . . . . . 0 C--N 1.294 -1.817 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.823 178.501 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 2' ' ' LYS . 73.4 mmtt . . . . . 0 CA--C 1.505 -0.758 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -110.6 120.19 41.61 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.114 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 31.3 m -93.66 116.68 29.18 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.49 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 29.5 pt20 -85.89 119.62 26.41 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -133.19 129.03 20.71 Favored Pre-proline 0 C--N 1.307 -1.244 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.118 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -72.46 134.61 22.83 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.898 1.732 . . . . 0.0 109.575 173.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.0 m -116.03 160.34 20.42 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.17 -15.11 75.35 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.235 -0.438 . . . . 0.0 112.036 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 p -69.63 -51.07 38.2 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.493 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 2.2 t90 -58.77 136.67 57.81 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.379 171.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.2 p -148.85 129.66 14.22 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.868 173.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.42 -173.32 27.23 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-O 121.656 0.587 . . . . 0.0 114.258 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.3 t -81.41 148.38 5.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.3 t -67.35 112.55 4.64 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 123.303 0.377 . . . . 0.0 111.145 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.1 -50.46 1.91 Allowed Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -123.13 117.16 24.75 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.534 ' HA ' ' SG ' ' A' ' 36' ' ' CYS . 13.2 m120 -57.79 -52.35 65.83 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 124.163 0.915 . . . . 0.0 110.748 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -66.47 -24.69 66.46 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.366 -0.833 . . . . 0.0 113.004 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.05 -57.77 4.6 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 123.051 0.219 . . . . 0.0 110.591 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.4 p -69.95 -30.36 67.73 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.41 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 38.1 ttmt -53.89 -57.31 11.4 Favored 'General case' 0 C--O 1.251 1.135 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -60.71 -39.12 87.42 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.329 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -60.33 -41.27 93.22 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.808 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.4 m -63.63 -52.33 61.29 Favored 'General case' 0 C--O 1.257 1.476 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 66.4 mt -55.95 -30.29 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.173 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -87.13 -33.9 19.28 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.2 mt -96.61 -47.65 5.83 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.196 -1.002 . . . . 0.0 113.352 -169.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -107.51 -5.93 17.32 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 120.906 0.384 . . . . 0.0 110.73 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 99.7 mttt 64.55 54.85 1.4 Allowed 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.7 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.53 159.85 33.25 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -81.84 -29.55 32.51 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.933 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -156.46 174.8 14.9 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 22' ' ' LYS . . . -153.59 144.01 10.82 Favored Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 107.634 -2.186 . . . . 0.0 107.634 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.545 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 41.7 t -154.52 148.99 26.23 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 117.899 0.849 . . . . 0.0 109.31 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.534 ' SG ' ' HA ' ' A' ' 18' ' ' ASN . 60.6 m -87.35 108.21 18.88 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.842 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.2 t30 . . . . . 0 C--N 1.301 -1.51 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.737 -178.502 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.493 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 39.8 mmtm . . . . . 0 CA--C 1.499 -0.997 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.479 ' HB2' ' CD1' ' A' ' 11' ' ' TRP . 85.0 m -87.13 107.65 18.55 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.443 0.64 . . . . 0.0 109.622 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.445 HG21 ' HB2' ' A' ' 5' ' ' GLN . 42.9 mm -104.4 135.39 42.43 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 33.9 m -91.5 132.93 35.93 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.545 ' CE1' ' HB3' ' A' ' 35' ' ' SER . 27.6 m-85 -105.93 120.1 40.88 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.543 0.687 . . . . 0.0 110.671 -176.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -102.58 161.42 23.3 Favored Pre-proline 0 C--N 1.288 -2.079 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.312 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -80.76 119.72 3.71 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 121.552 1.501 . . . . 0.0 112.704 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 56.8 m . . . . . 0 C--N 1.312 -1.06 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 174.589 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt . . . . . 0 N--CA 1.443 -0.802 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.9 mt -113.4 121.07 43.23 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 121.047 0.451 . . . . 0.0 109.964 177.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 80.9 m -94.89 132.09 40.08 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.492 ' HB3' HG21 ' A' ' 46' ' ' ILE . 16.1 mt-30 -83.39 146.22 28.58 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.235 0.54 . . . . 0.0 111.691 -174.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -131.83 101.81 15.23 Favored Pre-proline 0 C--N 1.291 -1.954 0 C-N-CA 124.111 0.964 . . . . 0.0 108.904 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.62 -74.29 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.127 1.885 . . . . 0.0 113.895 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.5 m -100.63 83.56 2.61 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -170.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.11 -71.36 0.25 Allowed Glycine 0 N--CA 1.427 -1.926 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 172.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.569 HG21 ' HA ' ' A' ' 25' ' ' CYS . 5.6 t -103.69 -30.17 10.6 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 120.808 0.337 . . . . 0.0 110.902 173.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.57 ' CZ2' ' HB2' ' A' ' 44' ' ' LYS . 27.0 t90 -59.96 127.75 33.47 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.5 m -157.41 109.39 2.38 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 125.239 1.415 . . . . 0.0 107.944 171.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.01 -166.36 24.04 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 119.662 -1.256 . . . . 0.0 113.431 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.1 t -83.38 150.54 4.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 17.5 t -94.91 100.85 12.63 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.09 -55.54 1.37 Allowed Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.085 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -121.61 121.97 38.59 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.907 0.384 . . . . 0.0 110.519 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -63.19 -42.33 99.31 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.984 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -73.75 -21.98 60.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.156 0.503 . . . . 0.0 110.835 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.81 -51.09 20.33 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.651 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.6 p -73.3 -31.3 63.95 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.966 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -54.55 -57.51 11.12 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -56.8 -40.13 75.39 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.957 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -64.33 -37.97 89.38 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.569 ' HA ' HG21 ' A' ' 10' ' ' THR . 72.8 m -63.06 -53.53 52.23 Favored 'General case' 0 C--O 1.256 1.419 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 73.0 mt -55.45 -37.09 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.441 -178.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -83.14 -27.56 30.02 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -98.13 -57.47 2.21 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -108.25 -0.51 20.82 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.065 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 62.1 mttp 67.14 47.22 1.38 Allowed 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.077 173.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.69 177.08 8.91 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.893 -1.048 . . . . 0.0 108.231 175.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -99.69 -27.29 13.74 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.538 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -149.19 170.35 18.66 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -175.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.14 138.52 4.96 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.5 m -163.14 162.48 25.64 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 117.437 0.619 . . . . 0.0 109.941 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 38.1 m -59.36 118.26 5.77 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 175.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 . . . . . 0 C--N 1.296 -1.723 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.448 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.57 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 4.0 mptp? . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.615 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 33.6 t -68.5 126.8 30.8 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 118.345 0.521 . . . . 0.0 109.981 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.492 HG21 ' HB3' ' A' ' 5' ' ' GLN . 41.5 mm -120.11 135.77 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.316 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 56.1 m -82.97 160.24 22.07 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.449 ' CE1' ' HG2' ' A' ' 5' ' ' GLN . 98.5 m-85 -129.58 127.64 41.09 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 120.844 0.354 . . . . 0.0 111.468 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -106.53 148.93 37.67 Favored Pre-proline 0 C--N 1.305 -1.33 0 C-N-CA 123.936 0.894 . . . . 0.0 109.836 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.47 129.47 6.59 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.674 2.249 . . . . 0.0 112.363 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 82.8 m . . . . . 0 N--CA 1.427 -1.603 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.6 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 51' ' ' CYS . 3.7 mptp? . . . . . 0 CA--C 1.511 -0.556 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -111.68 112.55 24.33 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.621 0.724 . . . . 0.0 111.155 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 70.8 m -86.99 111.12 20.54 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.618 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 10.3 pt20 -76.11 135.82 39.85 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.487 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.475 ' HD3' ' CE1' ' A' ' 49' ' ' PHE . 51.9 ttt180 -146.38 116.3 4.66 Favored Pre-proline 0 C--N 1.296 -1.753 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.555 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -79.17 86.14 1.74 Allowed 'Trans proline' 0 N--CA 1.438 -1.759 0 C-N-CA 122.058 1.839 . . . . 0.0 109.06 173.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.48 ' HB3' ' OE2' ' A' ' 29' ' ' GLU . 61.6 m -69.49 160.06 32.13 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.419 -176.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.58 -9.79 82.7 Favored Glycine 0 CA--C 1.502 -0.727 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.524 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.505 HG21 ' HB3' ' A' ' 28' ' ' LEU . 4.1 p -68.78 -44.62 73.24 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.48 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 2.8 t90 -66.75 132.46 48.14 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.199 169.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.9 t -145.99 112.02 5.69 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.14 -145.87 15.89 Favored Glycine 0 N--CA 1.425 -2.094 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.787 176.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 p -118.43 162.68 16.31 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.8 t -67.07 134.56 52.11 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.7 -49.58 0.31 Allowed Glycine 0 N--CA 1.421 -2.315 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 173.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -145.99 120.14 9.49 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.185 0.594 . . . . 0.0 110.129 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -55.24 -52.74 62.41 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.072 0.949 . . . . 0.0 111.925 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -65.61 -31.58 72.69 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.935 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.42 -44.28 65.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.503 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.3 p -76.53 -32.18 58.08 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.181 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -54.9 -54.87 37.03 Favored 'General case' 0 C--O 1.253 1.239 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.509 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 47.4 t30 -57.36 -44.39 84.3 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.672 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -56.24 -43.0 78.22 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.264 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.8 m -63.62 -48.8 75.84 Favored 'General case' 0 C--O 1.271 2.224 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 64.9 mt -59.94 -37.73 73.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 114.24 -1.345 . . . . 0.0 111.372 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 31.7 mmt180 -81.47 -19.98 41.21 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.505 ' HB3' HG21 ' A' ' 10' ' ' THR . 4.6 mm? -98.01 -63.61 1.11 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.209 -176.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.48 ' OE2' ' HB3' ' A' ' 8' ' ' SER . 8.3 pt-20 -113.29 3.47 15.96 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.3 0.571 . . . . 0.0 111.685 -177.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 94.4 mttt 67.92 63.74 0.39 Allowed 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.421 174.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' HG12 ' A' ' 26' ' ' ILE . . . -81.07 177.48 9.02 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 173.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -96.01 -41.09 8.93 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -147.15 176.33 10.04 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -173.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.7 143.5 8.9 Favored Glycine 0 C--N 1.307 -1.059 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 m -149.03 152.84 36.96 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 118.466 1.133 . . . . 0.0 110.895 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.0 m -89.13 100.4 13.19 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.501 0.667 . . . . 0.0 109.697 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.1 t30 . . . . . 0 C--N 1.297 -1.681 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.454 -175.78 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 95.1 mttt . . . . . 0 N--CA 1.442 -0.858 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 22.4 t -92.87 117.11 29.68 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.86 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.598 HG21 ' HB2' ' A' ' 5' ' ' GLN . 25.0 mm -101.44 134.49 41.58 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 66.5 m -84.75 136.78 33.56 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.618 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 77.9 m-85 -113.1 122.96 49.14 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.473 0.654 . . . . 0.0 110.925 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.475 ' CE1' ' HD3' ' A' ' 6' ' ' ARG . 81.4 m-85 -107.98 156.53 38.07 Favored Pre-proline 0 C--N 1.288 -2.093 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.709 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -77.66 126.86 8.44 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 121.638 1.558 . . . . 0.0 112.701 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 2' ' ' LYS . 12.2 m . . . . . 0 C--N 1.294 -1.843 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 172.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.1 tttm . . . . . 0 N--CA 1.434 -1.234 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 86.6 mt -80.53 110.89 16.44 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.0 p -102.22 129.97 48.76 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.862 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.487 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 10.9 pt20 -78.76 140.64 38.23 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.35 0.595 . . . . 0.0 111.054 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -137.23 127.93 16.07 Favored Pre-proline 0 C--N 1.282 -2.329 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.26 106.24 0.14 Allowed 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 122.698 2.265 . . . . 0.0 109.751 174.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.603 ' HB2' ' HB3' ' A' ' 11' ' ' TRP . 1.5 m -53.94 133.38 43.13 Favored 'General case' 0 N--CA 1.417 -2.101 0 C-N-CA 125.806 1.642 . . . . 0.0 111.461 -176.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.93 -32.04 6.36 Favored Glycine 0 N--CA 1.428 -1.879 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.985 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -74.53 -38.05 62.89 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 120.708 0.29 . . . . 0.0 110.659 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.603 ' HB3' ' HB2' ' A' ' 8' ' ' SER . 1.7 t90 -58.97 132.91 55.42 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.466 0.706 . . . . 0.0 111.654 174.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.1 p -156.46 97.58 1.76 Allowed 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.22 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.98 -156.48 26.71 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -91.72 150.94 3.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 41.1 t -93.51 101.07 13.25 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 173.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.66 -35.88 7.63 Favored Glycine 0 N--CA 1.429 -1.817 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.654 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -133.62 128.47 35.19 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-O 120.906 0.384 . . . . 0.0 110.964 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -60.39 -47.57 85.49 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.402 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.4 p30 -63.46 -36.69 84.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.219 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.73 -47.41 63.2 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.345 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.9 p -76.17 -25.36 55.16 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.46 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -54.81 -57.72 10.45 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -62.83 -36.67 83.98 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.132 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -61.03 -41.71 97.08 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 122.846 0.459 . . . . 0.0 109.815 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.3 m -64.81 -56.04 15.9 Favored 'General case' 0 C--O 1.257 1.488 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 77.0 mt -54.16 -36.42 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.425 1.49 . . . . 0.0 112.251 -176.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 27' ' ' ARG . 52.0 mtt180 -87.18 -25.07 24.24 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . 0.264 7.3 mp -104.35 -50.98 3.2 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 117.983 -1.487 . . . . 0.0 113.63 -174.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -109.24 1.98 20.58 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.305 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 27.7 mtpp 59.39 63.01 1.65 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 125.773 1.629 . . . . 0.0 114.034 174.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.25 179.73 7.7 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.375 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -94.32 -30.45 14.52 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 55.9 t-80 -156.41 174.0 16.06 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -165.23 150.86 19.22 Favored Glycine 0 C--N 1.304 -1.237 0 N-CA-C 107.868 -2.093 . . . . 0.0 107.868 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.0 t -167.04 151.84 7.26 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 118.31 1.055 . . . . 0.0 112.06 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 38.5 m -63.62 117.37 6.7 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 170.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 . . . . . 0 C--N 1.297 -1.686 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.724 -175.628 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt . . . . . 0 C--O 1.25 1.094 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.496 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 41.9 t -98.75 131.12 45.14 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 175.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.437 HG21 ' HB2' ' A' ' 5' ' ' GLN . 16.4 mm -113.02 137.36 46.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 73.1 m -89.38 141.31 28.67 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -177.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.487 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 62.1 m-85 -111.22 126.38 54.81 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.22 0.533 . . . . 0.0 110.588 -178.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -113.93 161.46 27.75 Favored Pre-proline 0 C--N 1.286 -2.158 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.149 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -86.21 112.81 1.16 Allowed 'Trans proline' 0 N--CA 1.436 -1.868 0 C-N-CA 121.993 1.795 . . . . 0.0 111.692 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 47.8 m . . . . . 0 C--N 1.285 -2.238 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.046 175.929 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 C--O 1.256 1.421 0 CA-C-O 121.24 0.543 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 95.1 mt -99.15 119.33 37.68 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.652 177.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.3 m -73.68 120.54 19.42 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.42 ' HB2' HG21 ' A' ' 46' ' ' ILE . 19.6 pt20 -91.97 139.34 30.74 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.062 0.458 . . . . 0.0 110.479 -176.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -145.4 121.68 5.97 Favored Pre-proline 0 N--CA 1.431 -1.391 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.024 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -76.08 86.39 1.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.859 1.706 . . . . 0.0 108.882 171.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.416 ' HB3' ' OE1' ' A' ' 29' ' ' GLU . 61.4 m -75.38 160.86 29.79 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.673 -173.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.64 -6.09 85.96 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.421 -0.809 . . . . 0.0 113.68 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 p -70.93 -58.65 3.38 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.51 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 2.8 t90 -59.65 143.29 50.98 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.793 168.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.4 m -149.87 123.77 9.32 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 119.29 -122.98 5.5 Favored Glycine 0 C--O 1.247 0.915 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.689 176.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.3 p -134.03 170.06 20.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.6 t -67.48 109.96 3.43 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 118.013 0.37 . . . . 0.0 110.414 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.87 -57.36 0.92 Allowed Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 176.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -138.93 118.7 13.14 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -50.36 -50.03 52.44 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.984 0.914 . . . . 0.0 110.898 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -60.64 -36.41 78.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.863 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.15 -47.55 35.19 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.457 -173.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.3 p -75.48 -32.52 60.61 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -56.45 -54.5 44.95 Favored 'General case' 0 C--O 1.253 1.254 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 173.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.51 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 64.1 t30 -59.24 -43.54 92.38 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.744 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -58.06 -36.92 73.48 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.139 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.2 m -68.25 -54.4 17.91 Favored 'General case' 0 C--O 1.258 1.537 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 69.8 mt -60.08 -32.87 51.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.242 -174.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 30.4 mmt180 -91.46 -17.47 25.7 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.48 -52.07 2.97 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 118.833 -1.147 . . . . 0.0 112.558 -174.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.416 ' OE1' ' HB3' ' A' ' 8' ' ' SER . 9.0 pt-20 -109.09 -8.44 15.17 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.706 0.765 . . . . 0.0 109.986 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.588 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 53.9 mtmt 69.14 63.36 0.29 Allowed 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 113.906 -1.497 . . . . 0.0 112.155 176.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.38 169.91 16.64 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 114.656 -1.157 . . . . 0.0 109.098 176.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.401 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 28.8 tpt180 -88.61 -34.23 17.37 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.934 0.873 . . . . 0.0 108.674 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -152.02 171.62 17.55 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.287 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.29 137.16 4.59 Favored Glycine 0 N--CA 1.424 -2.151 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.1 p -161.77 174.88 12.6 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 117.751 0.775 . . . . 0.0 111.232 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 51.3 m -90.13 109.48 20.54 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.153 0.501 . . . . 0.0 110.025 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 . . . . . 0 C--N 1.307 -1.249 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 179.777 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.474 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 68.4 mttm . . . . . 0 N--CA 1.432 -1.372 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.51 ' HB2' ' CD1' ' A' ' 11' ' ' TRP . 97.0 m -80.14 114.55 19.13 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.474 0.654 . . . . 0.0 110.318 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.42 HG21 ' HB2' ' A' ' 5' ' ' GLN . 50.7 mm -111.23 135.85 49.12 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.696 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 61.3 m -87.63 139.92 30.04 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.455 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 88.6 m-85 -117.48 129.2 55.67 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.441 0.639 . . . . 0.0 111.305 -176.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -114.61 157.69 42.17 Favored Pre-proline 0 C--N 1.286 -2.177 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.401 ' HD3' ' HB2' ' A' ' 32' ' ' ARG . 30.6 Cg_endo -79.51 127.35 7.25 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.354 1.369 . . . . 0.0 110.758 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 73.8 m . . . . . 0 C--N 1.315 -0.905 0 O-C-N 122.097 -0.377 . . . . 0.0 111.334 -179.161 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? . . . . . 0 N--CA 1.439 -1.004 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.482 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 89.8 mt -88.77 101.69 14.27 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 64.5 m -83.3 133.88 34.95 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.913 -175.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.406 ' HB2' HG21 ' A' ' 46' ' ' ILE . 25.7 pt20 -81.17 132.96 35.38 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.973 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -144.15 125.31 7.92 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.87 135.01 49.51 Favored 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.628 2.219 . . . . 0.0 110.896 176.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.781 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . 5.9 p -90.03 160.45 16.33 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -176.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.13 -13.61 38.8 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.5 t -81.86 -37.94 26.17 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.158 0.504 . . . . 0.0 109.953 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.565 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 1.6 t90 -82.09 145.17 30.31 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 173.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 t -157.32 95.6 1.48 Allowed 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.35 -140.48 8.82 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.724 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 p -104.4 170.98 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.3 t -58.99 133.6 56.23 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 123.253 0.621 . . . . 0.0 112.656 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.99 -76.05 0.9 Allowed Glycine 0 N--CA 1.426 -1.979 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 173.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -142.5 130.54 21.89 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -48.42 -57.4 6.13 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.459 1.104 . . . . 0.0 112.105 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -66.56 -31.51 72.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.993 -174.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.18 -48.12 68.91 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.755 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.527 ' HA ' ' HB3' ' A' ' 24' ' ' GLN . 5.6 p -78.6 -23.55 45.92 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -58.53 -55.14 38.85 Favored 'General case' 0 C--O 1.256 1.44 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -57.95 -46.27 85.34 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.067 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.527 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 61.6 tt0 -55.82 -40.56 72.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.762 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 97.0 m -62.98 -57.35 11.03 Favored 'General case' 0 C--O 1.257 1.492 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.1 mt -55.0 -39.59 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 114.141 -1.39 . . . . 0.0 111.465 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -79.44 -26.45 41.79 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.4 -55.99 2.24 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 118.558 -1.257 . . . . 0.0 113.177 -174.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -108.05 2.25 22.98 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.8 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 61.48 59.3 1.9 Allowed 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.367 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -84.07 175.44 9.51 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 175.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.455 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 26.2 tpt180 -85.81 -41.34 15.12 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -147.54 173.43 12.7 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -177.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.27 149.56 15.67 Favored Glycine 0 CA--C 1.476 -2.396 0 N-CA-C 107.036 -2.425 . . . . 0.0 107.036 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.3 t -169.88 173.38 6.14 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 118.544 1.172 . . . . 0.0 109.432 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 75.4 m -78.32 92.06 4.5 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.611 0.72 . . . . 0.0 110.215 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 . . . . . 0 C--N 1.295 -1.796 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -179.644 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.565 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 98.6 mttt . . . . . 0 N--CA 1.44 -0.956 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 11' ' ' TRP . 71.2 m -82.51 98.27 8.85 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.942 0.877 . . . . 0.0 111.519 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.406 HG21 ' HB2' ' A' ' 5' ' ' GLN . 50.8 mm -105.62 138.47 30.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.781 ' SG ' ' HB3' ' A' ' 8' ' ' SER . 60.6 m -91.73 154.63 18.84 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -177.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.482 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 84.8 m-85 -122.31 129.43 52.17 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -111.58 152.68 44.19 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.455 ' HD3' ' HB2' ' A' ' 32' ' ' ARG . 70.7 Cg_endo -79.6 133.98 10.78 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.104 1.87 . . . . 0.0 112.256 -175.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 67.6 m . . . . . 0 C--N 1.291 -1.957 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.745 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? . . . . . 0 N--CA 1.432 -1.369 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 78.1 mt -114.1 115.49 27.62 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-O 121.195 0.522 . . . . 0.0 110.181 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.3 m -89.76 117.18 28.42 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.441 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -72.04 139.54 48.56 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.712 -175.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.421 ' HD3' ' OE1' ' A' ' 29' ' ' GLU . 51.6 ttt180 -142.16 108.18 5.78 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 175.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -72.27 -62.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.01 1.807 . . . . 0.0 112.904 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.2 m -91.79 101.0 13.59 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.746 0.784 . . . . 0.0 112.683 -172.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.62 -71.4 0.04 OUTLIER Glycine 0 C--N 1.286 -2.196 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 172.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.465 HG22 ' OE2' ' A' ' 29' ' ' GLU . 8.1 t -112.75 -30.26 7.13 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.077 -0.562 . . . . 0.0 109.946 172.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.425 ' CZ2' ' HB2' ' A' ' 44' ' ' LYS . 48.1 t90 -55.71 129.79 40.65 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.389 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 m -140.5 89.43 2.28 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.049 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 56.05 45.63 86.72 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 115.495 0.958 . . . . 0.0 115.495 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.9 t -120.31 124.12 71.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 117.232 0.516 . . . . 0.0 111.932 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.555 ' HB2' ' HB3' ' A' ' 44' ' ' LYS . 42.4 t -141.72 82.75 1.82 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 167.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.69 -82.99 0.08 OUTLIER Glycine 0 N--CA 1.426 -2.0 0 C-N-CA 120.471 -0.871 . . . . 0.0 110.944 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -88.29 96.28 10.51 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.546 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 2.6 m-20 -58.56 -44.0 89.57 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.261 0.624 . . . . 0.0 112.153 -176.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -67.43 -28.84 68.23 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.131 0.491 . . . . 0.0 110.893 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.26 -39.35 23.11 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.901 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.546 ' SG ' ' HA ' ' A' ' 18' ' ' ASN . 21.5 p -71.45 -31.13 66.82 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.178 177.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -58.06 -53.01 63.06 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 172.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 55.1 t30 -57.59 -43.79 84.88 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.773 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -57.07 -40.7 77.41 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.447 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 71.2 m -63.08 -54.37 39.1 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 62.3 mt -56.16 -37.41 49.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 124.626 1.17 . . . . 0.0 111.027 -177.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 25.2 mmt180 -83.52 -23.06 32.25 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -177.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.58 -49.33 3.18 Favored 'General case' 0 CA--C 1.501 -0.934 0 C-N-CA 119.017 -1.073 . . . . 0.0 112.961 -175.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.465 ' OE2' HG22 ' A' ' 10' ' ' THR . 12.5 pt-20 -107.31 -4.8 18.28 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.128 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 55.2 mtmt 66.12 41.56 3.51 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.029 176.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -72.13 164.48 26.12 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.148 175.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.424 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 13.3 tpp180 -95.18 -22.09 18.06 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.368 0.604 . . . . 0.0 110.193 -175.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -155.11 170.15 22.48 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.86 141.38 5.98 Favored Glycine 0 CA--C 1.482 -2.003 0 N-CA-C 107.562 -2.215 . . . . 0.0 107.562 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.3 t -175.79 168.48 3.06 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 86.1 m -63.51 106.67 0.98 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.835 0.826 . . . . 0.0 110.065 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 t30 . . . . . 0 C--N 1.295 -1.789 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.151 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 15' ' ' CYS . 33.7 mmtp . . . . . 0 N--CA 1.45 -0.425 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 99.0 m -60.55 111.05 1.44 Allowed 'General case' 0 C--O 1.203 -1.389 0 CA-C-N 118.661 0.664 . . . . 0.0 110.208 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 44' ' ' LYS . 49.9 mm -110.71 137.7 41.99 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 59.6 m -86.56 148.52 25.47 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.488 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 92.2 m-85 -123.79 132.26 53.75 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 122.113 -0.367 . . . . 0.0 110.43 -177.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -105.97 148.79 37.18 Favored Pre-proline 0 C--N 1.285 -2.221 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.514 175.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.424 ' HD3' ' HB2' ' A' ' 32' ' ' ARG . 69.8 Cg_endo -78.28 132.18 11.19 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 122.256 1.971 . . . . 0.0 112.259 -176.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 74.2 m . . . . . 0 C--N 1.284 -2.246 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.555 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.1 tttp . . . . . 0 N--CA 1.444 -0.735 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 88.5 mt -93.2 99.99 12.45 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.33 0.586 . . . . 0.0 109.872 176.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.8 m -89.74 118.64 29.49 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.561 ' HB2' HG21 ' A' ' 46' ' ' ILE . 3.8 pt20 -81.89 138.44 35.02 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -173.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -133.38 118.28 14.82 Favored Pre-proline 0 C--N 1.308 -1.201 0 C-N-CA 125.161 1.384 . . . . 0.0 108.121 178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.25 -63.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.732 1.621 . . . . 0.0 113.035 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.6 p -88.63 128.06 35.58 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -172.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.07 -75.28 0.06 OUTLIER Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.8 t -104.22 -36.82 7.52 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 171.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -67.62 135.68 53.24 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.448 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.7 t -156.26 89.67 1.14 Allowed 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.67 34.42 83.44 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.062 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.5 t -118.82 102.41 13.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.166 0.508 . . . . 0.0 110.783 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.8 t -140.28 80.24 1.75 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.452 0.644 . . . . 0.0 109.528 176.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.87 -60.98 0.53 Allowed Glycine 0 N--CA 1.426 -2.021 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -122.94 132.82 54.33 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 44.3 m-80 -63.89 -45.1 90.87 Favored 'General case' 0 C--O 1.205 -1.285 0 O-C-N 123.746 0.654 . . . . 0.0 109.863 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -63.76 -33.68 76.2 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.6 -46.52 63.25 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.2 p -76.38 -28.48 56.78 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.524 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 38.9 ttmt -56.02 -56.26 22.96 Favored 'General case' 0 C--O 1.251 1.137 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 173.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -58.74 -40.71 84.59 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.026 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -59.78 -40.88 89.73 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.9 m -64.98 -55.02 21.48 Favored 'General case' 0 C--O 1.252 1.209 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 54.9 mt -56.78 -41.52 75.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.159 -177.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -82.82 -17.02 45.47 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -106.7 -59.95 1.73 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 119.507 -0.877 . . . . 0.0 113.124 -177.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -104.83 1.08 28.73 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.988 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 97.2 mttt 65.95 60.57 0.67 Allowed 'General case' 0 CA--C 1.498 -1.042 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.567 172.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.38 176.02 7.09 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.241 176.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -93.66 -39.75 10.63 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.237 0.542 . . . . 0.0 109.625 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -146.57 170.68 16.41 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.78 137.81 4.81 Favored Glycine 0 C--N 1.292 -1.884 0 N-CA-C 108.029 -2.028 . . . . 0.0 108.029 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.2 p -172.14 161.54 5.51 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 117.451 0.626 . . . . 0.0 111.352 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 81.4 m -73.47 101.42 3.51 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.29 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 . . . . . 0 C--N 1.291 -1.965 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.16 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 66.6 mttm . . . . . 0 CA--C 1.499 -1.009 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 22.9 t -78.2 119.43 21.58 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.517 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.561 HG21 ' HB2' ' A' ' 5' ' ' GLN . 21.2 mm -114.44 138.92 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.446 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 69.0 m -85.67 137.93 32.49 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.452 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 88.8 m-85 -113.15 122.25 46.95 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 122.043 -0.411 . . . . 0.0 110.444 -178.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -103.6 143.59 26.94 Favored Pre-proline 0 C--N 1.293 -1.876 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.537 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -79.84 116.08 3.41 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 122.464 2.109 . . . . 0.0 112.737 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 84.3 m . . . . . 0 C--N 1.293 -1.873 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.695 176.659 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.3 mttm . . . . . 0 N--CA 1.442 -0.842 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.9 mt -123.35 113.93 19.5 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.586 0.707 . . . . 0.0 110.048 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.9 m -98.33 123.57 42.51 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.425 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -85.94 143.64 28.08 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.424 -176.776 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -148.84 123.01 4.75 Favored Pre-proline 0 C--N 1.298 -1.673 0 C-N-CA 123.756 0.822 . . . . 0.0 109.564 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.96 153.65 63.33 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 122.357 2.038 . . . . 0.0 109.389 173.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.8 t -147.73 160.3 42.86 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.52 -3.85 86.86 Favored Glycine 0 C--O 1.239 0.45 0 O-C-N 123.42 0.45 . . . . 0.0 112.572 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.6 p -71.6 -55.76 7.16 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -56.53 143.69 34.43 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.324 169.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.2 t -156.98 137.33 12.91 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.271 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.22 -164.85 31.13 Favored Glycine 0 C--O 1.249 1.075 0 C-N-CA 121.462 -0.399 . . . . 0.0 113.543 175.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.9 t -84.48 147.52 5.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.6 t -93.01 129.93 38.76 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -122.2 -44.88 0.34 Allowed Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -107.92 104.69 14.21 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -54.97 -53.5 54.86 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.484 1.114 . . . . 0.0 111.183 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -64.83 -32.65 74.45 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.819 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.9 -49.33 65.94 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.459 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.8 p -77.3 -27.84 53.13 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.495 -177.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -55.92 -56.97 14.31 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 173.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -59.5 -38.78 81.79 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.102 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -60.68 -46.22 91.17 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.897 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.519 ' HA ' ' OE2' ' A' ' 29' ' ' GLU . 75.1 m -62.42 -45.29 93.77 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-O 122.451 1.12 . . . . 0.0 108.943 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 72.6 mt -59.97 -32.44 50.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.678 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -86.23 -15.23 41.46 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.2 mt -109.27 -60.62 1.74 Allowed 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.864 -176.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.519 ' OE2' ' HA ' ' A' ' 25' ' ' CYS . 1.8 pm0 -99.38 -1.35 38.97 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.04 0.448 . . . . 0.0 111.347 178.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 68.2 mttm 63.64 45.73 4.47 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.584 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.462 ' O ' HG12 ' A' ' 26' ' ' ILE . . . -71.81 179.99 2.91 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.986 177.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -104.99 -31.3 9.29 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.557 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.609 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 84.4 t60 -147.39 171.56 15.29 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -176.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.9 136.04 3.67 Favored Glycine 0 CA--C 1.488 -1.634 0 N-CA-C 107.471 -2.252 . . . . 0.0 107.471 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.8 m -158.63 163.64 36.74 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 118.531 1.165 . . . . 0.0 113.709 -177.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 34.0 m -70.11 100.64 1.68 Allowed 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 113.9 -1.5 . . . . 0.0 109.35 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.3 t30 . . . . . 0 C--N 1.297 -1.683 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.925 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? . . . . . 0 C--O 1.219 -0.526 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.0 t -90.95 126.49 36.08 Favored 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.22 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.5 mm -116.57 139.61 42.6 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.2 m -88.46 140.62 29.28 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.609 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 30.9 m-85 -114.49 129.25 56.64 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.275 0.56 . . . . 0.0 109.986 -177.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -109.19 152.36 42.51 Favored Pre-proline 0 C--N 1.288 -2.069 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -78.02 142.57 19.72 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 121.642 1.561 . . . . 0.0 111.529 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 76.2 m . . . . . 0 C--N 1.287 -2.126 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.836 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 C--O 1.253 1.241 0 CA-C-O 121.152 0.501 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 80.8 mt -126.73 138.8 53.44 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.78 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.2 m -89.12 123.54 33.49 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.496 ' HG2' ' CE2' ' A' ' 48' ' ' TYR . 41.7 mt-30 -85.44 130.82 34.5 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.152 -176.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -135.79 107.39 9.83 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -68.24 -74.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.703 2.269 . . . . 0.0 115.325 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 p -84.91 134.82 34.25 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -169.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.23 -85.38 0.09 OUTLIER Glycine 0 N--CA 1.42 -2.419 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 t -86.14 -39.71 16.41 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.482 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 21.5 t90 -62.57 128.73 37.36 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.349 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.2 m -155.49 102.17 2.23 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 124.988 1.315 . . . . 0.0 107.675 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.23 -146.77 18.37 Favored Glycine 0 N--CA 1.42 -2.373 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.43 170.69 13.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.2 t -69.84 110.81 5.17 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.382 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.52 -55.03 1.37 Allowed Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -140.72 129.59 23.15 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -58.26 -46.64 85.63 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.483 0.489 . . . . 0.0 110.972 -176.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -65.75 -31.27 72.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.604 -177.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -48.45 65.44 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.709 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.1 p -74.46 -25.55 59.48 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.873 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -56.13 -57.92 10.13 Favored 'General case' 0 C--O 1.249 1.059 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 171.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -61.2 -36.29 79.47 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.8 -1.546 . . . . 0.0 110.629 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -64.89 -38.78 92.1 Favored 'General case' 0 C--O 1.21 -0.982 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 86.6 m -66.81 -54.49 22.0 Favored 'General case' 0 C--O 1.253 1.268 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 65.9 mt -56.47 -37.06 49.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.742 -177.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -86.53 -21.91 26.66 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -104.0 -55.56 2.35 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 118.9 -1.12 . . . . 0.0 113.156 -175.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -107.81 1.19 22.67 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.566 -0.853 . . . . 0.0 111.821 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm 62.64 60.99 1.25 Allowed 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.548 -1.206 . . . . 0.0 112.709 174.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.08 171.84 9.25 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.807 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -81.78 -33.38 30.92 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -157.85 171.58 20.03 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.9 137.88 5.75 Favored Glycine 0 C--N 1.295 -1.744 0 N-CA-C 106.813 -2.515 . . . . 0.0 106.813 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.1 t -160.14 162.52 33.98 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 118.113 0.957 . . . . 0.0 110.717 -176.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 21.0 m -78.59 104.55 9.27 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.439 ' HB3' ' CG1' ' A' ' 46' ' ' ILE . 6.8 t30 . . . . . 0 C--N 1.3 -1.555 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.372 -173.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.482 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 48.2 mtmt . . . . . 0 N--CA 1.434 -1.245 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.1 m -86.28 132.18 34.05 Favored 'General case' 0 CA--C 1.494 -1.196 0 O-C-N 123.608 0.567 . . . . 0.0 109.638 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.487 HG21 ' HB3' ' A' ' 5' ' ' GLN . 36.2 mm -120.91 139.89 46.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 82.9 m -87.03 138.15 31.74 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.496 ' CE2' ' HG2' ' A' ' 5' ' ' GLN . 93.3 m-85 -113.33 116.31 29.5 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -177.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -99.89 148.21 34.49 Favored Pre-proline 0 C--N 1.295 -1.801 0 C-N-CA 122.769 0.427 . . . . 0.0 110.379 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.16 125.04 9.96 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.045 1.83 . . . . 0.0 112.97 -175.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 77.6 m . . . . . 0 C--O 1.252 1.192 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 176.5 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.2 tttp . . . . . 0 N--CA 1.428 -1.567 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.474 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 86.2 mt -76.42 104.89 7.17 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.677 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.7 m -87.19 126.71 34.97 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.406 ' HB2' ' CG2' ' A' ' 46' ' ' ILE . 29.7 pt20 -80.89 145.74 31.17 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.201 0.524 . . . . 0.0 111.779 -173.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -125.42 109.14 26.47 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.4 -56.16 0.95 Allowed 'Trans proline' 0 C--O 1.203 -1.248 0 C-N-CA 122.542 2.161 . . . . 0.0 113.62 -176.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.3 m -137.66 101.43 4.47 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.687 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -109.63 -61.01 0.51 Allowed Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 171.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.416 HG22 ' OE1' ' A' ' 29' ' ' GLU . 4.8 t -118.1 -36.95 3.47 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.441 -0.38 . . . . 0.0 111.689 172.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.61 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 17.8 t90 -46.5 130.97 11.19 Favored 'General case' 0 C--N 1.358 0.941 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.5 m -150.44 121.2 7.54 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.2 -159.23 22.67 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.46 161.12 4.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.478 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 30.3 t -85.5 90.37 7.95 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.25 -35.81 4.06 Favored Glycine 0 C--N 1.313 -0.72 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.607 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -137.67 110.91 7.87 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -56.19 -43.16 78.19 Favored 'General case' 0 CA--C 1.49 -1.333 0 O-C-N 123.624 0.578 . . . . 0.0 109.872 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.409 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 11.1 m120 -59.41 -35.47 74.03 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.315 -177.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.59 -53.16 9.92 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.971 -177.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 4.8 p -70.55 -32.23 69.59 Favored 'General case' 0 C--O 1.214 -0.792 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 19' ' ' ASN . 27.3 ttpp -54.62 -52.22 62.92 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 173.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -58.49 -46.58 86.37 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.632 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -54.32 -44.21 71.85 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.784 0.677 . . . . 0.0 111.225 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 68.8 m -61.45 -56.96 14.4 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 59.6 mt -55.23 -35.78 37.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 124.894 1.277 . . . . 0.0 111.322 -177.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -75.99 -34.15 59.74 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -110.47 -49.3 3.07 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 118.483 -1.287 . . . . 0.0 113.639 -171.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.416 ' OE1' HG22 ' A' ' 10' ' ' THR . 11.7 pt-20 -97.03 -9.64 27.74 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.629 0.728 . . . . 0.0 109.414 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 97.2 mttt 61.51 61.55 1.47 Allowed 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 113.921 -1.491 . . . . 0.0 112.619 177.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.25 -179.51 5.44 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.009 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.402 ' HG2' ' HD3' ' A' ' 50' ' ' PRO . 23.1 mmt180 -100.96 -34.93 9.57 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.173 0.511 . . . . 0.0 110.084 177.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -143.2 168.91 18.64 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.76 132.63 2.89 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.7 p -155.07 -179.88 8.49 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 117.737 0.769 . . . . 0.0 112.234 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 84.6 m -81.91 126.5 31.98 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.009 0.433 . . . . 0.0 110.948 -176.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.4 m120 . . . . . 0 C--N 1.289 -2.063 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 169.241 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.9 mttp . . . . . 0 N--CA 1.439 -1.003 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.61 ' HB2' ' CD1' ' A' ' 11' ' ' TRP . 96.4 m -88.49 113.03 23.66 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.406 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 28.6 mm -105.28 135.65 42.48 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.718 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 177.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.6 m -87.46 159.96 18.47 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 123.692 0.62 . . . . 0.0 109.701 -177.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.474 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 96.3 m-85 -132.15 128.1 37.34 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -176.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -111.17 150.73 42.41 Favored Pre-proline 0 C--N 1.308 -1.218 0 C-N-CA 123.637 0.775 . . . . 0.0 110.158 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.402 ' HD3' ' HG2' ' A' ' 32' ' ' ARG . 91.0 Cg_endo -84.18 113.91 1.83 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.73 2.287 . . . . 0.0 113.466 -177.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 82.9 m . . . . . 0 C--N 1.295 -1.798 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.224 175.821 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.427 ' HA ' ' OXT' ' A' ' 51' ' ' CYS . 7.4 tt0 . . . . . 0 CA--C 1.511 -0.546 0 CA-C-O 120.677 0.275 . . . . 0.0 110.657 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -134.04 -173.51 3.28 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 171.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.9 mt -108.21 127.77 54.13 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.249 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.4 p -108.87 141.83 40.35 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.519 ' HB2' HG21 ' A' ' 46' ' ' ILE . 10.2 pt20 -96.71 144.13 27.0 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -174.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 -147.58 114.17 4.07 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -75.36 -39.02 1.21 Allowed 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.096 1.864 . . . . 0.0 114.728 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.2 m -94.4 139.37 31.2 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -172.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.7 -86.29 0.1 Allowed Glycine 0 N--CA 1.411 -3.025 0 N-CA-C 107.808 -2.117 . . . . 0.0 107.808 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.442 HG22 ' OE2' ' A' ' 29' ' ' GLU . 10.2 t -101.31 -33.72 9.92 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-O 121.263 0.554 . . . . 0.0 110.65 178.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.59 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 60.9 t90 -72.74 140.32 47.72 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.396 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.7 m -160.46 110.38 1.77 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.581 1.552 . . . . 0.0 107.588 170.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.19 -121.12 2.13 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.795 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -120.71 171.06 9.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 C-N-CA 122.977 0.511 . . . . 0.0 110.127 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.649 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 31.6 t -96.42 99.17 10.86 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 176.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.26 -71.27 1.14 Allowed Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.714 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -127.54 133.5 49.8 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -53.42 -56.76 14.16 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 124.369 1.043 . . . . 0.0 110.777 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.42 -34.26 77.35 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.411 -174.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.33 -60.0 3.7 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 124.04 0.837 . . . . 0.0 111.524 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.5 p -74.11 -23.53 59.33 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.763 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -55.53 -56.95 14.27 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 172.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -60.43 -41.39 93.91 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.973 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -60.1 -41.67 93.05 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.848 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 76.8 m -62.86 -56.49 16.91 Favored 'General case' 0 C--O 1.253 1.272 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 61.2 mt -53.24 -36.86 26.74 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.578 -176.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -78.9 -41.55 29.36 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.68 -62.72 1.41 Allowed 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.84 -168.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.442 ' OE2' HG22 ' A' ' 10' ' ' THR . 10.9 pt-20 -93.9 -6.88 44.63 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.532 0.682 . . . . 0.0 110.213 -176.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 56.6 mttp 64.19 66.84 0.61 Allowed 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 113.758 -1.564 . . . . 0.0 112.589 175.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.71 -178.91 4.69 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 113.363 -1.744 . . . . 0.0 108.189 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -102.79 -29.5 11.44 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.424 0.63 . . . . 0.0 109.894 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 68.7 t60 -152.63 179.54 8.51 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.06 139.58 4.48 Favored Glycine 0 C--N 1.302 -1.311 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.4 m -161.5 173.68 14.49 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 118.417 1.108 . . . . 0.0 111.762 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.6 m -75.05 102.22 4.79 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.311 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.425 ' HB3' HG13 ' A' ' 46' ' ' ILE . 26.0 t-20 -99.54 132.95 44.54 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -85.34 92.59 8.5 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-O 121.79 0.805 . . . . 0.0 111.69 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.1 m -99.6 144.38 12.22 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 169.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 69.6 t80 -62.34 134.56 94.86 Favored Pre-proline 0 C--N 1.301 -1.507 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.042 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 63.2 Cg_endo -107.03 19.01 7.98 Favored 'Cis proline' 0 CA--C 1.548 1.223 0 C-N-CA 124.841 -0.899 . . . . 0.0 114.41 0.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.65 151.33 20.23 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 118.574 0.625 . . . . 0.0 112.41 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -59.76 132.87 55.28 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.771 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -131.43 152.31 50.78 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.841 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.649 ' SG ' ' HA ' ' A' ' 15' ' ' CYS . 78.0 m -79.25 104.97 10.24 Favored 'General case' 0 CA--C 1.479 -1.757 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.519 HG21 ' HB2' ' A' ' 5' ' ' GLN . 22.0 mm -103.48 129.82 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.761 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 60.1 m -84.61 136.9 33.57 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.476 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 76.9 m-85 -110.4 123.44 49.88 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-O 121.394 0.616 . . . . 0.0 110.957 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -105.99 157.65 34.27 Favored Pre-proline 0 C--N 1.283 -2.311 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.166 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -77.41 116.15 4.05 Favored 'Trans proline' 0 N--CA 1.435 -1.939 0 C-N-CA 121.548 1.499 . . . . 0.0 111.404 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.427 ' OXT' ' HA ' ' A' ' 1' ' ' GLN . 95.0 m . . . . . 0 C--N 1.282 -2.367 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 . . . . . 0 N--CA 1.448 -0.563 0 CA-C-O 121.529 0.681 . . . . 0.0 109.65 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -131.53 141.97 49.84 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 90.5 mt -89.08 99.88 12.77 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.78 0.8 . . . . 0.0 110.128 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.9 m -86.07 112.28 21.11 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.971 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.484 ' HB2' HG21 ' A' ' 46' ' ' ILE . 27.7 pt20 -73.99 136.38 43.18 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.868 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 46.6 ttp180 -145.17 115.26 5.0 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 6' ' ' ARG . 13.8 Cg_exo -68.7 -73.31 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.683 2.255 . . . . 0.0 115.776 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.9 m -90.29 97.36 11.14 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -170.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -119.92 -73.62 0.39 Allowed Glycine 0 N--CA 1.422 -2.234 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 168.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.442 HG22 ' OE2' ' A' ' 29' ' ' GLU . 8.7 t -108.25 -26.53 10.51 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 173.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.656 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 20.2 t90 -62.17 136.07 57.78 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-O 121.252 0.549 . . . . 0.0 112.3 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -157.4 108.22 2.27 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.288 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.31 -157.57 22.78 Favored Glycine 0 N--CA 1.431 -1.675 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.806 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.67 149.3 4.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 33.7 t -83.76 123.85 30.29 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.77 -64.26 0.88 Allowed Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.211 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 56.0 t-20 -122.5 126.16 47.26 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -177.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -54.85 -47.72 73.79 Favored 'General case' 0 C--O 1.207 -1.162 0 O-C-N 123.903 0.752 . . . . 0.0 110.066 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -62.27 -40.5 96.44 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.704 -177.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 17' ' ' ASN . . . -69.28 -47.06 65.68 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.54 -177.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.5 p -73.35 -34.48 65.65 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.5 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -55.33 -54.43 43.68 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.586 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 48.2 t30 -56.69 -46.74 81.02 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.228 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -56.2 -41.87 76.27 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.498 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.3 m -62.46 -51.97 65.39 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.6 mt -58.24 -35.7 54.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.08 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 9.3 mmp_? -74.78 -29.98 61.29 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.89 -57.67 2.07 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 119.463 -0.895 . . . . 0.0 112.546 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.442 ' OE2' HG22 ' A' ' 10' ' ' THR . 12.9 pt-20 -98.05 -5.12 34.59 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.555 -175.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 62.32 63.14 1.08 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.283 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.15 -179.02 5.56 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.648 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.543 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 4.5 mmp_? -106.88 -21.21 13.09 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.145 0.498 . . . . 0.0 110.534 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 78.2 t60 -158.13 170.28 22.64 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.67 140.54 6.49 Favored Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 106.378 -2.689 . . . . 0.0 106.378 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.0 t -155.21 153.29 30.47 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 118.37 1.085 . . . . 0.0 111.025 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 61.0 m -73.16 93.52 1.84 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -105.21 143.49 33.31 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -81.35 120.31 24.79 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.556 0.693 . . . . 0.0 110.917 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.6 m -129.07 -177.38 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.576 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 172.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 67.8 t80 -75.92 129.73 80.26 Favored Pre-proline 0 C--N 1.285 -2.22 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.816 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 61.3 Cg_endo -110.86 25.93 3.34 Favored 'Cis proline' 0 CA--C 1.555 1.533 0 C-N-CA 124.806 -0.914 . . . . 0.0 111.647 -5.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.22 175.84 12.94 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 120.906 0.384 . . . . 0.0 111.84 -174.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -73.85 110.92 8.52 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.049 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.656 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 97.3 mttt -119.43 157.64 27.82 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 24.6 t -90.67 123.9 34.65 Favored 'General case' 0 CA--C 1.48 -1.731 0 C-N-CA 118.624 -1.23 . . . . 0.0 109.278 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.484 HG21 ' HB2' ' A' ' 5' ' ' GLN . 20.0 mm -111.35 128.98 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.541 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 37.8 m -85.18 147.04 26.8 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.427 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 93.3 m-85 -118.11 122.82 44.07 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.913 -0.492 . . . . 0.0 110.539 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -104.85 152.39 39.54 Favored Pre-proline 0 C--N 1.3 -1.562 0 C-N-CA 123.589 0.756 . . . . 0.0 110.988 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -88.33 107.76 0.54 Allowed 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 122.79 2.326 . . . . 0.0 112.67 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 82.0 m . . . . . 0 C--N 1.279 -2.46 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 174.736 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 120.883 0.373 . . . . 0.0 111.491 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -104.69 -175.43 2.79 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.8 mt -121.95 132.04 54.33 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 67.7 m -106.69 129.6 54.56 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.65 151.42 25.3 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -144.45 123.74 7.12 Favored Pre-proline 0 C--N 1.305 -1.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.838 -177.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -68.65 103.03 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.022 1.815 . . . . 0.0 108.129 170.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.533 ' HB3' ' OE1' ' A' ' 29' ' ' GLU . 61.8 m -98.33 161.46 13.68 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -171.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.56 -35.21 52.26 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.307 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.2 t -60.85 -34.53 74.73 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.9 0.381 . . . . 0.0 110.142 175.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -57.82 106.34 0.35 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.784 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.4 t -150.28 91.69 1.79 Allowed 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.6 173.78 23.13 Favored Glycine 0 N--CA 1.422 -2.29 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.187 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.4 m -98.0 171.51 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 123.004 0.521 . . . . 0.0 110.248 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.5 t -69.03 108.38 3.52 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.031 -0.532 . . . . 0.0 112.175 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.36 -91.45 0.69 Allowed Glycine 0 N--CA 1.42 -2.402 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 173.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -91.13 114.92 27.58 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -65.38 -43.64 90.06 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 123.752 0.657 . . . . 0.0 111.002 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -70.16 -36.5 74.75 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.111 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.85 -43.68 95.42 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.981 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.2 p -76.2 -29.36 57.61 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.68 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -57.72 -56.68 18.79 Favored 'General case' 0 C--O 1.251 1.154 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -61.01 -36.87 80.63 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.46 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -63.5 -41.4 98.53 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.08 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 97.7 m -62.65 -49.71 74.09 Favored 'General case' 0 C--O 1.259 1.577 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 60.9 mt -58.91 -33.59 50.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.149 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -83.6 -21.49 32.56 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.74 -65.14 0.98 Allowed 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.245 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.533 ' OE1' ' HB3' ' A' ' 8' ' ' SER . 10.9 pt-20 -106.26 -1.3 23.66 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.845 -177.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.2 mttp 64.26 65.11 0.68 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.708 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.85 -176.17 5.4 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.437 175.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.405 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 4.1 tpm_? -101.97 -29.88 11.54 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.083 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.563 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 31.4 t60 -151.2 173.56 14.28 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.0 139.75 5.96 Favored Glycine 0 C--N 1.295 -1.735 0 N-CA-C 106.478 -2.649 . . . . 0.0 106.478 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.0 t -163.04 167.47 22.34 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 118.384 1.092 . . . . 0.0 109.974 -174.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 89.6 m -72.83 95.16 1.89 Allowed 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.061 175.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -90.9 137.21 32.54 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -81.61 95.58 7.22 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.474 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.1 m -99.49 159.41 3.55 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 172.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 56.2 t80 -74.05 133.69 78.39 Favored Pre-proline 0 C--N 1.28 -2.439 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.377 -175.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 14.8 Cg_endo -106.69 19.82 8.52 Favored 'Cis proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.779 -0.925 . . . . 0.0 112.702 -2.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -155.72 151.0 26.82 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 122.145 -0.347 . . . . 0.0 110.887 -175.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -58.99 133.8 56.41 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.819 0.848 . . . . 0.0 112.313 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -134.63 156.31 48.95 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.3 m -81.91 94.61 7.14 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.618 0.723 . . . . 0.0 111.458 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.75 143.59 11.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 74.2 m -90.0 148.22 23.21 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.481 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.563 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 38.9 m-85 -120.11 130.34 54.59 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.224 0.535 . . . . 0.0 110.844 -177.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -110.8 151.07 42.66 Favored Pre-proline 0 C--N 1.297 -1.678 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.338 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.57 132.06 10.8 Favored 'Trans proline' 0 C--O 1.253 1.262 0 C-N-CA 122.412 2.075 . . . . 0.0 113.276 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 68.9 m . . . . . 0 N--CA 1.435 -1.225 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.705 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 . . . . . 0 C--O 1.237 0.401 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -120.59 161.66 20.96 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 172.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 92.4 mt -93.21 110.16 21.68 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-O 121.351 0.596 . . . . 0.0 110.46 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.42 ' SG ' ' HB2' ' A' ' 49' ' ' PHE . 8.2 p -89.08 127.43 35.7 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.5 ' HB2' HG21 ' A' ' 46' ' ' ILE . 26.9 pt20 -87.43 133.4 33.74 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.209 0.528 . . . . 0.0 111.516 -175.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -126.04 119.84 23.87 Favored Pre-proline 0 C--O 1.265 1.878 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.267 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -71.44 125.96 11.75 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.582 2.188 . . . . 0.0 107.427 169.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.5 t -144.27 160.89 40.23 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.878 -171.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.26 20.04 43.03 Favored Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.655 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.4 p -83.8 -58.29 2.86 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.466 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 1.6 t90 -57.8 144.46 38.44 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.161 169.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.8 t -146.33 119.68 8.99 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.26 -135.23 12.45 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.948 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -125.55 170.92 14.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -175.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.4 t -60.66 108.52 0.85 Allowed 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.093 0.473 . . . . 0.0 111.227 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -116.0 -88.41 1.45 Allowed Glycine 0 N--CA 1.427 -1.949 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -95.46 106.43 18.5 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 122.534 0.333 . . . . 0.0 110.228 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -59.9 -56.09 26.01 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.424 1.09 . . . . 0.0 111.751 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -71.53 -30.1 65.53 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.789 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.64 -42.01 64.86 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.363 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 30.6 p -70.66 -32.33 69.56 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.823 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -55.71 -56.7 17.36 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 172.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -58.8 -37.27 75.99 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.127 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.52 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 20.9 tt0 -63.77 -44.19 94.14 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.236 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 99.0 m -62.08 -49.48 75.79 Favored 'General case' 0 C--O 1.259 1.562 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.632 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 65.9 mt -59.24 -32.81 49.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.401 -177.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.515 ' HA ' ' NE ' ' A' ' 27' ' ' ARG . 4.1 mmp_? -97.05 -8.94 29.12 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 24' ' ' GLN . 42.4 mt -102.04 -62.98 1.19 Allowed 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.63 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -99.17 -3.85 33.48 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.177 0.513 . . . . 0.0 110.01 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 56.4 mtmt 68.92 50.74 0.59 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.646 175.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.08 178.66 7.35 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.063 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -98.74 -34.2 10.61 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 80.0 t60 -151.61 175.17 12.62 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 -176.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -169.0 141.34 6.67 Favored Glycine 0 C--N 1.289 -2.064 0 N-CA-C 106.869 -2.492 . . . . 0.0 106.869 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.0 p -169.03 169.51 9.49 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 118.114 0.957 . . . . 0.0 112.062 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 44' ' ' LYS . 78.0 m -80.63 117.49 21.37 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.631 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -126.25 142.85 51.37 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -75.65 120.45 21.07 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.208 0.528 . . . . 0.0 111.103 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.5 m -133.77 -177.52 2.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 175.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 69.2 t80 -75.77 132.16 75.3 Favored Pre-proline 0 C--N 1.285 -2.207 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 89.1 Cg_endo -104.76 10.32 10.77 Favored 'Cis proline' 0 CA--C 1.553 1.451 0 C-N-CA 124.498 -1.042 . . . . 0.0 113.797 -1.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -163.95 -176.82 4.74 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -67.33 117.22 9.03 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.473 0.654 . . . . 0.0 110.232 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 31.1 mmtp -120.95 162.96 19.0 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 23.8 t -92.22 113.54 25.83 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' A' ' 5' ' ' GLN . 38.8 mm -105.71 142.07 19.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 61.3 m -88.46 145.63 25.66 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.471 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 70.6 m-85 -121.45 136.58 54.94 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.067 0.46 . . . . 0.0 111.375 -176.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.42 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 73.3 m-85 -117.82 164.58 19.12 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -85.31 108.78 1.12 Allowed 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 121.893 1.729 . . . . 0.0 111.837 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 98.9 m . . . . . 0 C--N 1.302 -1.497 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.992 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 . . . . . 0 CA--C 1.505 -0.76 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -113.01 151.54 30.51 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 88.7 mt -96.76 108.58 21.26 Favored 'General case' 0 C--N 1.288 -2.085 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.096 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.7 m -82.22 129.63 34.89 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.608 ' HB2' HG21 ' A' ' 46' ' ' ILE . 11.1 pt20 -85.6 141.32 29.9 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.216 0.531 . . . . 0.0 110.987 -177.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -144.57 108.56 4.8 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -77.49 -55.25 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.472 2.114 . . . . 0.0 115.433 -175.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 m -98.22 109.85 22.54 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -172.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.85 -69.88 0.02 OUTLIER Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 108.051 -2.02 . . . . 0.0 108.051 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.524 HG21 ' HA ' ' A' ' 25' ' ' CYS . 7.0 t -103.96 -39.17 6.7 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 170.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.48 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 78.7 t90 -70.76 123.38 21.81 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-O 121.484 0.659 . . . . 0.0 110.731 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.1 m -162.06 96.62 1.0 Allowed 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 125.739 1.616 . . . . 0.0 106.661 174.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.33 -131.73 3.69 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.408 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.9 m -117.66 164.73 13.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 122.627 0.371 . . . . 0.0 110.696 -177.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.7 t -92.74 106.71 18.64 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 120.821 0.343 . . . . 0.0 110.66 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.51 -67.75 1.5 Allowed Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 176.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.618 ' HB2' ' HB3' ' A' ' 20' ' ' ALA . 32.8 m-80 -129.38 132.57 47.07 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -66.41 -47.1 74.35 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.682 0.753 . . . . 0.0 110.001 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -72.65 -16.86 61.7 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.786 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 17' ' ' ASN . . . -88.94 -38.06 14.77 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.776 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.4 p -72.71 -30.88 64.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -53.25 -53.57 48.83 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 171.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -61.79 -40.27 94.62 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 113.855 -1.52 . . . . 0.0 110.062 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -59.88 -39.11 84.16 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 123.358 0.663 . . . . 0.0 110.4 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.524 ' HA ' HG21 ' A' ' 10' ' ' THR . 91.5 m -64.12 -55.5 21.53 Favored 'General case' 0 C--O 1.25 1.107 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 55.9 mt -58.17 -33.83 47.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.701 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -85.42 -21.4 28.79 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.25 -67.9 0.88 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.401 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -97.18 2.67 51.32 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.56 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 49.7 mttp 60.96 57.68 2.5 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 114.057 -1.429 . . . . 0.0 112.215 171.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.64 -179.09 7.23 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.256 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -101.19 -27.23 13.34 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.681 0.753 . . . . 0.0 109.256 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 86.5 t60 -151.55 171.48 17.53 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.722 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.96 143.63 8.17 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 106.829 -2.508 . . . . 0.0 106.829 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.6 p -165.58 151.3 9.29 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 117.888 0.844 . . . . 0.0 111.284 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 62.5 m -81.79 100.32 9.49 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.718 0.771 . . . . 0.0 110.241 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -79.36 142.77 35.73 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.603 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -73.27 105.94 4.89 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.412 0.625 . . . . 0.0 110.322 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.6 m -126.84 164.48 27.23 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 83.6 t80 -82.0 137.24 46.65 Favored Pre-proline 0 C--N 1.289 -2.03 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 65.6 Cg_endo -98.83 3.61 29.36 Favored 'Cis proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.209 -1.163 . . . . 0.0 113.281 -1.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.83 156.03 41.75 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 73.2 m80 -61.78 123.98 19.47 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 123.54 0.525 . . . . 0.0 110.473 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 97.6 mttt -118.58 147.77 43.37 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 11.7 t -84.66 125.95 32.94 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 121.178 0.513 . . . . 0.0 110.739 -173.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.608 HG21 ' HB2' ' A' ' 5' ' ' GLN . 18.4 mm -117.22 134.2 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.451 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 67.6 m -82.9 149.88 26.82 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.478 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 76.1 m-85 -127.24 126.84 43.43 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.086 0.469 . . . . 0.0 111.266 -177.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -110.53 144.87 31.09 Favored Pre-proline 0 C--N 1.302 -1.472 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.775 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -82.65 114.31 2.35 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 122.337 2.025 . . . . 0.0 112.269 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 C--N 1.288 -2.069 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.929 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 . . . . . 0 C--O 1.236 0.37 0 CA-C-O 121.254 0.549 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -93.53 168.34 11.1 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 83.4 mt -79.94 117.35 20.71 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-O 121.193 0.521 . . . . 0.0 110.653 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.1 p -98.18 129.88 44.94 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.468 ' HB2' HG21 ' A' ' 46' ' ' ILE . 4.7 pt20 -87.89 130.74 34.81 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.308 0.575 . . . . 0.0 111.774 -173.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -132.69 120.03 16.41 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.138 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -74.79 142.62 28.79 Favored 'Trans proline' 0 C--O 1.247 0.937 0 C-N-CA 122.21 1.94 . . . . 0.0 107.759 168.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.1 t -151.67 161.74 42.17 Favored 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.925 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.6 -7.32 87.19 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.399 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 p -65.54 -56.72 10.81 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.5 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 1.7 t90 -59.51 138.04 57.82 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.492 166.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.8 t -134.02 110.42 9.64 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-O 120.659 0.266 . . . . 0.0 111.052 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.78 -115.5 5.91 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 115.936 1.134 . . . . 0.0 115.936 171.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 p -83.94 137.15 21.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.807 0.813 . . . . 0.0 112.47 -174.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.1 t -90.73 112.5 24.29 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.36 -59.33 1.04 Allowed Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -112.92 120.35 41.13 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -54.97 -44.67 74.62 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.731 0.645 . . . . 0.0 110.354 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -66.04 -33.51 75.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.011 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.15 -46.41 56.56 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.11 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.4 p -73.22 -32.0 64.5 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.868 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -53.07 -60.08 3.74 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 123.854 0.862 . . . . 0.0 109.177 173.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -61.54 -34.47 75.6 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.004 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -65.8 -38.62 89.48 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.451 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.1 m -64.93 -49.07 71.81 Favored 'General case' 0 C--O 1.255 1.374 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 73.0 mt -57.14 -42.79 80.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.844 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -81.24 -14.15 57.76 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.7 mt -107.06 -55.72 2.29 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 119.087 -1.045 . . . . 0.0 112.078 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -110.89 1.42 17.58 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.097 0.475 . . . . 0.0 111.626 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 36.5 mtmm 66.82 45.92 1.78 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.122 174.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.21 172.42 11.17 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.999 -1.001 . . . . 0.0 108.88 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -91.62 -35.95 13.93 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -152.63 176.56 11.6 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -175.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.62 150.64 11.55 Favored Glycine 0 C--N 1.308 -0.987 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.2 p -172.27 168.27 5.66 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-N 118.372 1.086 . . . . 0.0 111.696 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.0 m -68.41 107.57 2.92 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -94.64 -29.69 14.71 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.702 0.763 . . . . 0.0 109.866 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.579 ' HB3' ' H ' ' A' ' 44' ' ' LYS . 19.3 t80 -93.16 -178.93 4.93 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.5 m -133.51 -155.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 125.303 1.441 . . . . 0.0 108.039 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.543 ' CD1' ' HA ' ' A' ' 41' ' ' PRO . 87.1 t80 -48.69 145.24 6.22 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 124.38 1.072 . . . . 0.0 110.35 175.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.543 ' HA ' ' CD1' ' A' ' 40' ' ' PHE . 59.3 Cg_endo -90.26 6.8 67.73 Favored 'Cis proline' 0 C--N 1.353 0.775 0 C-N-CA 124.15 -1.188 . . . . 0.0 113.805 2.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.78 105.8 1.62 Allowed 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -59.51 128.34 36.54 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.579 ' H ' ' HB3' ' A' ' 38' ' ' TYR . 32.4 mmtp -105.33 146.4 29.43 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 45.2 t -103.9 131.7 50.87 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.468 HG21 ' HB2' ' A' ' 5' ' ' GLN . 50.1 mm -116.68 137.55 50.14 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.7 m -89.49 153.0 21.15 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.479 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 87.6 m-85 -126.0 135.96 52.43 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -116.78 159.42 40.7 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -82.42 101.4 1.08 Allowed 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.936 1.758 . . . . 0.0 112.149 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 85.2 m . . . . . 0 C--N 1.298 -1.635 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.709 179.117 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 . . . . . 0 CA--C 1.515 -0.37 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 51' ' ' CYS . 23.0 pttm -146.82 156.67 43.3 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 82.2 mt -95.43 105.47 17.44 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.248 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 86.3 m -80.78 135.65 36.0 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.732 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.425 ' HB2' HG21 ' A' ' 46' ' ' ILE . 19.0 pt20 -90.67 128.72 36.73 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.208 0.527 . . . . 0.0 110.696 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -129.07 117.99 19.28 Favored Pre-proline 0 C--N 1.301 -1.52 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.161 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -78.53 116.78 3.88 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.036 1.824 . . . . 0.0 109.301 173.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.1 m -124.79 160.12 29.42 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.33 -25.67 60.67 Favored Glycine 0 C--N 1.334 0.421 0 O-C-N 124.217 0.948 . . . . 0.0 114.142 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.7 t -53.81 -47.64 70.65 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 117.219 0.51 . . . . 0.0 110.052 174.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -71.44 121.94 19.5 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 121.25 0.548 . . . . 0.0 109.796 173.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.0 p -153.41 100.2 2.41 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.432 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.96 -145.39 16.86 Favored Glycine 0 N--CA 1.427 -1.951 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.502 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.6 m -99.61 153.01 4.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -177.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 43' ' ' HIS . 44.8 t -90.77 91.66 8.47 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.96 -60.17 2.98 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -120.95 129.9 53.62 Favored 'General case' 0 CA--C 1.486 -1.508 0 CA-C-N 115.472 -0.364 . . . . 0.0 110.111 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -56.17 -46.8 79.19 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 124.313 1.008 . . . . 0.0 109.577 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -64.64 -30.9 71.92 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.89 -53.37 21.54 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.5 p -74.89 -29.11 60.9 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.599 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -52.62 -58.68 6.02 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-O 122.021 0.915 . . . . 0.0 108.623 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -59.17 -41.38 88.28 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.69 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -65.04 -32.34 74.01 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.327 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 98.5 m -66.97 -49.65 64.77 Favored 'General case' 0 C--O 1.255 1.359 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 57.0 mt -61.24 -28.03 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.33 -1.304 . . . . 0.0 111.176 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.46 ' HA ' ' NE ' ' A' ' 27' ' ' ARG . 3.3 mmp_? -92.82 -15.7 26.2 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -103.91 -62.41 1.31 Allowed 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.194 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -102.66 -1.4 30.21 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.199 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 56.0 mtpt 69.62 37.41 1.92 Allowed 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.215 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.58 175.88 3.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.144 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.483 ' HG2' ' HD3' ' A' ' 50' ' ' PRO . 6.7 mmp_? -90.94 -32.14 16.1 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.146 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 43.1 t-80 -155.82 175.02 14.48 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -174.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -169.96 142.75 7.43 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 107.145 -2.382 . . . . 0.0 107.145 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.7 p -163.0 169.92 18.85 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 117.892 0.846 . . . . 0.0 110.9 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 68.6 m -67.91 107.4 2.64 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 175.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -90.96 -28.95 17.71 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.751 0.786 . . . . 0.0 109.092 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.436 ' HB3' ' H ' ' A' ' 44' ' ' LYS . 14.1 t80 -110.82 162.5 14.73 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.466 HG22 ' H ' ' A' ' 40' ' ' PHE . 8.7 p -118.27 -179.5 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -171.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.624 ' CG ' ' HA ' ' A' ' 41' ' ' PRO . 50.8 t80 -51.83 145.59 16.34 Favored Pre-proline 0 C--N 1.31 -1.147 0 C-N-CA 124.188 0.995 . . . . 0.0 109.527 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.624 ' HA ' ' CG ' ' A' ' 40' ' ' PHE . 5.9 Cg_exo -78.87 -7.58 37.42 Favored 'Cis proline' 0 C--N 1.35 0.621 0 N-CA-C 115.147 1.172 . . . . 0.0 115.147 5.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -131.1 79.79 1.91 Allowed 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -175.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 89.2 m-70 -64.41 113.1 3.42 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 175.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.436 ' H ' ' HB3' ' A' ' 38' ' ' TYR . 71.5 mmtt -98.49 141.61 31.14 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 176.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.9 t -100.55 128.96 46.44 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.425 HG21 ' HB2' ' A' ' 5' ' ' GLN . 47.9 mm -122.85 141.02 44.82 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 41.5 m -88.73 156.92 18.71 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.481 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 95.9 m-85 -126.54 142.65 51.47 Favored 'General case' 0 C--O 1.252 1.211 0 CA-C-O 121.039 0.447 . . . . 0.0 112.182 -177.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -126.67 151.31 73.1 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 124.312 1.045 . . . . 0.0 109.908 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.483 ' HD3' ' HG2' ' A' ' 32' ' ' ARG . 94.5 Cg_endo -86.99 107.37 0.7 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.725 2.283 . . . . 0.0 112.38 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 20.7 m . . . . . 0 C--N 1.291 -1.967 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 . . . . . 0 CA--C 1.503 -0.829 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.77 158.5 15.64 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 90.6 mt -96.74 99.99 11.56 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.7 p -87.63 114.68 24.47 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 114.596 -1.183 . . . . 0.0 109.681 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.507 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 18.8 pt20 -83.14 144.32 29.92 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -173.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -138.22 120.7 10.85 Favored Pre-proline 0 C--N 1.313 -1.004 0 C-N-CA 124.743 1.217 . . . . 0.0 108.453 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -73.82 108.76 2.72 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 121.681 1.587 . . . . 0.0 108.991 173.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.7 p -79.73 160.97 26.03 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.373 0.606 . . . . 0.0 112.567 -174.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.01 -24.64 57.41 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.3 t -71.34 -41.24 70.05 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.765 -0.218 . . . . 0.0 110.575 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -48.92 130.93 18.65 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.05 0.54 . . . . 0.0 112.225 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.9 t -91.23 127.94 36.86 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -33.23 -48.47 0.43 Allowed Glycine 0 N--CA 1.478 1.447 0 N-CA-C 117.513 1.765 . . . . 0.0 117.513 -171.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.6 131.67 36.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 117.355 0.577 . . . . 0.0 110.024 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.6 t -73.58 127.7 33.48 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.838 0.351 . . . . 0.0 110.143 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.77 -73.31 0.81 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -122.46 125.18 45.28 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -59.03 -46.03 89.25 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 123.756 0.66 . . . . 0.0 111.123 -175.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -75.02 -9.37 58.47 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.79 -47.04 8.49 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.6 p -75.16 -34.66 61.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.321 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -54.4 -55.02 32.91 Favored 'General case' 0 C--O 1.25 1.087 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 174.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.597 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 7.2 t30 -60.51 -41.9 95.32 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.052 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -58.29 -39.4 79.18 Favored 'General case' 0 C--O 1.211 -0.969 0 C-N-CA 122.795 0.438 . . . . 0.0 110.524 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 99.1 m -64.69 -54.5 30.65 Favored 'General case' 0 C--O 1.253 1.265 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 69.5 mt -58.38 -30.15 39.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.165 -1.379 . . . . 0.0 111.788 -175.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.597 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 28.3 mmt180 -89.5 -32.69 17.07 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.414 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.12 -66.55 0.91 Allowed 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.423 -172.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -94.59 -3.06 50.34 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.762 0.792 . . . . 0.0 110.154 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 47.9 mttp 61.84 65.44 0.92 Allowed 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 113.801 -1.545 . . . . 0.0 112.552 173.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.401 ' H ' ' HA ' ' A' ' 26' ' ' ILE . . . -92.91 -177.53 4.54 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.401 177.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -99.43 -26.95 13.96 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.316 178.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 81.0 t60 -153.03 176.19 12.16 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -174.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.74 142.27 7.5 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 107.871 -2.091 . . . . 0.0 107.871 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.0 m -155.29 154.01 31.45 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 118.019 0.909 . . . . 0.0 111.064 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 76.1 m -87.08 91.23 8.63 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 122.397 1.094 . . . . 0.0 109.389 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -79.45 129.96 34.96 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.652 -1.613 . . . . 0.0 107.818 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -79.31 109.65 13.85 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.202 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.4 m -125.0 -170.69 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.528 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 68.4 t80 -77.65 131.25 71.45 Favored Pre-proline 0 C--N 1.287 -2.117 0 C-N-CA 118.737 -1.185 . . . . 0.0 108.878 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 87.0 Cg_endo -109.66 18.72 4.85 Favored 'Cis proline' 0 CA--C 1.546 1.109 0 C-N-CA 124.855 -0.894 . . . . 0.0 112.55 -2.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.64 -178.73 6.75 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 120.846 0.355 . . . . 0.0 110.958 -173.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 93.6 m-70 -73.8 113.54 11.07 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -119.38 136.47 54.26 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 6.9 t -79.62 115.26 19.13 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.531 0.681 . . . . 0.0 110.583 -173.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.487 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 22.5 mm -112.27 141.11 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.43 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 5' ' ' GLN . 51.7 m -83.61 144.3 29.54 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.507 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 63.5 m-85 -119.09 118.35 31.18 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.499 0.666 . . . . 0.0 111.643 -177.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -100.59 163.49 18.04 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.081 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -88.06 126.12 1.99 Allowed 'Trans proline' 0 N--CA 1.441 -1.586 0 C-N-CA 122.136 1.89 . . . . 0.0 111.667 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 69.6 m . . . . . 0 C--N 1.294 -1.829 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.662 177.554 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 . . . . . 0 CA--C 1.496 -1.097 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -96.12 175.55 6.42 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.2 mt -118.86 130.56 55.81 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 66.8 m -108.81 133.38 52.93 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 175.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.552 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 17.5 pt20 -94.52 134.84 36.63 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.658 0.742 . . . . 0.0 112.305 -177.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -137.53 120.77 11.54 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.634 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -66.72 132.94 30.1 Favored 'Trans proline' 0 C--O 1.246 0.88 0 C-N-CA 122.146 1.897 . . . . 0.0 109.415 172.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -118.43 160.36 21.84 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.496 -174.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.0 -12.52 76.68 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.263 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.9 p -71.01 -43.8 67.2 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.526 0.679 . . . . 0.0 109.592 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.415 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 3.9 t90 -64.97 140.21 58.84 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.261 171.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.8 t -146.07 119.61 9.11 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.064 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.19 -135.12 11.99 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 172.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.8 p -108.31 168.4 3.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.7 t -59.29 118.26 5.74 Favored 'General case' 0 C--O 1.25 1.109 0 C-N-CA 123.495 0.718 . . . . 0.0 112.642 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.47 -76.7 1.05 Allowed Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 171.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -143.32 138.21 29.35 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -50.81 -54.91 19.68 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.205 1.002 . . . . 0.0 112.408 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.403 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 29.5 p-10 -70.23 -32.22 69.99 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.597 -177.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.29 -49.13 68.14 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.825 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 24' ' ' GLN . 11.0 p -76.53 -22.9 53.77 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 119.205 -0.998 . . . . 0.0 112.287 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 19' ' ' ASN . 28.2 ttpp -57.87 -53.42 58.39 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -58.78 -42.3 88.69 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.898 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 0.8 OUTLIER -55.98 -39.29 71.59 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.457 0.473 . . . . 0.0 111.268 177.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 89.4 m -68.91 -51.48 39.61 Favored 'General case' 0 C--O 1.255 1.373 0 CA-C-O 121.993 0.902 . . . . 0.0 108.869 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.5 mt -57.01 -36.6 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.702 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -73.6 -32.3 64.03 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.0 mt -100.01 -57.1 2.2 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.19 -1.004 . . . . 0.0 113.265 -170.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -105.79 -10.35 16.76 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 120.026 -0.669 . . . . 0.0 111.605 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.8 mttm 72.26 68.97 0.14 Allowed 'General case' 0 C--N 1.319 -0.733 0 O-C-N 124.355 1.035 . . . . 0.0 111.498 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.49 175.71 7.82 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -98.66 -27.3 14.05 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.14 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 79.9 t60 -151.66 173.82 14.23 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.22 141.68 6.96 Favored Glycine 0 C--N 1.283 -2.367 0 N-CA-C 106.457 -2.657 . . . . 0.0 106.457 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.5 t -159.54 165.33 33.16 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 118.387 1.094 . . . . 0.0 110.069 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 43' ' ' HIS . 44.7 m -86.61 102.59 14.31 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.73 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -95.76 145.7 25.11 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -79.4 118.66 21.5 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.826 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.3 m -128.11 176.94 6.69 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.821 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 172.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 69.5 t80 -80.34 129.35 69.68 Favored Pre-proline 0 C--N 1.281 -2.383 0 C-N-CA 119.184 -1.006 . . . . 0.0 109.288 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 30.3 Cg_endo -106.25 9.81 8.59 Favored 'Cis proline' 0 CA--C 1.549 1.228 0 C-N-CA 124.628 -0.988 . . . . 0.0 113.984 -0.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -151.07 169.41 21.91 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.707 0.289 . . . . 0.0 110.609 -175.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 73.7 m80 -66.22 122.96 18.64 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.929 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.415 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 56.0 mttm -123.69 153.26 41.08 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.268 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 86.9 m -83.23 113.33 20.6 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.393 0.616 . . . . 0.0 111.081 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.424 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 33.2 mm -109.56 138.05 38.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 60.5 m -88.43 136.04 33.18 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.552 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 34.7 m-85 -107.83 124.69 50.45 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.421 0.629 . . . . 0.0 110.355 -177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -108.83 153.41 42.38 Favored Pre-proline 0 C--N 1.292 -1.895 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.188 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -77.7 133.52 12.85 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 122.21 1.94 . . . . 0.0 113.03 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 81.7 m . . . . . 0 C--N 1.294 -1.817 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.823 178.501 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 . . . . . 0 CA--C 1.507 -0.692 0 CA-C-O 121.379 0.609 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 2' ' ' LYS . 73.4 mmtt -121.71 -172.9 2.52 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 174.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -110.6 120.19 41.61 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.114 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 31.3 m -93.66 116.68 29.18 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.49 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 29.5 pt20 -85.89 119.62 26.41 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -133.19 129.03 20.71 Favored Pre-proline 0 C--N 1.307 -1.244 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.118 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -72.46 134.61 22.83 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.898 1.732 . . . . 0.0 109.575 173.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.0 m -116.03 160.34 20.42 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.17 -15.11 75.35 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.235 -0.438 . . . . 0.0 112.036 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 p -69.63 -51.07 38.2 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.493 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 2.2 t90 -58.77 136.67 57.81 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.379 171.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.2 p -148.85 129.66 14.22 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.868 173.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.42 -173.32 27.23 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-O 121.656 0.587 . . . . 0.0 114.258 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.3 t -81.41 148.38 5.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.3 t -67.35 112.55 4.64 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 123.303 0.377 . . . . 0.0 111.145 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.1 -50.46 1.91 Allowed Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -123.13 117.16 24.75 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.534 ' HA ' ' SG ' ' A' ' 36' ' ' CYS . 13.2 m120 -57.79 -52.35 65.83 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 124.163 0.915 . . . . 0.0 110.748 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -66.47 -24.69 66.46 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.366 -0.833 . . . . 0.0 113.004 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.05 -57.77 4.6 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 123.051 0.219 . . . . 0.0 110.591 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.4 p -69.95 -30.36 67.73 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.41 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 38.1 ttmt -53.89 -57.31 11.4 Favored 'General case' 0 C--O 1.251 1.135 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -60.71 -39.12 87.42 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.329 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -60.33 -41.27 93.22 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.808 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.4 m -63.63 -52.33 61.29 Favored 'General case' 0 C--O 1.257 1.476 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 66.4 mt -55.95 -30.29 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.173 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -87.13 -33.9 19.28 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.2 mt -96.61 -47.65 5.83 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.196 -1.002 . . . . 0.0 113.352 -169.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -107.51 -5.93 17.32 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 120.906 0.384 . . . . 0.0 110.73 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 99.7 mttt 64.55 54.85 1.4 Allowed 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.7 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.53 159.85 33.25 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -81.84 -29.55 32.51 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.933 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -156.46 174.8 14.9 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 22' ' ' LYS . . . -153.59 144.01 10.82 Favored Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 107.634 -2.186 . . . . 0.0 107.634 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.545 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 41.7 t -154.52 148.99 26.23 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 117.899 0.849 . . . . 0.0 109.31 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.534 ' SG ' ' HA ' ' A' ' 18' ' ' ASN . 60.6 m -87.35 108.21 18.88 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.842 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -94.37 137.97 32.88 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.737 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -81.72 116.22 21.33 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.4 m -126.13 -178.99 2.28 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 66.8 t80 -84.03 134.0 44.59 Favored Pre-proline 0 C--N 1.287 -2.14 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.655 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 61.9 Cg_endo -96.61 -7.66 23.31 Favored 'Cis proline' 0 CA--C 1.547 1.141 0 C-N-CA 124.213 -1.161 . . . . 0.0 113.27 -4.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.55 168.02 20.76 Favored 'General case' 0 C--O 1.25 1.109 0 O-C-N 122.366 -0.209 . . . . 0.0 111.293 -176.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -59.76 131.15 50.01 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.237 1.015 . . . . 0.0 112.186 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.493 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 39.8 mmtm -117.7 154.93 30.83 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.479 ' HB2' ' CD1' ' A' ' 11' ' ' TRP . 85.0 m -87.13 107.65 18.55 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.443 0.64 . . . . 0.0 109.622 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.445 HG21 ' HB2' ' A' ' 5' ' ' GLN . 42.9 mm -104.4 135.39 42.43 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 33.9 m -91.5 132.93 35.93 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.545 ' CE1' ' HB3' ' A' ' 35' ' ' SER . 27.6 m-85 -105.93 120.1 40.88 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.543 0.687 . . . . 0.0 110.671 -176.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -102.58 161.42 23.3 Favored Pre-proline 0 C--N 1.288 -2.079 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.312 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -80.76 119.72 3.71 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 121.552 1.501 . . . . 0.0 112.704 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 56.8 m . . . . . 0 C--N 1.312 -1.06 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 174.589 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 . . . . . 0 C--O 1.24 0.557 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -100.95 165.97 11.06 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.9 mt -113.4 121.07 43.23 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 121.047 0.451 . . . . 0.0 109.964 177.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 80.9 m -94.89 132.09 40.08 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.492 ' HB3' HG21 ' A' ' 46' ' ' ILE . 16.1 mt-30 -83.39 146.22 28.58 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.235 0.54 . . . . 0.0 111.691 -174.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -131.83 101.81 15.23 Favored Pre-proline 0 C--N 1.291 -1.954 0 C-N-CA 124.111 0.964 . . . . 0.0 108.904 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.62 -74.29 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.127 1.885 . . . . 0.0 113.895 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.5 m -100.63 83.56 2.61 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -170.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.11 -71.36 0.25 Allowed Glycine 0 N--CA 1.427 -1.926 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 172.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.569 HG21 ' HA ' ' A' ' 25' ' ' CYS . 5.6 t -103.69 -30.17 10.6 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 120.808 0.337 . . . . 0.0 110.902 173.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.57 ' CZ2' ' HB2' ' A' ' 44' ' ' LYS . 27.0 t90 -59.96 127.75 33.47 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.5 m -157.41 109.39 2.38 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 125.239 1.415 . . . . 0.0 107.944 171.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.01 -166.36 24.04 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 119.662 -1.256 . . . . 0.0 113.431 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.1 t -83.38 150.54 4.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 17.5 t -94.91 100.85 12.63 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.09 -55.54 1.37 Allowed Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.085 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -121.61 121.97 38.59 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.907 0.384 . . . . 0.0 110.519 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -63.19 -42.33 99.31 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.984 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -73.75 -21.98 60.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.156 0.503 . . . . 0.0 110.835 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.81 -51.09 20.33 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.651 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.6 p -73.3 -31.3 63.95 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.966 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -54.55 -57.51 11.12 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -56.8 -40.13 75.39 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.957 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -64.33 -37.97 89.38 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.569 ' HA ' HG21 ' A' ' 10' ' ' THR . 72.8 m -63.06 -53.53 52.23 Favored 'General case' 0 C--O 1.256 1.419 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 73.0 mt -55.45 -37.09 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.441 -178.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -83.14 -27.56 30.02 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -98.13 -57.47 2.21 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -108.25 -0.51 20.82 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.065 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 62.1 mttp 67.14 47.22 1.38 Allowed 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.077 173.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.69 177.08 8.91 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.893 -1.048 . . . . 0.0 108.231 175.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -99.69 -27.29 13.74 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.538 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -149.19 170.35 18.66 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -175.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.14 138.52 4.96 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.5 m -163.14 162.48 25.64 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 117.437 0.619 . . . . 0.0 109.941 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 38.1 m -59.36 118.26 5.77 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 175.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -124.27 96.1 4.79 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -90.56 110.59 21.72 Favored 'General case' 0 N--CA 1.421 -1.922 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.063 -177.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.1 m -127.62 159.99 37.55 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 171.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.522 ' CD1' ' HA ' ' A' ' 41' ' ' PRO . 89.2 t80 -61.55 138.16 94.96 Favored Pre-proline 0 C--N 1.309 -1.18 0 O-C-N 123.79 0.681 . . . . 0.0 109.768 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.522 ' HA ' ' CD1' ' A' ' 40' ' ' PHE . 7.0 Cg_exo -74.74 -57.02 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.625 0 C-N-CA 123.999 -1.25 . . . . 0.0 112.943 1.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -155.62 101.76 2.18 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.443 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -108.63 160.42 15.94 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.014 0.435 . . . . 0.0 110.639 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.57 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 4.0 mptp? -116.42 -142.09 0.37 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -176.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.615 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 33.6 t -68.5 126.8 30.8 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 118.345 0.521 . . . . 0.0 109.981 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.492 HG21 ' HB3' ' A' ' 5' ' ' GLN . 41.5 mm -120.11 135.77 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.316 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 56.1 m -82.97 160.24 22.07 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.449 ' CE1' ' HG2' ' A' ' 5' ' ' GLN . 98.5 m-85 -129.58 127.64 41.09 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 120.844 0.354 . . . . 0.0 111.468 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -106.53 148.93 37.67 Favored Pre-proline 0 C--N 1.305 -1.33 0 C-N-CA 123.936 0.894 . . . . 0.0 109.836 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.47 129.47 6.59 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.674 2.249 . . . . 0.0 112.363 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 82.8 m . . . . . 0 N--CA 1.427 -1.603 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.6 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 . . . . . 0 C--O 1.242 0.663 0 CA-C-O 122.048 0.928 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 51' ' ' CYS . 3.7 mptp? -112.79 -178.62 3.44 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 174.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -111.68 112.55 24.33 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.621 0.724 . . . . 0.0 111.155 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 70.8 m -86.99 111.12 20.54 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.618 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 10.3 pt20 -76.11 135.82 39.85 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.487 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.475 ' HD3' ' CE1' ' A' ' 49' ' ' PHE . 51.9 ttt180 -146.38 116.3 4.66 Favored Pre-proline 0 C--N 1.296 -1.753 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.555 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -79.17 86.14 1.74 Allowed 'Trans proline' 0 N--CA 1.438 -1.759 0 C-N-CA 122.058 1.839 . . . . 0.0 109.06 173.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.48 ' HB3' ' OE2' ' A' ' 29' ' ' GLU . 61.6 m -69.49 160.06 32.13 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.419 -176.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.58 -9.79 82.7 Favored Glycine 0 CA--C 1.502 -0.727 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.524 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.505 HG21 ' HB3' ' A' ' 28' ' ' LEU . 4.1 p -68.78 -44.62 73.24 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.48 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 2.8 t90 -66.75 132.46 48.14 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.199 169.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.9 t -145.99 112.02 5.69 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.14 -145.87 15.89 Favored Glycine 0 N--CA 1.425 -2.094 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.787 176.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 p -118.43 162.68 16.31 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.8 t -67.07 134.56 52.11 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.7 -49.58 0.31 Allowed Glycine 0 N--CA 1.421 -2.315 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 173.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -145.99 120.14 9.49 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.185 0.594 . . . . 0.0 110.129 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -55.24 -52.74 62.41 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.072 0.949 . . . . 0.0 111.925 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -65.61 -31.58 72.69 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.935 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.42 -44.28 65.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.503 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.3 p -76.53 -32.18 58.08 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.181 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -54.9 -54.87 37.03 Favored 'General case' 0 C--O 1.253 1.239 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.509 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 47.4 t30 -57.36 -44.39 84.3 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.672 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -56.24 -43.0 78.22 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.264 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.8 m -63.62 -48.8 75.84 Favored 'General case' 0 C--O 1.271 2.224 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 64.9 mt -59.94 -37.73 73.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 114.24 -1.345 . . . . 0.0 111.372 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 31.7 mmt180 -81.47 -19.98 41.21 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.505 ' HB3' HG21 ' A' ' 10' ' ' THR . 4.6 mm? -98.01 -63.61 1.11 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.209 -176.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.48 ' OE2' ' HB3' ' A' ' 8' ' ' SER . 8.3 pt-20 -113.29 3.47 15.96 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.3 0.571 . . . . 0.0 111.685 -177.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 94.4 mttt 67.92 63.74 0.39 Allowed 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.421 174.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' HG12 ' A' ' 26' ' ' ILE . . . -81.07 177.48 9.02 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 173.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -96.01 -41.09 8.93 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -147.15 176.33 10.04 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -173.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.7 143.5 8.9 Favored Glycine 0 C--N 1.307 -1.059 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 m -149.03 152.84 36.96 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 118.466 1.133 . . . . 0.0 110.895 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.0 m -89.13 100.4 13.19 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.501 0.667 . . . . 0.0 109.697 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -93.03 134.38 35.22 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.454 -175.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -78.34 110.64 13.55 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 121.513 0.673 . . . . 0.0 110.15 177.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.44 175.46 10.91 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 174.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 48.2 t80 -77.15 137.7 64.96 Favored Pre-proline 0 C--N 1.28 -2.434 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 175.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 63.0 Cg_endo -101.67 7.17 18.49 Favored 'Cis proline' 0 CA--C 1.546 1.108 0 C-N-CA 124.195 -1.169 . . . . 0.0 113.138 -2.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.85 171.3 20.31 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -176.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -65.42 117.23 7.64 Favored 'General case' 0 C--O 1.24 0.576 0 O-C-N 123.551 0.532 . . . . 0.0 111.172 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 95.1 mttt -109.29 146.55 34.11 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 22.4 t -92.87 117.11 29.68 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.86 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.598 HG21 ' HB2' ' A' ' 5' ' ' GLN . 25.0 mm -101.44 134.49 41.58 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 66.5 m -84.75 136.78 33.56 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.618 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 77.9 m-85 -113.1 122.96 49.14 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.473 0.654 . . . . 0.0 110.925 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.475 ' CE1' ' HD3' ' A' ' 6' ' ' ARG . 81.4 m-85 -107.98 156.53 38.07 Favored Pre-proline 0 C--N 1.288 -2.093 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.709 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -77.66 126.86 8.44 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 121.638 1.558 . . . . 0.0 112.701 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 2' ' ' LYS . 12.2 m . . . . . 0 C--N 1.294 -1.843 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 172.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 . . . . . 0 CA--C 1.509 -0.614 0 CA-C-O 120.938 0.399 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -161.52 144.97 12.59 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 86.6 mt -80.53 110.89 16.44 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.0 p -102.22 129.97 48.76 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.862 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.487 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 10.9 pt20 -78.76 140.64 38.23 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.35 0.595 . . . . 0.0 111.054 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -137.23 127.93 16.07 Favored Pre-proline 0 C--N 1.282 -2.329 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.26 106.24 0.14 Allowed 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 122.698 2.265 . . . . 0.0 109.751 174.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.603 ' HB2' ' HB3' ' A' ' 11' ' ' TRP . 1.5 m -53.94 133.38 43.13 Favored 'General case' 0 N--CA 1.417 -2.101 0 C-N-CA 125.806 1.642 . . . . 0.0 111.461 -176.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.93 -32.04 6.36 Favored Glycine 0 N--CA 1.428 -1.879 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.985 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -74.53 -38.05 62.89 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 120.708 0.29 . . . . 0.0 110.659 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.603 ' HB3' ' HB2' ' A' ' 8' ' ' SER . 1.7 t90 -58.97 132.91 55.42 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.466 0.706 . . . . 0.0 111.654 174.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.1 p -156.46 97.58 1.76 Allowed 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.22 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.98 -156.48 26.71 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -91.72 150.94 3.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 41.1 t -93.51 101.07 13.25 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 173.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.66 -35.88 7.63 Favored Glycine 0 N--CA 1.429 -1.817 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.654 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -133.62 128.47 35.19 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-O 120.906 0.384 . . . . 0.0 110.964 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -60.39 -47.57 85.49 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.402 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.4 p30 -63.46 -36.69 84.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.219 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.73 -47.41 63.2 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.345 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.9 p -76.17 -25.36 55.16 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.46 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -54.81 -57.72 10.45 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -62.83 -36.67 83.98 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.132 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -61.03 -41.71 97.08 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 122.846 0.459 . . . . 0.0 109.815 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.3 m -64.81 -56.04 15.9 Favored 'General case' 0 C--O 1.257 1.488 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 77.0 mt -54.16 -36.42 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.425 1.49 . . . . 0.0 112.251 -176.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 27' ' ' ARG . 52.0 mtt180 -87.18 -25.07 24.24 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . 0.264 7.3 mp -104.35 -50.98 3.2 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 117.983 -1.487 . . . . 0.0 113.63 -174.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -109.24 1.98 20.58 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.305 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 27.7 mtpp 59.39 63.01 1.65 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 125.773 1.629 . . . . 0.0 114.034 174.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.25 179.73 7.7 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.375 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -94.32 -30.45 14.52 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 55.9 t-80 -156.41 174.0 16.06 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -165.23 150.86 19.22 Favored Glycine 0 C--N 1.304 -1.237 0 N-CA-C 107.868 -2.093 . . . . 0.0 107.868 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.0 t -167.04 151.84 7.26 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 118.31 1.055 . . . . 0.0 112.06 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 38.5 m -63.62 117.37 6.7 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 170.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -119.03 -22.04 7.42 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.724 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.505 ' HB3' ' H ' ' A' ' 44' ' ' LYS . 32.8 t80 -92.58 179.0 5.64 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.3 m -124.41 -162.46 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 124.069 0.948 . . . . 0.0 109.191 -172.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.531 ' CG ' ' HA ' ' A' ' 41' ' ' PRO . 66.5 t80 -59.86 144.45 85.91 Favored Pre-proline 0 C--N 1.312 -1.057 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.531 ' HA ' ' CG ' ' A' ' 40' ' ' PHE . 1.6 Cg_endo -86.78 -15.45 29.41 Favored 'Cis proline' 0 C--O 1.239 0.535 0 C-N-CA 124.287 -1.13 . . . . 0.0 114.336 3.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.465 ' O ' ' HD2' ' A' ' 38' ' ' TYR . . . -126.6 93.73 3.86 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -174.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -64.96 104.42 0.86 Allowed 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 175.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.505 ' H ' ' HB3' ' A' ' 38' ' ' TYR . 45.7 mtmt -92.86 149.26 21.38 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.496 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 41.9 t -98.75 131.12 45.14 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 175.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.437 HG21 ' HB2' ' A' ' 5' ' ' GLN . 16.4 mm -113.02 137.36 46.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 73.1 m -89.38 141.31 28.67 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -177.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.487 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 62.1 m-85 -111.22 126.38 54.81 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.22 0.533 . . . . 0.0 110.588 -178.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -113.93 161.46 27.75 Favored Pre-proline 0 C--N 1.286 -2.158 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.149 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -86.21 112.81 1.16 Allowed 'Trans proline' 0 N--CA 1.436 -1.868 0 C-N-CA 121.993 1.795 . . . . 0.0 111.692 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 47.8 m . . . . . 0 C--N 1.285 -2.238 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.046 175.929 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 . . . . . 0 CA--C 1.507 -0.71 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -84.9 128.32 34.57 Favored 'General case' 0 C--O 1.256 1.421 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.296 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 95.1 mt -99.15 119.33 37.68 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.652 177.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.3 m -73.68 120.54 19.42 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.42 ' HB2' HG21 ' A' ' 46' ' ' ILE . 19.6 pt20 -91.97 139.34 30.74 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.062 0.458 . . . . 0.0 110.479 -176.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -145.4 121.68 5.97 Favored Pre-proline 0 N--CA 1.431 -1.391 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.024 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -76.08 86.39 1.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.859 1.706 . . . . 0.0 108.882 171.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.416 ' HB3' ' OE1' ' A' ' 29' ' ' GLU . 61.4 m -75.38 160.86 29.79 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.673 -173.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.64 -6.09 85.96 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.421 -0.809 . . . . 0.0 113.68 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 p -70.93 -58.65 3.38 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.51 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 2.8 t90 -59.65 143.29 50.98 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.793 168.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.4 m -149.87 123.77 9.32 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 119.29 -122.98 5.5 Favored Glycine 0 C--O 1.247 0.915 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.689 176.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.3 p -134.03 170.06 20.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.6 t -67.48 109.96 3.43 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 118.013 0.37 . . . . 0.0 110.414 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.87 -57.36 0.92 Allowed Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 176.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -138.93 118.7 13.14 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -50.36 -50.03 52.44 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.984 0.914 . . . . 0.0 110.898 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -60.64 -36.41 78.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.863 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.15 -47.55 35.19 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.457 -173.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.3 p -75.48 -32.52 60.61 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -56.45 -54.5 44.95 Favored 'General case' 0 C--O 1.253 1.254 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 173.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.51 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 64.1 t30 -59.24 -43.54 92.38 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.744 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -58.06 -36.92 73.48 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.139 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.2 m -68.25 -54.4 17.91 Favored 'General case' 0 C--O 1.258 1.537 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 69.8 mt -60.08 -32.87 51.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.242 -174.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 30.4 mmt180 -91.46 -17.47 25.7 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.48 -52.07 2.97 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 118.833 -1.147 . . . . 0.0 112.558 -174.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.416 ' OE1' ' HB3' ' A' ' 8' ' ' SER . 9.0 pt-20 -109.09 -8.44 15.17 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.706 0.765 . . . . 0.0 109.986 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.588 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 53.9 mtmt 69.14 63.36 0.29 Allowed 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 113.906 -1.497 . . . . 0.0 112.155 176.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.38 169.91 16.64 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 114.656 -1.157 . . . . 0.0 109.098 176.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.401 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 28.8 tpt180 -88.61 -34.23 17.37 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.934 0.873 . . . . 0.0 108.674 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -152.02 171.62 17.55 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.287 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.29 137.16 4.59 Favored Glycine 0 N--CA 1.424 -2.151 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.1 p -161.77 174.88 12.6 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 117.751 0.775 . . . . 0.0 111.232 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 51.3 m -90.13 109.48 20.54 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.153 0.501 . . . . 0.0 110.025 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -101.06 143.72 30.85 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.525 ' CZ ' ' HA ' ' A' ' 42' ' ' ALA . 3.9 t80 -87.21 111.27 20.83 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 118.961 -1.095 . . . . 0.0 109.468 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.3 m -125.46 -171.58 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 78.1 t80 -78.72 132.75 63.86 Favored Pre-proline 0 C--N 1.294 -1.848 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.704 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 60.2 Cg_endo -101.87 5.92 18.02 Favored 'Cis proline' 0 CA--C 1.544 0.98 0 C-N-CA 124.46 -1.058 . . . . 0.0 112.979 -2.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 38' ' ' TYR . . . -158.62 -173.09 4.11 Favored 'General case' 0 C--O 1.244 0.816 0 C-N-CA 122.37 0.268 . . . . 0.0 110.577 -175.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -67.87 122.34 17.95 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.331 0.586 . . . . 0.0 110.214 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.474 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 68.4 mttm -124.93 153.06 43.28 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.51 ' HB2' ' CD1' ' A' ' 11' ' ' TRP . 97.0 m -80.14 114.55 19.13 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.474 0.654 . . . . 0.0 110.318 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.42 HG21 ' HB2' ' A' ' 5' ' ' GLN . 50.7 mm -111.23 135.85 49.12 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.696 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 61.3 m -87.63 139.92 30.04 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.455 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 88.6 m-85 -117.48 129.2 55.67 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.441 0.639 . . . . 0.0 111.305 -176.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -114.61 157.69 42.17 Favored Pre-proline 0 C--N 1.286 -2.177 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.401 ' HD3' ' HB2' ' A' ' 32' ' ' ARG . 30.6 Cg_endo -79.51 127.35 7.25 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.354 1.369 . . . . 0.0 110.758 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 73.8 m . . . . . 0 C--N 1.315 -0.905 0 O-C-N 122.097 -0.377 . . . . 0.0 111.334 -179.161 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 . . . . . 0 CA--C 1.506 -0.721 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -108.49 131.92 54.33 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.482 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 89.8 mt -88.77 101.69 14.27 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 64.5 m -83.3 133.88 34.95 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.913 -175.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.406 ' HB2' HG21 ' A' ' 46' ' ' ILE . 25.7 pt20 -81.17 132.96 35.38 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.973 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -144.15 125.31 7.92 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.87 135.01 49.51 Favored 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.628 2.219 . . . . 0.0 110.896 176.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.781 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . 5.9 p -90.03 160.45 16.33 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -176.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.13 -13.61 38.8 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.5 t -81.86 -37.94 26.17 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.158 0.504 . . . . 0.0 109.953 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.565 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 1.6 t90 -82.09 145.17 30.31 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 173.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 t -157.32 95.6 1.48 Allowed 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.35 -140.48 8.82 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.724 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 p -104.4 170.98 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.3 t -58.99 133.6 56.23 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 123.253 0.621 . . . . 0.0 112.656 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.99 -76.05 0.9 Allowed Glycine 0 N--CA 1.426 -1.979 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 173.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -142.5 130.54 21.89 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -48.42 -57.4 6.13 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.459 1.104 . . . . 0.0 112.105 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -66.56 -31.51 72.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.993 -174.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.18 -48.12 68.91 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.755 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.527 ' HA ' ' HB3' ' A' ' 24' ' ' GLN . 5.6 p -78.6 -23.55 45.92 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -58.53 -55.14 38.85 Favored 'General case' 0 C--O 1.256 1.44 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -57.95 -46.27 85.34 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.067 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.527 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 61.6 tt0 -55.82 -40.56 72.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.762 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 97.0 m -62.98 -57.35 11.03 Favored 'General case' 0 C--O 1.257 1.492 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.1 mt -55.0 -39.59 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 114.141 -1.39 . . . . 0.0 111.465 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -79.44 -26.45 41.79 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.4 -55.99 2.24 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 118.558 -1.257 . . . . 0.0 113.177 -174.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -108.05 2.25 22.98 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.8 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 61.48 59.3 1.9 Allowed 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.367 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -84.07 175.44 9.51 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 175.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.455 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 26.2 tpt180 -85.81 -41.34 15.12 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -147.54 173.43 12.7 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -177.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.27 149.56 15.67 Favored Glycine 0 CA--C 1.476 -2.396 0 N-CA-C 107.036 -2.425 . . . . 0.0 107.036 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.3 t -169.88 173.38 6.14 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 118.544 1.172 . . . . 0.0 109.432 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.517 ' HB3' ' HB3' ' A' ' 43' ' ' HIS . 75.4 m -78.32 92.06 4.5 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.611 0.72 . . . . 0.0 110.215 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -80.11 144.56 32.98 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -95.97 119.07 33.8 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.995 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.09 171.0 16.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 175.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 79.0 t80 -77.13 131.71 72.03 Favored Pre-proline 0 C--N 1.289 -2.033 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 175.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 71.6 Cg_endo -106.71 12.66 8.09 Favored 'Cis proline' 0 CA--C 1.546 1.103 0 C-N-CA 124.485 -1.048 . . . . 0.0 113.551 -1.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -150.76 170.71 18.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.957 0.408 . . . . 0.0 111.114 -174.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.517 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 70.1 m80 -76.13 136.76 39.82 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.566 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.565 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 98.6 mttt -131.97 152.31 51.19 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 11' ' ' TRP . 71.2 m -82.51 98.27 8.85 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.942 0.877 . . . . 0.0 111.519 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.406 HG21 ' HB2' ' A' ' 5' ' ' GLN . 50.8 mm -105.62 138.47 30.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.781 ' SG ' ' HB3' ' A' ' 8' ' ' SER . 60.6 m -91.73 154.63 18.84 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -177.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.482 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 84.8 m-85 -122.31 129.43 52.17 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -111.58 152.68 44.19 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.455 ' HD3' ' HB2' ' A' ' 32' ' ' ARG . 70.7 Cg_endo -79.6 133.98 10.78 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.104 1.87 . . . . 0.0 112.256 -175.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 67.6 m . . . . . 0 C--N 1.291 -1.957 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.745 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 . . . . . 0 C--O 1.237 0.433 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -103.41 157.05 17.3 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 174.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 78.1 mt -114.1 115.49 27.62 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-O 121.195 0.522 . . . . 0.0 110.181 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.3 m -89.76 117.18 28.42 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.441 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -72.04 139.54 48.56 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.712 -175.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.421 ' HD3' ' OE1' ' A' ' 29' ' ' GLU . 51.6 ttt180 -142.16 108.18 5.78 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 175.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -72.27 -62.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.01 1.807 . . . . 0.0 112.904 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.2 m -91.79 101.0 13.59 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.746 0.784 . . . . 0.0 112.683 -172.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.62 -71.4 0.04 OUTLIER Glycine 0 C--N 1.286 -2.196 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 172.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.465 HG22 ' OE2' ' A' ' 29' ' ' GLU . 8.1 t -112.75 -30.26 7.13 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.077 -0.562 . . . . 0.0 109.946 172.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.425 ' CZ2' ' HB2' ' A' ' 44' ' ' LYS . 48.1 t90 -55.71 129.79 40.65 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.389 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 m -140.5 89.43 2.28 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.049 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 56.05 45.63 86.72 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 115.495 0.958 . . . . 0.0 115.495 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.9 t -120.31 124.12 71.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 117.232 0.516 . . . . 0.0 111.932 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.555 ' HB2' ' HB3' ' A' ' 44' ' ' LYS . 42.4 t -141.72 82.75 1.82 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 167.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.69 -82.99 0.08 OUTLIER Glycine 0 N--CA 1.426 -2.0 0 C-N-CA 120.471 -0.871 . . . . 0.0 110.944 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -88.29 96.28 10.51 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.546 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 2.6 m-20 -58.56 -44.0 89.57 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.261 0.624 . . . . 0.0 112.153 -176.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -67.43 -28.84 68.23 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.131 0.491 . . . . 0.0 110.893 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.26 -39.35 23.11 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.901 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.546 ' SG ' ' HA ' ' A' ' 18' ' ' ASN . 21.5 p -71.45 -31.13 66.82 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.178 177.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -58.06 -53.01 63.06 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 172.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 55.1 t30 -57.59 -43.79 84.88 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.773 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -57.07 -40.7 77.41 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.447 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 71.2 m -63.08 -54.37 39.1 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 62.3 mt -56.16 -37.41 49.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 124.626 1.17 . . . . 0.0 111.027 -177.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 25.2 mmt180 -83.52 -23.06 32.25 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -177.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.58 -49.33 3.18 Favored 'General case' 0 CA--C 1.501 -0.934 0 C-N-CA 119.017 -1.073 . . . . 0.0 112.961 -175.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.465 ' OE2' HG22 ' A' ' 10' ' ' THR . 12.5 pt-20 -107.31 -4.8 18.28 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.128 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 55.2 mtmt 66.12 41.56 3.51 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.029 176.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -72.13 164.48 26.12 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.148 175.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.424 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 13.3 tpp180 -95.18 -22.09 18.06 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.368 0.604 . . . . 0.0 110.193 -175.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -155.11 170.15 22.48 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.86 141.38 5.98 Favored Glycine 0 CA--C 1.482 -2.003 0 N-CA-C 107.562 -2.215 . . . . 0.0 107.562 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.3 t -175.79 168.48 3.06 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 86.1 m -63.51 106.67 0.98 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.835 0.826 . . . . 0.0 110.065 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -109.29 95.17 5.45 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -84.58 106.76 16.39 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.284 -176.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.0 m -130.79 162.4 38.94 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 172.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -59.54 140.67 88.75 Favored Pre-proline 0 C--N 1.305 -1.349 0 O-C-N 124.285 0.991 . . . . 0.0 109.669 178.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -74.6 -52.68 0.16 OUTLIER 'Cis proline' 0 N--CA 1.474 0.352 0 C-N-CA 124.018 -1.243 . . . . 0.0 111.952 -1.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -156.68 96.23 1.62 Allowed 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -98.43 159.08 15.18 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.402 0.62 . . . . 0.0 111.4 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 15' ' ' CYS . 33.7 mmtp -120.34 -144.2 0.35 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -174.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 99.0 m -60.55 111.05 1.44 Allowed 'General case' 0 C--O 1.203 -1.389 0 CA-C-N 118.661 0.664 . . . . 0.0 110.208 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 44' ' ' LYS . 49.9 mm -110.71 137.7 41.99 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 59.6 m -86.56 148.52 25.47 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.488 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 92.2 m-85 -123.79 132.26 53.75 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 122.113 -0.367 . . . . 0.0 110.43 -177.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -105.97 148.79 37.18 Favored Pre-proline 0 C--N 1.285 -2.221 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.514 175.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.424 ' HD3' ' HB2' ' A' ' 32' ' ' ARG . 69.8 Cg_endo -78.28 132.18 11.19 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 122.256 1.971 . . . . 0.0 112.259 -176.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 74.2 m . . . . . 0 C--N 1.284 -2.246 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.555 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 . . . . . 0 CA--C 1.508 -0.669 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -83.22 147.59 27.92 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 88.5 mt -93.2 99.99 12.45 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.33 0.586 . . . . 0.0 109.872 176.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.8 m -89.74 118.64 29.49 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.561 ' HB2' HG21 ' A' ' 46' ' ' ILE . 3.8 pt20 -81.89 138.44 35.02 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -173.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -133.38 118.28 14.82 Favored Pre-proline 0 C--N 1.308 -1.201 0 C-N-CA 125.161 1.384 . . . . 0.0 108.121 178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.25 -63.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.732 1.621 . . . . 0.0 113.035 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.6 p -88.63 128.06 35.58 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -172.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.07 -75.28 0.06 OUTLIER Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.8 t -104.22 -36.82 7.52 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 171.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -67.62 135.68 53.24 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.448 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.7 t -156.26 89.67 1.14 Allowed 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.67 34.42 83.44 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.062 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.5 t -118.82 102.41 13.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.166 0.508 . . . . 0.0 110.783 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.8 t -140.28 80.24 1.75 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.452 0.644 . . . . 0.0 109.528 176.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.87 -60.98 0.53 Allowed Glycine 0 N--CA 1.426 -2.021 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -122.94 132.82 54.33 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 44.3 m-80 -63.89 -45.1 90.87 Favored 'General case' 0 C--O 1.205 -1.285 0 O-C-N 123.746 0.654 . . . . 0.0 109.863 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -63.76 -33.68 76.2 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.6 -46.52 63.25 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.2 p -76.38 -28.48 56.78 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.524 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 38.9 ttmt -56.02 -56.26 22.96 Favored 'General case' 0 C--O 1.251 1.137 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 173.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -58.74 -40.71 84.59 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.026 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -59.78 -40.88 89.73 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.9 m -64.98 -55.02 21.48 Favored 'General case' 0 C--O 1.252 1.209 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 54.9 mt -56.78 -41.52 75.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.159 -177.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -82.82 -17.02 45.47 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -106.7 -59.95 1.73 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 119.507 -0.877 . . . . 0.0 113.124 -177.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -104.83 1.08 28.73 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.988 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 97.2 mttt 65.95 60.57 0.67 Allowed 'General case' 0 CA--C 1.498 -1.042 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.567 172.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.38 176.02 7.09 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.241 176.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -93.66 -39.75 10.63 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.237 0.542 . . . . 0.0 109.625 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -146.57 170.68 16.41 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.78 137.81 4.81 Favored Glycine 0 C--N 1.292 -1.884 0 N-CA-C 108.029 -2.028 . . . . 0.0 108.029 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.2 p -172.14 161.54 5.51 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 117.451 0.626 . . . . 0.0 111.352 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 81.4 m -73.47 101.42 3.51 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.29 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -97.84 148.8 23.04 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -79.87 92.45 5.5 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-O 122.292 1.044 . . . . 0.0 109.52 174.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.2 m -101.11 158.95 4.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.537 0 N-CA-C 105.437 -2.061 . . . . 0.0 105.437 172.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 48.5 t80 -68.91 132.21 90.62 Favored Pre-proline 0 C--N 1.279 -2.474 0 C-N-CA 119.11 -1.036 . . . . 0.0 108.884 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 88.7 Cg_endo -108.04 18.07 6.72 Favored 'Cis proline' 0 CA--C 1.555 1.541 0 C-N-CA 124.865 -0.89 . . . . 0.0 113.949 -1.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -156.02 163.92 39.09 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.857 -0.527 . . . . 0.0 111.474 -174.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -70.13 113.97 7.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.89 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 66.6 mttm -129.82 147.69 51.62 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 22.9 t -78.2 119.43 21.58 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.517 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.561 HG21 ' HB2' ' A' ' 5' ' ' GLN . 21.2 mm -114.44 138.92 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.446 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 69.0 m -85.67 137.93 32.49 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.452 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 88.8 m-85 -113.15 122.25 46.95 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 122.043 -0.411 . . . . 0.0 110.444 -178.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -103.6 143.59 26.94 Favored Pre-proline 0 C--N 1.293 -1.876 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.537 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -79.84 116.08 3.41 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 122.464 2.109 . . . . 0.0 112.737 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 84.3 m . . . . . 0 C--N 1.293 -1.873 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.695 176.659 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 . . . . . 0 C--O 1.242 0.702 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -88.9 170.67 10.51 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.9 mt -123.35 113.93 19.5 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.586 0.707 . . . . 0.0 110.048 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.9 m -98.33 123.57 42.51 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.425 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -85.94 143.64 28.08 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.424 -176.776 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -148.84 123.01 4.75 Favored Pre-proline 0 C--N 1.298 -1.673 0 C-N-CA 123.756 0.822 . . . . 0.0 109.564 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.96 153.65 63.33 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 122.357 2.038 . . . . 0.0 109.389 173.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.8 t -147.73 160.3 42.86 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.52 -3.85 86.86 Favored Glycine 0 C--O 1.239 0.45 0 O-C-N 123.42 0.45 . . . . 0.0 112.572 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.6 p -71.6 -55.76 7.16 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -56.53 143.69 34.43 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.324 169.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.2 t -156.98 137.33 12.91 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.271 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.22 -164.85 31.13 Favored Glycine 0 C--O 1.249 1.075 0 C-N-CA 121.462 -0.399 . . . . 0.0 113.543 175.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.9 t -84.48 147.52 5.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.6 t -93.01 129.93 38.76 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -122.2 -44.88 0.34 Allowed Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -107.92 104.69 14.21 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -54.97 -53.5 54.86 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.484 1.114 . . . . 0.0 111.183 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -64.83 -32.65 74.45 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.819 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.9 -49.33 65.94 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.459 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.8 p -77.3 -27.84 53.13 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.495 -177.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -55.92 -56.97 14.31 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 173.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -59.5 -38.78 81.79 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.102 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -60.68 -46.22 91.17 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.897 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.519 ' HA ' ' OE2' ' A' ' 29' ' ' GLU . 75.1 m -62.42 -45.29 93.77 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-O 122.451 1.12 . . . . 0.0 108.943 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 72.6 mt -59.97 -32.44 50.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.678 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -86.23 -15.23 41.46 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.2 mt -109.27 -60.62 1.74 Allowed 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.864 -176.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.519 ' OE2' ' HA ' ' A' ' 25' ' ' CYS . 1.8 pm0 -99.38 -1.35 38.97 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.04 0.448 . . . . 0.0 111.347 178.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 68.2 mttm 63.64 45.73 4.47 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.584 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.462 ' O ' HG12 ' A' ' 26' ' ' ILE . . . -71.81 179.99 2.91 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.986 177.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -104.99 -31.3 9.29 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.557 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.609 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 84.4 t60 -147.39 171.56 15.29 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -176.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.9 136.04 3.67 Favored Glycine 0 CA--C 1.488 -1.634 0 N-CA-C 107.471 -2.252 . . . . 0.0 107.471 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.8 m -158.63 163.64 36.74 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 118.531 1.165 . . . . 0.0 113.709 -177.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 43' ' ' HIS . 34.0 m -70.11 100.64 1.68 Allowed 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 113.9 -1.5 . . . . 0.0 109.35 176.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -97.33 142.5 29.13 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -84.25 104.49 14.33 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.852 0.835 . . . . 0.0 111.969 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.7 m -105.97 160.11 5.83 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 171.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 86.1 t80 -73.57 128.3 87.33 Favored Pre-proline 0 C--N 1.279 -2.477 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.103 -179.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 95.3 Cg_endo -112.59 24.31 2.37 Favored 'Cis proline' 0 CA--C 1.561 1.859 0 C-N-CA 125.058 -0.809 . . . . 0.0 112.949 -3.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.55 160.7 40.69 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.048 0.451 . . . . 0.0 111.154 -175.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 73.6 m80 -76.5 122.54 24.71 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.374 0.607 . . . . 0.0 111.853 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -120.35 153.47 36.43 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.0 t -90.95 126.49 36.08 Favored 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.22 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.5 mm -116.57 139.61 42.6 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.2 m -88.46 140.62 29.28 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.609 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 30.9 m-85 -114.49 129.25 56.64 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.275 0.56 . . . . 0.0 109.986 -177.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -109.19 152.36 42.51 Favored Pre-proline 0 C--N 1.288 -2.069 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -78.02 142.57 19.72 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 121.642 1.561 . . . . 0.0 111.529 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 76.2 m . . . . . 0 C--N 1.287 -2.126 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.836 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -93.42 154.23 18.05 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.152 0.501 . . . . 0.0 110.588 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 80.8 mt -126.73 138.8 53.44 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.78 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.2 m -89.12 123.54 33.49 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.496 ' HG2' ' CE2' ' A' ' 48' ' ' TYR . 41.7 mt-30 -85.44 130.82 34.5 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.152 -176.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -135.79 107.39 9.83 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -68.24 -74.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.703 2.269 . . . . 0.0 115.325 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 p -84.91 134.82 34.25 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -169.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.23 -85.38 0.09 OUTLIER Glycine 0 N--CA 1.42 -2.419 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 t -86.14 -39.71 16.41 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.482 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 21.5 t90 -62.57 128.73 37.36 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.349 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.2 m -155.49 102.17 2.23 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 124.988 1.315 . . . . 0.0 107.675 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.23 -146.77 18.37 Favored Glycine 0 N--CA 1.42 -2.373 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.43 170.69 13.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.2 t -69.84 110.81 5.17 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.382 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.52 -55.03 1.37 Allowed Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -140.72 129.59 23.15 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -58.26 -46.64 85.63 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.483 0.489 . . . . 0.0 110.972 -176.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -65.75 -31.27 72.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.604 -177.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -48.45 65.44 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.709 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.1 p -74.46 -25.55 59.48 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.873 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -56.13 -57.92 10.13 Favored 'General case' 0 C--O 1.249 1.059 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 171.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -61.2 -36.29 79.47 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.8 -1.546 . . . . 0.0 110.629 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -64.89 -38.78 92.1 Favored 'General case' 0 C--O 1.21 -0.982 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 86.6 m -66.81 -54.49 22.0 Favored 'General case' 0 C--O 1.253 1.268 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 65.9 mt -56.47 -37.06 49.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.742 -177.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -86.53 -21.91 26.66 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -104.0 -55.56 2.35 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 118.9 -1.12 . . . . 0.0 113.156 -175.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -107.81 1.19 22.67 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.566 -0.853 . . . . 0.0 111.821 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm 62.64 60.99 1.25 Allowed 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.548 -1.206 . . . . 0.0 112.709 174.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.08 171.84 9.25 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.807 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -81.78 -33.38 30.92 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -157.85 171.58 20.03 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.9 137.88 5.75 Favored Glycine 0 C--N 1.295 -1.744 0 N-CA-C 106.813 -2.515 . . . . 0.0 106.813 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.1 t -160.14 162.52 33.98 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 118.113 0.957 . . . . 0.0 110.717 -176.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 21.0 m -78.59 104.55 9.27 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.439 ' HB3' ' CG1' ' A' ' 46' ' ' ILE . 6.8 t30 -99.04 -39.33 8.58 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.372 -173.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.473 ' HB3' ' H ' ' A' ' 44' ' ' LYS . 14.9 t80 -80.78 168.41 18.83 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -177.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.55 -159.25 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 124.539 1.136 . . . . 0.0 108.921 -173.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.604 ' CD1' ' HA ' ' A' ' 41' ' ' PRO . 75.8 t80 -49.72 140.81 14.39 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 123.105 0.562 . . . . 0.0 110.31 178.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.604 ' HA ' ' CD1' ' A' ' 40' ' ' PHE . 87.1 Cg_endo -82.99 -5.26 51.07 Favored 'Cis proline' 0 C--O 1.242 0.678 0 C-N-CA 123.876 -1.302 . . . . 0.0 115.269 4.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.82 106.24 3.64 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.702 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -61.0 120.87 11.08 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 173.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.482 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 48.2 mtmt -111.18 141.02 45.23 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.1 m -86.28 132.18 34.05 Favored 'General case' 0 CA--C 1.494 -1.196 0 O-C-N 123.608 0.567 . . . . 0.0 109.638 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.487 HG21 ' HB3' ' A' ' 5' ' ' GLN . 36.2 mm -120.91 139.89 46.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 82.9 m -87.03 138.15 31.74 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.496 ' CE2' ' HG2' ' A' ' 5' ' ' GLN . 93.3 m-85 -113.33 116.31 29.5 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -177.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -99.89 148.21 34.49 Favored Pre-proline 0 C--N 1.295 -1.801 0 C-N-CA 122.769 0.427 . . . . 0.0 110.379 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.16 125.04 9.96 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.045 1.83 . . . . 0.0 112.97 -175.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 77.6 m . . . . . 0 C--O 1.252 1.192 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 176.5 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 . . . . . 0 CA--C 1.496 -1.131 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -102.3 121.38 42.17 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.259 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.474 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 86.2 mt -76.42 104.89 7.17 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.677 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.7 m -87.19 126.71 34.97 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.406 ' HB2' ' CG2' ' A' ' 46' ' ' ILE . 29.7 pt20 -80.89 145.74 31.17 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.201 0.524 . . . . 0.0 111.779 -173.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -125.42 109.14 26.47 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.4 -56.16 0.95 Allowed 'Trans proline' 0 C--O 1.203 -1.248 0 C-N-CA 122.542 2.161 . . . . 0.0 113.62 -176.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.3 m -137.66 101.43 4.47 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.687 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -109.63 -61.01 0.51 Allowed Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 171.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.416 HG22 ' OE1' ' A' ' 29' ' ' GLU . 4.8 t -118.1 -36.95 3.47 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.441 -0.38 . . . . 0.0 111.689 172.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.61 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 17.8 t90 -46.5 130.97 11.19 Favored 'General case' 0 C--N 1.358 0.941 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.5 m -150.44 121.2 7.54 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.2 -159.23 22.67 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.46 161.12 4.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.478 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 30.3 t -85.5 90.37 7.95 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.25 -35.81 4.06 Favored Glycine 0 C--N 1.313 -0.72 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.607 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -137.67 110.91 7.87 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -56.19 -43.16 78.19 Favored 'General case' 0 CA--C 1.49 -1.333 0 O-C-N 123.624 0.578 . . . . 0.0 109.872 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.409 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 11.1 m120 -59.41 -35.47 74.03 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.315 -177.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.59 -53.16 9.92 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.971 -177.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 4.8 p -70.55 -32.23 69.59 Favored 'General case' 0 C--O 1.214 -0.792 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 19' ' ' ASN . 27.3 ttpp -54.62 -52.22 62.92 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 173.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -58.49 -46.58 86.37 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.632 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -54.32 -44.21 71.85 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.784 0.677 . . . . 0.0 111.225 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 68.8 m -61.45 -56.96 14.4 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 59.6 mt -55.23 -35.78 37.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 124.894 1.277 . . . . 0.0 111.322 -177.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -75.99 -34.15 59.74 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -110.47 -49.3 3.07 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 118.483 -1.287 . . . . 0.0 113.639 -171.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.416 ' OE1' HG22 ' A' ' 10' ' ' THR . 11.7 pt-20 -97.03 -9.64 27.74 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.629 0.728 . . . . 0.0 109.414 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 97.2 mttt 61.51 61.55 1.47 Allowed 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 113.921 -1.491 . . . . 0.0 112.619 177.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.25 -179.51 5.44 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.009 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.402 ' HG2' ' HD3' ' A' ' 50' ' ' PRO . 23.1 mmt180 -100.96 -34.93 9.57 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.173 0.511 . . . . 0.0 110.084 177.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -143.2 168.91 18.64 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.76 132.63 2.89 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.7 p -155.07 -179.88 8.49 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 117.737 0.769 . . . . 0.0 112.234 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 84.6 m -81.91 126.5 31.98 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.009 0.433 . . . . 0.0 110.948 -176.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -119.8 132.34 55.57 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -87.51 112.08 21.86 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 121.617 0.722 . . . . 0.0 110.232 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 m -122.93 142.1 40.79 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 171.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 78.0 t80 -55.99 131.09 73.77 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 123.317 0.386 . . . . 0.0 110.449 -175.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 23.9 Cg_endo -110.73 20.8 3.67 Favored 'Cis proline' 0 CA--C 1.554 1.496 0 C-N-CA 124.692 -0.962 . . . . 0.0 114.272 -0.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -153.76 154.33 33.85 Favored 'General case' 0 C--O 1.243 0.73 0 O-C-N 121.709 -0.62 . . . . 0.0 112.32 -173.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -73.59 121.38 20.57 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.449 -177.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -117.21 157.75 25.47 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.553 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.61 ' HB2' ' CD1' ' A' ' 11' ' ' TRP . 96.4 m -88.49 113.03 23.66 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.406 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 28.6 mm -105.28 135.65 42.48 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.718 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 177.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.6 m -87.46 159.96 18.47 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 123.692 0.62 . . . . 0.0 109.701 -177.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.474 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 96.3 m-85 -132.15 128.1 37.34 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -176.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -111.17 150.73 42.41 Favored Pre-proline 0 C--N 1.308 -1.218 0 C-N-CA 123.637 0.775 . . . . 0.0 110.158 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.402 ' HD3' ' HG2' ' A' ' 32' ' ' ARG . 91.0 Cg_endo -84.18 113.91 1.83 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.73 2.287 . . . . 0.0 113.466 -177.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 82.9 m . . . . . 0 C--N 1.295 -1.798 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.224 175.821 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt . . . . . 0 CA--C 1.513 -0.458 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.9 mt -108.21 127.77 54.13 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.249 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.4 p -108.87 141.83 40.35 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.519 ' HB2' HG21 ' A' ' 46' ' ' ILE . 3.9 pt20 -96.71 144.13 27.0 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -174.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 -147.58 114.17 4.07 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -75.36 -39.02 1.21 Allowed 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.096 1.864 . . . . 0.0 114.728 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.2 m -94.4 139.37 31.2 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -172.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.7 -86.29 0.1 Allowed Glycine 0 N--CA 1.411 -3.025 0 N-CA-C 107.808 -2.117 . . . . 0.0 107.808 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.442 HG22 ' OE2' ' A' ' 29' ' ' GLU . 10.2 t -101.31 -33.72 9.92 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-O 121.263 0.554 . . . . 0.0 110.65 178.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.59 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 60.9 t90 -72.74 140.32 47.72 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.396 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.7 m -160.46 110.38 1.77 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.581 1.552 . . . . 0.0 107.588 170.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.19 -121.12 2.13 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.795 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -120.71 171.06 9.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 C-N-CA 122.977 0.511 . . . . 0.0 110.127 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.649 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 31.6 t -96.42 99.17 10.86 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 176.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.26 -71.27 1.14 Allowed Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.714 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -127.54 133.5 49.8 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -53.42 -56.76 14.16 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 124.369 1.043 . . . . 0.0 110.777 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.42 -34.26 77.35 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.411 -174.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.33 -60.0 3.7 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 124.04 0.837 . . . . 0.0 111.524 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.5 p -74.11 -23.53 59.33 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.763 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -55.53 -56.95 14.27 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 172.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -60.43 -41.39 93.91 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.973 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -60.1 -41.67 93.05 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.848 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 76.8 m -62.86 -56.49 16.91 Favored 'General case' 0 C--O 1.253 1.272 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 61.2 mt -53.24 -36.86 26.74 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.578 -176.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -78.9 -41.55 29.36 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.68 -62.72 1.41 Allowed 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.84 -168.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.442 ' OE2' HG22 ' A' ' 10' ' ' THR . 10.9 pt-20 -93.9 -6.88 44.63 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.532 0.682 . . . . 0.0 110.213 -176.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 56.6 mttp 64.19 66.84 0.61 Allowed 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 113.758 -1.564 . . . . 0.0 112.589 175.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.71 -178.91 4.69 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 113.363 -1.744 . . . . 0.0 108.189 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -102.79 -29.5 11.44 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.424 0.63 . . . . 0.0 109.894 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 68.7 t60 -152.63 179.54 8.51 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.06 139.58 4.48 Favored Glycine 0 C--N 1.302 -1.311 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.4 m -161.5 173.68 14.49 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 118.417 1.108 . . . . 0.0 111.762 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.6 m -75.05 102.22 4.79 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.311 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.425 ' HB3' HG13 ' A' ' 46' ' ' ILE . 26.0 t-20 . . . . . 0 C--N 1.29 -1.997 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.8 mttp . . . . . 0 N--CA 1.44 -0.96 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.649 ' SG ' ' HA ' ' A' ' 15' ' ' CYS . 78.0 m -79.25 104.97 10.24 Favored 'General case' 0 CA--C 1.479 -1.757 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.519 HG21 ' HB2' ' A' ' 5' ' ' GLN . 22.0 mm -103.48 129.82 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.761 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 60.1 m -84.61 136.9 33.57 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.476 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 76.9 m-85 -110.4 123.44 49.88 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-O 121.394 0.616 . . . . 0.0 110.957 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -105.99 157.65 34.27 Favored Pre-proline 0 C--N 1.283 -2.311 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.166 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -77.41 116.15 4.05 Favored 'Trans proline' 0 N--CA 1.435 -1.939 0 C-N-CA 121.548 1.499 . . . . 0.0 111.404 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 95.0 m . . . . . 0 C--N 1.282 -2.367 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.358 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.0 tttt . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 90.5 mt -89.08 99.88 12.77 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.78 0.8 . . . . 0.0 110.128 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.9 m -86.07 112.28 21.11 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.971 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.484 ' HB2' HG21 ' A' ' 46' ' ' ILE . 4.8 pt20 -73.99 136.38 43.18 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.868 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 46.6 ttp180 -145.17 115.26 5.0 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 6' ' ' ARG . 13.8 Cg_exo -68.7 -73.31 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.683 2.255 . . . . 0.0 115.776 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.9 m -90.29 97.36 11.14 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -170.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -119.92 -73.62 0.39 Allowed Glycine 0 N--CA 1.422 -2.234 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 168.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.442 HG22 ' OE2' ' A' ' 29' ' ' GLU . 8.7 t -108.25 -26.53 10.51 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 173.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.656 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 20.2 t90 -62.17 136.07 57.78 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-O 121.252 0.549 . . . . 0.0 112.3 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -157.4 108.22 2.27 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.288 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.31 -157.57 22.78 Favored Glycine 0 N--CA 1.431 -1.675 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.806 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.67 149.3 4.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 33.7 t -83.76 123.85 30.29 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.77 -64.26 0.88 Allowed Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.211 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 56.0 t-20 -122.5 126.16 47.26 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -177.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -54.85 -47.72 73.79 Favored 'General case' 0 C--O 1.207 -1.162 0 O-C-N 123.903 0.752 . . . . 0.0 110.066 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -62.27 -40.5 96.44 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.704 -177.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 17' ' ' ASN . . . -69.28 -47.06 65.68 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.54 -177.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.5 p -73.35 -34.48 65.65 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.5 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -55.33 -54.43 43.68 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.586 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 48.2 t30 -56.69 -46.74 81.02 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.228 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -56.2 -41.87 76.27 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.498 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.3 m -62.46 -51.97 65.39 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.6 mt -58.24 -35.7 54.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.08 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 9.3 mmp_? -74.78 -29.98 61.29 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.89 -57.67 2.07 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 119.463 -0.895 . . . . 0.0 112.546 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.442 ' OE2' HG22 ' A' ' 10' ' ' THR . 12.9 pt-20 -98.05 -5.12 34.59 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.555 -175.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 62.32 63.14 1.08 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.283 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.15 -179.02 5.56 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.648 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.543 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 4.5 mmp_? -106.88 -21.21 13.09 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.145 0.498 . . . . 0.0 110.534 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 78.2 t60 -158.13 170.28 22.64 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.67 140.54 6.49 Favored Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 106.378 -2.689 . . . . 0.0 106.378 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.0 t -155.21 153.29 30.47 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 118.37 1.085 . . . . 0.0 111.025 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 61.0 m -73.16 93.52 1.84 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 . . . . . 0 C--N 1.294 -1.82 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -178.634 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.656 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 97.3 mttt . . . . . 0 N--CA 1.421 -1.895 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 24.6 t -90.67 123.9 34.65 Favored 'General case' 0 CA--C 1.48 -1.731 0 C-N-CA 118.624 -1.23 . . . . 0.0 109.278 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.484 HG21 ' HB2' ' A' ' 5' ' ' GLN . 20.0 mm -111.35 128.98 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.541 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 37.8 m -85.18 147.04 26.8 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.427 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 93.3 m-85 -118.11 122.82 44.07 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.913 -0.492 . . . . 0.0 110.539 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -104.85 152.39 39.54 Favored Pre-proline 0 C--N 1.3 -1.562 0 C-N-CA 123.589 0.756 . . . . 0.0 110.988 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -88.33 107.76 0.54 Allowed 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 122.79 2.326 . . . . 0.0 112.67 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 82.0 m . . . . . 0 C--N 1.279 -2.46 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 174.736 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt . . . . . 0 C--O 1.239 0.527 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.8 mt -121.95 132.04 54.33 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 67.7 m -106.69 129.6 54.56 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.65 151.42 25.3 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -144.45 123.74 7.12 Favored Pre-proline 0 C--N 1.305 -1.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.838 -177.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -68.65 103.03 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.022 1.815 . . . . 0.0 108.129 170.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.533 ' HB3' ' OE1' ' A' ' 29' ' ' GLU . 61.8 m -98.33 161.46 13.68 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -171.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.56 -35.21 52.26 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.307 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.2 t -60.85 -34.53 74.73 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.9 0.381 . . . . 0.0 110.142 175.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -57.82 106.34 0.35 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.784 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.4 t -150.28 91.69 1.79 Allowed 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.6 173.78 23.13 Favored Glycine 0 N--CA 1.422 -2.29 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.187 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.4 m -98.0 171.51 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 123.004 0.521 . . . . 0.0 110.248 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.5 t -69.03 108.38 3.52 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.031 -0.532 . . . . 0.0 112.175 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.36 -91.45 0.69 Allowed Glycine 0 N--CA 1.42 -2.402 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 173.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -91.13 114.92 27.58 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -65.38 -43.64 90.06 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 123.752 0.657 . . . . 0.0 111.002 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -70.16 -36.5 74.75 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.111 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.85 -43.68 95.42 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.981 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.2 p -76.2 -29.36 57.61 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.68 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -57.72 -56.68 18.79 Favored 'General case' 0 C--O 1.251 1.154 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -61.01 -36.87 80.63 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.46 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -63.5 -41.4 98.53 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.08 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 97.7 m -62.65 -49.71 74.09 Favored 'General case' 0 C--O 1.259 1.577 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 60.9 mt -58.91 -33.59 50.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.149 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -83.6 -21.49 32.56 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.74 -65.14 0.98 Allowed 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.245 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.533 ' OE1' ' HB3' ' A' ' 8' ' ' SER . 10.9 pt-20 -106.26 -1.3 23.66 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.845 -177.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.2 mttp 64.26 65.11 0.68 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.708 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.85 -176.17 5.4 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.437 175.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.405 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 4.1 tpm_? -101.97 -29.88 11.54 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.083 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.563 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 31.4 t60 -151.2 173.56 14.28 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.0 139.75 5.96 Favored Glycine 0 C--N 1.295 -1.735 0 N-CA-C 106.478 -2.649 . . . . 0.0 106.478 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.0 t -163.04 167.47 22.34 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 118.384 1.092 . . . . 0.0 109.974 -174.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 89.6 m -72.83 95.16 1.89 Allowed 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.061 175.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 . . . . . 0 C--N 1.291 -1.967 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 177.383 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm . . . . . 0 CA--C 1.507 -0.705 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.3 m -81.91 94.61 7.14 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.618 0.723 . . . . 0.0 111.458 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.75 143.59 11.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 74.2 m -90.0 148.22 23.21 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.481 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.563 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 38.9 m-85 -120.11 130.34 54.59 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.224 0.535 . . . . 0.0 110.844 -177.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -110.8 151.07 42.66 Favored Pre-proline 0 C--N 1.297 -1.678 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.338 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.57 132.06 10.8 Favored 'Trans proline' 0 C--O 1.253 1.262 0 C-N-CA 122.412 2.075 . . . . 0.0 113.276 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 68.9 m . . . . . 0 N--CA 1.435 -1.225 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.705 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.9 pttm . . . . . 0 CA--C 1.5 -0.947 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 92.4 mt -93.21 110.16 21.68 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-O 121.351 0.596 . . . . 0.0 110.46 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.42 ' SG ' ' HB2' ' A' ' 49' ' ' PHE . 8.2 p -89.08 127.43 35.7 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.5 ' HB2' HG21 ' A' ' 46' ' ' ILE . 4.3 pt20 -87.43 133.4 33.74 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.209 0.528 . . . . 0.0 111.516 -175.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -126.04 119.84 23.87 Favored Pre-proline 0 C--O 1.265 1.878 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.267 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -71.44 125.96 11.75 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.582 2.188 . . . . 0.0 107.427 169.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.5 t -144.27 160.89 40.23 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.878 -171.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.26 20.04 43.03 Favored Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.655 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.4 p -83.8 -58.29 2.86 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.466 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 1.6 t90 -57.8 144.46 38.44 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.161 169.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.8 t -146.33 119.68 8.99 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.26 -135.23 12.45 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.948 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -125.55 170.92 14.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -175.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.4 t -60.66 108.52 0.85 Allowed 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.093 0.473 . . . . 0.0 111.227 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -116.0 -88.41 1.45 Allowed Glycine 0 N--CA 1.427 -1.949 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -95.46 106.43 18.5 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 122.534 0.333 . . . . 0.0 110.228 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -59.9 -56.09 26.01 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.424 1.09 . . . . 0.0 111.751 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -71.53 -30.1 65.53 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.789 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.64 -42.01 64.86 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.363 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 30.6 p -70.66 -32.33 69.56 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.823 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -55.71 -56.7 17.36 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 172.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -58.8 -37.27 75.99 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.127 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.52 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 20.9 tt0 -63.77 -44.19 94.14 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.236 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 99.0 m -62.08 -49.48 75.79 Favored 'General case' 0 C--O 1.259 1.562 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.632 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 65.9 mt -59.24 -32.81 49.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.401 -177.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.515 ' HA ' ' NE ' ' A' ' 27' ' ' ARG . 4.1 mmp_? -97.05 -8.94 29.12 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 24' ' ' GLN . 42.4 mt -102.04 -62.98 1.19 Allowed 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.63 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -99.17 -3.85 33.48 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.177 0.513 . . . . 0.0 110.01 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 56.4 mtmt 68.92 50.74 0.59 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.646 175.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.08 178.66 7.35 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.063 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -98.74 -34.2 10.61 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 80.0 t60 -151.61 175.17 12.62 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 -176.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -169.0 141.34 6.67 Favored Glycine 0 C--N 1.289 -2.064 0 N-CA-C 106.869 -2.492 . . . . 0.0 106.869 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.0 p -169.03 169.51 9.49 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 118.114 0.957 . . . . 0.0 112.062 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 44' ' ' LYS . 78.0 m -80.63 117.49 21.37 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.631 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 . . . . . 0 C--N 1.287 -2.133 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.033 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 31.1 mmtp . . . . . 0 N--CA 1.422 -1.841 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 23.8 t -92.22 113.54 25.83 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' A' ' 5' ' ' GLN . 38.8 mm -105.71 142.07 19.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 61.3 m -88.46 145.63 25.66 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.471 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 70.6 m-85 -121.45 136.58 54.94 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.067 0.46 . . . . 0.0 111.375 -176.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.42 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 73.3 m-85 -117.82 164.58 19.12 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -85.31 108.78 1.12 Allowed 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 121.893 1.729 . . . . 0.0 111.837 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 98.9 m . . . . . 0 C--N 1.302 -1.497 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.992 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 CA--C 1.5 -0.968 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 88.7 mt -96.76 108.58 21.26 Favored 'General case' 0 C--N 1.288 -2.085 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.096 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.7 m -82.22 129.63 34.89 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.608 ' HB2' HG21 ' A' ' 46' ' ' ILE . 4.0 pt20 -85.6 141.32 29.9 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.216 0.531 . . . . 0.0 110.987 -177.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -144.57 108.56 4.8 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -77.49 -55.25 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.472 2.114 . . . . 0.0 115.433 -175.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 m -98.22 109.85 22.54 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -172.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.85 -69.88 0.02 OUTLIER Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 108.051 -2.02 . . . . 0.0 108.051 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.524 HG21 ' HA ' ' A' ' 25' ' ' CYS . 7.0 t -103.96 -39.17 6.7 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 170.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.48 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 78.7 t90 -70.76 123.38 21.81 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-O 121.484 0.659 . . . . 0.0 110.731 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.1 m -162.06 96.62 1.0 Allowed 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 125.739 1.616 . . . . 0.0 106.661 174.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.33 -131.73 3.69 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.408 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.9 m -117.66 164.73 13.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 122.627 0.371 . . . . 0.0 110.696 -177.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.7 t -92.74 106.71 18.64 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 120.821 0.343 . . . . 0.0 110.66 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.51 -67.75 1.5 Allowed Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 176.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.618 ' HB2' ' HB3' ' A' ' 20' ' ' ALA . 32.8 m-80 -129.38 132.57 47.07 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -66.41 -47.1 74.35 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.682 0.753 . . . . 0.0 110.001 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -72.65 -16.86 61.7 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.786 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 17' ' ' ASN . . . -88.94 -38.06 14.77 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.776 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.4 p -72.71 -30.88 64.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -53.25 -53.57 48.83 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 171.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -61.79 -40.27 94.62 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 113.855 -1.52 . . . . 0.0 110.062 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -59.88 -39.11 84.16 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 123.358 0.663 . . . . 0.0 110.4 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.524 ' HA ' HG21 ' A' ' 10' ' ' THR . 91.5 m -64.12 -55.5 21.53 Favored 'General case' 0 C--O 1.25 1.107 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 55.9 mt -58.17 -33.83 47.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.701 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -85.42 -21.4 28.79 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.25 -67.9 0.88 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.401 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -97.18 2.67 51.32 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.56 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 49.7 mttp 60.96 57.68 2.5 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 114.057 -1.429 . . . . 0.0 112.215 171.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.64 -179.09 7.23 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.256 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -101.19 -27.23 13.34 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.681 0.753 . . . . 0.0 109.256 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 86.5 t60 -151.55 171.48 17.53 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.722 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.96 143.63 8.17 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 106.829 -2.508 . . . . 0.0 106.829 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.6 p -165.58 151.3 9.29 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 117.888 0.844 . . . . 0.0 111.284 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 62.5 m -81.79 100.32 9.49 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.718 0.771 . . . . 0.0 110.241 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.8 t30 . . . . . 0 C--N 1.307 -1.249 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.603 -177.766 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 97.6 mttt . . . . . 0 CA--C 1.506 -0.735 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 11.7 t -84.66 125.95 32.94 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 121.178 0.513 . . . . 0.0 110.739 -173.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.608 HG21 ' HB2' ' A' ' 5' ' ' GLN . 18.4 mm -117.22 134.2 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.451 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 67.6 m -82.9 149.88 26.82 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.478 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 76.1 m-85 -127.24 126.84 43.43 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.086 0.469 . . . . 0.0 111.266 -177.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -110.53 144.87 31.09 Favored Pre-proline 0 C--N 1.302 -1.472 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.775 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -82.65 114.31 2.35 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 122.337 2.025 . . . . 0.0 112.269 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 C--N 1.288 -2.069 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.929 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.0 mttm . . . . . 0 N--CA 1.437 -1.102 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 83.4 mt -79.94 117.35 20.71 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-O 121.193 0.521 . . . . 0.0 110.653 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.1 p -98.18 129.88 44.94 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.468 ' HB2' HG21 ' A' ' 46' ' ' ILE . 4.7 pt20 -87.89 130.74 34.81 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.308 0.575 . . . . 0.0 111.774 -173.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -132.69 120.03 16.41 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.138 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -74.79 142.62 28.79 Favored 'Trans proline' 0 C--O 1.247 0.937 0 C-N-CA 122.21 1.94 . . . . 0.0 107.759 168.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.1 t -151.67 161.74 42.17 Favored 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.925 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.6 -7.32 87.19 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.399 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 p -65.54 -56.72 10.81 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.5 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 1.7 t90 -59.51 138.04 57.82 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.492 166.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.8 t -134.02 110.42 9.64 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-O 120.659 0.266 . . . . 0.0 111.052 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.78 -115.5 5.91 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 115.936 1.134 . . . . 0.0 115.936 171.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 p -83.94 137.15 21.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.807 0.813 . . . . 0.0 112.47 -174.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.1 t -90.73 112.5 24.29 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.36 -59.33 1.04 Allowed Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -112.92 120.35 41.13 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -54.97 -44.67 74.62 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.731 0.645 . . . . 0.0 110.354 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -66.04 -33.51 75.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.011 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.15 -46.41 56.56 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.11 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.4 p -73.22 -32.0 64.5 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.868 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -53.07 -60.08 3.74 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 123.854 0.862 . . . . 0.0 109.177 173.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -61.54 -34.47 75.6 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.004 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -65.8 -38.62 89.48 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.451 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.1 m -64.93 -49.07 71.81 Favored 'General case' 0 C--O 1.255 1.374 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 73.0 mt -57.14 -42.79 80.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.844 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -81.24 -14.15 57.76 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.7 mt -107.06 -55.72 2.29 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 119.087 -1.045 . . . . 0.0 112.078 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -110.89 1.42 17.58 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.097 0.475 . . . . 0.0 111.626 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 36.5 mtmm 66.82 45.92 1.78 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.122 174.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.21 172.42 11.17 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.999 -1.001 . . . . 0.0 108.88 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -91.62 -35.95 13.93 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -152.63 176.56 11.6 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -175.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.62 150.64 11.55 Favored Glycine 0 C--N 1.308 -0.987 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.2 p -172.27 168.27 5.66 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-N 118.372 1.086 . . . . 0.0 111.696 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.0 m -68.41 107.57 2.92 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.4 t30 . . . . . 0 C--N 1.311 -1.079 0 CA-C-O 121.702 0.763 . . . . 0.0 109.866 -177.58 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.5 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 32.4 mmtp . . . . . 0 C--O 1.242 0.666 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 45.2 t -103.9 131.7 50.87 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.468 HG21 ' HB2' ' A' ' 5' ' ' GLN . 50.1 mm -116.68 137.55 50.14 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.7 m -89.49 153.0 21.15 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.479 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 87.6 m-85 -126.0 135.96 52.43 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -116.78 159.42 40.7 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -82.42 101.4 1.08 Allowed 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.936 1.758 . . . . 0.0 112.149 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 85.2 m . . . . . 0 C--N 1.298 -1.635 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.709 179.117 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 51' ' ' CYS . 23.0 pttm . . . . . 0 CA--C 1.511 -0.529 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 82.2 mt -95.43 105.47 17.44 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.248 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 86.3 m -80.78 135.65 36.0 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.732 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.425 ' HB2' HG21 ' A' ' 46' ' ' ILE . 19.0 pt20 -90.67 128.72 36.73 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.208 0.527 . . . . 0.0 110.696 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -129.07 117.99 19.28 Favored Pre-proline 0 C--N 1.301 -1.52 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.161 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -78.53 116.78 3.88 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.036 1.824 . . . . 0.0 109.301 173.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.1 m -124.79 160.12 29.42 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.33 -25.67 60.67 Favored Glycine 0 C--N 1.334 0.421 0 O-C-N 124.217 0.948 . . . . 0.0 114.142 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.7 t -53.81 -47.64 70.65 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 117.219 0.51 . . . . 0.0 110.052 174.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -71.44 121.94 19.5 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 121.25 0.548 . . . . 0.0 109.796 173.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.0 p -153.41 100.2 2.41 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.432 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.96 -145.39 16.86 Favored Glycine 0 N--CA 1.427 -1.951 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.502 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.6 m -99.61 153.01 4.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -177.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.8 t -90.77 91.66 8.47 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.96 -60.17 2.98 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -120.95 129.9 53.62 Favored 'General case' 0 CA--C 1.486 -1.508 0 CA-C-N 115.472 -0.364 . . . . 0.0 110.111 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -56.17 -46.8 79.19 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 124.313 1.008 . . . . 0.0 109.577 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -64.64 -30.9 71.92 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.89 -53.37 21.54 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.5 p -74.89 -29.11 60.9 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.599 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.448 ' HE2' ' CE1' ' A' ' 33' ' ' HIS . 38.5 ttmt -52.62 -58.68 6.02 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-O 122.021 0.915 . . . . 0.0 108.623 173.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -59.17 -41.38 88.28 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.69 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -65.04 -32.34 74.01 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.327 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 98.5 m -66.97 -49.65 64.77 Favored 'General case' 0 C--O 1.255 1.359 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 57.0 mt -61.24 -28.03 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.33 -1.304 . . . . 0.0 111.176 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.46 ' HA ' ' NE ' ' A' ' 27' ' ' ARG . 3.3 mmp_? -92.82 -15.7 26.2 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -103.91 -62.41 1.31 Allowed 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.194 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -102.66 -1.4 30.21 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.199 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 56.0 mtpt 69.62 37.41 1.92 Allowed 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.215 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.58 175.88 3.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.144 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.483 ' HG2' ' HD3' ' A' ' 50' ' ' PRO . 6.7 mmp_? -90.94 -32.14 16.1 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.146 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 28.9 t60 -155.82 175.02 14.48 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -174.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -169.96 142.75 7.43 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 107.145 -2.382 . . . . 0.0 107.145 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.7 p -163.0 169.92 18.85 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 117.892 0.846 . . . . 0.0 110.9 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 68.6 m -67.91 107.4 2.64 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 175.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 . . . . . 0 C--N 1.296 -1.722 0 CA-C-O 121.751 0.786 . . . . 0.0 109.092 -175.532 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.9 t -100.55 128.96 46.44 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.425 HG21 ' HB2' ' A' ' 5' ' ' GLN . 47.9 mm -122.85 141.02 44.82 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 41.5 m -88.73 156.92 18.71 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.481 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 95.9 m-85 -126.54 142.65 51.47 Favored 'General case' 0 C--O 1.252 1.211 0 CA-C-O 121.039 0.447 . . . . 0.0 112.182 -177.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -126.67 151.31 73.1 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 124.312 1.045 . . . . 0.0 109.908 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.483 ' HD3' ' HG2' ' A' ' 32' ' ' ARG . 94.5 Cg_endo -86.99 107.37 0.7 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.725 2.283 . . . . 0.0 112.38 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 20.7 m . . . . . 0 C--N 1.291 -1.967 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 N--CA 1.435 -1.216 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 90.6 mt -96.74 99.99 11.56 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.7 p -87.63 114.68 24.47 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 114.596 -1.183 . . . . 0.0 109.681 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.507 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 18.8 pt20 -83.14 144.32 29.92 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -173.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -138.22 120.7 10.85 Favored Pre-proline 0 C--N 1.313 -1.004 0 C-N-CA 124.743 1.217 . . . . 0.0 108.453 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -73.82 108.76 2.72 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 121.681 1.587 . . . . 0.0 108.991 173.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.7 p -79.73 160.97 26.03 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.373 0.606 . . . . 0.0 112.567 -174.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.01 -24.64 57.41 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.3 t -71.34 -41.24 70.05 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.765 -0.218 . . . . 0.0 110.575 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -48.92 130.93 18.65 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.05 0.54 . . . . 0.0 112.225 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.9 t -91.23 127.94 36.86 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -33.23 -48.47 0.43 Allowed Glycine 0 N--CA 1.478 1.447 0 N-CA-C 117.513 1.765 . . . . 0.0 117.513 -171.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.6 131.67 36.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 117.355 0.577 . . . . 0.0 110.024 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.6 t -73.58 127.7 33.48 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.838 0.351 . . . . 0.0 110.143 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.77 -73.31 0.81 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -122.46 125.18 45.28 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -59.03 -46.03 89.25 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 123.756 0.66 . . . . 0.0 111.123 -175.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -75.02 -9.37 58.47 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.79 -47.04 8.49 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.6 p -75.16 -34.66 61.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.321 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -54.4 -55.02 32.91 Favored 'General case' 0 C--O 1.25 1.087 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 174.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.597 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 7.2 t30 -60.51 -41.9 95.32 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.052 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -58.29 -39.4 79.18 Favored 'General case' 0 C--O 1.211 -0.969 0 C-N-CA 122.795 0.438 . . . . 0.0 110.524 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 99.1 m -64.69 -54.5 30.65 Favored 'General case' 0 C--O 1.253 1.265 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 69.5 mt -58.38 -30.15 39.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.165 -1.379 . . . . 0.0 111.788 -175.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.597 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 28.3 mmt180 -89.5 -32.69 17.07 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.414 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.12 -66.55 0.91 Allowed 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.423 -172.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -94.59 -3.06 50.34 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.762 0.792 . . . . 0.0 110.154 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 47.9 mttp 61.84 65.44 0.92 Allowed 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 113.801 -1.545 . . . . 0.0 112.552 173.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.401 ' H ' ' HA ' ' A' ' 26' ' ' ILE . . . -92.91 -177.53 4.54 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.401 177.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -99.43 -26.95 13.96 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.316 178.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 81.0 t60 -153.03 176.19 12.16 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -174.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.74 142.27 7.5 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 107.871 -2.091 . . . . 0.0 107.871 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.0 m -155.29 154.01 31.45 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 118.019 0.909 . . . . 0.0 111.064 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 76.1 m -87.08 91.23 8.63 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 122.397 1.094 . . . . 0.0 109.389 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 . . . . . 0 C--N 1.298 -1.633 0 CA-C-N 113.652 -1.613 . . . . 0.0 107.818 -176.616 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp . . . . . 0 N--CA 1.439 -0.982 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 6.9 t -79.62 115.26 19.13 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.531 0.681 . . . . 0.0 110.583 -173.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.487 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 22.5 mm -112.27 141.11 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.43 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 5' ' ' GLN . 51.7 m -83.61 144.3 29.54 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.507 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 63.5 m-85 -119.09 118.35 31.18 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.499 0.666 . . . . 0.0 111.643 -177.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -100.59 163.49 18.04 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.081 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -88.06 126.12 1.99 Allowed 'Trans proline' 0 N--CA 1.441 -1.586 0 C-N-CA 122.136 1.89 . . . . 0.0 111.667 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 69.6 m . . . . . 0 C--N 1.294 -1.829 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.662 177.554 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.2 mt -118.86 130.56 55.81 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 66.8 m -108.81 133.38 52.93 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 175.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.552 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 17.5 pt20 -94.52 134.84 36.63 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.658 0.742 . . . . 0.0 112.305 -177.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -137.53 120.77 11.54 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.634 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -66.72 132.94 30.1 Favored 'Trans proline' 0 C--O 1.246 0.88 0 C-N-CA 122.146 1.897 . . . . 0.0 109.415 172.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -118.43 160.36 21.84 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.496 -174.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.0 -12.52 76.68 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.263 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.9 p -71.01 -43.8 67.2 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.526 0.679 . . . . 0.0 109.592 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.415 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 3.9 t90 -64.97 140.21 58.84 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.261 171.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.8 t -146.07 119.61 9.11 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.064 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.19 -135.12 11.99 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 172.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.8 p -108.31 168.4 3.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.7 t -59.29 118.26 5.74 Favored 'General case' 0 C--O 1.25 1.109 0 C-N-CA 123.495 0.718 . . . . 0.0 112.642 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.47 -76.7 1.05 Allowed Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 171.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -143.32 138.21 29.35 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -50.81 -54.91 19.68 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.205 1.002 . . . . 0.0 112.408 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.403 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 29.5 p-10 -70.23 -32.22 69.99 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.597 -177.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.29 -49.13 68.14 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.825 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 24' ' ' GLN . 11.0 p -76.53 -22.9 53.77 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 119.205 -0.998 . . . . 0.0 112.287 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 19' ' ' ASN . 28.2 ttpp -57.87 -53.42 58.39 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -58.78 -42.3 88.69 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.898 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 0.8 OUTLIER -55.98 -39.29 71.59 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.457 0.473 . . . . 0.0 111.268 177.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 89.4 m -68.91 -51.48 39.61 Favored 'General case' 0 C--O 1.255 1.373 0 CA-C-O 121.993 0.902 . . . . 0.0 108.869 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.5 mt -57.01 -36.6 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.702 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -73.6 -32.3 64.03 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.0 mt -100.01 -57.1 2.2 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.19 -1.004 . . . . 0.0 113.265 -170.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -105.79 -10.35 16.76 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 120.026 -0.669 . . . . 0.0 111.605 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.8 mttm 72.26 68.97 0.14 Allowed 'General case' 0 C--N 1.319 -0.733 0 O-C-N 124.355 1.035 . . . . 0.0 111.498 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.49 175.71 7.82 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -98.66 -27.3 14.05 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.14 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 79.9 t60 -151.66 173.82 14.23 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.22 141.68 6.96 Favored Glycine 0 C--N 1.283 -2.367 0 N-CA-C 106.457 -2.657 . . . . 0.0 106.457 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.5 t -159.54 165.33 33.16 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 118.387 1.094 . . . . 0.0 110.069 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.7 m -86.61 102.59 14.31 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.73 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 . . . . . 0 C--N 1.295 -1.77 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -179.85 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.415 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 56.0 mttm . . . . . 0 N--CA 1.433 -1.291 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 86.9 m -83.23 113.33 20.6 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.393 0.616 . . . . 0.0 111.081 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.424 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 33.2 mm -109.56 138.05 38.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 60.5 m -88.43 136.04 33.18 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.552 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 34.7 m-85 -107.83 124.69 50.45 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.421 0.629 . . . . 0.0 110.355 -177.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -108.83 153.41 42.38 Favored Pre-proline 0 C--N 1.292 -1.895 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.188 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -77.7 133.52 12.85 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 122.21 1.94 . . . . 0.0 113.03 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 81.7 m . . . . . 0 C--N 1.294 -1.817 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.823 178.501 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 2' ' ' LYS . 73.4 mmtt . . . . . 0 CA--C 1.505 -0.758 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -110.6 120.19 41.61 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.114 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 31.3 m -93.66 116.68 29.18 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.49 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 4.3 pt20 -85.89 119.62 26.41 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -133.19 129.03 20.71 Favored Pre-proline 0 C--N 1.307 -1.244 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.118 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -72.46 134.61 22.83 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.898 1.732 . . . . 0.0 109.575 173.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.0 m -116.03 160.34 20.42 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.17 -15.11 75.35 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.235 -0.438 . . . . 0.0 112.036 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 p -69.63 -51.07 38.2 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.493 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 2.2 t90 -58.77 136.67 57.81 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.379 171.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.2 p -148.85 129.66 14.22 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.868 173.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.42 -173.32 27.23 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-O 121.656 0.587 . . . . 0.0 114.258 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.3 t -81.41 148.38 5.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.3 t -67.35 112.55 4.64 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 123.303 0.377 . . . . 0.0 111.145 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.1 -50.46 1.91 Allowed Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -123.13 117.16 24.75 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.534 ' HA ' ' SG ' ' A' ' 36' ' ' CYS . 13.2 m120 -57.79 -52.35 65.83 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 124.163 0.915 . . . . 0.0 110.748 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -66.47 -24.69 66.46 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.366 -0.833 . . . . 0.0 113.004 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.05 -57.77 4.6 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 123.051 0.219 . . . . 0.0 110.591 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.4 p -69.95 -30.36 67.73 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.41 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 38.1 ttmt -53.89 -57.31 11.4 Favored 'General case' 0 C--O 1.251 1.135 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -60.71 -39.12 87.42 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.329 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -60.33 -41.27 93.22 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.808 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.4 m -63.63 -52.33 61.29 Favored 'General case' 0 C--O 1.257 1.476 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 66.4 mt -55.95 -30.29 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.173 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -87.13 -33.9 19.28 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.2 mt -96.61 -47.65 5.83 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.196 -1.002 . . . . 0.0 113.352 -169.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -107.51 -5.93 17.32 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 120.906 0.384 . . . . 0.0 110.73 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 99.7 mttt 64.55 54.85 1.4 Allowed 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.7 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.53 159.85 33.25 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -81.84 -29.55 32.51 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.933 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -156.46 174.8 14.9 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 22' ' ' LYS . . . -153.59 144.01 10.82 Favored Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 107.634 -2.186 . . . . 0.0 107.634 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.545 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 41.7 t -154.52 148.99 26.23 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 117.899 0.849 . . . . 0.0 109.31 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.534 ' SG ' ' HA ' ' A' ' 18' ' ' ASN . 60.6 m -87.35 108.21 18.88 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.842 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.2 t30 . . . . . 0 C--N 1.301 -1.51 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.737 -178.502 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.493 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 39.8 mmtm . . . . . 0 CA--C 1.499 -0.997 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.479 ' HB2' ' CD1' ' A' ' 11' ' ' TRP . 85.0 m -87.13 107.65 18.55 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.443 0.64 . . . . 0.0 109.622 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.445 HG21 ' HB2' ' A' ' 5' ' ' GLN . 42.9 mm -104.4 135.39 42.43 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 33.9 m -91.5 132.93 35.93 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.545 ' CE1' ' HB3' ' A' ' 35' ' ' SER . 27.6 m-85 -105.93 120.1 40.88 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.543 0.687 . . . . 0.0 110.671 -176.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -102.58 161.42 23.3 Favored Pre-proline 0 C--N 1.288 -2.079 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.312 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -80.76 119.72 3.71 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 121.552 1.501 . . . . 0.0 112.704 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 56.8 m . . . . . 0 C--N 1.312 -1.06 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 174.589 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt . . . . . 0 N--CA 1.443 -0.802 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.9 mt -113.4 121.07 43.23 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 121.047 0.451 . . . . 0.0 109.964 177.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 80.9 m -94.89 132.09 40.08 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.492 ' HB3' HG21 ' A' ' 46' ' ' ILE . 16.1 mt-30 -83.39 146.22 28.58 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.235 0.54 . . . . 0.0 111.691 -174.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -131.83 101.81 15.23 Favored Pre-proline 0 C--N 1.291 -1.954 0 C-N-CA 124.111 0.964 . . . . 0.0 108.904 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.62 -74.29 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.127 1.885 . . . . 0.0 113.895 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.5 m -100.63 83.56 2.61 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -170.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.11 -71.36 0.25 Allowed Glycine 0 N--CA 1.427 -1.926 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 172.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.569 HG21 ' HA ' ' A' ' 25' ' ' CYS . 5.6 t -103.69 -30.17 10.6 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 120.808 0.337 . . . . 0.0 110.902 173.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.57 ' CZ2' ' HB2' ' A' ' 44' ' ' LYS . 27.0 t90 -59.96 127.75 33.47 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.5 m -157.41 109.39 2.38 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 125.239 1.415 . . . . 0.0 107.944 171.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.01 -166.36 24.04 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 119.662 -1.256 . . . . 0.0 113.431 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.1 t -83.38 150.54 4.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 17.5 t -94.91 100.85 12.63 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.09 -55.54 1.37 Allowed Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.085 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -121.61 121.97 38.59 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.907 0.384 . . . . 0.0 110.519 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -63.19 -42.33 99.31 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.984 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -73.75 -21.98 60.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.156 0.503 . . . . 0.0 110.835 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.81 -51.09 20.33 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.651 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.6 p -73.3 -31.3 63.95 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.966 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -54.55 -57.51 11.12 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -56.8 -40.13 75.39 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.957 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -64.33 -37.97 89.38 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.569 ' HA ' HG21 ' A' ' 10' ' ' THR . 72.8 m -63.06 -53.53 52.23 Favored 'General case' 0 C--O 1.256 1.419 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 73.0 mt -55.45 -37.09 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.441 -178.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -83.14 -27.56 30.02 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -98.13 -57.47 2.21 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -108.25 -0.51 20.82 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.065 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 62.1 mttp 67.14 47.22 1.38 Allowed 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.077 173.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.69 177.08 8.91 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.893 -1.048 . . . . 0.0 108.231 175.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -99.69 -27.29 13.74 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.538 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -149.19 170.35 18.66 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -175.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.14 138.52 4.96 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.5 m -163.14 162.48 25.64 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 117.437 0.619 . . . . 0.0 109.941 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 38.1 m -59.36 118.26 5.77 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 175.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 . . . . . 0 C--N 1.296 -1.723 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.448 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.57 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 4.0 mptp? . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.615 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 33.6 t -68.5 126.8 30.8 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 118.345 0.521 . . . . 0.0 109.981 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.492 HG21 ' HB3' ' A' ' 5' ' ' GLN . 41.5 mm -120.11 135.77 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.316 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 56.1 m -82.97 160.24 22.07 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.449 ' CE1' ' HG2' ' A' ' 5' ' ' GLN . 98.5 m-85 -129.58 127.64 41.09 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 120.844 0.354 . . . . 0.0 111.468 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -106.53 148.93 37.67 Favored Pre-proline 0 C--N 1.305 -1.33 0 C-N-CA 123.936 0.894 . . . . 0.0 109.836 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.47 129.47 6.59 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.674 2.249 . . . . 0.0 112.363 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 82.8 m . . . . . 0 N--CA 1.427 -1.603 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.6 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 51' ' ' CYS . 3.7 mptp? . . . . . 0 CA--C 1.511 -0.556 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -111.68 112.55 24.33 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.621 0.724 . . . . 0.0 111.155 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 70.8 m -86.99 111.12 20.54 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.618 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 3.8 pt20 -76.11 135.82 39.85 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.487 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.475 ' HD3' ' CE1' ' A' ' 49' ' ' PHE . 51.9 ttt180 -146.38 116.3 4.66 Favored Pre-proline 0 C--N 1.296 -1.753 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.555 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -79.17 86.14 1.74 Allowed 'Trans proline' 0 N--CA 1.438 -1.759 0 C-N-CA 122.058 1.839 . . . . 0.0 109.06 173.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.48 ' HB3' ' OE2' ' A' ' 29' ' ' GLU . 61.6 m -69.49 160.06 32.13 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.419 -176.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.58 -9.79 82.7 Favored Glycine 0 CA--C 1.502 -0.727 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.524 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.505 HG21 ' HB3' ' A' ' 28' ' ' LEU . 4.1 p -68.78 -44.62 73.24 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.48 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 2.8 t90 -66.75 132.46 48.14 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.199 169.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.9 t -145.99 112.02 5.69 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.14 -145.87 15.89 Favored Glycine 0 N--CA 1.425 -2.094 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.787 176.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 p -118.43 162.68 16.31 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.8 t -67.07 134.56 52.11 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.7 -49.58 0.31 Allowed Glycine 0 N--CA 1.421 -2.315 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 173.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -145.99 120.14 9.49 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.185 0.594 . . . . 0.0 110.129 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -55.24 -52.74 62.41 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.072 0.949 . . . . 0.0 111.925 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -65.61 -31.58 72.69 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.935 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.42 -44.28 65.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.503 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.3 p -76.53 -32.18 58.08 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.181 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -54.9 -54.87 37.03 Favored 'General case' 0 C--O 1.253 1.239 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.509 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 47.4 t30 -57.36 -44.39 84.3 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.672 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -56.24 -43.0 78.22 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.264 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.8 m -63.62 -48.8 75.84 Favored 'General case' 0 C--O 1.271 2.224 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 64.9 mt -59.94 -37.73 73.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 114.24 -1.345 . . . . 0.0 111.372 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 31.7 mmt180 -81.47 -19.98 41.21 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.505 ' HB3' HG21 ' A' ' 10' ' ' THR . 4.6 mm? -98.01 -63.61 1.11 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.209 -176.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.48 ' OE2' ' HB3' ' A' ' 8' ' ' SER . 8.3 pt-20 -113.29 3.47 15.96 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.3 0.571 . . . . 0.0 111.685 -177.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 94.4 mttt 67.92 63.74 0.39 Allowed 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.421 174.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' HG12 ' A' ' 26' ' ' ILE . . . -81.07 177.48 9.02 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 173.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -96.01 -41.09 8.93 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -147.15 176.33 10.04 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -173.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.7 143.5 8.9 Favored Glycine 0 C--N 1.307 -1.059 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 m -149.03 152.84 36.96 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 118.466 1.133 . . . . 0.0 110.895 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.0 m -89.13 100.4 13.19 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.501 0.667 . . . . 0.0 109.697 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.1 t30 . . . . . 0 C--N 1.297 -1.681 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.454 -175.78 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 95.1 mttt . . . . . 0 N--CA 1.442 -0.858 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 22.4 t -92.87 117.11 29.68 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.86 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.598 HG21 ' HB2' ' A' ' 5' ' ' GLN . 25.0 mm -101.44 134.49 41.58 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 66.5 m -84.75 136.78 33.56 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.618 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 77.9 m-85 -113.1 122.96 49.14 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.473 0.654 . . . . 0.0 110.925 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.475 ' CE1' ' HD3' ' A' ' 6' ' ' ARG . 81.4 m-85 -107.98 156.53 38.07 Favored Pre-proline 0 C--N 1.288 -2.093 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.709 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -77.66 126.86 8.44 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 121.638 1.558 . . . . 0.0 112.701 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 2' ' ' LYS . 12.2 m . . . . . 0 C--N 1.294 -1.843 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 172.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.1 tttm . . . . . 0 N--CA 1.434 -1.234 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 86.6 mt -80.53 110.89 16.44 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.0 p -102.22 129.97 48.76 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.862 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.487 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 4.0 pt20 -78.76 140.64 38.23 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.35 0.595 . . . . 0.0 111.054 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -137.23 127.93 16.07 Favored Pre-proline 0 C--N 1.282 -2.329 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.26 106.24 0.14 Allowed 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 122.698 2.265 . . . . 0.0 109.751 174.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.603 ' HB2' ' HB3' ' A' ' 11' ' ' TRP . 1.5 m -53.94 133.38 43.13 Favored 'General case' 0 N--CA 1.417 -2.101 0 C-N-CA 125.806 1.642 . . . . 0.0 111.461 -176.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.93 -32.04 6.36 Favored Glycine 0 N--CA 1.428 -1.879 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.985 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -74.53 -38.05 62.89 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 120.708 0.29 . . . . 0.0 110.659 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.603 ' HB3' ' HB2' ' A' ' 8' ' ' SER . 1.7 t90 -58.97 132.91 55.42 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.466 0.706 . . . . 0.0 111.654 174.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.1 p -156.46 97.58 1.76 Allowed 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.22 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.98 -156.48 26.71 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -91.72 150.94 3.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 41.1 t -93.51 101.07 13.25 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 173.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.66 -35.88 7.63 Favored Glycine 0 N--CA 1.429 -1.817 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.654 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -133.62 128.47 35.19 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-O 120.906 0.384 . . . . 0.0 110.964 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -60.39 -47.57 85.49 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.402 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.4 p30 -63.46 -36.69 84.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.219 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.73 -47.41 63.2 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.345 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.9 p -76.17 -25.36 55.16 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.46 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -54.81 -57.72 10.45 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -62.83 -36.67 83.98 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.132 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -61.03 -41.71 97.08 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 122.846 0.459 . . . . 0.0 109.815 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.3 m -64.81 -56.04 15.9 Favored 'General case' 0 C--O 1.257 1.488 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 77.0 mt -54.16 -36.42 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.425 1.49 . . . . 0.0 112.251 -176.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 27' ' ' ARG . 52.0 mtt180 -87.18 -25.07 24.24 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . 0.264 7.3 mp -104.35 -50.98 3.2 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 117.983 -1.487 . . . . 0.0 113.63 -174.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -109.24 1.98 20.58 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.305 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 27.7 mtpp 59.39 63.01 1.65 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 125.773 1.629 . . . . 0.0 114.034 174.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.25 179.73 7.7 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.375 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -94.32 -30.45 14.52 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 80.9 t60 -156.41 174.0 16.06 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -165.23 150.86 19.22 Favored Glycine 0 C--N 1.304 -1.237 0 N-CA-C 107.868 -2.093 . . . . 0.0 107.868 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.0 t -167.04 151.84 7.26 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 118.31 1.055 . . . . 0.0 112.06 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 38.5 m -63.62 117.37 6.7 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 170.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 . . . . . 0 C--N 1.297 -1.686 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.724 -175.628 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt . . . . . 0 C--O 1.25 1.094 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.496 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 41.9 t -98.75 131.12 45.14 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 175.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.437 HG21 ' HB2' ' A' ' 5' ' ' GLN . 16.4 mm -113.02 137.36 46.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 73.1 m -89.38 141.31 28.67 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -177.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.487 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 62.1 m-85 -111.22 126.38 54.81 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.22 0.533 . . . . 0.0 110.588 -178.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -113.93 161.46 27.75 Favored Pre-proline 0 C--N 1.286 -2.158 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.149 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -86.21 112.81 1.16 Allowed 'Trans proline' 0 N--CA 1.436 -1.868 0 C-N-CA 121.993 1.795 . . . . 0.0 111.692 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 47.8 m . . . . . 0 C--N 1.285 -2.238 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.046 175.929 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 C--O 1.256 1.421 0 CA-C-O 121.24 0.543 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 95.1 mt -99.15 119.33 37.68 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.652 177.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.3 m -73.68 120.54 19.42 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.42 ' HB2' HG21 ' A' ' 46' ' ' ILE . 19.6 pt20 -91.97 139.34 30.74 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.062 0.458 . . . . 0.0 110.479 -176.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -145.4 121.68 5.97 Favored Pre-proline 0 N--CA 1.431 -1.391 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.024 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -76.08 86.39 1.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.859 1.706 . . . . 0.0 108.882 171.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.416 ' HB3' ' OE1' ' A' ' 29' ' ' GLU . 61.4 m -75.38 160.86 29.79 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.673 -173.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.64 -6.09 85.96 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.421 -0.809 . . . . 0.0 113.68 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 p -70.93 -58.65 3.38 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.51 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 2.8 t90 -59.65 143.29 50.98 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.793 168.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.4 m -149.87 123.77 9.32 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 119.29 -122.98 5.5 Favored Glycine 0 C--O 1.247 0.915 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.689 176.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.3 p -134.03 170.06 20.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.6 t -67.48 109.96 3.43 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 118.013 0.37 . . . . 0.0 110.414 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.87 -57.36 0.92 Allowed Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 176.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -138.93 118.7 13.14 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -50.36 -50.03 52.44 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.984 0.914 . . . . 0.0 110.898 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -60.64 -36.41 78.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.863 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.15 -47.55 35.19 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.457 -173.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.3 p -75.48 -32.52 60.61 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -56.45 -54.5 44.95 Favored 'General case' 0 C--O 1.253 1.254 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 173.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.51 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 64.1 t30 -59.24 -43.54 92.38 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.744 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -58.06 -36.92 73.48 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.139 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.2 m -68.25 -54.4 17.91 Favored 'General case' 0 C--O 1.258 1.537 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 69.8 mt -60.08 -32.87 51.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.242 -174.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 30.4 mmt180 -91.46 -17.47 25.7 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.48 -52.07 2.97 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 118.833 -1.147 . . . . 0.0 112.558 -174.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.416 ' OE1' ' HB3' ' A' ' 8' ' ' SER . 9.0 pt-20 -109.09 -8.44 15.17 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.706 0.765 . . . . 0.0 109.986 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.588 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 53.9 mtmt 69.14 63.36 0.29 Allowed 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 113.906 -1.497 . . . . 0.0 112.155 176.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.38 169.91 16.64 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 114.656 -1.157 . . . . 0.0 109.098 176.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.401 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 28.8 tpt180 -88.61 -34.23 17.37 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.934 0.873 . . . . 0.0 108.674 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -152.02 171.62 17.55 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.287 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.29 137.16 4.59 Favored Glycine 0 N--CA 1.424 -2.151 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.1 p -161.77 174.88 12.6 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 117.751 0.775 . . . . 0.0 111.232 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 51.3 m -90.13 109.48 20.54 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.153 0.501 . . . . 0.0 110.025 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 . . . . . 0 C--N 1.307 -1.249 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 179.777 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.474 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 68.4 mttm . . . . . 0 N--CA 1.432 -1.372 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.51 ' HB2' ' CD1' ' A' ' 11' ' ' TRP . 97.0 m -80.14 114.55 19.13 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.474 0.654 . . . . 0.0 110.318 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.42 HG21 ' HB2' ' A' ' 5' ' ' GLN . 50.7 mm -111.23 135.85 49.12 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.696 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 61.3 m -87.63 139.92 30.04 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.455 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 88.6 m-85 -117.48 129.2 55.67 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.441 0.639 . . . . 0.0 111.305 -176.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -114.61 157.69 42.17 Favored Pre-proline 0 C--N 1.286 -2.177 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.401 ' HD3' ' HB2' ' A' ' 32' ' ' ARG . 30.6 Cg_endo -79.51 127.35 7.25 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.354 1.369 . . . . 0.0 110.758 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 73.8 m . . . . . 0 C--N 1.315 -0.905 0 O-C-N 122.097 -0.377 . . . . 0.0 111.334 -179.161 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? . . . . . 0 N--CA 1.439 -1.004 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.482 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 89.8 mt -88.77 101.69 14.27 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 64.5 m -83.3 133.88 34.95 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.913 -175.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.406 ' HB2' HG21 ' A' ' 46' ' ' ILE . 4.3 pt20 -81.17 132.96 35.38 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.973 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -144.15 125.31 7.92 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.87 135.01 49.51 Favored 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.628 2.219 . . . . 0.0 110.896 176.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.781 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . 5.9 p -90.03 160.45 16.33 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -176.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.13 -13.61 38.8 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.5 t -81.86 -37.94 26.17 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.158 0.504 . . . . 0.0 109.953 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.565 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 1.6 t90 -82.09 145.17 30.31 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 173.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 t -157.32 95.6 1.48 Allowed 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.35 -140.48 8.82 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.724 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 p -104.4 170.98 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.3 t -58.99 133.6 56.23 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 123.253 0.621 . . . . 0.0 112.656 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.99 -76.05 0.9 Allowed Glycine 0 N--CA 1.426 -1.979 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 173.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -142.5 130.54 21.89 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -48.42 -57.4 6.13 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.459 1.104 . . . . 0.0 112.105 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -66.56 -31.51 72.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.993 -174.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.18 -48.12 68.91 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.755 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.527 ' HA ' ' HB3' ' A' ' 24' ' ' GLN . 5.6 p -78.6 -23.55 45.92 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -58.53 -55.14 38.85 Favored 'General case' 0 C--O 1.256 1.44 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -57.95 -46.27 85.34 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.067 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.527 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 61.6 tt0 -55.82 -40.56 72.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.762 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 97.0 m -62.98 -57.35 11.03 Favored 'General case' 0 C--O 1.257 1.492 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.1 mt -55.0 -39.59 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 114.141 -1.39 . . . . 0.0 111.465 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -79.44 -26.45 41.79 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.4 -55.99 2.24 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 118.558 -1.257 . . . . 0.0 113.177 -174.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -108.05 2.25 22.98 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.8 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 61.48 59.3 1.9 Allowed 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.367 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -84.07 175.44 9.51 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 175.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.455 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 26.2 tpt180 -85.81 -41.34 15.12 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -147.54 173.43 12.7 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -177.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.27 149.56 15.67 Favored Glycine 0 CA--C 1.476 -2.396 0 N-CA-C 107.036 -2.425 . . . . 0.0 107.036 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.3 t -169.88 173.38 6.14 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 118.544 1.172 . . . . 0.0 109.432 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 75.4 m -78.32 92.06 4.5 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.611 0.72 . . . . 0.0 110.215 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 . . . . . 0 C--N 1.295 -1.796 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -179.644 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.565 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 98.6 mttt . . . . . 0 N--CA 1.44 -0.956 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 11' ' ' TRP . 71.2 m -82.51 98.27 8.85 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.942 0.877 . . . . 0.0 111.519 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.406 HG21 ' HB2' ' A' ' 5' ' ' GLN . 50.8 mm -105.62 138.47 30.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.781 ' SG ' ' HB3' ' A' ' 8' ' ' SER . 60.6 m -91.73 154.63 18.84 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -177.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.482 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 84.8 m-85 -122.31 129.43 52.17 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -111.58 152.68 44.19 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.455 ' HD3' ' HB2' ' A' ' 32' ' ' ARG . 70.7 Cg_endo -79.6 133.98 10.78 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.104 1.87 . . . . 0.0 112.256 -175.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 67.6 m . . . . . 0 C--N 1.291 -1.957 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.745 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? . . . . . 0 N--CA 1.432 -1.369 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 78.1 mt -114.1 115.49 27.62 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-O 121.195 0.522 . . . . 0.0 110.181 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.3 m -89.76 117.18 28.42 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.441 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -72.04 139.54 48.56 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.712 -175.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.421 ' HD3' ' OE1' ' A' ' 29' ' ' GLU . 51.6 ttt180 -142.16 108.18 5.78 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 175.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -72.27 -62.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.01 1.807 . . . . 0.0 112.904 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.2 m -91.79 101.0 13.59 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.746 0.784 . . . . 0.0 112.683 -172.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.62 -71.4 0.04 OUTLIER Glycine 0 C--N 1.286 -2.196 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 172.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.465 HG22 ' OE2' ' A' ' 29' ' ' GLU . 8.1 t -112.75 -30.26 7.13 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.077 -0.562 . . . . 0.0 109.946 172.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.425 ' CZ2' ' HB2' ' A' ' 44' ' ' LYS . 48.1 t90 -55.71 129.79 40.65 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.389 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 m -140.5 89.43 2.28 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.049 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 56.05 45.63 86.72 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 115.495 0.958 . . . . 0.0 115.495 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.9 t -120.31 124.12 71.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 117.232 0.516 . . . . 0.0 111.932 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.555 ' HB2' ' HB3' ' A' ' 44' ' ' LYS . 42.4 t -141.72 82.75 1.82 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 167.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.69 -82.99 0.08 OUTLIER Glycine 0 N--CA 1.426 -2.0 0 C-N-CA 120.471 -0.871 . . . . 0.0 110.944 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -88.29 96.28 10.51 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.546 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 2.6 m-20 -58.56 -44.0 89.57 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.261 0.624 . . . . 0.0 112.153 -176.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -67.43 -28.84 68.23 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.131 0.491 . . . . 0.0 110.893 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.26 -39.35 23.11 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.901 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.546 ' SG ' ' HA ' ' A' ' 18' ' ' ASN . 21.5 p -71.45 -31.13 66.82 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.178 177.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -58.06 -53.01 63.06 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 172.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 55.1 t30 -57.59 -43.79 84.88 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.773 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -57.07 -40.7 77.41 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.447 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 71.2 m -63.08 -54.37 39.1 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 62.3 mt -56.16 -37.41 49.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 124.626 1.17 . . . . 0.0 111.027 -177.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 25.2 mmt180 -83.52 -23.06 32.25 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -177.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.58 -49.33 3.18 Favored 'General case' 0 CA--C 1.501 -0.934 0 C-N-CA 119.017 -1.073 . . . . 0.0 112.961 -175.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.465 ' OE2' HG22 ' A' ' 10' ' ' THR . 12.5 pt-20 -107.31 -4.8 18.28 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.128 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 55.2 mtmt 66.12 41.56 3.51 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.029 176.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -72.13 164.48 26.12 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.148 175.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.424 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 13.3 tpp180 -95.18 -22.09 18.06 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.368 0.604 . . . . 0.0 110.193 -175.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -155.11 170.15 22.48 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.86 141.38 5.98 Favored Glycine 0 CA--C 1.482 -2.003 0 N-CA-C 107.562 -2.215 . . . . 0.0 107.562 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.3 t -175.79 168.48 3.06 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 86.1 m -63.51 106.67 0.98 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.835 0.826 . . . . 0.0 110.065 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 t30 . . . . . 0 C--N 1.295 -1.789 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.151 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 15' ' ' CYS . 33.7 mmtp . . . . . 0 N--CA 1.45 -0.425 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 99.0 m -60.55 111.05 1.44 Allowed 'General case' 0 C--O 1.203 -1.389 0 CA-C-N 118.661 0.664 . . . . 0.0 110.208 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 44' ' ' LYS . 49.9 mm -110.71 137.7 41.99 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 59.6 m -86.56 148.52 25.47 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.488 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 92.2 m-85 -123.79 132.26 53.75 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 122.113 -0.367 . . . . 0.0 110.43 -177.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -105.97 148.79 37.18 Favored Pre-proline 0 C--N 1.285 -2.221 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.514 175.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.424 ' HD3' ' HB2' ' A' ' 32' ' ' ARG . 69.8 Cg_endo -78.28 132.18 11.19 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 122.256 1.971 . . . . 0.0 112.259 -176.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 74.2 m . . . . . 0 C--N 1.284 -2.246 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.555 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.1 tttp . . . . . 0 N--CA 1.444 -0.735 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 88.5 mt -93.2 99.99 12.45 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.33 0.586 . . . . 0.0 109.872 176.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.8 m -89.74 118.64 29.49 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.561 ' HB2' HG21 ' A' ' 46' ' ' ILE . 3.8 pt20 -81.89 138.44 35.02 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -173.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -133.38 118.28 14.82 Favored Pre-proline 0 C--N 1.308 -1.201 0 C-N-CA 125.161 1.384 . . . . 0.0 108.121 178.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.25 -63.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.732 1.621 . . . . 0.0 113.035 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.6 p -88.63 128.06 35.58 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -172.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.07 -75.28 0.06 OUTLIER Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.8 t -104.22 -36.82 7.52 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 171.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -67.62 135.68 53.24 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.448 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.7 t -156.26 89.67 1.14 Allowed 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.67 34.42 83.44 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.062 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.5 t -118.82 102.41 13.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.166 0.508 . . . . 0.0 110.783 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.8 t -140.28 80.24 1.75 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.452 0.644 . . . . 0.0 109.528 176.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.87 -60.98 0.53 Allowed Glycine 0 N--CA 1.426 -2.021 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -122.94 132.82 54.33 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 44.3 m-80 -63.89 -45.1 90.87 Favored 'General case' 0 C--O 1.205 -1.285 0 O-C-N 123.746 0.654 . . . . 0.0 109.863 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -63.76 -33.68 76.2 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.6 -46.52 63.25 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.2 p -76.38 -28.48 56.78 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.524 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 38.9 ttmt -56.02 -56.26 22.96 Favored 'General case' 0 C--O 1.251 1.137 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 173.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -58.74 -40.71 84.59 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.026 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -59.78 -40.88 89.73 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.9 m -64.98 -55.02 21.48 Favored 'General case' 0 C--O 1.252 1.209 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 54.9 mt -56.78 -41.52 75.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.159 -177.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -82.82 -17.02 45.47 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -106.7 -59.95 1.73 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 119.507 -0.877 . . . . 0.0 113.124 -177.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -104.83 1.08 28.73 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.988 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 97.2 mttt 65.95 60.57 0.67 Allowed 'General case' 0 CA--C 1.498 -1.042 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.567 172.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.38 176.02 7.09 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.241 176.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -93.66 -39.75 10.63 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.237 0.542 . . . . 0.0 109.625 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -146.57 170.68 16.41 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.78 137.81 4.81 Favored Glycine 0 C--N 1.292 -1.884 0 N-CA-C 108.029 -2.028 . . . . 0.0 108.029 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.2 p -172.14 161.54 5.51 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 117.451 0.626 . . . . 0.0 111.352 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 81.4 m -73.47 101.42 3.51 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.29 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 . . . . . 0 C--N 1.291 -1.965 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.16 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 66.6 mttm . . . . . 0 CA--C 1.499 -1.009 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 22.9 t -78.2 119.43 21.58 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.517 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.561 HG21 ' HB2' ' A' ' 5' ' ' GLN . 21.2 mm -114.44 138.92 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.446 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 69.0 m -85.67 137.93 32.49 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.452 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 88.8 m-85 -113.15 122.25 46.95 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 122.043 -0.411 . . . . 0.0 110.444 -178.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -103.6 143.59 26.94 Favored Pre-proline 0 C--N 1.293 -1.876 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.537 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -79.84 116.08 3.41 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 122.464 2.109 . . . . 0.0 112.737 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 84.3 m . . . . . 0 C--N 1.293 -1.873 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.695 176.659 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.3 mttm . . . . . 0 N--CA 1.442 -0.842 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.9 mt -123.35 113.93 19.5 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.586 0.707 . . . . 0.0 110.048 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.9 m -98.33 123.57 42.51 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.425 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -85.94 143.64 28.08 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.424 -176.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -148.84 123.01 4.75 Favored Pre-proline 0 C--N 1.298 -1.673 0 C-N-CA 123.756 0.822 . . . . 0.0 109.564 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.96 153.65 63.33 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 122.357 2.038 . . . . 0.0 109.389 173.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.8 t -147.73 160.3 42.86 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.52 -3.85 86.86 Favored Glycine 0 C--O 1.239 0.45 0 O-C-N 123.42 0.45 . . . . 0.0 112.572 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.6 p -71.6 -55.76 7.16 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -56.53 143.69 34.43 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.324 169.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.2 t -156.98 137.33 12.91 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.271 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.22 -164.85 31.13 Favored Glycine 0 C--O 1.249 1.075 0 C-N-CA 121.462 -0.399 . . . . 0.0 113.543 175.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.9 t -84.48 147.52 5.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.6 t -93.01 129.93 38.76 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -122.2 -44.88 0.34 Allowed Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -107.92 104.69 14.21 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -54.97 -53.5 54.86 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.484 1.114 . . . . 0.0 111.183 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -64.83 -32.65 74.45 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.819 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.9 -49.33 65.94 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.459 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.8 p -77.3 -27.84 53.13 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.495 -177.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -55.92 -56.97 14.31 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 173.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -59.5 -38.78 81.79 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.102 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -60.68 -46.22 91.17 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.897 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.519 ' HA ' ' OE2' ' A' ' 29' ' ' GLU . 75.1 m -62.42 -45.29 93.77 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-O 122.451 1.12 . . . . 0.0 108.943 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 72.6 mt -59.97 -32.44 50.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.678 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -86.23 -15.23 41.46 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.2 mt -109.27 -60.62 1.74 Allowed 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.864 -176.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.519 ' OE2' ' HA ' ' A' ' 25' ' ' CYS . 1.8 pm0 -99.38 -1.35 38.97 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.04 0.448 . . . . 0.0 111.347 178.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 68.2 mttm 63.64 45.73 4.47 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.584 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.462 ' O ' HG12 ' A' ' 26' ' ' ILE . . . -71.81 179.99 2.91 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.986 177.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -104.99 -31.3 9.29 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.557 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.609 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 84.4 t60 -147.39 171.56 15.29 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -176.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.9 136.04 3.67 Favored Glycine 0 CA--C 1.488 -1.634 0 N-CA-C 107.471 -2.252 . . . . 0.0 107.471 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.8 m -158.63 163.64 36.74 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 118.531 1.165 . . . . 0.0 113.709 -177.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 34.0 m -70.11 100.64 1.68 Allowed 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 113.9 -1.5 . . . . 0.0 109.35 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.3 t30 . . . . . 0 C--N 1.297 -1.683 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.925 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? . . . . . 0 C--O 1.219 -0.526 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.0 t -90.95 126.49 36.08 Favored 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.22 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.5 mm -116.57 139.61 42.6 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.2 m -88.46 140.62 29.28 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.609 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 30.9 m-85 -114.49 129.25 56.64 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.275 0.56 . . . . 0.0 109.986 -177.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -109.19 152.36 42.51 Favored Pre-proline 0 C--N 1.288 -2.069 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -78.02 142.57 19.72 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 121.642 1.561 . . . . 0.0 111.529 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 76.2 m . . . . . 0 C--N 1.287 -2.126 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.836 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 C--O 1.253 1.241 0 CA-C-O 121.152 0.501 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 80.8 mt -126.73 138.8 53.44 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.78 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.2 m -89.12 123.54 33.49 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.496 ' HG2' ' CE2' ' A' ' 48' ' ' TYR . 41.7 mt-30 -85.44 130.82 34.5 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.152 -176.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -135.79 107.39 9.83 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -68.24 -74.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.703 2.269 . . . . 0.0 115.325 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 p -84.91 134.82 34.25 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -169.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.23 -85.38 0.09 OUTLIER Glycine 0 N--CA 1.42 -2.419 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 t -86.14 -39.71 16.41 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.482 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 21.5 t90 -62.57 128.73 37.36 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.349 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.2 m -155.49 102.17 2.23 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 124.988 1.315 . . . . 0.0 107.675 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.23 -146.77 18.37 Favored Glycine 0 N--CA 1.42 -2.373 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.43 170.69 13.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.2 t -69.84 110.81 5.17 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.382 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.52 -55.03 1.37 Allowed Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -140.72 129.59 23.15 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -58.26 -46.64 85.63 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.483 0.489 . . . . 0.0 110.972 -176.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -65.75 -31.27 72.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.604 -177.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -48.45 65.44 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.709 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.1 p -74.46 -25.55 59.48 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.873 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -56.13 -57.92 10.13 Favored 'General case' 0 C--O 1.249 1.059 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 171.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -61.2 -36.29 79.47 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.8 -1.546 . . . . 0.0 110.629 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -64.89 -38.78 92.1 Favored 'General case' 0 C--O 1.21 -0.982 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 86.6 m -66.81 -54.49 22.0 Favored 'General case' 0 C--O 1.253 1.268 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 65.9 mt -56.47 -37.06 49.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.742 -177.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -86.53 -21.91 26.66 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -104.0 -55.56 2.35 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 118.9 -1.12 . . . . 0.0 113.156 -175.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -107.81 1.19 22.67 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.566 -0.853 . . . . 0.0 111.821 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm 62.64 60.99 1.25 Allowed 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.548 -1.206 . . . . 0.0 112.709 174.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.08 171.84 9.25 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.807 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -81.78 -33.38 30.92 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -157.85 171.58 20.03 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.9 137.88 5.75 Favored Glycine 0 C--N 1.295 -1.744 0 N-CA-C 106.813 -2.515 . . . . 0.0 106.813 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.1 t -160.14 162.52 33.98 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 118.113 0.957 . . . . 0.0 110.717 -176.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 21.0 m -78.59 104.55 9.27 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.439 ' HB3' ' CG1' ' A' ' 46' ' ' ILE . 6.8 t30 . . . . . 0 C--N 1.3 -1.555 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.372 -173.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.482 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 48.2 mtmt . . . . . 0 N--CA 1.434 -1.245 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.1 m -86.28 132.18 34.05 Favored 'General case' 0 CA--C 1.494 -1.196 0 O-C-N 123.608 0.567 . . . . 0.0 109.638 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.487 HG21 ' HB3' ' A' ' 5' ' ' GLN . 36.2 mm -120.91 139.89 46.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 82.9 m -87.03 138.15 31.74 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.496 ' CE2' ' HG2' ' A' ' 5' ' ' GLN . 93.3 m-85 -113.33 116.31 29.5 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -177.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -99.89 148.21 34.49 Favored Pre-proline 0 C--N 1.295 -1.801 0 C-N-CA 122.769 0.427 . . . . 0.0 110.379 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.16 125.04 9.96 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.045 1.83 . . . . 0.0 112.97 -175.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 77.6 m . . . . . 0 C--O 1.252 1.192 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 176.5 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.2 tttp . . . . . 0 N--CA 1.428 -1.567 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.474 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 86.2 mt -76.42 104.89 7.17 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.677 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.7 m -87.19 126.71 34.97 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.406 ' HB2' ' CG2' ' A' ' 46' ' ' ILE . 4.0 pt20 -80.89 145.74 31.17 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.201 0.524 . . . . 0.0 111.779 -173.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -125.42 109.14 26.47 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.4 -56.16 0.95 Allowed 'Trans proline' 0 C--O 1.203 -1.248 0 C-N-CA 122.542 2.161 . . . . 0.0 113.62 -176.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.3 m -137.66 101.43 4.47 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.687 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -109.63 -61.01 0.51 Allowed Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 171.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.416 HG22 ' OE1' ' A' ' 29' ' ' GLU . 4.8 t -118.1 -36.95 3.47 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.441 -0.38 . . . . 0.0 111.689 172.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.61 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 17.8 t90 -46.5 130.97 11.19 Favored 'General case' 0 C--N 1.358 0.941 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.5 m -150.44 121.2 7.54 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.2 -159.23 22.67 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.46 161.12 4.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.478 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 30.3 t -85.5 90.37 7.95 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.25 -35.81 4.06 Favored Glycine 0 C--N 1.313 -0.72 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.607 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -137.67 110.91 7.87 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -56.19 -43.16 78.19 Favored 'General case' 0 CA--C 1.49 -1.333 0 O-C-N 123.624 0.578 . . . . 0.0 109.872 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.409 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 11.1 m120 -59.41 -35.47 74.03 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.315 -177.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.59 -53.16 9.92 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.971 -177.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 4.8 p -70.55 -32.23 69.59 Favored 'General case' 0 C--O 1.214 -0.792 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 19' ' ' ASN . 27.3 ttpp -54.62 -52.22 62.92 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 173.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -58.49 -46.58 86.37 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.632 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -54.32 -44.21 71.85 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.784 0.677 . . . . 0.0 111.225 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 68.8 m -61.45 -56.96 14.4 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 59.6 mt -55.23 -35.78 37.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 124.894 1.277 . . . . 0.0 111.322 -177.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -75.99 -34.15 59.74 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -110.47 -49.3 3.07 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 118.483 -1.287 . . . . 0.0 113.639 -171.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.416 ' OE1' HG22 ' A' ' 10' ' ' THR . 11.7 pt-20 -97.03 -9.64 27.74 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.629 0.728 . . . . 0.0 109.414 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 97.2 mttt 61.51 61.55 1.47 Allowed 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 113.921 -1.491 . . . . 0.0 112.619 177.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.25 -179.51 5.44 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.009 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.402 ' HG2' ' HD3' ' A' ' 50' ' ' PRO . 23.1 mmt180 -100.96 -34.93 9.57 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.173 0.511 . . . . 0.0 110.084 177.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -143.2 168.91 18.64 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.76 132.63 2.89 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.7 p -155.07 -179.88 8.49 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 117.737 0.769 . . . . 0.0 112.234 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 84.6 m -81.91 126.5 31.98 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.009 0.433 . . . . 0.0 110.948 -176.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.4 m120 . . . . . 0 C--N 1.289 -2.063 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 169.241 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.9 mttp . . . . . 0 N--CA 1.439 -1.003 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.61 ' HB2' ' CD1' ' A' ' 11' ' ' TRP . 96.4 m -88.49 113.03 23.66 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.406 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 28.6 mm -105.28 135.65 42.48 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.718 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 177.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.6 m -87.46 159.96 18.47 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 123.692 0.62 . . . . 0.0 109.701 -177.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.474 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 96.3 m-85 -132.15 128.1 37.34 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -176.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -111.17 150.73 42.41 Favored Pre-proline 0 C--N 1.308 -1.218 0 C-N-CA 123.637 0.775 . . . . 0.0 110.158 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.402 ' HD3' ' HG2' ' A' ' 32' ' ' ARG . 91.0 Cg_endo -84.18 113.91 1.83 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.73 2.287 . . . . 0.0 113.466 -177.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 82.9 m . . . . . 0 C--N 1.295 -1.798 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.224 175.821 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.427 ' HA ' ' OXT' ' A' ' 51' ' ' CYS . 7.4 tt0 . . . . . 0 CA--C 1.511 -0.546 0 CA-C-O 120.677 0.275 . . . . 0.0 110.657 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -134.04 -173.51 3.28 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 171.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.9 mt -108.21 127.77 54.13 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.249 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.4 p -108.87 141.83 40.35 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.519 ' HB2' HG21 ' A' ' 46' ' ' ILE . 3.9 pt20 -96.71 144.13 27.0 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -174.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 -147.58 114.17 4.07 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -75.36 -39.02 1.21 Allowed 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.096 1.864 . . . . 0.0 114.728 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.2 m -94.4 139.37 31.2 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -172.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.7 -86.29 0.1 Allowed Glycine 0 N--CA 1.411 -3.025 0 N-CA-C 107.808 -2.117 . . . . 0.0 107.808 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.442 HG22 ' OE2' ' A' ' 29' ' ' GLU . 10.2 t -101.31 -33.72 9.92 Favored 'General case' 0 C--N 1.283 -2.324 0 CA-C-O 121.263 0.554 . . . . 0.0 110.65 178.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.59 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 60.9 t90 -72.74 140.32 47.72 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.396 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.7 m -160.46 110.38 1.77 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.581 1.552 . . . . 0.0 107.588 170.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.19 -121.12 2.13 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.795 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -120.71 171.06 9.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 C-N-CA 122.977 0.511 . . . . 0.0 110.127 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.649 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 31.6 t -96.42 99.17 10.86 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 176.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.26 -71.27 1.14 Allowed Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.714 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -127.54 133.5 49.8 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -53.42 -56.76 14.16 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 124.369 1.043 . . . . 0.0 110.777 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.42 -34.26 77.35 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.411 -174.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.33 -60.0 3.7 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 124.04 0.837 . . . . 0.0 111.524 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.5 p -74.11 -23.53 59.33 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.763 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -55.53 -56.95 14.27 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 172.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -60.43 -41.39 93.91 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.973 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -60.1 -41.67 93.05 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.848 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 76.8 m -62.86 -56.49 16.91 Favored 'General case' 0 C--O 1.253 1.272 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 61.2 mt -53.24 -36.86 26.74 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.578 -176.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -78.9 -41.55 29.36 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -89.68 -62.72 1.41 Allowed 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.84 -168.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.442 ' OE2' HG22 ' A' ' 10' ' ' THR . 10.9 pt-20 -93.9 -6.88 44.63 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.532 0.682 . . . . 0.0 110.213 -176.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 56.6 mttp 64.19 66.84 0.61 Allowed 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 113.758 -1.564 . . . . 0.0 112.589 175.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.71 -178.91 4.69 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 113.363 -1.744 . . . . 0.0 108.189 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -102.79 -29.5 11.44 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.424 0.63 . . . . 0.0 109.894 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 68.7 t60 -152.63 179.54 8.51 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.06 139.58 4.48 Favored Glycine 0 C--N 1.302 -1.311 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.4 m -161.5 173.68 14.49 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 118.417 1.108 . . . . 0.0 111.762 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.6 m -75.05 102.22 4.79 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.311 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.425 ' HB3' HG13 ' A' ' 46' ' ' ILE . 26.0 t-20 -99.54 132.95 44.54 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -85.34 92.59 8.5 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-O 121.79 0.805 . . . . 0.0 111.69 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.1 m -99.6 144.38 12.22 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 169.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 69.6 t80 -62.34 134.56 94.86 Favored Pre-proline 0 C--N 1.301 -1.507 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.042 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 63.2 Cg_endo -107.03 19.01 7.98 Favored 'Cis proline' 0 CA--C 1.548 1.223 0 C-N-CA 124.841 -0.899 . . . . 0.0 114.41 0.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.65 151.33 20.23 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 118.574 0.625 . . . . 0.0 112.41 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -59.76 132.87 55.28 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.771 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -131.43 152.31 50.78 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.841 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.649 ' SG ' ' HA ' ' A' ' 15' ' ' CYS . 78.0 m -79.25 104.97 10.24 Favored 'General case' 0 CA--C 1.479 -1.757 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.519 HG21 ' HB2' ' A' ' 5' ' ' GLN . 22.0 mm -103.48 129.82 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.761 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 60.1 m -84.61 136.9 33.57 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.476 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 76.9 m-85 -110.4 123.44 49.88 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-O 121.394 0.616 . . . . 0.0 110.957 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -105.99 157.65 34.27 Favored Pre-proline 0 C--N 1.283 -2.311 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.166 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -77.41 116.15 4.05 Favored 'Trans proline' 0 N--CA 1.435 -1.939 0 C-N-CA 121.548 1.499 . . . . 0.0 111.404 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.427 ' OXT' ' HA ' ' A' ' 1' ' ' GLN . 95.0 m . . . . . 0 C--N 1.282 -2.367 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 . . . . . 0 N--CA 1.448 -0.563 0 CA-C-O 121.529 0.681 . . . . 0.0 109.65 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -131.53 141.97 49.84 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 90.5 mt -89.08 99.88 12.77 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.78 0.8 . . . . 0.0 110.128 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.9 m -86.07 112.28 21.11 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.971 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.484 ' HB2' HG21 ' A' ' 46' ' ' ILE . 4.8 pt20 -73.99 136.38 43.18 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.868 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 46.6 ttp180 -145.17 115.26 5.0 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 6' ' ' ARG . 13.8 Cg_exo -68.7 -73.31 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.683 2.255 . . . . 0.0 115.776 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.9 m -90.29 97.36 11.14 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -170.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -119.92 -73.62 0.39 Allowed Glycine 0 N--CA 1.422 -2.234 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 168.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.442 HG22 ' OE2' ' A' ' 29' ' ' GLU . 8.7 t -108.25 -26.53 10.51 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 173.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.656 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 20.2 t90 -62.17 136.07 57.78 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-O 121.252 0.549 . . . . 0.0 112.3 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -157.4 108.22 2.27 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.288 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.31 -157.57 22.78 Favored Glycine 0 N--CA 1.431 -1.675 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.806 176.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.67 149.3 4.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 33.7 t -83.76 123.85 30.29 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.77 -64.26 0.88 Allowed Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.211 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 56.0 t-20 -122.5 126.16 47.26 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -177.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -54.85 -47.72 73.79 Favored 'General case' 0 C--O 1.207 -1.162 0 O-C-N 123.903 0.752 . . . . 0.0 110.066 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -62.27 -40.5 96.44 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.704 -177.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 17' ' ' ASN . . . -69.28 -47.06 65.68 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.54 -177.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.5 p -73.35 -34.48 65.65 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.5 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -55.33 -54.43 43.68 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.586 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 48.2 t30 -56.69 -46.74 81.02 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.228 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -56.2 -41.87 76.27 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.498 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.3 m -62.46 -51.97 65.39 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.6 mt -58.24 -35.7 54.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.08 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 9.3 mmp_? -74.78 -29.98 61.29 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.89 -57.67 2.07 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 119.463 -0.895 . . . . 0.0 112.546 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.442 ' OE2' HG22 ' A' ' 10' ' ' THR . 12.9 pt-20 -98.05 -5.12 34.59 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.555 -175.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.2 mttt 62.32 63.14 1.08 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.283 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.15 -179.02 5.56 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.648 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.543 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 4.5 mmp_? -106.88 -21.21 13.09 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.145 0.498 . . . . 0.0 110.534 176.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 78.2 t60 -158.13 170.28 22.64 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.67 140.54 6.49 Favored Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 106.378 -2.689 . . . . 0.0 106.378 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.0 t -155.21 153.29 30.47 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 118.37 1.085 . . . . 0.0 111.025 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 61.0 m -73.16 93.52 1.84 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -105.21 143.49 33.31 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -81.35 120.31 24.79 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.556 0.693 . . . . 0.0 110.917 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.6 m -129.07 -177.38 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.576 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 172.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 67.8 t80 -75.92 129.73 80.26 Favored Pre-proline 0 C--N 1.285 -2.22 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.816 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 61.3 Cg_endo -110.86 25.93 3.34 Favored 'Cis proline' 0 CA--C 1.555 1.533 0 C-N-CA 124.806 -0.914 . . . . 0.0 111.647 -5.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.22 175.84 12.94 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 120.906 0.384 . . . . 0.0 111.84 -174.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -73.85 110.92 8.52 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.049 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.656 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 97.3 mttt -119.43 157.64 27.82 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 24.6 t -90.67 123.9 34.65 Favored 'General case' 0 CA--C 1.48 -1.731 0 C-N-CA 118.624 -1.23 . . . . 0.0 109.278 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.484 HG21 ' HB2' ' A' ' 5' ' ' GLN . 20.0 mm -111.35 128.98 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.541 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 37.8 m -85.18 147.04 26.8 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.427 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 93.3 m-85 -118.11 122.82 44.07 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.913 -0.492 . . . . 0.0 110.539 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -104.85 152.39 39.54 Favored Pre-proline 0 C--N 1.3 -1.562 0 C-N-CA 123.589 0.756 . . . . 0.0 110.988 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -88.33 107.76 0.54 Allowed 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 122.79 2.326 . . . . 0.0 112.67 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 82.0 m . . . . . 0 C--N 1.279 -2.46 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 174.736 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 120.883 0.373 . . . . 0.0 111.491 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -104.69 -175.43 2.79 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.8 mt -121.95 132.04 54.33 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 67.7 m -106.69 129.6 54.56 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.65 151.42 25.3 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -144.45 123.74 7.12 Favored Pre-proline 0 C--N 1.305 -1.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.838 -177.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -68.65 103.03 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.022 1.815 . . . . 0.0 108.129 170.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.533 ' HB3' ' OE1' ' A' ' 29' ' ' GLU . 61.8 m -98.33 161.46 13.68 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -171.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.56 -35.21 52.26 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.307 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.2 t -60.85 -34.53 74.73 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.9 0.381 . . . . 0.0 110.142 175.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -57.82 106.34 0.35 Allowed 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.784 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.4 t -150.28 91.69 1.79 Allowed 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.6 173.78 23.13 Favored Glycine 0 N--CA 1.422 -2.29 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.187 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.4 m -98.0 171.51 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 123.004 0.521 . . . . 0.0 110.248 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.5 t -69.03 108.38 3.52 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.031 -0.532 . . . . 0.0 112.175 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.36 -91.45 0.69 Allowed Glycine 0 N--CA 1.42 -2.402 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 173.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -91.13 114.92 27.58 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 111.614 0.228 . . . . 0.0 111.614 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -65.38 -43.64 90.06 Favored 'General case' 0 CA--C 1.504 -0.806 0 O-C-N 123.752 0.657 . . . . 0.0 111.002 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -70.16 -36.5 74.75 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.111 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.85 -43.68 95.42 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.981 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.2 p -76.2 -29.36 57.61 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.68 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -57.72 -56.68 18.79 Favored 'General case' 0 C--O 1.251 1.154 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -61.01 -36.87 80.63 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.46 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -63.5 -41.4 98.53 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.08 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 97.7 m -62.65 -49.71 74.09 Favored 'General case' 0 C--O 1.259 1.577 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 60.9 mt -58.91 -33.59 50.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.149 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -83.6 -21.49 32.56 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.74 -65.14 0.98 Allowed 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.245 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.533 ' OE1' ' HB3' ' A' ' 8' ' ' SER . 10.9 pt-20 -106.26 -1.3 23.66 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.845 -177.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.2 mttp 64.26 65.11 0.68 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.708 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.85 -176.17 5.4 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.437 175.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.405 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 4.1 tpm_? -101.97 -29.88 11.54 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.083 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.563 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 31.4 t60 -151.2 173.56 14.28 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.0 139.75 5.96 Favored Glycine 0 C--N 1.295 -1.735 0 N-CA-C 106.478 -2.649 . . . . 0.0 106.478 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.0 t -163.04 167.47 22.34 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 118.384 1.092 . . . . 0.0 109.974 -174.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 89.6 m -72.83 95.16 1.89 Allowed 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.061 175.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -90.9 137.21 32.54 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -81.61 95.58 7.22 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.474 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.1 m -99.49 159.41 3.55 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 172.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 56.2 t80 -74.05 133.69 78.39 Favored Pre-proline 0 C--N 1.28 -2.439 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.377 -175.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 14.8 Cg_endo -106.69 19.82 8.52 Favored 'Cis proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.779 -0.925 . . . . 0.0 112.702 -2.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -155.72 151.0 26.82 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 122.145 -0.347 . . . . 0.0 110.887 -175.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -58.99 133.8 56.41 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.819 0.848 . . . . 0.0 112.313 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -134.63 156.31 48.95 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.3 m -81.91 94.61 7.14 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.618 0.723 . . . . 0.0 111.458 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.75 143.59 11.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 74.2 m -90.0 148.22 23.21 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.481 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.563 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 38.9 m-85 -120.11 130.34 54.59 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.224 0.535 . . . . 0.0 110.844 -177.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -110.8 151.07 42.66 Favored Pre-proline 0 C--N 1.297 -1.678 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.338 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.57 132.06 10.8 Favored 'Trans proline' 0 C--O 1.253 1.262 0 C-N-CA 122.412 2.075 . . . . 0.0 113.276 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 68.9 m . . . . . 0 N--CA 1.435 -1.225 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.705 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 . . . . . 0 C--O 1.237 0.401 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -120.59 161.66 20.96 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 172.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 92.4 mt -93.21 110.16 21.68 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-O 121.351 0.596 . . . . 0.0 110.46 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.42 ' SG ' ' HB2' ' A' ' 49' ' ' PHE . 8.2 p -89.08 127.43 35.7 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.5 ' HB2' HG21 ' A' ' 46' ' ' ILE . 4.3 pt20 -87.43 133.4 33.74 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.209 0.528 . . . . 0.0 111.516 -175.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -126.04 119.84 23.87 Favored Pre-proline 0 C--O 1.265 1.878 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.267 -177.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -71.44 125.96 11.75 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.582 2.188 . . . . 0.0 107.427 169.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.5 t -144.27 160.89 40.23 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.878 -171.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.26 20.04 43.03 Favored Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.655 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.4 p -83.8 -58.29 2.86 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.466 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 1.6 t90 -57.8 144.46 38.44 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.007 -1.451 . . . . 0.0 110.161 169.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.8 t -146.33 119.68 8.99 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.26 -135.23 12.45 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.948 173.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -125.55 170.92 14.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -175.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.4 t -60.66 108.52 0.85 Allowed 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.093 0.473 . . . . 0.0 111.227 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -116.0 -88.41 1.45 Allowed Glycine 0 N--CA 1.427 -1.949 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -95.46 106.43 18.5 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 122.534 0.333 . . . . 0.0 110.228 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -59.9 -56.09 26.01 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.424 1.09 . . . . 0.0 111.751 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -71.53 -30.1 65.53 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.789 -175.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.64 -42.01 64.86 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.363 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 30.6 p -70.66 -32.33 69.56 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.823 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -55.71 -56.7 17.36 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 172.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -58.8 -37.27 75.99 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.127 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.52 ' O ' ' HG ' ' A' ' 28' ' ' LEU . 20.9 tt0 -63.77 -44.19 94.14 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.236 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 99.0 m -62.08 -49.48 75.79 Favored 'General case' 0 C--O 1.259 1.562 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.632 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 65.9 mt -59.24 -32.81 49.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.401 -177.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.515 ' HA ' ' NE ' ' A' ' 27' ' ' ARG . 4.1 mmp_? -97.05 -8.94 29.12 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 24' ' ' GLN . 42.4 mt -102.04 -62.98 1.19 Allowed 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.63 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -99.17 -3.85 33.48 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.177 0.513 . . . . 0.0 110.01 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 56.4 mtmt 68.92 50.74 0.59 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.646 175.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.08 178.66 7.35 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.063 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -98.74 -34.2 10.61 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 80.0 t60 -151.61 175.17 12.62 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 -176.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -169.0 141.34 6.67 Favored Glycine 0 C--N 1.289 -2.064 0 N-CA-C 106.869 -2.492 . . . . 0.0 106.869 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.0 p -169.03 169.51 9.49 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 118.114 0.957 . . . . 0.0 112.062 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 44' ' ' LYS . 78.0 m -80.63 117.49 21.37 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.631 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -126.25 142.85 51.37 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -75.65 120.45 21.07 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.208 0.528 . . . . 0.0 111.103 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.5 m -133.77 -177.52 2.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 175.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 69.2 t80 -75.77 132.16 75.3 Favored Pre-proline 0 C--N 1.285 -2.207 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 89.1 Cg_endo -104.76 10.32 10.77 Favored 'Cis proline' 0 CA--C 1.553 1.451 0 C-N-CA 124.498 -1.042 . . . . 0.0 113.797 -1.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -163.95 -176.82 4.74 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -67.33 117.22 9.03 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.473 0.654 . . . . 0.0 110.232 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 31.1 mmtp -120.95 162.96 19.0 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 23.8 t -92.22 113.54 25.83 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' A' ' 5' ' ' GLN . 38.8 mm -105.71 142.07 19.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 61.3 m -88.46 145.63 25.66 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.471 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 70.6 m-85 -121.45 136.58 54.94 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.067 0.46 . . . . 0.0 111.375 -176.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.42 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 73.3 m-85 -117.82 164.58 19.12 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -85.31 108.78 1.12 Allowed 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 121.893 1.729 . . . . 0.0 111.837 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 98.9 m . . . . . 0 C--N 1.302 -1.497 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.992 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 . . . . . 0 CA--C 1.505 -0.76 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -113.01 151.54 30.51 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 88.7 mt -96.76 108.58 21.26 Favored 'General case' 0 C--N 1.288 -2.085 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.096 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.7 m -82.22 129.63 34.89 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.608 ' HB2' HG21 ' A' ' 46' ' ' ILE . 4.0 pt20 -85.6 141.32 29.9 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.216 0.531 . . . . 0.0 110.987 -177.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -144.57 108.56 4.8 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -77.49 -55.25 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.472 2.114 . . . . 0.0 115.433 -175.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 m -98.22 109.85 22.54 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -172.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.85 -69.88 0.02 OUTLIER Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 108.051 -2.02 . . . . 0.0 108.051 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.524 HG21 ' HA ' ' A' ' 25' ' ' CYS . 7.0 t -103.96 -39.17 6.7 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 170.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.48 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 78.7 t90 -70.76 123.38 21.81 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-O 121.484 0.659 . . . . 0.0 110.731 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.1 m -162.06 96.62 1.0 Allowed 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 125.739 1.616 . . . . 0.0 106.661 174.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.33 -131.73 3.69 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.408 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.9 m -117.66 164.73 13.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 122.627 0.371 . . . . 0.0 110.696 -177.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.7 t -92.74 106.71 18.64 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 120.821 0.343 . . . . 0.0 110.66 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.51 -67.75 1.5 Allowed Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 176.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.618 ' HB2' ' HB3' ' A' ' 20' ' ' ALA . 32.8 m-80 -129.38 132.57 47.07 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -66.41 -47.1 74.35 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.682 0.753 . . . . 0.0 110.001 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -72.65 -16.86 61.7 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.786 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 17' ' ' ASN . . . -88.94 -38.06 14.77 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.776 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.4 p -72.71 -30.88 64.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -53.25 -53.57 48.83 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 171.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -61.79 -40.27 94.62 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 113.855 -1.52 . . . . 0.0 110.062 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -59.88 -39.11 84.16 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 123.358 0.663 . . . . 0.0 110.4 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.524 ' HA ' HG21 ' A' ' 10' ' ' THR . 91.5 m -64.12 -55.5 21.53 Favored 'General case' 0 C--O 1.25 1.107 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 55.9 mt -58.17 -33.83 47.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.701 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -85.42 -21.4 28.79 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.25 -67.9 0.88 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.401 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -97.18 2.67 51.32 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.56 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 49.7 mttp 60.96 57.68 2.5 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 114.057 -1.429 . . . . 0.0 112.215 171.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.64 -179.09 7.23 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.256 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -101.19 -27.23 13.34 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.681 0.753 . . . . 0.0 109.256 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 86.5 t60 -151.55 171.48 17.53 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.722 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.96 143.63 8.17 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 106.829 -2.508 . . . . 0.0 106.829 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.6 p -165.58 151.3 9.29 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 117.888 0.844 . . . . 0.0 111.284 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 62.5 m -81.79 100.32 9.49 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.718 0.771 . . . . 0.0 110.241 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -79.36 142.77 35.73 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.603 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -73.27 105.94 4.89 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.412 0.625 . . . . 0.0 110.322 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.6 m -126.84 164.48 27.23 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 83.6 t80 -82.0 137.24 46.65 Favored Pre-proline 0 C--N 1.289 -2.03 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 65.6 Cg_endo -98.83 3.61 29.36 Favored 'Cis proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.209 -1.163 . . . . 0.0 113.281 -1.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.83 156.03 41.75 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 73.2 m80 -61.78 123.98 19.47 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 123.54 0.525 . . . . 0.0 110.473 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 97.6 mttt -118.58 147.77 43.37 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 11.7 t -84.66 125.95 32.94 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 121.178 0.513 . . . . 0.0 110.739 -173.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.608 HG21 ' HB2' ' A' ' 5' ' ' GLN . 18.4 mm -117.22 134.2 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.451 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 67.6 m -82.9 149.88 26.82 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.478 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 76.1 m-85 -127.24 126.84 43.43 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.086 0.469 . . . . 0.0 111.266 -177.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -110.53 144.87 31.09 Favored Pre-proline 0 C--N 1.302 -1.472 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.775 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -82.65 114.31 2.35 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 122.337 2.025 . . . . 0.0 112.269 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 C--N 1.288 -2.069 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.929 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 . . . . . 0 C--O 1.236 0.37 0 CA-C-O 121.254 0.549 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -93.53 168.34 11.1 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 83.4 mt -79.94 117.35 20.71 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-O 121.193 0.521 . . . . 0.0 110.653 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.1 p -98.18 129.88 44.94 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.468 ' HB2' HG21 ' A' ' 46' ' ' ILE . 4.7 pt20 -87.89 130.74 34.81 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.308 0.575 . . . . 0.0 111.774 -173.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -132.69 120.03 16.41 Favored Pre-proline 0 C--N 1.309 -1.191 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.138 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -74.79 142.62 28.79 Favored 'Trans proline' 0 C--O 1.247 0.937 0 C-N-CA 122.21 1.94 . . . . 0.0 107.759 168.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.1 t -151.67 161.74 42.17 Favored 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.925 -175.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.6 -7.32 87.19 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.399 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 p -65.54 -56.72 10.81 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.5 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 1.7 t90 -59.51 138.04 57.82 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.492 166.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.8 t -134.02 110.42 9.64 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-O 120.659 0.266 . . . . 0.0 111.052 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.78 -115.5 5.91 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 115.936 1.134 . . . . 0.0 115.936 171.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 p -83.94 137.15 21.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.807 0.813 . . . . 0.0 112.47 -174.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.1 t -90.73 112.5 24.29 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.36 -59.33 1.04 Allowed Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -112.92 120.35 41.13 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -54.97 -44.67 74.62 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 123.731 0.645 . . . . 0.0 110.354 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -66.04 -33.51 75.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.011 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.15 -46.41 56.56 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 116.726 -0.215 . . . . 0.0 111.11 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.4 p -73.22 -32.0 64.5 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.868 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -53.07 -60.08 3.74 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 123.854 0.862 . . . . 0.0 109.177 173.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -61.54 -34.47 75.6 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.004 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -65.8 -38.62 89.48 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.451 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.1 m -64.93 -49.07 71.81 Favored 'General case' 0 C--O 1.255 1.374 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 73.0 mt -57.14 -42.79 80.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.844 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -81.24 -14.15 57.76 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.7 mt -107.06 -55.72 2.29 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 119.087 -1.045 . . . . 0.0 112.078 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -110.89 1.42 17.58 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.097 0.475 . . . . 0.0 111.626 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 36.5 mtmm 66.82 45.92 1.78 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.122 174.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.21 172.42 11.17 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.999 -1.001 . . . . 0.0 108.88 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -91.62 -35.95 13.93 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -152.63 176.56 11.6 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -175.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.62 150.64 11.55 Favored Glycine 0 C--N 1.308 -0.987 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.2 p -172.27 168.27 5.66 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-N 118.372 1.086 . . . . 0.0 111.696 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 58.0 m -68.41 107.57 2.92 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -94.64 -29.69 14.71 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.702 0.763 . . . . 0.0 109.866 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.579 ' HB3' ' H ' ' A' ' 44' ' ' LYS . 19.3 t80 -93.16 -178.93 4.93 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.504 ' HA ' ' CD2' ' A' ' 43' ' ' HIS . 16.5 m -133.51 -155.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 125.303 1.441 . . . . 0.0 108.039 -176.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.543 ' CD1' ' HA ' ' A' ' 41' ' ' PRO . 87.1 t80 -48.69 145.24 6.22 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 124.38 1.072 . . . . 0.0 110.35 175.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.543 ' HA ' ' CD1' ' A' ' 40' ' ' PHE . 59.3 Cg_endo -90.26 6.8 67.73 Favored 'Cis proline' 0 C--N 1.353 0.775 0 C-N-CA 124.15 -1.188 . . . . 0.0 113.805 2.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.78 105.8 1.62 Allowed 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.504 ' CD2' ' HA ' ' A' ' 39' ' ' VAL . 56.5 m80 -59.51 128.34 36.54 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.579 ' H ' ' HB3' ' A' ' 38' ' ' TYR . 32.4 mmtp -105.33 146.4 29.43 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 45.2 t -103.9 131.7 50.87 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.468 HG21 ' HB2' ' A' ' 5' ' ' GLN . 50.1 mm -116.68 137.55 50.14 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.7 m -89.49 153.0 21.15 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.479 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 87.6 m-85 -126.0 135.96 52.43 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -116.78 159.42 40.7 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -82.42 101.4 1.08 Allowed 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.936 1.758 . . . . 0.0 112.149 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 85.2 m . . . . . 0 C--N 1.298 -1.635 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.709 179.117 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 . . . . . 0 CA--C 1.515 -0.37 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 51' ' ' CYS . 23.0 pttm -146.82 156.67 43.3 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 82.2 mt -95.43 105.47 17.44 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.248 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 86.3 m -80.78 135.65 36.0 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.732 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.425 ' HB2' HG21 ' A' ' 46' ' ' ILE . 19.0 pt20 -90.67 128.72 36.73 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.208 0.527 . . . . 0.0 110.696 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -129.07 117.99 19.28 Favored Pre-proline 0 C--N 1.301 -1.52 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.161 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -78.53 116.78 3.88 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.036 1.824 . . . . 0.0 109.301 173.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.1 m -124.79 160.12 29.42 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.33 -25.67 60.67 Favored Glycine 0 C--N 1.334 0.421 0 O-C-N 124.217 0.948 . . . . 0.0 114.142 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.7 t -53.81 -47.64 70.65 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 117.219 0.51 . . . . 0.0 110.052 174.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -71.44 121.94 19.5 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 121.25 0.548 . . . . 0.0 109.796 173.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.0 p -153.41 100.2 2.41 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.432 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.96 -145.39 16.86 Favored Glycine 0 N--CA 1.427 -1.951 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.502 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.6 m -99.61 153.01 4.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -177.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 43' ' ' HIS . 44.8 t -90.77 91.66 8.47 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.96 -60.17 2.98 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -120.95 129.9 53.62 Favored 'General case' 0 CA--C 1.486 -1.508 0 CA-C-N 115.472 -0.364 . . . . 0.0 110.111 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -56.17 -46.8 79.19 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 124.313 1.008 . . . . 0.0 109.577 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -64.64 -30.9 71.92 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.89 -53.37 21.54 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.5 p -74.89 -29.11 60.9 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.599 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.448 ' HE2' ' CE1' ' A' ' 33' ' ' HIS . 38.5 ttmt -52.62 -58.68 6.02 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-O 122.021 0.915 . . . . 0.0 108.623 173.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -59.17 -41.38 88.28 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 113.693 -1.594 . . . . 0.0 109.69 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -65.04 -32.34 74.01 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.327 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 98.5 m -66.97 -49.65 64.77 Favored 'General case' 0 C--O 1.255 1.359 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 57.0 mt -61.24 -28.03 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.33 -1.304 . . . . 0.0 111.176 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.46 ' HA ' ' NE ' ' A' ' 27' ' ' ARG . 3.3 mmp_? -92.82 -15.7 26.2 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -103.91 -62.41 1.31 Allowed 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 119.946 -0.702 . . . . 0.0 112.194 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -102.66 -1.4 30.21 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.199 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 56.0 mtpt 69.62 37.41 1.92 Allowed 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.215 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.58 175.88 3.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.144 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.483 ' HG2' ' HD3' ' A' ' 50' ' ' PRO . 6.7 mmp_? -90.94 -32.14 16.1 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.146 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 28.9 t60 -155.82 175.02 14.48 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -174.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -169.96 142.75 7.43 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 107.145 -2.382 . . . . 0.0 107.145 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.7 p -163.0 169.92 18.85 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 117.892 0.846 . . . . 0.0 110.9 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 68.6 m -67.91 107.4 2.64 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 175.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -90.96 -28.95 17.71 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.751 0.786 . . . . 0.0 109.092 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.436 ' HB3' ' H ' ' A' ' 44' ' ' LYS . 14.1 t80 -110.82 162.5 14.73 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.598 ' HA ' ' CD2' ' A' ' 43' ' ' HIS . 8.7 p -118.27 -179.5 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -171.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.624 ' CG ' ' HA ' ' A' ' 41' ' ' PRO . 50.8 t80 -51.83 145.59 16.34 Favored Pre-proline 0 C--N 1.31 -1.147 0 C-N-CA 124.188 0.995 . . . . 0.0 109.527 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.624 ' HA ' ' CG ' ' A' ' 40' ' ' PHE . 5.9 Cg_exo -78.87 -7.58 37.42 Favored 'Cis proline' 0 C--N 1.35 0.621 0 N-CA-C 115.147 1.172 . . . . 0.0 115.147 5.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -131.1 79.79 1.91 Allowed 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -175.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.598 ' CD2' ' HA ' ' A' ' 39' ' ' VAL . 73.9 m80 -64.41 113.1 3.42 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 175.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.436 ' H ' ' HB3' ' A' ' 38' ' ' TYR . 71.5 mmtt -98.49 141.61 31.14 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 176.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.9 t -100.55 128.96 46.44 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.425 HG21 ' HB2' ' A' ' 5' ' ' GLN . 47.9 mm -122.85 141.02 44.82 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.503 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 41.5 m -88.73 156.92 18.71 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.481 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 95.9 m-85 -126.54 142.65 51.47 Favored 'General case' 0 C--O 1.252 1.211 0 CA-C-O 121.039 0.447 . . . . 0.0 112.182 -177.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -126.67 151.31 73.1 Favored Pre-proline 0 C--N 1.319 -0.746 0 C-N-CA 124.312 1.045 . . . . 0.0 109.908 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.483 ' HD3' ' HG2' ' A' ' 32' ' ' ARG . 94.5 Cg_endo -86.99 107.37 0.7 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.725 2.283 . . . . 0.0 112.38 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 20.7 m . . . . . 0 C--N 1.291 -1.967 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 . . . . . 0 CA--C 1.503 -0.829 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.77 158.5 15.64 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 90.6 mt -96.74 99.99 11.56 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.7 p -87.63 114.68 24.47 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 114.596 -1.183 . . . . 0.0 109.681 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.507 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 18.8 pt20 -83.14 144.32 29.92 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -173.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -138.22 120.7 10.85 Favored Pre-proline 0 C--N 1.313 -1.004 0 C-N-CA 124.743 1.217 . . . . 0.0 108.453 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -73.82 108.76 2.72 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 121.681 1.587 . . . . 0.0 108.991 173.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.7 p -79.73 160.97 26.03 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.373 0.606 . . . . 0.0 112.567 -174.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.01 -24.64 57.41 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.3 t -71.34 -41.24 70.05 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.765 -0.218 . . . . 0.0 110.575 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -48.92 130.93 18.65 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.05 0.54 . . . . 0.0 112.225 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.9 t -91.23 127.94 36.86 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -33.23 -48.47 0.43 Allowed Glycine 0 N--CA 1.478 1.447 0 N-CA-C 117.513 1.765 . . . . 0.0 117.513 -171.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.6 131.67 36.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 117.355 0.577 . . . . 0.0 110.024 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.6 t -73.58 127.7 33.48 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.838 0.351 . . . . 0.0 110.143 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.77 -73.31 0.81 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -122.46 125.18 45.28 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -59.03 -46.03 89.25 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 123.756 0.66 . . . . 0.0 111.123 -175.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -75.02 -9.37 58.47 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.79 -47.04 8.49 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.6 p -75.16 -34.66 61.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.321 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -54.4 -55.02 32.91 Favored 'General case' 0 C--O 1.25 1.087 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 174.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.597 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 7.2 t30 -60.51 -41.9 95.32 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.052 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -58.29 -39.4 79.18 Favored 'General case' 0 C--O 1.211 -0.969 0 C-N-CA 122.795 0.438 . . . . 0.0 110.524 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 99.1 m -64.69 -54.5 30.65 Favored 'General case' 0 C--O 1.253 1.265 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 69.5 mt -58.38 -30.15 39.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.165 -1.379 . . . . 0.0 111.788 -175.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.597 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 28.3 mmt180 -89.5 -32.69 17.07 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.414 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.12 -66.55 0.91 Allowed 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.423 -172.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -94.59 -3.06 50.34 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.762 0.792 . . . . 0.0 110.154 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 47.9 mttp 61.84 65.44 0.92 Allowed 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 113.801 -1.545 . . . . 0.0 112.552 173.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.401 ' H ' ' HA ' ' A' ' 26' ' ' ILE . . . -92.91 -177.53 4.54 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.401 177.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -99.43 -26.95 13.96 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.316 178.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 81.0 t60 -153.03 176.19 12.16 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -174.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.74 142.27 7.5 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 107.871 -2.091 . . . . 0.0 107.871 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.0 m -155.29 154.01 31.45 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 118.019 0.909 . . . . 0.0 111.064 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 76.1 m -87.08 91.23 8.63 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 122.397 1.094 . . . . 0.0 109.389 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -79.45 129.96 34.96 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.652 -1.613 . . . . 0.0 107.818 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.415 ' HB2' ' CD2' ' A' ' 43' ' ' HIS . 25.2 t80 -79.31 109.65 13.85 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.202 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.4 m -125.0 -170.69 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.528 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 68.4 t80 -77.65 131.25 71.45 Favored Pre-proline 0 C--N 1.287 -2.117 0 C-N-CA 118.737 -1.185 . . . . 0.0 108.878 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 87.0 Cg_endo -109.66 18.72 4.85 Favored 'Cis proline' 0 CA--C 1.546 1.109 0 C-N-CA 124.855 -0.894 . . . . 0.0 112.55 -2.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.64 -178.73 6.75 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 120.846 0.355 . . . . 0.0 110.958 -173.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 49.0 m80 -73.8 113.54 11.07 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -119.38 136.47 54.26 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 6.9 t -79.62 115.26 19.13 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.531 0.681 . . . . 0.0 110.583 -173.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.487 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 22.5 mm -112.27 141.11 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.43 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 5' ' ' GLN . 51.7 m -83.61 144.3 29.54 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.507 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 63.5 m-85 -119.09 118.35 31.18 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.499 0.666 . . . . 0.0 111.643 -177.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -100.59 163.49 18.04 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.081 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -88.06 126.12 1.99 Allowed 'Trans proline' 0 N--CA 1.441 -1.586 0 C-N-CA 122.136 1.89 . . . . 0.0 111.667 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 69.6 m . . . . . 0 C--N 1.294 -1.829 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.662 177.554 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 . . . . . 0 CA--C 1.496 -1.097 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -96.12 175.55 6.42 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.2 mt -118.86 130.56 55.81 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 66.8 m -108.81 133.38 52.93 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 175.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.552 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 17.5 pt20 -94.52 134.84 36.63 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.658 0.742 . . . . 0.0 112.305 -177.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -137.53 120.77 11.54 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.634 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -66.72 132.94 30.1 Favored 'Trans proline' 0 C--O 1.246 0.88 0 C-N-CA 122.146 1.897 . . . . 0.0 109.415 172.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -118.43 160.36 21.84 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.496 -174.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.0 -12.52 76.68 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.263 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.9 p -71.01 -43.8 67.2 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.526 0.679 . . . . 0.0 109.592 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.415 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 3.9 t90 -64.97 140.21 58.84 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.261 171.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.8 t -146.07 119.61 9.11 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.064 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.19 -135.12 11.99 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 114.887 0.715 . . . . 0.0 114.887 172.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.8 p -108.31 168.4 3.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.7 t -59.29 118.26 5.74 Favored 'General case' 0 C--O 1.25 1.109 0 C-N-CA 123.495 0.718 . . . . 0.0 112.642 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.47 -76.7 1.05 Allowed Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 171.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -143.32 138.21 29.35 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -50.81 -54.91 19.68 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.205 1.002 . . . . 0.0 112.408 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.403 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 29.5 p-10 -70.23 -32.22 69.99 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.597 -177.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.29 -49.13 68.14 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.825 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 24' ' ' GLN . 11.0 p -76.53 -22.9 53.77 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 119.205 -0.998 . . . . 0.0 112.287 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 19' ' ' ASN . 28.2 ttpp -57.87 -53.42 58.39 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -58.78 -42.3 88.69 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.898 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 0.8 OUTLIER -55.98 -39.29 71.59 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.457 0.473 . . . . 0.0 111.268 177.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 89.4 m -68.91 -51.48 39.61 Favored 'General case' 0 C--O 1.255 1.373 0 CA-C-O 121.993 0.902 . . . . 0.0 108.869 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.5 mt -57.01 -36.6 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.702 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -73.6 -32.3 64.03 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.0 mt -100.01 -57.1 2.2 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.19 -1.004 . . . . 0.0 113.265 -170.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -105.79 -10.35 16.76 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 120.026 -0.669 . . . . 0.0 111.605 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.8 mttm 72.26 68.97 0.14 Allowed 'General case' 0 C--N 1.319 -0.733 0 O-C-N 124.355 1.035 . . . . 0.0 111.498 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.49 175.71 7.82 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -98.66 -27.3 14.05 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.14 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 79.9 t60 -151.66 173.82 14.23 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.22 141.68 6.96 Favored Glycine 0 C--N 1.283 -2.367 0 N-CA-C 106.457 -2.657 . . . . 0.0 106.457 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.5 t -159.54 165.33 33.16 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 118.387 1.094 . . . . 0.0 110.069 -177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 43' ' ' HIS . 44.7 m -86.61 102.59 14.31 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.73 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -95.76 145.7 25.11 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -79.4 118.66 21.5 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.826 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.3 m -128.11 176.94 6.69 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.821 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 172.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 69.5 t80 -80.34 129.35 69.68 Favored Pre-proline 0 C--N 1.281 -2.383 0 C-N-CA 119.184 -1.006 . . . . 0.0 109.288 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 30.3 Cg_endo -106.25 9.81 8.59 Favored 'Cis proline' 0 CA--C 1.549 1.228 0 C-N-CA 124.628 -0.988 . . . . 0.0 113.984 -0.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -151.07 169.41 21.91 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.707 0.289 . . . . 0.0 110.609 -175.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 73.7 m80 -66.22 122.96 18.64 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.929 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.415 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 56.0 mttm -123.69 153.26 41.08 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.268 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 86.9 m -83.23 113.33 20.6 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.393 0.616 . . . . 0.0 111.081 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.424 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 33.2 mm -109.56 138.05 38.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 60.5 m -88.43 136.04 33.18 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.552 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 34.7 m-85 -107.83 124.69 50.45 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.421 0.629 . . . . 0.0 110.355 -177.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -108.83 153.41 42.38 Favored Pre-proline 0 C--N 1.292 -1.895 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.188 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -77.7 133.52 12.85 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 122.21 1.94 . . . . 0.0 113.03 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 81.7 m . . . . . 0 C--N 1.294 -1.817 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.823 178.501 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 CA--C 1.507 -0.692 0 CA-C-O 121.379 0.609 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 2' ' ' LYS . 73.4 mmtt -121.71 -172.9 2.52 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 174.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -110.6 120.19 41.61 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.114 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 31.3 m -93.66 116.68 29.18 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.49 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 4.3 pt20 -85.89 119.62 26.41 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -133.19 129.03 20.71 Favored Pre-proline 0 C--N 1.307 -1.244 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.118 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -72.46 134.61 22.83 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.898 1.732 . . . . 0.0 109.575 173.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.0 m -116.03 160.34 20.42 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.17 -15.11 75.35 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.235 -0.438 . . . . 0.0 112.036 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 p -69.63 -51.07 38.2 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.493 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 2.2 t90 -58.77 136.67 57.81 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.379 171.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.2 p -148.85 129.66 14.22 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.868 173.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.42 -173.32 27.23 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-O 121.656 0.587 . . . . 0.0 114.258 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.3 t -81.41 148.38 5.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.3 t -67.35 112.55 4.64 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 123.303 0.377 . . . . 0.0 111.145 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.1 -50.46 1.91 Allowed Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -123.13 117.16 24.75 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.534 ' HA ' ' SG ' ' A' ' 36' ' ' CYS . 13.2 m120 -57.79 -52.35 65.83 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 124.163 0.915 . . . . 0.0 110.748 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -66.47 -24.69 66.46 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.366 -0.833 . . . . 0.0 113.004 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.05 -57.77 4.6 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 123.051 0.219 . . . . 0.0 110.591 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.4 p -69.95 -30.36 67.73 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.41 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 38.1 ttmt -53.89 -57.31 11.4 Favored 'General case' 0 C--O 1.251 1.135 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -60.71 -39.12 87.42 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.329 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -60.33 -41.27 93.22 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.808 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.4 m -63.63 -52.33 61.29 Favored 'General case' 0 C--O 1.257 1.476 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 66.4 mt -55.95 -30.29 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.173 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -87.13 -33.9 19.28 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.2 mt -96.61 -47.65 5.83 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.196 -1.002 . . . . 0.0 113.352 -169.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -107.51 -5.93 17.32 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 120.906 0.384 . . . . 0.0 110.73 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 99.7 mttt 64.55 54.85 1.4 Allowed 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.7 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.53 159.85 33.25 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -81.84 -29.55 32.51 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.933 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -156.46 174.8 14.9 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 22' ' ' LYS . . . -153.59 144.01 10.82 Favored Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 107.634 -2.186 . . . . 0.0 107.634 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.545 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 41.7 t -154.52 148.99 26.23 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 117.899 0.849 . . . . 0.0 109.31 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.534 ' SG ' ' HA ' ' A' ' 18' ' ' ASN . 60.6 m -87.35 108.21 18.88 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.842 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -94.37 137.97 32.88 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.737 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -81.72 116.22 21.33 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.4 m -126.13 -178.99 2.28 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 66.8 t80 -84.03 134.0 44.59 Favored Pre-proline 0 C--N 1.287 -2.14 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.655 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 61.9 Cg_endo -96.61 -7.66 23.31 Favored 'Cis proline' 0 CA--C 1.547 1.141 0 C-N-CA 124.213 -1.161 . . . . 0.0 113.27 -4.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.55 168.02 20.76 Favored 'General case' 0 C--O 1.25 1.109 0 O-C-N 122.366 -0.209 . . . . 0.0 111.293 -176.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -59.76 131.15 50.01 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.237 1.015 . . . . 0.0 112.186 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.493 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 39.8 mmtm -117.7 154.93 30.83 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.479 ' HB2' ' CD1' ' A' ' 11' ' ' TRP . 85.0 m -87.13 107.65 18.55 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.443 0.64 . . . . 0.0 109.622 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.445 HG21 ' HB2' ' A' ' 5' ' ' GLN . 42.9 mm -104.4 135.39 42.43 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 33.9 m -91.5 132.93 35.93 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.545 ' CE1' ' HB3' ' A' ' 35' ' ' SER . 27.6 m-85 -105.93 120.1 40.88 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.543 0.687 . . . . 0.0 110.671 -176.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -102.58 161.42 23.3 Favored Pre-proline 0 C--N 1.288 -2.079 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.312 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -80.76 119.72 3.71 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 121.552 1.501 . . . . 0.0 112.704 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 56.8 m . . . . . 0 C--N 1.312 -1.06 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 174.589 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 . . . . . 0 C--O 1.24 0.557 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -100.95 165.97 11.06 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 82.9 mt -113.4 121.07 43.23 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 121.047 0.451 . . . . 0.0 109.964 177.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 80.9 m -94.89 132.09 40.08 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.492 ' HB3' HG21 ' A' ' 46' ' ' ILE . 16.1 mt-30 -83.39 146.22 28.58 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.235 0.54 . . . . 0.0 111.691 -174.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -131.83 101.81 15.23 Favored Pre-proline 0 C--N 1.291 -1.954 0 C-N-CA 124.111 0.964 . . . . 0.0 108.904 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.62 -74.29 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.127 1.885 . . . . 0.0 113.895 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.5 m -100.63 83.56 2.61 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -170.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.11 -71.36 0.25 Allowed Glycine 0 N--CA 1.427 -1.926 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 172.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.569 HG21 ' HA ' ' A' ' 25' ' ' CYS . 5.6 t -103.69 -30.17 10.6 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 120.808 0.337 . . . . 0.0 110.902 173.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.57 ' CZ2' ' HB2' ' A' ' 44' ' ' LYS . 27.0 t90 -59.96 127.75 33.47 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.5 m -157.41 109.39 2.38 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 125.239 1.415 . . . . 0.0 107.944 171.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.01 -166.36 24.04 Favored Glycine 0 N--CA 1.438 -1.224 0 C-N-CA 119.662 -1.256 . . . . 0.0 113.431 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.1 t -83.38 150.54 4.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 17.5 t -94.91 100.85 12.63 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.09 -55.54 1.37 Allowed Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.085 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -121.61 121.97 38.59 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.907 0.384 . . . . 0.0 110.519 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -63.19 -42.33 99.31 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.984 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -73.75 -21.98 60.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.156 0.503 . . . . 0.0 110.835 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.81 -51.09 20.33 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.651 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.6 p -73.3 -31.3 63.95 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.966 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -54.55 -57.51 11.12 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -56.8 -40.13 75.39 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.957 177.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -64.33 -37.97 89.38 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.569 ' HA ' HG21 ' A' ' 10' ' ' THR . 72.8 m -63.06 -53.53 52.23 Favored 'General case' 0 C--O 1.256 1.419 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 73.0 mt -55.45 -37.09 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 113.967 -1.47 . . . . 0.0 111.441 -178.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -83.14 -27.56 30.02 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -98.13 -57.47 2.21 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -108.25 -0.51 20.82 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.065 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 62.1 mttp 67.14 47.22 1.38 Allowed 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 113.94 -1.482 . . . . 0.0 113.077 173.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.69 177.08 8.91 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.893 -1.048 . . . . 0.0 108.231 175.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -99.69 -27.29 13.74 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.538 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -149.19 170.35 18.66 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -175.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.14 138.52 4.96 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.5 m -163.14 162.48 25.64 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 117.437 0.619 . . . . 0.0 109.941 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 38.1 m -59.36 118.26 5.77 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 175.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -124.27 96.1 4.79 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -90.56 110.59 21.72 Favored 'General case' 0 N--CA 1.421 -1.922 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.063 -177.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.1 m -127.62 159.99 37.55 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 171.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.522 ' CD1' ' HA ' ' A' ' 41' ' ' PRO . 89.2 t80 -61.55 138.16 94.96 Favored Pre-proline 0 C--N 1.309 -1.18 0 O-C-N 123.79 0.681 . . . . 0.0 109.768 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.522 ' HA ' ' CD1' ' A' ' 40' ' ' PHE . 7.0 Cg_exo -74.74 -57.02 0.14 OUTLIER 'Cis proline' 0 C--N 1.35 0.625 0 C-N-CA 123.999 -1.25 . . . . 0.0 112.943 1.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -155.62 101.76 2.18 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.443 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -108.63 160.42 15.94 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.014 0.435 . . . . 0.0 110.639 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.57 ' HB2' ' CZ2' ' A' ' 11' ' ' TRP . 4.0 mptp? -116.42 -142.09 0.37 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -176.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.615 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 33.6 t -68.5 126.8 30.8 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 118.345 0.521 . . . . 0.0 109.981 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.492 HG21 ' HB3' ' A' ' 5' ' ' GLN . 41.5 mm -120.11 135.77 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.316 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 56.1 m -82.97 160.24 22.07 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.449 ' CE1' ' HG2' ' A' ' 5' ' ' GLN . 98.5 m-85 -129.58 127.64 41.09 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 120.844 0.354 . . . . 0.0 111.468 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -106.53 148.93 37.67 Favored Pre-proline 0 C--N 1.305 -1.33 0 C-N-CA 123.936 0.894 . . . . 0.0 109.836 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.47 129.47 6.59 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.674 2.249 . . . . 0.0 112.363 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 82.8 m . . . . . 0 N--CA 1.427 -1.603 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.6 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 . . . . . 0 C--O 1.242 0.663 0 CA-C-O 122.048 0.928 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 51' ' ' CYS . 3.7 mptp? -112.79 -178.62 3.44 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 174.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -111.68 112.55 24.33 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.621 0.724 . . . . 0.0 111.155 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 70.8 m -86.99 111.12 20.54 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.618 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 3.8 pt20 -76.11 135.82 39.85 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.487 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.475 ' HD3' ' CE1' ' A' ' 49' ' ' PHE . 51.9 ttt180 -146.38 116.3 4.66 Favored Pre-proline 0 C--N 1.296 -1.753 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.555 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -79.17 86.14 1.74 Allowed 'Trans proline' 0 N--CA 1.438 -1.759 0 C-N-CA 122.058 1.839 . . . . 0.0 109.06 173.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.48 ' HB3' ' OE2' ' A' ' 29' ' ' GLU . 61.6 m -69.49 160.06 32.13 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.419 -176.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.58 -9.79 82.7 Favored Glycine 0 CA--C 1.502 -0.727 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.524 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.505 HG21 ' HB3' ' A' ' 28' ' ' LEU . 4.1 p -68.78 -44.62 73.24 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.48 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 2.8 t90 -66.75 132.46 48.14 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.199 169.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.9 t -145.99 112.02 5.69 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.14 -145.87 15.89 Favored Glycine 0 N--CA 1.425 -2.094 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.787 176.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 p -118.43 162.68 16.31 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.8 t -67.07 134.56 52.11 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.7 -49.58 0.31 Allowed Glycine 0 N--CA 1.421 -2.315 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 173.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -145.99 120.14 9.49 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.185 0.594 . . . . 0.0 110.129 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -55.24 -52.74 62.41 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.072 0.949 . . . . 0.0 111.925 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -65.61 -31.58 72.69 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.935 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.42 -44.28 65.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.503 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.3 p -76.53 -32.18 58.08 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.181 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -54.9 -54.87 37.03 Favored 'General case' 0 C--O 1.253 1.239 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.509 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 47.4 t30 -57.36 -44.39 84.3 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.672 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -56.24 -43.0 78.22 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.264 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.8 m -63.62 -48.8 75.84 Favored 'General case' 0 C--O 1.271 2.224 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 64.9 mt -59.94 -37.73 73.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 114.24 -1.345 . . . . 0.0 111.372 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 31.7 mmt180 -81.47 -19.98 41.21 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.505 ' HB3' HG21 ' A' ' 10' ' ' THR . 4.6 mm? -98.01 -63.61 1.11 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.209 -176.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.48 ' OE2' ' HB3' ' A' ' 8' ' ' SER . 8.3 pt-20 -113.29 3.47 15.96 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.3 0.571 . . . . 0.0 111.685 -177.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 94.4 mttt 67.92 63.74 0.39 Allowed 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 114.613 -1.176 . . . . 0.0 112.421 174.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' HG12 ' A' ' 26' ' ' ILE . . . -81.07 177.48 9.02 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 173.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -96.01 -41.09 8.93 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -147.15 176.33 10.04 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -173.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.7 143.5 8.9 Favored Glycine 0 C--N 1.307 -1.059 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 m -149.03 152.84 36.96 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 118.466 1.133 . . . . 0.0 110.895 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 76.0 m -89.13 100.4 13.19 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.501 0.667 . . . . 0.0 109.697 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -93.03 134.38 35.22 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.454 -175.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -78.34 110.64 13.55 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 121.513 0.673 . . . . 0.0 110.15 177.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.44 175.46 10.91 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 174.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 48.2 t80 -77.15 137.7 64.96 Favored Pre-proline 0 C--N 1.28 -2.434 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 175.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 63.0 Cg_endo -101.67 7.17 18.49 Favored 'Cis proline' 0 CA--C 1.546 1.108 0 C-N-CA 124.195 -1.169 . . . . 0.0 113.138 -2.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.85 171.3 20.31 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -176.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -65.42 117.23 7.64 Favored 'General case' 0 C--O 1.24 0.576 0 O-C-N 123.551 0.532 . . . . 0.0 111.172 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 95.1 mttt -109.29 146.55 34.11 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 22.4 t -92.87 117.11 29.68 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.86 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.598 HG21 ' HB2' ' A' ' 5' ' ' GLN . 25.0 mm -101.44 134.49 41.58 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 66.5 m -84.75 136.78 33.56 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.618 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 77.9 m-85 -113.1 122.96 49.14 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.473 0.654 . . . . 0.0 110.925 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.475 ' CE1' ' HD3' ' A' ' 6' ' ' ARG . 81.4 m-85 -107.98 156.53 38.07 Favored Pre-proline 0 C--N 1.288 -2.093 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.709 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -77.66 126.86 8.44 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 121.638 1.558 . . . . 0.0 112.701 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 2' ' ' LYS . 12.2 m . . . . . 0 C--N 1.294 -1.843 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 172.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 . . . . . 0 CA--C 1.509 -0.614 0 CA-C-O 120.938 0.399 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -161.52 144.97 12.59 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 175.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 86.6 mt -80.53 110.89 16.44 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.0 p -102.22 129.97 48.76 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.862 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.487 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 4.0 pt20 -78.76 140.64 38.23 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.35 0.595 . . . . 0.0 111.054 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -137.23 127.93 16.07 Favored Pre-proline 0 C--N 1.282 -2.329 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.26 106.24 0.14 Allowed 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 122.698 2.265 . . . . 0.0 109.751 174.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.603 ' HB2' ' HB3' ' A' ' 11' ' ' TRP . 1.5 m -53.94 133.38 43.13 Favored 'General case' 0 N--CA 1.417 -2.101 0 C-N-CA 125.806 1.642 . . . . 0.0 111.461 -176.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.93 -32.04 6.36 Favored Glycine 0 N--CA 1.428 -1.879 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.985 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -74.53 -38.05 62.89 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 120.708 0.29 . . . . 0.0 110.659 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.603 ' HB3' ' HB2' ' A' ' 8' ' ' SER . 1.7 t90 -58.97 132.91 55.42 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.466 0.706 . . . . 0.0 111.654 174.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.1 p -156.46 97.58 1.76 Allowed 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.22 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.98 -156.48 26.71 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -91.72 150.94 3.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 41.1 t -93.51 101.07 13.25 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 173.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.66 -35.88 7.63 Favored Glycine 0 N--CA 1.429 -1.817 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.654 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -133.62 128.47 35.19 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-O 120.906 0.384 . . . . 0.0 110.964 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -60.39 -47.57 85.49 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.402 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.4 p30 -63.46 -36.69 84.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.219 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.73 -47.41 63.2 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.345 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.9 p -76.17 -25.36 55.16 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.46 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -54.81 -57.72 10.45 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -62.83 -36.67 83.98 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.132 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -61.03 -41.71 97.08 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 122.846 0.459 . . . . 0.0 109.815 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.3 m -64.81 -56.04 15.9 Favored 'General case' 0 C--O 1.257 1.488 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 77.0 mt -54.16 -36.42 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.425 1.49 . . . . 0.0 112.251 -176.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 27' ' ' ARG . 52.0 mtt180 -87.18 -25.07 24.24 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . 0.264 7.3 mp -104.35 -50.98 3.2 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 117.983 -1.487 . . . . 0.0 113.63 -174.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -109.24 1.98 20.58 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.305 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 27.7 mtpp 59.39 63.01 1.65 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 125.773 1.629 . . . . 0.0 114.034 174.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.25 179.73 7.7 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.375 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -94.32 -30.45 14.52 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 80.9 t60 -156.41 174.0 16.06 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -165.23 150.86 19.22 Favored Glycine 0 C--N 1.304 -1.237 0 N-CA-C 107.868 -2.093 . . . . 0.0 107.868 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.0 t -167.04 151.84 7.26 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 118.31 1.055 . . . . 0.0 112.06 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 38.5 m -63.62 117.37 6.7 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 170.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -119.03 -22.04 7.42 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.724 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.505 ' HB3' ' H ' ' A' ' 44' ' ' LYS . 32.8 t80 -92.58 179.0 5.64 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.419 ' HA ' ' CD2' ' A' ' 43' ' ' HIS . 20.3 m -124.41 -162.46 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 124.069 0.948 . . . . 0.0 109.191 -172.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.531 ' CG ' ' HA ' ' A' ' 41' ' ' PRO . 66.5 t80 -59.86 144.45 85.91 Favored Pre-proline 0 C--N 1.312 -1.057 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.531 ' HA ' ' CG ' ' A' ' 40' ' ' PHE . 1.6 Cg_endo -86.78 -15.45 29.41 Favored 'Cis proline' 0 C--O 1.239 0.535 0 C-N-CA 124.287 -1.13 . . . . 0.0 114.336 3.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.465 ' O ' ' HD2' ' A' ' 38' ' ' TYR . . . -126.6 93.73 3.86 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -174.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.419 ' CD2' ' HA ' ' A' ' 39' ' ' VAL . 72.9 m80 -64.96 104.42 0.86 Allowed 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 175.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.505 ' H ' ' HB3' ' A' ' 38' ' ' TYR . 45.7 mtmt -92.86 149.26 21.38 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.496 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 41.9 t -98.75 131.12 45.14 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 175.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.437 HG21 ' HB2' ' A' ' 5' ' ' GLN . 16.4 mm -113.02 137.36 46.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 73.1 m -89.38 141.31 28.67 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -177.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.487 ' CE2' ' HB3' ' A' ' 5' ' ' GLN . 62.1 m-85 -111.22 126.38 54.81 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.22 0.533 . . . . 0.0 110.588 -178.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -113.93 161.46 27.75 Favored Pre-proline 0 C--N 1.286 -2.158 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.149 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -86.21 112.81 1.16 Allowed 'Trans proline' 0 N--CA 1.436 -1.868 0 C-N-CA 121.993 1.795 . . . . 0.0 111.692 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 47.8 m . . . . . 0 C--N 1.285 -2.238 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.046 175.929 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 . . . . . 0 CA--C 1.507 -0.71 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -84.9 128.32 34.57 Favored 'General case' 0 C--O 1.256 1.421 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.296 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 95.1 mt -99.15 119.33 37.68 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.652 177.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.3 m -73.68 120.54 19.42 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.42 ' HB2' HG21 ' A' ' 46' ' ' ILE . 19.6 pt20 -91.97 139.34 30.74 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.062 0.458 . . . . 0.0 110.479 -176.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -145.4 121.68 5.97 Favored Pre-proline 0 N--CA 1.431 -1.391 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.024 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -76.08 86.39 1.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.859 1.706 . . . . 0.0 108.882 171.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.416 ' HB3' ' OE1' ' A' ' 29' ' ' GLU . 61.4 m -75.38 160.86 29.79 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.673 -173.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.64 -6.09 85.96 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.421 -0.809 . . . . 0.0 113.68 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 p -70.93 -58.65 3.38 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.51 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 2.8 t90 -59.65 143.29 50.98 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.793 168.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.4 m -149.87 123.77 9.32 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 119.29 -122.98 5.5 Favored Glycine 0 C--O 1.247 0.915 0 C-N-CA 120.257 -0.973 . . . . 0.0 113.689 176.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.3 p -134.03 170.06 20.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.6 t -67.48 109.96 3.43 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 118.013 0.37 . . . . 0.0 110.414 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.87 -57.36 0.92 Allowed Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 176.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -138.93 118.7 13.14 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -50.36 -50.03 52.44 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.984 0.914 . . . . 0.0 110.898 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -60.64 -36.41 78.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.863 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.15 -47.55 35.19 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.457 -173.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.3 p -75.48 -32.52 60.61 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -56.45 -54.5 44.95 Favored 'General case' 0 C--O 1.253 1.254 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 173.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.51 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 64.1 t30 -59.24 -43.54 92.38 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.744 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -58.06 -36.92 73.48 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.139 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.2 m -68.25 -54.4 17.91 Favored 'General case' 0 C--O 1.258 1.537 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 69.8 mt -60.08 -32.87 51.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.242 -174.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 30.4 mmt180 -91.46 -17.47 25.7 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -104.48 -52.07 2.97 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 118.833 -1.147 . . . . 0.0 112.558 -174.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.416 ' OE1' ' HB3' ' A' ' 8' ' ' SER . 9.0 pt-20 -109.09 -8.44 15.17 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.706 0.765 . . . . 0.0 109.986 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.588 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 53.9 mtmt 69.14 63.36 0.29 Allowed 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 113.906 -1.497 . . . . 0.0 112.155 176.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.38 169.91 16.64 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 114.656 -1.157 . . . . 0.0 109.098 176.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.401 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 28.8 tpt180 -88.61 -34.23 17.37 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.934 0.873 . . . . 0.0 108.674 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -152.02 171.62 17.55 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.287 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.29 137.16 4.59 Favored Glycine 0 N--CA 1.424 -2.151 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 177.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.1 p -161.77 174.88 12.6 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 117.751 0.775 . . . . 0.0 111.232 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 51.3 m -90.13 109.48 20.54 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.153 0.501 . . . . 0.0 110.025 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -101.06 143.72 30.85 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.525 ' CZ ' ' HA ' ' A' ' 42' ' ' ALA . 3.9 t80 -87.21 111.27 20.83 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 118.961 -1.095 . . . . 0.0 109.468 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.3 m -125.46 -171.58 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 78.1 t80 -78.72 132.75 63.86 Favored Pre-proline 0 C--N 1.294 -1.848 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.704 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 60.2 Cg_endo -101.87 5.92 18.02 Favored 'Cis proline' 0 CA--C 1.544 0.98 0 C-N-CA 124.46 -1.058 . . . . 0.0 112.979 -2.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 38' ' ' TYR . . . -158.62 -173.09 4.11 Favored 'General case' 0 C--O 1.244 0.816 0 C-N-CA 122.37 0.268 . . . . 0.0 110.577 -175.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -67.87 122.34 17.95 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.331 0.586 . . . . 0.0 110.214 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.474 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 68.4 mttm -124.93 153.06 43.28 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.51 ' HB2' ' CD1' ' A' ' 11' ' ' TRP . 97.0 m -80.14 114.55 19.13 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.474 0.654 . . . . 0.0 110.318 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.42 HG21 ' HB2' ' A' ' 5' ' ' GLN . 50.7 mm -111.23 135.85 49.12 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.696 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 61.3 m -87.63 139.92 30.04 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.455 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 88.6 m-85 -117.48 129.2 55.67 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.441 0.639 . . . . 0.0 111.305 -176.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -114.61 157.69 42.17 Favored Pre-proline 0 C--N 1.286 -2.177 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.401 ' HD3' ' HB2' ' A' ' 32' ' ' ARG . 30.6 Cg_endo -79.51 127.35 7.25 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.354 1.369 . . . . 0.0 110.758 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 73.8 m . . . . . 0 C--N 1.315 -0.905 0 O-C-N 122.097 -0.377 . . . . 0.0 111.334 -179.161 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 . . . . . 0 CA--C 1.506 -0.721 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -108.49 131.92 54.33 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.482 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 89.8 mt -88.77 101.69 14.27 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 48' ' ' TYR . 64.5 m -83.3 133.88 34.95 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.913 -175.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.406 ' HB2' HG21 ' A' ' 46' ' ' ILE . 4.3 pt20 -81.17 132.96 35.38 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.973 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -144.15 125.31 7.92 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.87 135.01 49.51 Favored 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.628 2.219 . . . . 0.0 110.896 176.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.781 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . 5.9 p -90.03 160.45 16.33 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -176.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.13 -13.61 38.8 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.5 t -81.86 -37.94 26.17 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.158 0.504 . . . . 0.0 109.953 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.565 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 1.6 t90 -82.09 145.17 30.31 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 173.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 t -157.32 95.6 1.48 Allowed 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.35 -140.48 8.82 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.724 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 p -104.4 170.98 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.3 t -58.99 133.6 56.23 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 123.253 0.621 . . . . 0.0 112.656 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.99 -76.05 0.9 Allowed Glycine 0 N--CA 1.426 -1.979 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 173.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -142.5 130.54 21.89 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -48.42 -57.4 6.13 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.459 1.104 . . . . 0.0 112.105 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -66.56 -31.51 72.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.993 -174.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.18 -48.12 68.91 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.755 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.527 ' HA ' ' HB3' ' A' ' 24' ' ' GLN . 5.6 p -78.6 -23.55 45.92 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -58.53 -55.14 38.85 Favored 'General case' 0 C--O 1.256 1.44 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -57.95 -46.27 85.34 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.067 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.527 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 61.6 tt0 -55.82 -40.56 72.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.762 178.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 97.0 m -62.98 -57.35 11.03 Favored 'General case' 0 C--O 1.257 1.492 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.1 mt -55.0 -39.59 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 114.141 -1.39 . . . . 0.0 111.465 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -79.44 -26.45 41.79 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.4 -55.99 2.24 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 118.558 -1.257 . . . . 0.0 113.177 -174.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -108.05 2.25 22.98 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.46 -0.896 . . . . 0.0 111.8 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 61.48 59.3 1.9 Allowed 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 114.561 -1.199 . . . . 0.0 112.367 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -84.07 175.44 9.51 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 175.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.455 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 26.2 tpt180 -85.81 -41.34 15.12 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -147.54 173.43 12.7 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -177.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.27 149.56 15.67 Favored Glycine 0 CA--C 1.476 -2.396 0 N-CA-C 107.036 -2.425 . . . . 0.0 107.036 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.3 t -169.88 173.38 6.14 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 118.544 1.172 . . . . 0.0 109.432 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.517 ' HB3' ' HB3' ' A' ' 43' ' ' HIS . 75.4 m -78.32 92.06 4.5 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.611 0.72 . . . . 0.0 110.215 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -80.11 144.56 32.98 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -95.97 119.07 33.8 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.995 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.09 171.0 16.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 175.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 79.0 t80 -77.13 131.71 72.03 Favored Pre-proline 0 C--N 1.289 -2.033 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 175.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 71.6 Cg_endo -106.71 12.66 8.09 Favored 'Cis proline' 0 CA--C 1.546 1.103 0 C-N-CA 124.485 -1.048 . . . . 0.0 113.551 -1.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -150.76 170.71 18.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.957 0.408 . . . . 0.0 111.114 -174.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.517 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 70.1 m80 -76.13 136.76 39.82 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.566 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.565 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 98.6 mttt -131.97 152.31 51.19 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 11' ' ' TRP . 71.2 m -82.51 98.27 8.85 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.942 0.877 . . . . 0.0 111.519 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.406 HG21 ' HB2' ' A' ' 5' ' ' GLN . 50.8 mm -105.62 138.47 30.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.781 ' SG ' ' HB3' ' A' ' 8' ' ' SER . 60.6 m -91.73 154.63 18.84 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -177.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.482 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 84.8 m-85 -122.31 129.43 52.17 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -111.58 152.68 44.19 Favored Pre-proline 0 C--N 1.286 -2.155 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.455 ' HD3' ' HB2' ' A' ' 32' ' ' ARG . 70.7 Cg_endo -79.6 133.98 10.78 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.104 1.87 . . . . 0.0 112.256 -175.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 67.6 m . . . . . 0 C--N 1.291 -1.957 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.745 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 . . . . . 0 C--O 1.237 0.433 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -103.41 157.05 17.3 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 174.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 78.1 mt -114.1 115.49 27.62 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-O 121.195 0.522 . . . . 0.0 110.181 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.3 m -89.76 117.18 28.42 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.441 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -72.04 139.54 48.56 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.712 -175.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.421 ' HD3' ' OE1' ' A' ' 29' ' ' GLU . 51.6 ttt180 -142.16 108.18 5.78 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 175.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -72.27 -62.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.01 1.807 . . . . 0.0 112.904 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.2 m -91.79 101.0 13.59 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.746 0.784 . . . . 0.0 112.683 -172.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.62 -71.4 0.04 OUTLIER Glycine 0 C--N 1.286 -2.196 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 172.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.465 HG22 ' OE2' ' A' ' 29' ' ' GLU . 8.1 t -112.75 -30.26 7.13 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.077 -0.562 . . . . 0.0 109.946 172.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.425 ' CZ2' ' HB2' ' A' ' 44' ' ' LYS . 48.1 t90 -55.71 129.79 40.65 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.389 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 m -140.5 89.43 2.28 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.049 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 56.05 45.63 86.72 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 115.495 0.958 . . . . 0.0 115.495 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.9 t -120.31 124.12 71.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 117.232 0.516 . . . . 0.0 111.932 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.555 ' HB2' ' HB3' ' A' ' 44' ' ' LYS . 42.4 t -141.72 82.75 1.82 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 167.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.69 -82.99 0.08 OUTLIER Glycine 0 N--CA 1.426 -2.0 0 C-N-CA 120.471 -0.871 . . . . 0.0 110.944 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -88.29 96.28 10.51 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.546 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 2.6 m-20 -58.56 -44.0 89.57 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.261 0.624 . . . . 0.0 112.153 -176.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -67.43 -28.84 68.23 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.131 0.491 . . . . 0.0 110.893 -178.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.26 -39.35 23.11 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.901 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.546 ' SG ' ' HA ' ' A' ' 18' ' ' ASN . 21.5 p -71.45 -31.13 66.82 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.178 177.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -58.06 -53.01 63.06 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 172.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 55.1 t30 -57.59 -43.79 84.88 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.773 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -57.07 -40.7 77.41 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.447 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 71.2 m -63.08 -54.37 39.1 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 62.3 mt -56.16 -37.41 49.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 124.626 1.17 . . . . 0.0 111.027 -177.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 23' ' ' ASN . 25.2 mmt180 -83.52 -23.06 32.25 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -177.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.58 -49.33 3.18 Favored 'General case' 0 CA--C 1.501 -0.934 0 C-N-CA 119.017 -1.073 . . . . 0.0 112.961 -175.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.465 ' OE2' HG22 ' A' ' 10' ' ' THR . 12.5 pt-20 -107.31 -4.8 18.28 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.128 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 55.2 mtmt 66.12 41.56 3.51 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.029 176.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -72.13 164.48 26.12 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.148 175.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.424 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 13.3 tpp180 -95.18 -22.09 18.06 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.368 0.604 . . . . 0.0 110.193 -175.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -155.11 170.15 22.48 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.86 141.38 5.98 Favored Glycine 0 CA--C 1.482 -2.003 0 N-CA-C 107.562 -2.215 . . . . 0.0 107.562 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.3 t -175.79 168.48 3.06 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 86.1 m -63.51 106.67 0.98 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.835 0.826 . . . . 0.0 110.065 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -109.29 95.17 5.45 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -84.58 106.76 16.39 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.284 -176.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.0 m -130.79 162.4 38.94 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 172.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -59.54 140.67 88.75 Favored Pre-proline 0 C--N 1.305 -1.349 0 O-C-N 124.285 0.991 . . . . 0.0 109.669 178.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -74.6 -52.68 0.16 OUTLIER 'Cis proline' 0 N--CA 1.474 0.352 0 C-N-CA 124.018 -1.243 . . . . 0.0 111.952 -1.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -156.68 96.23 1.62 Allowed 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -98.43 159.08 15.18 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.402 0.62 . . . . 0.0 111.4 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 15' ' ' CYS . 33.7 mmtp -120.34 -144.2 0.35 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -174.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 99.0 m -60.55 111.05 1.44 Allowed 'General case' 0 C--O 1.203 -1.389 0 CA-C-N 118.661 0.664 . . . . 0.0 110.208 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 44' ' ' LYS . 49.9 mm -110.71 137.7 41.99 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 59.6 m -86.56 148.52 25.47 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.488 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 92.2 m-85 -123.79 132.26 53.75 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 122.113 -0.367 . . . . 0.0 110.43 -177.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -105.97 148.79 37.18 Favored Pre-proline 0 C--N 1.285 -2.221 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.514 175.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.424 ' HD3' ' HB2' ' A' ' 32' ' ' ARG . 69.8 Cg_endo -78.28 132.18 11.19 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 122.256 1.971 . . . . 0.0 112.259 -176.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 74.2 m . . . . . 0 C--N 1.284 -2.246 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.555 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 . . . . . 0 CA--C 1.508 -0.669 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -83.22 147.59 27.92 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 88.5 mt -93.2 99.99 12.45 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.33 0.586 . . . . 0.0 109.872 176.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.8 m -89.74 118.64 29.49 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.561 ' HB2' HG21 ' A' ' 46' ' ' ILE . 3.8 pt20 -81.89 138.44 35.02 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -173.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -133.38 118.28 14.82 Favored Pre-proline 0 C--N 1.308 -1.201 0 C-N-CA 125.161 1.384 . . . . 0.0 108.121 178.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.25 -63.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.732 1.621 . . . . 0.0 113.035 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.6 p -88.63 128.06 35.58 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -172.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.07 -75.28 0.06 OUTLIER Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 177.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.8 t -104.22 -36.82 7.52 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 171.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -67.62 135.68 53.24 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.448 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.7 t -156.26 89.67 1.14 Allowed 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.67 34.42 83.44 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.062 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.5 t -118.82 102.41 13.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.166 0.508 . . . . 0.0 110.783 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.8 t -140.28 80.24 1.75 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.452 0.644 . . . . 0.0 109.528 176.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.87 -60.98 0.53 Allowed Glycine 0 N--CA 1.426 -2.021 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 176.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -122.94 132.82 54.33 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 44.3 m-80 -63.89 -45.1 90.87 Favored 'General case' 0 C--O 1.205 -1.285 0 O-C-N 123.746 0.654 . . . . 0.0 109.863 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -63.76 -33.68 76.2 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.6 -46.52 63.25 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.099 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.2 p -76.38 -28.48 56.78 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.524 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 38.9 ttmt -56.02 -56.26 22.96 Favored 'General case' 0 C--O 1.251 1.137 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 173.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -58.74 -40.71 84.59 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.026 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -59.78 -40.88 89.73 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.9 m -64.98 -55.02 21.48 Favored 'General case' 0 C--O 1.252 1.209 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 54.9 mt -56.78 -41.52 75.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.159 -177.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -82.82 -17.02 45.47 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -106.7 -59.95 1.73 Allowed 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 119.507 -0.877 . . . . 0.0 113.124 -177.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -104.83 1.08 28.73 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.988 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 97.2 mttt 65.95 60.57 0.67 Allowed 'General case' 0 CA--C 1.498 -1.042 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.567 172.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.38 176.02 7.09 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.241 176.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -93.66 -39.75 10.63 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 121.237 0.542 . . . . 0.0 109.625 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -146.57 170.68 16.41 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.78 137.81 4.81 Favored Glycine 0 C--N 1.292 -1.884 0 N-CA-C 108.029 -2.028 . . . . 0.0 108.029 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.2 p -172.14 161.54 5.51 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 117.451 0.626 . . . . 0.0 111.352 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 45' ' ' CYS . 81.4 m -73.47 101.42 3.51 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.29 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -97.84 148.8 23.04 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -79.87 92.45 5.5 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-O 122.292 1.044 . . . . 0.0 109.52 174.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.2 m -101.11 158.95 4.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.537 0 N-CA-C 105.437 -2.061 . . . . 0.0 105.437 172.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 48.5 t80 -68.91 132.21 90.62 Favored Pre-proline 0 C--N 1.279 -2.474 0 C-N-CA 119.11 -1.036 . . . . 0.0 108.884 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 88.7 Cg_endo -108.04 18.07 6.72 Favored 'Cis proline' 0 CA--C 1.555 1.541 0 C-N-CA 124.865 -0.89 . . . . 0.0 113.949 -1.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -156.02 163.92 39.09 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.857 -0.527 . . . . 0.0 111.474 -174.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -70.13 113.97 7.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.89 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 66.6 mttm -129.82 147.69 51.62 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 22.9 t -78.2 119.43 21.58 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.517 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.561 HG21 ' HB2' ' A' ' 5' ' ' GLN . 21.2 mm -114.44 138.92 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.446 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 69.0 m -85.67 137.93 32.49 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.452 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 88.8 m-85 -113.15 122.25 46.95 Favored 'General case' 0 C--N 1.291 -1.973 0 O-C-N 122.043 -0.411 . . . . 0.0 110.444 -178.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -103.6 143.59 26.94 Favored Pre-proline 0 C--N 1.293 -1.876 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.537 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -79.84 116.08 3.41 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 122.464 2.109 . . . . 0.0 112.737 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 84.3 m . . . . . 0 C--N 1.293 -1.873 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.695 176.659 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 . . . . . 0 C--O 1.242 0.702 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -88.9 170.67 10.51 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.9 mt -123.35 113.93 19.5 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.586 0.707 . . . . 0.0 110.048 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.9 m -98.33 123.57 42.51 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.425 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -85.94 143.64 28.08 Favored 'General case' 0 N--CA 1.437 -1.125 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.424 -176.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -148.84 123.01 4.75 Favored Pre-proline 0 C--N 1.298 -1.673 0 C-N-CA 123.756 0.822 . . . . 0.0 109.564 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.96 153.65 63.33 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 122.357 2.038 . . . . 0.0 109.389 173.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.8 t -147.73 160.3 42.86 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.52 -3.85 86.86 Favored Glycine 0 C--O 1.239 0.45 0 O-C-N 123.42 0.45 . . . . 0.0 112.572 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.6 p -71.6 -55.76 7.16 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -56.53 143.69 34.43 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.324 169.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.2 t -156.98 137.33 12.91 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.271 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.22 -164.85 31.13 Favored Glycine 0 C--O 1.249 1.075 0 C-N-CA 121.462 -0.399 . . . . 0.0 113.543 175.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.9 t -84.48 147.52 5.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.6 t -93.01 129.93 38.76 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -122.2 -44.88 0.34 Allowed Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -107.92 104.69 14.21 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -54.97 -53.5 54.86 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.484 1.114 . . . . 0.0 111.183 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -64.83 -32.65 74.45 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.819 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.9 -49.33 65.94 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.459 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 28.8 p -77.3 -27.84 53.13 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.495 -177.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -55.92 -56.97 14.31 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 173.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -59.5 -38.78 81.79 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.102 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -60.68 -46.22 91.17 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.897 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.519 ' HA ' ' OE2' ' A' ' 29' ' ' GLU . 75.1 m -62.42 -45.29 93.77 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-O 122.451 1.12 . . . . 0.0 108.943 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 72.6 mt -59.97 -32.44 50.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.678 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -86.23 -15.23 41.46 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.2 mt -109.27 -60.62 1.74 Allowed 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.641 -0.823 . . . . 0.0 111.864 -176.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.519 ' OE2' ' HA ' ' A' ' 25' ' ' CYS . 1.8 pm0 -99.38 -1.35 38.97 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.04 0.448 . . . . 0.0 111.347 178.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 68.2 mttm 63.64 45.73 4.47 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.584 176.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.462 ' O ' HG12 ' A' ' 26' ' ' ILE . . . -71.81 179.99 2.91 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.986 177.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -104.99 -31.3 9.29 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.557 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.609 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 84.4 t60 -147.39 171.56 15.29 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -176.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.9 136.04 3.67 Favored Glycine 0 CA--C 1.488 -1.634 0 N-CA-C 107.471 -2.252 . . . . 0.0 107.471 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.8 m -158.63 163.64 36.74 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 118.531 1.165 . . . . 0.0 113.709 -177.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 43' ' ' HIS . 34.0 m -70.11 100.64 1.68 Allowed 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 113.9 -1.5 . . . . 0.0 109.35 176.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -97.33 142.5 29.13 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -84.25 104.49 14.33 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.852 0.835 . . . . 0.0 111.969 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.7 m -105.97 160.11 5.83 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 171.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 86.1 t80 -73.57 128.3 87.33 Favored Pre-proline 0 C--N 1.279 -2.477 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.103 -179.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 95.3 Cg_endo -112.59 24.31 2.37 Favored 'Cis proline' 0 CA--C 1.561 1.859 0 C-N-CA 125.058 -0.809 . . . . 0.0 112.949 -3.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.55 160.7 40.69 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.048 0.451 . . . . 0.0 111.154 -175.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 36' ' ' CYS . 73.6 m80 -76.5 122.54 24.71 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.374 0.607 . . . . 0.0 111.853 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -120.35 153.47 36.43 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.0 t -90.95 126.49 36.08 Favored 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.22 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.5 mm -116.57 139.61 42.6 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.2 m -88.46 140.62 29.28 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.609 ' HB2' ' HB3' ' A' ' 33' ' ' HIS . 30.9 m-85 -114.49 129.25 56.64 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.275 0.56 . . . . 0.0 109.986 -177.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -109.19 152.36 42.51 Favored Pre-proline 0 C--N 1.288 -2.069 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -78.02 142.57 19.72 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 121.642 1.561 . . . . 0.0 111.529 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 76.2 m . . . . . 0 C--N 1.287 -2.126 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.836 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -93.42 154.23 18.05 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.152 0.501 . . . . 0.0 110.588 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 80.8 mt -126.73 138.8 53.44 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.78 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.2 m -89.12 123.54 33.49 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.496 ' HG2' ' CE2' ' A' ' 48' ' ' TYR . 41.7 mt-30 -85.44 130.82 34.5 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.152 -176.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -135.79 107.39 9.83 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -68.24 -74.49 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.703 2.269 . . . . 0.0 115.325 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 p -84.91 134.82 34.25 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -169.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.23 -85.38 0.09 OUTLIER Glycine 0 N--CA 1.42 -2.419 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 t -86.14 -39.71 16.41 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.482 ' CZ2' ' HB3' ' A' ' 44' ' ' LYS . 21.5 t90 -62.57 128.73 37.36 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.349 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.2 m -155.49 102.17 2.23 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 124.988 1.315 . . . . 0.0 107.675 176.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.23 -146.77 18.37 Favored Glycine 0 N--CA 1.42 -2.373 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.43 170.69 13.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.2 t -69.84 110.81 5.17 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.382 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -95.52 -55.03 1.37 Allowed Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -140.72 129.59 23.15 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -58.26 -46.64 85.63 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.483 0.489 . . . . 0.0 110.972 -176.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -65.75 -31.27 72.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.604 -177.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -48.45 65.44 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.709 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.1 p -74.46 -25.55 59.48 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.873 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -56.13 -57.92 10.13 Favored 'General case' 0 C--O 1.249 1.059 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 171.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -61.2 -36.29 79.47 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.8 -1.546 . . . . 0.0 110.629 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -64.89 -38.78 92.1 Favored 'General case' 0 C--O 1.21 -0.982 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 86.6 m -66.81 -54.49 22.0 Favored 'General case' 0 C--O 1.253 1.268 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 65.9 mt -56.47 -37.06 49.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.742 -177.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -86.53 -21.91 26.66 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -104.0 -55.56 2.35 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 118.9 -1.12 . . . . 0.0 113.156 -175.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -107.81 1.19 22.67 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.566 -0.853 . . . . 0.0 111.821 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm 62.64 60.99 1.25 Allowed 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.548 -1.206 . . . . 0.0 112.709 174.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.08 171.84 9.25 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.807 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -81.78 -33.38 30.92 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -157.85 171.58 20.03 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.9 137.88 5.75 Favored Glycine 0 C--N 1.295 -1.744 0 N-CA-C 106.813 -2.515 . . . . 0.0 106.813 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.1 t -160.14 162.52 33.98 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 118.113 0.957 . . . . 0.0 110.717 -176.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 21.0 m -78.59 104.55 9.27 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.439 ' HB3' ' CG1' ' A' ' 46' ' ' ILE . 6.8 t30 -99.04 -39.33 8.58 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.372 -173.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.473 ' HB3' ' H ' ' A' ' 44' ' ' LYS . 14.9 t80 -80.78 168.41 18.83 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -177.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.533 ' HA ' ' CD2' ' A' ' 43' ' ' HIS . 18.6 m -126.55 -159.25 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 124.539 1.136 . . . . 0.0 108.921 -173.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.604 ' CD1' ' HA ' ' A' ' 41' ' ' PRO . 75.8 t80 -49.72 140.81 14.39 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 123.105 0.562 . . . . 0.0 110.31 178.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.604 ' HA ' ' CD1' ' A' ' 40' ' ' PHE . 87.1 Cg_endo -82.99 -5.26 51.07 Favored 'Cis proline' 0 C--O 1.242 0.678 0 C-N-CA 123.876 -1.302 . . . . 0.0 115.269 4.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.82 106.24 3.64 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.702 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.533 ' CD2' ' HA ' ' A' ' 39' ' ' VAL . 62.5 m80 -61.0 120.87 11.08 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 173.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.482 ' HB3' ' CZ2' ' A' ' 11' ' ' TRP . 48.2 mtmt -111.18 141.02 45.23 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.1 m -86.28 132.18 34.05 Favored 'General case' 0 CA--C 1.494 -1.196 0 O-C-N 123.608 0.567 . . . . 0.0 109.638 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.487 HG21 ' HB3' ' A' ' 5' ' ' GLN . 36.2 mm -120.91 139.89 46.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 82.9 m -87.03 138.15 31.74 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.496 ' CE2' ' HG2' ' A' ' 5' ' ' GLN . 93.3 m-85 -113.33 116.31 29.5 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -177.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -99.89 148.21 34.49 Favored Pre-proline 0 C--N 1.295 -1.801 0 C-N-CA 122.769 0.427 . . . . 0.0 110.379 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.16 125.04 9.96 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.045 1.83 . . . . 0.0 112.97 -175.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 77.6 m . . . . . 0 C--O 1.252 1.192 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 176.5 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 . . . . . 0 CA--C 1.496 -1.131 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -102.3 121.38 42.17 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.259 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.474 ' HB3' ' HB3' ' A' ' 48' ' ' TYR . 86.2 mt -76.42 104.89 7.17 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.677 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 74.7 m -87.19 126.71 34.97 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.406 ' HB2' ' CG2' ' A' ' 46' ' ' ILE . 4.0 pt20 -80.89 145.74 31.17 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.201 0.524 . . . . 0.0 111.779 -173.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -125.42 109.14 26.47 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.4 -56.16 0.95 Allowed 'Trans proline' 0 C--O 1.203 -1.248 0 C-N-CA 122.542 2.161 . . . . 0.0 113.62 -176.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.3 m -137.66 101.43 4.47 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.687 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -109.63 -61.01 0.51 Allowed Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 171.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.416 HG22 ' OE1' ' A' ' 29' ' ' GLU . 4.8 t -118.1 -36.95 3.47 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.441 -0.38 . . . . 0.0 111.689 172.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.61 ' CD1' ' HB2' ' A' ' 45' ' ' CYS . 17.8 t90 -46.5 130.97 11.19 Favored 'General case' 0 C--N 1.358 0.941 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.5 m -150.44 121.2 7.54 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.2 -159.23 22.67 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.46 161.12 4.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.478 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 30.3 t -85.5 90.37 7.95 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -101.25 -35.81 4.06 Favored Glycine 0 C--N 1.313 -0.72 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.607 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -137.67 110.91 7.87 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -56.19 -43.16 78.19 Favored 'General case' 0 CA--C 1.49 -1.333 0 O-C-N 123.624 0.578 . . . . 0.0 109.872 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.409 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . 11.1 m120 -59.41 -35.47 74.03 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.315 -177.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.59 -53.16 9.92 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.971 -177.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 4.8 p -70.55 -32.23 69.59 Favored 'General case' 0 C--O 1.214 -0.792 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 19' ' ' ASN . 27.3 ttpp -54.62 -52.22 62.92 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 173.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -58.49 -46.58 86.37 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.632 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -54.32 -44.21 71.85 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.784 0.677 . . . . 0.0 111.225 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 68.8 m -61.45 -56.96 14.4 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 59.6 mt -55.23 -35.78 37.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 124.894 1.277 . . . . 0.0 111.322 -177.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -75.99 -34.15 59.74 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -110.47 -49.3 3.07 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 118.483 -1.287 . . . . 0.0 113.639 -171.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.416 ' OE1' HG22 ' A' ' 10' ' ' THR . 11.7 pt-20 -97.03 -9.64 27.74 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.629 0.728 . . . . 0.0 109.414 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 97.2 mttt 61.51 61.55 1.47 Allowed 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 113.921 -1.491 . . . . 0.0 112.619 177.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.25 -179.51 5.44 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.009 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.402 ' HG2' ' HD3' ' A' ' 50' ' ' PRO . 23.1 mmt180 -100.96 -34.93 9.57 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.173 0.511 . . . . 0.0 110.084 177.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -143.2 168.91 18.64 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.76 132.63 2.89 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.7 p -155.07 -179.88 8.49 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 117.737 0.769 . . . . 0.0 112.234 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 84.6 m -81.91 126.5 31.98 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.009 0.433 . . . . 0.0 110.948 -176.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -119.8 132.34 55.57 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -87.51 112.08 21.86 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 121.617 0.722 . . . . 0.0 110.232 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 m -122.93 142.1 40.79 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 171.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 41' ' ' PRO . 78.0 t80 -55.99 131.09 73.77 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 123.317 0.386 . . . . 0.0 110.449 -175.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 40' ' ' PHE . 23.9 Cg_endo -110.73 20.8 3.67 Favored 'Cis proline' 0 CA--C 1.554 1.496 0 C-N-CA 124.692 -0.962 . . . . 0.0 114.272 -0.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -153.76 154.33 33.85 Favored 'General case' 0 C--O 1.243 0.73 0 O-C-N 121.709 -0.62 . . . . 0.0 112.32 -173.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -73.59 121.38 20.57 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.449 -177.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -117.21 157.75 25.47 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.553 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.61 ' HB2' ' CD1' ' A' ' 11' ' ' TRP . 96.4 m -88.49 113.03 23.66 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.406 ' CG2' ' HB2' ' A' ' 5' ' ' GLN . 28.6 mm -105.28 135.65 42.48 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.718 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 177.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.6 m -87.46 159.96 18.47 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 123.692 0.62 . . . . 0.0 109.701 -177.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.474 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . 96.3 m-85 -132.15 128.1 37.34 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -176.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -111.17 150.73 42.41 Favored Pre-proline 0 C--N 1.308 -1.218 0 C-N-CA 123.637 0.775 . . . . 0.0 110.158 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.402 ' HD3' ' HG2' ' A' ' 32' ' ' ARG . 91.0 Cg_endo -84.18 113.91 1.83 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.73 2.287 . . . . 0.0 113.466 -177.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 82.9 m . . . . . 0 C--N 1.295 -1.798 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.224 175.821 . . . . . . . . 0 0 . 1 stop_ save_